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1. Introduction and Goals 
 
The incorporation of conformationally constrained α- and β-amino acids into biologically 
active peptides has gained great interest in the preparation of peptide-based drug molecules. γ-
Chloro-α-amino acid derivatives or the chlorinated β-amino acid analogues, have received far 
less attention. Nevertheless these halogenated amino acid derivatives are biologically relevant 
compounds, which can also serve as very promising building blocks in synthetic organic 
chemistry.  
Nature uses α-amino acid derivatives with a leaving group at the γ-position as versatile 
building blocks in the biosynthesis of a broad range of biologically important natural 
products. For example, (S)-adenosylmethionine (SAM) is a biological sulfonium compound 
that is involved in many biological processes. SAM is the second most common cosubstrate 
for enzymes in the human body, after ATP, and it is known as the major biological methyl 
donor in reactions catalyzed by methyltransferases.
1
 Enzymological studies have 
demonstrated that SAM is not only used as a methyl donor in biological reactions, but that 
SAM is also a precursor for a variety of natural products such as 1-aminocyclopropane-1-
carboxylic acid (α-ACC), precursor of the plant hormone ethylene, N-acyl homoserine 
lactones (AHLs), signal molecules involved in bacterial quorum sensing, and L-azetidine-2-
carboxylic acid (L-Aze), a non-proteinogenic amino acid homologue of proline.
1c,2
 Besides 
the biosynthesis of these carbocylic and heterocyclic compounds starting from SAM, γ-
chloro-α-amino acids also constitute excellent precursors for the preparation of these 
molecules.
3
 Moreover, γ-chloro-α-amino acids are involved in the biosynthesis of a wide 
range of natural products such as cytotrienins 1 (apoptosis-inducing Streptomycete 
metabolite),
3a
 coronatine (phytotoxin) 2,
3b-c
 and bactobolins (antibiotic activity) 3 (Figure 1).
4
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Figure 1 
Some γ-chloro-α-amino acids are also biologically active as a free amino acid, such as 
armentomycin 4, a non-proteinogenic amino acid with antibiotic properties,
3a,5
 and  
4-chloro-L-threonine 5, which is biologically active as a serine hydroxymethyltransferase 
inhibitor,
3d
 and as a herbicidal antimetabolite (Figure 2).
6
 4-Chloro-L-threonine is also a 
constituent of naturally occurring syringomycins (antifungal compounds),
7
 and actinomycins 
(cytotoxic and antibacterial compounds).
8
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Figure 2 
Next to γ-chloro-α-amino acid derivatives, β-amino acids9 and α,β-diamino acid derivatives 
have also gained a lot of attention as non-proteinogenic amino acids among organic chemists 
and biochemists.
10,11
 This is due to the fact that these diamino carboxylic acids are present as 
key structural fragments in biologically active compounds such as β-(N-oxalyl)-L-α,β-
diaminopropionic acid (neurotoxin),
12
 β-methylamino-L-alanine (neurotoxin),13 L-quisqualic 
acid (vermicide),
14
 L-mimosine (cell proliferation blocker),
15
 and L-willardine (agonist of 
AMPA and kainate receptor).
16
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These α,β-diamino acids can also serve as building blocks for the synthesis of new 
heterocyclic compounds and peptides.
10,17
 For example, γ-chloro-α,β-diamino acid derivatives 
are precursors for the synthesis of 3-aminoazetidine-2-carboxylates, belonging to the class of 
3-aminoazetidines which have received considerable attention,
18
 especially because of their 
antibacterial activities.
19
 The constrained L-azetidine-2-carboxylic acid skeleton of these 3-
aminoazetidine-2-carboxylates has found many applications in the modification of peptide 
conformations,
2,20
 and is present in several natural products such as mugineic acid 6,
21
 2’-
deoxymugineic acid 7,
22
 nicotianamine 8,
23
 and medicanine 9 (Figure 3).
24
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N N
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N
HOOC
OH
 
Figure 3 
Moreover, some diamino acids are also bioactive as free diamino carboxylic acid 
derivatives.
7,10,11,25,26
 For example, α,γ-diaminoacylamides are known for their high potency 
and selectivity as dipeptidyl peptidase (DPP) inhibitors.
27
 
DPPIVs are proteases which specifically cleave off N-terminal dipeptides and are involved in 
the degradation of incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-
dependent insulinotropic polypeptide (GIP). GLP-1 is involved in the regulation of glucose 
homeostasis via stimulation of insulin secretion, inhibition of glucagon release and delay of 
gastric emptying. It has been demonstrated that the presence of intravenous GLP-1 increases 
insulin secretion as response to elevated glucose levels and as such, GLP-1 can offer 
therapeutic benefits for patients with type 2 diabetes. Unfortunately, therapeutic application of 
GLP-1 is problematic by the lack of oral activity and the rapid degradation by plasma DPPIV. 
Therefore, DPPIV inhibitors could offer a solution to this problem, as they can extend the 
duration of action of GLP-1 and prolong the beneficial effects.
28
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Besides DPPIV, a few related enzymes are present in the family of DPPs: DPPII, DPP8, 
DPP9 and FAP being the most important regarding the therapeutic potential, when focusing 
on the inhibitory potency and selectivity.
28
 In the research towards DPPII and DPPIV 
inhibitors, it has been found that the α,γ-diaminoacylpiperidine, (S)-2,4-diamino-1-
(piperidine-1-yl)butan-1-one 10, is a lead compound in the development of large series of 
highly potent and selective DPPII inhibitors (Figure 4).
27
 Next to the α,γ-
diaminoacylpyrrolidines and -piperidines which exhibit a DPP inhibitory effect, also some β-
amino carboxylic amides, such as sitagliptin are known as DPP inhibitors.
29
 Sitagliptin 11 is a 
commercialized oral antihyperglycemic drug of the DPPIV inhibitor class (Figure 4).
30
 
 
 
 
 
 
Figure 4 
As α,γ-diamino carboxylic amides, as well as β-amino carboxylic amides, are known for their 
activity as DPP inhibitors, an increasing interest to study the DPP inhibitory potency of 
analogous α,β-diamino carboxylic amides and α,β,γ-triamino carboxylic amides exists.31 
 
Next to the diamino carboxylic acid derivatives, α-hydroxy-β-amino carboxylic acids gained 
also a lot of interest among organic chemists.
32
 This can be explained by the fact that the α-
hydroxy-β-amino carboxylic acid unit is present in a wide range of biologically active 
molecules, such as (-)-bestatin 12, which is an aminopeptidase inhibitor, paclitaxel 13a and 
docetaxel 13b, which are both known for their anti-mitotic activity (Figure 5).
33
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Figure 5 
In light of the ubiquitous applications of α,β-diamino acid- and α-hydroxy-β-amino acid-
containing compounds as building blocks in organic chemistry and as biologically active 
molecules, efforts will be done to synthesize new representatives of these interesting classes 
of non-proteinogenic amino acids and their further transformations in this doctoral study. The 
entries developed in this study towards novel densely functionalized chiral α- or β-amino acid 
derivatives will fill up important gaps within the chemistry of these non-proteinogenic amino 
acid derivatives. 
 
In the literature, enantiopure p-toluenesulfinamide (Prof. Davis) as well as enantiopure tert-
butanesulfinamide (Prof. Ellman, Prof Garcia Ruano) have already been utilized quite 
extensively in the asymmetric synthesis of a large number of biologically interesting 
molecules. Both types of sulfinamides are commercially available and can easily been used in 
condensation reactions with aldehydes, ketones or orthoesters in the presence of a Lewis acid 
(e.g. Ti(OEt)4). The corresponding imines or imidates exhibited a high diastereofacial 
selectivity in nucleophilic addition reactions and are stable under mild conditions. In this way, 
the p-toluene- and tert-butanesulfinyl group serve both as powerful chiral directing groups 
and comprise one of the most efficient auxiliaries developed to date. Next to the difference in 
price, by which enantiopure tert-butanesulfinamides are significantly cheaper than 
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enantiopure p-toluenesulfinamide, both compounds differ also with respect to the electron 
withdrawing character of the sulfinyl group, which is more pronounced for the p-
toluenesulfinamides. Furthermore, the tert-butanesulfinyl group can be selectively 
deprotected with (dry) HCl, whereas the deprotection of the p-toluenesulfinyl group can easily 
be performed with aqueous TFA. 
 
In this PhD thesis, the synthesis and reactivity of N-sulfinyl-α-chloroaldimines in 
stereoselective Mannich-type additions, will be investigated. In the past, chiral N-
sulfinylimines 14 have already proven to be valuable synthons for the preparation of a wide 
range of enantiopure aliphatic and cyclic amines (Scheme 1), such as aziridines 16
34,35
 and 17 
(n = 1),
36,37
 azetidines 17 (n = 2),
37
 pyrrolidines 17 (n = 3),
36,37
 piperidines 17 (n = 4),
36,37
 
azepanes 17 (n = 5),
37
 α-branched and α,α-dibranched amines 18 and 19,34,35,38,39 β-amino 
esters 20,
34,35,38
 α-amino esters 21,34,35,38 1,2-amino alcohols 2234,35,38,39 and 1,3-amino 
alcohols 23.
35,38,40
 In addition, nucleophilic additions of α-chloroimines41,42 with different 
carbon and heteroatom nucleophiles have extensively been used in the past for the synthesis 
of azaheterocyclic compounds.
43,44,45,46,47,48
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Scheme 1 
In comparison with the huge number of reports on the synthesis of chiral N-(p-
toluenesulfinyl)-imines, the synthesis of N-(p-toluenesulfinyl)-α-chloroaldimines 26a or 
aliphatic N-(p-toluenesulfinyl)-α-aminoaldimines 26b has not been reported so far. Therefore, 
the synthesis of chiral N-(p-toluenesulfinyl)-α-functionalized aldimines 26, starting from a 
condensation reaction of the corresponding α-functionalized aldehydes 24 with chiral p-
toluenesulfinamide 25 in the presence of a Lewis acid, will be investigated in the first part of 
this PhD thesis (Scheme 2).  
Moreover, N-(tert-butanesulfinyl)aldimines have also proven to be valuable synthons in 
organic synthesis in contrast to the N-(tert-butanesulfinyl)-α-functionalized aldimines 28, 
which have received far less interest in the literature despite the synthetic potential of these 
compounds. The synthesis of these α-functionalized imines 28 will also be explored via 
condensation reaction of the corresponding α-functionalized aldehydes 24 with chiral tert-
butanesulfinamide 27 in the presence of a Lewis acid (Scheme 2). 
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Scheme 2 
In the next part, the asymmetric synthesis of protected γ-chloro-α,β-diamino esters 30 will be 
studied via stereoselective Mannich-type additions of N-protected glycine esters 29 across N-
sulfinyl-α-chloroaldimines 26a and 28a (Scheme 3). Hereby, the influence of the reaction 
conditions on the stereochemical outcome of the reaction will be optimized with the aim to 
develop an efficient and stereoselective approach towards these compounds 30. Bearing in 
mind that (chiral) β-haloamines are excellent precursors for the synthesis of aziridines, a base-
induced cyclization reaction towards the protected β,γ-aziridino-α-amino esters 31 will be 
attempted on the γ-chloro-α,β-diamino esters 30. Furthermore, several intramolecular ring 
transformations of β,γ-aziridino-α-amino esters 31 will be attempted in order to synthesize 
novel biologically interesting 3-aminoazetidine-2-carboxylates 32 and α,β-diamino-γ-
butyrolactones 33. 
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Scheme 3 
The asymmetric synthesis of chiral γ-chloro-α,β-diaminoacylpyrrolidines and -piperidines 35 
will also be investigated via stereoselective Mannich-type additions of N-protected 
glycinamides 34a,b across N-sulfinyl-α-chloroaldimines 26a and 28a (Scheme 4). In order to 
develop potential DPP inhibitors, the ring closure and selective deprotection of the α-amino 
functionality of these chiral γ-chloro-α,β-diaminoacylpyrrolidines and -piperidines 35 will be 
explored as well. Hereby, two possible approaches towards the α-deprotected β,γ-aziridino-α-
aminoacylpyrrolidines and β,γ-aziridino-α-aminoacylpiperidines 37 will be elaborated. In a 
first approach (A), ring closure of γ-chloro-α,β-diaminoacylpyrrolidines and -piperidines 
35a,b towards the corresponding β,γ-aziridino-α-aminoacylpyrrolidines and -piperidines 36 
will be followed by a selective deprotection of the α-amino functionality, while in a second 
approach (B) N
α
-deprotected γ-chloro-α,β-diaminoacylpyrrolidines and -piperidines 38 will be 
cyclized to the corresponding aziridines 37. 
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Scheme 4 
In the following part, the synthesis of chiral α,β,γ-triaminoacylpyrrolidines and -piperidines 
40 will be investigated via two reaction pathways, as these novel α,β,γ-triamino amides are 
also interesting in studies towards their potential activity as DPP and FAP inhibitors. In the 
first strategy (A), γ-chloro-α,β-diamino esters 30 and β,γ-aziridino-α-amino esters 31 will be 
reacted with different nitrogen nucleophiles via substitution or ring-opening reactions, 
respectively, in order to synthesize new α,β,γ-triamino esters 39 which could be converted in 
the corresponding α,β,γ-triaminoacylpyrrolidines and -piperidines 40 (Scheme 5). A second 
possible approach (B), would involve the synthesis of α,β,γ-triamino amides 40 via Mannich-
type addition of N-protected glycine amides 34 across N-sulfinyl-α-aminoaldimines 26b and 
28b (Scheme 5). 
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Scheme 5 
Furthermore, the asymmetric synthesis of α-halo-β,γ-diamino ester derivatives 43 will be 
studied, via stereoselective Mannich-type addition of α-haloacetates 41 or α-haloimidates 42 
across chiral N-sulfinyl-α-aminoaldimines 26b and 28b (Scheme 6). These α-halo-β,γ-
diamino ester derivatives 43 are potential precursors of 3-aminoazetidine-2-carboxylates 32, 
belonging to a very interesting class of molecules, with potential application as building 
blocks for the synthesis of oligopeptides and as antibiotics.  
 
Scheme 6 
The last part of this PhD thesis will include the asymmetric synthesis of protected γ-chloro-β-
amino-α-hydroxy esters 45, via stereoselective Mannich-type additions of O-protected glycol 
esters 44 across N-sulfinyl-α-chloroaldimines 26a and 28a (Scheme 7). These γ-chloro-β-
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amino-α-hydroxy esters 45 are considered as precursors for the synthesis of the corresponding 
β,γ-aziridino-α-hydroxy esters 46. Furthermore, several selective deprotection conditions will 
be tested on the γ-chloro-β-amino-α-hydroxy esters 45, in order to obtain O-deprotected 
and/or N-deprotected α-hydroxy esters 47-49. Compounds 49 could be used as precursor for 
the synthesis of oxazolidinones 50, which might serve as building blocks in biomedicinal 
chemistry.
49
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2. Literature Overview 
In the following chapter, the synthesis of 2-(carboxymethyl)aziridines will be dealt with. 2-
(Carboxymethyl)aziridines comprise key-intermediates in the synthesis of γ-functionalised-β-
amino acid derivatives and β-functionalised-γ-amino acid derivatives and can be synthesized 
starting from γ-chloro-β-amino acid derivatives. Moreover, some 2-(carboxymethyl)aziridines 
are showing interesting biological activities and can find application in as lead-compounds in 
medicinal chemistry. 
Several synthetic approaches towards 2-(carboxymethyl)aziridines 51 based on the different 
bond connections or transformations are schematically illustrated in Scheme 8. A distinction 
has been made between three types of intramolecular reactions (methods Ia, Ib and II), four 
types of intermolecular reactions (methods IIIa, IIIb, IV and V) and a final method based on 
functional group transformation (method VI). Hereby, all relevant references will be 
presented in the following sections. 
Furthermore, the intramolecular reactions and addition reactions were subdivided with respect 
to the mechanism of these reactions. The intramolecular nucleophilic substitution reactions 
(methods Ia and II) involve an attack of a nucleophilic amino group on an adjacent carbon 
atom bearing a leaving group (LG), to afford 2-(carboxymethyl)aziridines. To allow aziridine 
synthesis in an asymmetric way, the use of starting products 54 derived from the chiral pool 
was also described (method II). Besides, an intramolecular (thermal) rearrangement of 4-
isoxazoline-5-carboxylates 53 (Y = O) has been used as an approach towards the synthesis of 
this type of aziridines (method Ib). 
2-(Carboxymethyl)aziridines are also accessible via addition reactions with carbanions 55 and 
58 (methods IIIa and IIIb). Substitution reactions of stabilized aziridinyl anions 55 with 
acetates bearing a leaving group in α-position present an efficient synthetic pathway towards 
the corresponding 2-(carboxymethyl)aziridines (method IIIa). 
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Scheme 8 
Furthermore, addition reactions of α-deprotonated acetate derivatives 58 across 2H-azirines 
have been performed as well via Reformatsky, and Ivanov reactions (method IIIb). Moreover, 
addition reactions via addition of electron-deficient carbenes 59 or nitrenes 62 to double 
bonds will be discussed (methods IV and V). This part also includes the additions of sulfur 
ylides to imines (method IV) and the addition of substituted azides across olefins (method V).  
Furthermore, the synthesis of 2-(carboxymethyl)aziridines is effectuated via functional group 
transformations of compounds 63 derived from the chiral pool (method VI). 
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2.1. Synthesis through N1-C2 bond formation 
2.1.1. Synthesis via intramolecular nucleophilic substitution (method Ia) 
γ-Amino carboxylic acid derivatives which bear a leaving group in the β-position are suitable 
building blocks for the synthesis of monocyclic 2-(carboxymethyl)aziridines.
50,51,52
 
For example, γ,δ-aziridino-β-hydroxy esters syn-64 and anti-64 were transformed into 2-
(carboxymethyl)aziridines 66 (Scheme 9).
50
 The enantiopure amino alcohols syn-65 and anti-
65 were obtained in excellent yield by a regioselective ring opening of the chiral γ,δ-
aziridino-β-hydroxy esters syn-64 and anti-64 at the less substituted carbon atom with AcOH 
in CH2Cl2. Intramolecular ring closure of amino alcohols syn-65 and anti-65 with MsCl and 
Et3N provided the corresponding chiral non-activated 2-(carboxymethyl)aziridines 66. It is 
well known that cis-2,3-disubstituted aziridines are thermodynamically more stable than 
trans-2,3-disubstituted aziridines.
53
 The syn-γ,δ-aziridino-β-hydroxy ester syn-64 was readily 
transformed into the corresponding chiral cis-2,3-disubstituted aziridine cis-66, but the anti-
derivative anti-64 provided the diastereomeric mixture of chiral trans- and cis-2,3-
disubstituted aziridines 66. The mesylation of the amino alcohols anti-65 seemed to be 
followed by elimination in the presence of Et3N to provide the corresponding α,β-unsaturated 
ester to which the amino group adds conjugatively to result in a mixture of trans- and cis-2,3-
disubstituted aziridines 66.  
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γ-Azido-β-hydroxy carboxylic acid derivatives 67 were also used as precursor for the 
stereoselective synthesis of 2-(carboxymethyl)aziridines 68 via a Staudinger reduction 
(Scheme 10).
51
 The vicinal azido alcohols (±)-anti-67a, (±)-syn-67a and (±)-anti-67b were 
treated with PPh3 in anhydrous CH3CN under reflux to afford their corresponding N-H-
aziridines (±)-trans-68a, (±)-cis-68a and (±)-cis-68b, respectively, as the sole products. 
Purification of N-H-aziridine (±)-trans-68b was problematic due to the low molecular weight 
of this compound. In order to isolate this aziridine, an in situ N-tosylation was performed with 
TsCl in pyridine, which resulted in the formation of N-tosyl-2-(carboxymethyl)aziridine (±)-
trans-69b in a good overall yield. Tosylation of the diastereomerically pure aziridines (±)-
trans-68a and (±)-cis-68a afforded N-tosyl-2-(carboxymethyl)aziridines (±)-trans-69a and 
(±)-cis-69a in moderate to good yields. Additionally, aziridine (±)-trans-68a was reacted with 
ethyl chloroformate in basic medium to provide carbamate (±)-trans-70a (X = COOEt). 
 
Scheme 10 
In accordance with these results, Staudinger reduction has also been employed in the 
synthesis of 3-hydroxy-β-lactams 73 and 75, containing an aziridine moiety, starting from 3-
bromo-3-alkenyl-azetidin-2-ones 71 (Scheme 11).
52
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and 75 were efficiently synthesized via a three-step synthesis starting from the same 3-
alkenyl-β-lactam precursor 71. In the next step, both diastereomeric azides 72 and 74 were 
reduced with triethylphosphine in dry THF at 40 °C for two hours, to afford the corresponding 
β-lactams 73 and 75 in 50-80% yield via an aza-Payne-like ring opening54 of the epoxides 72 
and 74.  
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Scheme 11 
 
2.1.2. Synthesis via rearrangement of 4-isoxazoline-5-carboxylate 
derivatives (method Ib) 
2.1.2.1. Synthesis of N-alkyl- and N-arylaziridines 
The reaction of nitrones 76 with alkyl acetylenecarboxylates 77 via 1,3-dipolar cycloaddition 
resulted in the selective and efficient synthesis of 4-isoxazoline-5-carboxylates 78, which 
proved to be excellent precursors for the synthesis of the corresponding N-alkyl- and N-aryl-
2-oxalylaziridines 79 via a thermally induced sigmatropic rearrangement (Scheme 12). Some 
examples of this methodology will be described in the following part. 
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Scheme 12 
A 1,3-dipolar cycloaddition of tert-butylmethylenenitrone 80 with dimethyl 
acetylenedicarboxylate 81 proceeded rapidly at 0 °C and resulted quantitatively in the 
formation of dimethyl 2-tert-butyl-4-isoxazoline-4,5-dicarboxylate 82 (Scheme 13).
55,56
 It was 
shown that the latter compound 82 easily underwent thermal rearrangement upon heating at 
80 °C in the dark under N2-atmosphere to afford 4-oxazoline 84. The isomerization occurred 
most probably via formation of aziridine intermediate 83. 
 
 
 
 
 
 
Scheme 13 
Furthermore, it was shown that suitable choice of substituents could result in the formation of 
the corresponding 4-isoxazoline-4,5-dicarboxylate with a weakened N-O bond.
55
 In this way, 
the isolation of aziridine 83 as potential precursor in this thermal rearrangement, would 
become possible. 
Thus, the reaction of N-(2,4,6-trimethylphenyl)methylenenitrone 85 with dimethyl acetylene-
dicarboxylate 86 resulted in the synthesis of the even more thermally labile 87, which 
immediately rearranged to the corresponding aziridine 88 at room temperature (Scheme 14). 
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Treatment of this aziridine 88 in toluene under reflux gave again the thermally more stable 4-
oxazoline 89. 
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Scheme 14 
In another report, the reactivity of polyfunctionalized 4-isoxazoline-5-carboxylates 90 has 
been evaluated by thermal treatment (Scheme 15).57 Interestingly, by heating of these 
compounds 90 in toluene at 110 °C, the 2-acylaziridinyl-containing β-lactams 91 were 
obtained as single isomers. This result was again rationalized by a thermally induced 
sigmatropic rearrangement, where the stereochemical outcome of the reaction was controlled 
by steric interactions. 
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2.1.2.2. Synthesis of N-alkoxyaziridines 
The reaction of nitronium esters 92 with alkyl acetylenecarboxylates 93 resulted in the 
regioselective formation of N-alkoxyaziridines 95 (Scheme 16). This reaction proceeded via a 
1,3-dipolar cycloaddition through intermediacy of 4-isoxazoline-5-carboxylates 94. These 4-
isoxazolines 94 isomerized easily and selectively to deliver the corresponding aziridines 95 
via a sigmatropic rearrangement. Two examples of this synthetic approach are presented 
below. 
 
 
 
 
Scheme 16 
In contrast to the 1,3-dipolar cycloaddition of nitrones 76, 1,3-dipolar cycloaddition of 
nitronium esters 92 across acetylenecarboxylates 93 afforded N-alkoxyaziridines 95 as end 
products, while intermediate 4-isoxazoline-5-carboxylates 94 were never isolated. The 
synthesis of the disubstituted N-methoxyaziridines 99 was accomplished in high yield (74-
79%) by stirring nitronium esters 96 with methyl acetylenecarboxylate 97 neat at 0 °C to 
room temperature for one to five days (Scheme 17).
58,59
 The cycloaddition reaction of 
nitronium ester 96b across tetrolic acid methyl ester 97b proceeded more slowly and afforded 
the trisubstituted N-methoxyaziridine 99 only in 15% yield after 20 days.
58,59
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Similarly to the cycloaddition of monosubstituted nitronium esters 96 across methyl 
acetylenecarboxylate 97, also disubstituted nitronium ester 100 was used for the synthesis of 
N-methoxyaziridine 102 (Scheme 18). 
59
 
 
 
Scheme 18 
2.2. Synthesis through N1-C3 bond formation (method II) 
2.2.1. Enantioselective synthesis starting from the chiral pool 
The strategy of using the chiral pool for enantioselective synthesis has gained a lot of 
attention among (bio-)organic and medicinal chemists the past decades. Chiral pool synthesis 
is especially helpful if the desired compounds have a great resemblance to cheap and readily 
available enantiopure natural products. To date, the enantiopure synthesis of 2-
(carboxymethyl)aziridines starting from the chiral pool has used a few natural products. Two 
examples will be discussed in the following part, L- and D-aspartic acid L-103 and D-103 
(Figure 6). 
HOOC (S)
COOH
NH2
HOOC (R)
COOH
NH2
L-103 D-103  
Figure 6 
  
2.2.1.1. Synthesis through modifications of L-aspartic acid 
N-Protected L-aspartic acid derivatives 104 have been used for the enantioselective synthesis 
of N-Cbz-, N-Ts- and N-Boc-protected 2-(carboxymethyl)aziridines 108.
60,61,62,63,64
 The first 
step in the synthesis of N-Cbz-2-(carboxymethyl)aziridine 108a was an activation of N-Cbz-
protected L-aspartic acid derivative 104 with isobutyl chloroformate (Scheme 19).
60,61,63,65
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This reaction was performed by dissolving compound 104 in 1,2-dimethoxyethane at -15 °C, 
followed by the addition of N-methylmorpholine and isobutyl chloroformate. The activated 
aspartic acid derivative was subsequently reduced with aqueous sodium borohydride to lead 
to the corresponding alcohol 105 in very good yield. In a next step, amino alcohol 105 was 
treated either under Mitsunobu conditions (PPh3, DEAD, THF) or with methanesulfonyl 
chloride in the presence of diisopropylethylamine (Scheme 19).
60,61,63
 However, only the 
Mitsunobu reaction yielded N-Cbz-2-(carboxymethyl)-aziridine 108a. The mesylation of 
amino alcohol 105 followed by heating under reflux in THF with DIPEA gave the chloride 
107 as the sole product.
61
 This chloride resisted further treatment with various bases (K2CO3, 
KHCO3, NaHSO3, AgO, KF, NaH), which gave either no reaction or decomposition. Similar 
β-aminobutanoates have already been used as precursors in the synthesis of another class of β-
amino acids with a three-membered ring as a core structure, more speciﬁcally 2-
aminocyclopropanecarboxylic acids (not shown).
66
  
Remarkably, the procedure for the synthesis of N-Cbz-protected 2-(carboxymethyl)aziridine 
108a starting from N-Cbz-protected L-aspartic acid derivative 104 did not work for the 
synthesis of analogous N-Ts-protected 2-(carboxymethyl)aziridine 108b as the reduction step 
did not work at all, even when other reduction methods were applied.
63
 For that reason, an 
alternative attempt to access amino alcohol 108b was made by a de- and reprotection 
sequence starting from amino alcohol 105 (Scheme 19).
63
 Catalytic hydrogenolysis over Pd/C 
and subsequent N-tosylation gave amino alcohol 106 in 84% overall yield. Treatment of this 
amino alcohol 106 under the previously mentioned Mitsunobu conditions delivered the N-Ts-
protected 2-(carboxymethyl)aziridine 108b in 90% yield. 
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XHN
(S)
OH
CO2tBu
MsCl, DIPEA
THF, , 20 h CbzHN
(S)
Cl
CO2tBu
(S)
CO2tBu
N
PPh3, DEAD, THF
0 °C, 30' then rt, 18 h
x
X
CbzHN
(S)
CO2H
CO2tBu
1) ClCOOiBu,
    N-methylmorpholine,
    DME, -15 °C
2) NaBH4, H2O, -10 °C
 105 X = Cbz (89%)
 106 X = Ts (84%)
1) H2, Pd/C, EtOH, rt
2) TsCl, DMAP, Et3N, 
    CH2Cl2, rt
108a X = Cbz (60-90%)
108b X = Ts (90%)
X = Cbz
H
104
107
Scheme 19 
In contrast with the mesylation procedure of amino alcohol 105 by heating under reflux in 
THF with DIPEA which afforded the chloride 107 as the sole product,
61
 mesyloxy compound 
110 was obtained when amino alcohol 109 was treated with mesyl chloride in the presence of 
triethylamine and a catalytic amount of DMAP in CH2Cl2 at 0 °C (Scheme 20).
62
 In the next 
step, treatment of mesylate 110 with cyanocuprate in THF at -40 °C gave N-Cbz-protected 2-
(carboxymethyl)aziridine 112 in 26% yield, instead of the expected β-amino ester 111.  
(S)
COOt-Bu
NHCbz
HO
MsCl, Et3N
cat. DMAP
(S)
COOt-Bu
NHCbz
MsO
110 (54%)
N
(S)
Cbz
COOt-Bu
(nHex)CuCNLi2
112 (26%)
CH2Cl2, 0 °C THF, -40 °C
x
(R)
COOt-Bu
NHCbz
nHex
109
111
Scheme 20 
Furthermore, N-Boc-2-(carboxymethyl)aziridine 115 was synthesized via a similar reaction 
sequence as N-Cbz-2-(carboxymethyl)aziridine 112. At first, the activation of N-Boc-
protected L-aspartic acid derivative 113 with isobutyl chloroformate occurred in the presence 
of N-methylmorpholine in THF at 0 °C for one hour, followed by a reduction with sodium 
borohydride in THF which afforded N-Boc-amino alcohols 114 in high yields (Scheme 21).
64
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Subsequently, a Mitsunobu reaction with DIAD took place which delivered the corresponding 
N-Boc-2-(carboxymethyl)aziridine 115 in good yields (63-73%). 
N
(S)
Boc
H
CO2R
NHBoc
(S)
HO CO2R
THF, 0 °C, 30' 
then rt, 16 h
NHBoc
(S)HO2C
CO2R
1) ClCOOiBu
    N-methylmorpholine
    THF, 1 h, 0 °C
2) NaBH4
     THF, 4 h, 0 °C to rt
PPh3
DIAD
114 (65-98%) 115 (63-73%)
R = tBu, Bn, Me
113
 
Scheme 21 
In addition, besides the synthesis of enantiopure unsubstituted 2-(carboxymethyl)aziridines 
115, also the synthesis of branched 2-(carboxymethyl)aziridines was performed starting from 
N-protected L-aspartic acid derivatives.
67,68
 A first attempt for the synthesis of the unprotected 
(2R,3S)-2-benzyl-substituted 2-(carboxymethyl)aziridine (2R,3S)-121 was made starting from 
N-protected dibenzyl L-aspartate 116 (Scheme 22).
67
  
BnO
(S) OBn
O
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(S)
(R)
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O
NH O
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1) iBuOCOCl, Et3N, DME
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(S)
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(R)
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Ph
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1) TFA, CH2Cl2
2) TEA, CH2Cl2
(S)
(R)
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O
Ph
121 (60%)
HN
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(R)
(R)
OH
O
Ph
NH2
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H
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In order to obtain the unprotected branched (2R,3S)-2-(carboxymethyl)aziridines (2R,3S)-130, 
another synthetic route was developed starting from N-protected dimethyl L-aspartate 123 
(Scheme 23).
67
 As debenzylation of 2-(carboxymethyl)aziridine 121 via catalytic 
hydrogenolysis with Pd/C was not possible without ring opening of the aziridine ring, a final 
saponification of the methyl ester functionality has been performed to overcome this problem.  
 
Scheme 23 
Treatment of N-protected dimethyl L-aspartate 123 with two equivalents of LiHMDS at -78 
°C delivered the enolate dianion which reacted with an alkyl halide to give 124. In the case of 
methylation, two products in a diastereomeric relationship in about equal ratio were formed 
and separation by means of column chromatography proceeded readily. Application of bulkier 
alkylating reagents such as benzyl bromide and tert-butyl bromoacetate provided 
diastereomeric ratios of 4:1 and 7:1, respectively, in favor of the anti alkylation with respect 
to the Boc-protected amino group. Treatment of compounds 124 with a methanolic 
hydrochloride solution provided the N-deprotected products, which were then regioselectively 
hydrolyzed by using CuCO3·Cu(OH)2 in an ethanol/water mixture,
71
 to afford hydrochloride 
salts 125. In the case of compounds 124 (R = CH2CO2tBu), the tert-butyl ester moiety was 
MeO
OMe
O
NH O
Boc
MeO (R)
OMe
O
NH O
Boc
LiHMDS
RX
R
THF, -78 °C
HO (R)
OMe
O
HCl.H2N O
1) HCl, MeOH
2) CuCO3.Cu(OH)2
    EtOH/H2O, 70 °C
R
CbzCl, Na2CO3, H2O
HO (R)
OMe
NH O
Cbz
R1) N-hydroxysuccinimide,
    DCC, DME
2) NaBH4, THF, 0 °C to rtHO (R)
OMe
NH O
Cbz
R
PPh3, DEAD, THF
(S)
(R)
OMe
O
R
N
H2, Pd/C, MeOH
R = Me, Bn, 
       CH2CO2tBu
O
Cbz
(S)
(R)
OMe
O
R
HN
LiOH, MeOH/H2O (R)
OH
O
R
HN
(S)
(S) (S)
(S)(S)(S)
124 (38-73%)
126 (56-74%)127 (64-75%)128 (76-83%)
129 (85-97%) 130 (80-85%)
123
125
H
H H
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converted into the corresponding methyl ester under the latter reaction conditions. 
Subsequently, the amino group of the L-aspartic esters 125 was protected with CbzCl. The 
conversion of the α-carboxylate group into a hydroxymethyl group was accomplished in good 
yield by sodium borohydride reduction of the activated ester that was formed by treating 
compound 126 with N-hydroxysuccinimide in the presence of DCC.
72
 In the next step, the 
aziridine ring formation was effected under Mitsunobu conditions using triphenylphosphine in 
the presence of DEAD in 83% yield for 128 (R = Bn).
73
 The remaining steps to the target 
compound (2R,3S)-130 comprised removal of the Cbz group from the aziridine nitrogen and 
hydrolysis of the methyl ester moiety by catalytic hydrogenolysis in the presence of Pd/C and 
subsequent treatment with methanolic lithium hydroxide solution. The synthesis of the 
enantiomer of compound (2R,3S)-130 with a (2S,3R)-configuration was also performed for R 
= Bn in an overall yield of 13%, starting from D-aspartic acid 103 by an analogous synthetic 
pathway used for the preparation of (2R,3S)-130.
67
 
An alternative route had to be sought for the synthesis of the (2S,3S)- and (2R,3R)-
enantiomers (2S,3S)-130 and (2R,3R)-130 because the precursor to the key intermediate, 
namely, the γ-hydroxy ester that corresponds to 127 in the synthesis of (2S,3R)-130, had a 
strong tendency to cyclize to the corresponding γ-lactone.67,68 Thus, instead of a methyl ester, 
the corresponding Weinreb amide that resisted lactonization but still could be readily 
converted into the carboxylate via an aldehyde moiety was used (Scheme 24).
67,74
  
Lactone 131, that was prepared from L-aspartic acid,
75
 was subjected to α-benzylation in THF 
and HMPA using two equivalents of LDA to give a diastereomeric mixture, from which 
(2S,3S)-132 was isolated in 73% yield. Alkylation of γ-lactones such as 132 via a dianion 
intermediate is known to afford a mixture of diastereoisomers, in which the trans-alkylated 
product predominates, especially when the alkylating reagent bears a bulky group.
76
 The 
lactone 132 was then readily converted into 133 by treatment with N,O-
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dimethylhydroxylamine in the presence of trimethylaluminum.
77
 The aziridine ring formation 
was then effected by the intramolecular Mitsunobu-type reaction to yield 134.
73
 While the 
attempts towards a selective reduction of the Weinreb amide moiety in 135 to the aldehyde 
were unsuccessful, conversion of the Cbz protecting group into a bulkier trityl group allowed 
the selective reduction of the Weinreb amide by lithium aluminum hydride to deliver 
aldehyde 136.
74
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 24
 
Since this aldehyde 136 showed to be unstable upon exposure to air, it was not isolated and 
further reduction of the crude reaction mixture with lithium aluminum hydride gave the stable 
alcohol 137. Moreover, there was a potential risk of the aldehyde 136 undergoing 
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racemization during the workup and purification. Nonetheless, direct conversion of the 
Weinreb amide into a hydroxymethyl group with lithium aluminum hydride failed, as the 
reduced amide carbonyl formed an intramolecular complex with the lithium ion, which 
resisted further reduction.
78
 At this stage, the trityl moiety on the aziridine nitrogen atom was 
replaced with a 9-fluorenylmethyl carbamate (Fmoc) moiety, which showed excellent acid 
stability, demonstrated under the oxidation conditions for converting the primary alcohol 
group to a carboxylic acid.
79
 Ruthenium(VIII) oxide catalyzed periodate oxidation
80
 of 
compound 138 followed by deprotection of the Fmoc group with piperidine in DMF produced 
finally (2S,3S)-140. Compound (2R,3R)-140 was similarly synthesized in an overall yield of 
4% starting with D-aspartic acid. 
 
2.2.1.2. Synthesis through modifications of D-aspartic acid 
A last example of enantioselective synthesis starting from the chiral pool is the synthesis of 2-
(carboxymethyl)aziridine 144 starting from D-aspartic acid D-103 (Scheme 25).
81
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O NH2
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Scheme 25 
At first, a selective esterification of the β-carboxylic group occurred in high yield (82%) by 
reaction with thionyl chloride in methanol, followed by subsequent o-nosylation of the amine 
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which delivered monocarboxylic acid 142 in 74% yield. Chemoselective reduction of the 
carboxylic group by activation with N,N'-diisopropylcarbodiimide and N-hydroxysuccinimide 
and subsequent treatment with sodium borohydride in THF/EtOH successfully gave the 
alcohol 143 in 61% yield. Subsequent mesylation and cyclization using Cs2CO3 provided the 
chiral 2-(carboxymethyl)aziridine 144 in 73% yield. Furthermore, the chiral 2-
(carboxymethyl)aziridine 144 is an intermediate in the synthesis of emeriamine, which was 
obtained after five additional steps, including ring opening of the aziridine moiety with N-
chloro-N-sodiocarbamate (not shown) and deprotection of the o-nosyl group with thiophenol. 
 
2.2.2. Stereoselective synthesis starting from addition reactions across 
imines 
2.2.2.1. Synthesis via the Staudinger reaction 
The utility of β-lactams as synthons for a wide range of heterocyclic compounds has already 
been known for a long time and was demonstrated in the following example where β-lactams 
147, synthesized via a Staudinger reaction, were transformed in the corresponding 2-
(carboxymethyl)aziridine 148 (Scheme 26).
47,82
 4-(1-Chloroalkyl)-substituted 2-azetidinones 
147 were prepared in a stereochemical way by condensation of α-chloroimines 145 with in 
situ generated ketenes in a Staudinger reaction. α-Chloroimines 145 were reacted with 
different types of acid chlorides 146 in benzene in the presence of triethylamine to generate in 
situ the intermediate ketenes, which underwent [2+2]-cyclocondensation to afford the 
corresponding β-lactams 147 in good yields. In the next step, 4-(1-chloroalkyl)-2-azetidinone 
147 underwent ring opening via acidic methanolysis (Scheme 26).
47,82
 The intermediate salt 
was not characterized, but was immediately reacted with triethylamine in dichloromethane for 
four hours at room temperature to afford the corresponding 2-(carboxymethyl)aziridine 148 in 
75% yield.  
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Scheme 26 
Noteworthy, base-promoted ring opening of β-lactams 149 by treatment with sodium 
methoxide in methanol at reflux temperature did not afford the corresponding 2-
(carboxymethyl)aziridine 151, but the ring-opened products (Z)-152 (Scheme 27).
47,82
 The 
proposed reaction mechanism concerns the nucleophilic attack of sodium methoxide across 
the amide functionality of β-lactam 149, resulting in ring opening. The secondary amine 150 
obtained in this way attacked the halogenated carbon, leading to ring closure by 
intramolecular nucleophilic substitution. The ring-closed products 151 were the originally 
expected aziridine derivatives. However, in the presence of excess sodium methoxide, 
deprotonation at the α-position of the ester 151 occurred and anti elimination led 
unexpectedly to the stereospecific formation of alkenoates (Z)-152. 
N
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MeO
H
H
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Scheme 27 
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Another study towards the synthesis of 2-(carboxymethyl)aziridines 160 started from a 
Staudinger reaction between N,N-di-p-methoxyphenyl 1,2-diimine 154 and an in situ 
generated ketene from acid chlorides 153, which resulted in the formation of imino-β-lactams 
which were directly hydrolysed to the corresponding aldehydes 155 (Scheme 28).
83,84,85,86,87
 
Next, 4-formyl-β-lactams 155 were reduced with sodium borohydride in methanol to alcohols 
156,
86,87,88
 which were subsequently mesylated to give the corresponding mesyloxy-β-lactams 
157.
87,88,89 
Previously, the reactivity of these compounds 157 was studied in order to obtain 
the corresponding N,N-disubstituted 4-(aminomethyl)azetidin-2-ones 158 by reaction with 
secondary amines.
90
 In extension of this research, preparation of the unsubstituted 
aminomethyl-analogues was envisioned by changing the nucleophile from a secondary amine 
to ammonia, however, this resulted in the unexpected formation of 2-
(carboxymethyl)aziridines 160.
83,84 
Furthermore, the same type of aziridines 160 were obtained by reaction of these mesyloxy-β-
lactams 157 with methanolic sodium methoxide at room temperature to afford the 
corresponding ring-opened products 159.
83,84
 Subsequent treatment of 159 with ethanolic 
triethylamine furnished 2-(carboxymethyl)aziridines 160 in good yields (51-89%). 
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Scheme 28 
Surprisingly, application of pyrrolidine as nucleophile resulted also in an azetidinone-
aziridine transformation in contrast with all other used secondary amines (Scheme 29).
83
 
Thus, reaction of mesyloxy-β-lactams 161 with neat pyrrolidine at room temperature afforded 
the 2-aziridinylacetamide 162 together with compounds 163a and 163b.  
N
O PMP
O
OMs
Cl neat, rt, 12 h
H
N
N
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O N
N
H
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162 (29%) 163a (Y = pyrrolidinyl, 49%)
163b (Y = OH, 14%)
H
161
 
Scheme 29 
A possible explanation of these results was found in the difference in nucleophilicity of these 
reagents, based on their basicity and steric requirements. Thus, the nucleophilic methoxide 
anion reacted in all cases selectively with the electrophilic lactam carbonyl function, while the 
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nucleophilicity of piperidine, a quite strong base, was overruled by the sterical hindrance 
allowing only attack at the less hindered side chain electrophilic center. Pyrrolidine is situated 
intermediate (strong base with lower sterical requirements) between piperidine and ammonia 
and could react with both electrophilic centers. Therefore, the regioselectivity was here 
determined by the activation energy requirements being lower in the reaction with the 
carbonyl in comparison with the side chain center. Bearing in mind the low sterical 
requirements of ammonia, it could react with both centers, as a result of its weak basicity. 
Since the reaction was carried out at room temperature, the reaction, however, took place 
exclusively at the carbonyl center, which comprises a lower energy barrier pathway. 
 
2.2.2.2. Synthesis via the Mannich-type reaction 
In recent years, the diastereo- and enantioselective synthesis of 2-(carboxymethyl)aziridines 
via Mannich-type addition reactions has gained a lot of attention.
91,92
 This Mannich-type 
reaction proceeded via addition of enolates across N-Ts-α-haloimines 165 and resulted in the 
formation of γ-chloro-β-amino acid derivatives 166, which were further transformed into the 
corresponding 2-(carboxymethyl)aziridines 167 by a base-promoted ring-closure reaction 
(Scheme 30). 
In the first reaction, benzophenone imine glycine esters 164 were deprotonated with lithium 
diisopropylamide (LDA) in THF, followed by the addition of N-Ts-α-haloimines 165 
(Scheme 30).
91
 After quenching with aqueous ammonium chloride, a mixture of anti and syn 
diastereomers anti-166 and syn-166 was formed in good yield with moderate 
diastereoselectivity (dr 3.5:1 to 1:1). For most of the synthesized derivatives, the anti- and 
syn-γ-chloro-β-amino esters anti-166 and syn-166 could be isolated as single diastereomers by 
crystallization. 
Performing this reaction under thermodynamic control, i.e. prolonged reaction times (20 h), 
afforded only syn-γ-chloro-β-amino esters syn-166 and syn-2-(carboxymethyl)aziridines syn-
Chapter 2  Literature Overview 
36 
 
167 in a 1:1 ratio. When the reaction was performed under kinetic control (1 h), the anti/syn 
ratio was 9:1.
91
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Scheme 30 
Furthermore, the isomerization of the isolated anti-isomer anti-166 (R
1
,R
2
 = Me) into the 
thermodynamically more stable syn-isomer syn-166 (R
1
,R
2
 = Me) and syn-aziridine syn-167 
(R
1
,R
2
 = Me) was observed upon stirring under mild basic conditions for an extended time 
(iPr2NH, LiCl, rt, 15 h to 5 d) (Scheme 31).
91
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Scheme 31 
It was also possible to access diastereomerically pure β,γ-aziridino carboxylic acid esters anti-
167 and syn-167 via 1,3-displacement of the chlorine atom under basic conditions.
91,92
 The 
reaction of the pure diastereomers anti-166 and syn-166 was performed easily with K2CO3 in 
acetone for five hours at reflux temperature giving the β,γ-aziridino-α-(N-
diphenylmethylidene)amino esters anti-167 and syn-167 in 80-87% yield (Scheme 32). 
Interestingly, when the cyclization reaction from the anti-adduct anti-166 was continued for a 
longer time (16 h), the mixture of aziridines anti-167 and syn-167 was obtained in 5:1 ratio. In 
analogy with the isomerization of anti-166 (R
1
,R
2
 = Me) to syn-166 (R
1
,R
2
 = Me), the anti-
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aziridine anti-167 could be isomerized under mild basic conditions (iPr2NH, LiCl, THF, rt) to 
the syn-isomer syn-167 in 97% yield (Scheme 32).
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Scheme 32 
The complete separation of adducts anti-166 and syn-166 (R
1
,R
2
 = Et) proved impossible. 
Noteworthy, the aziridine formation from the mixture of these adducts gave a mixture of 
diethyl-substituted aziridines anti-167 and syn-167 (R
1
,R
2
 = Et), which could be separated by 
crystallization in good yields (Scheme 33).
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2.3. Synthesis through C2-C4 bond formation 
2.3.1. Synthesis through reaction of an aziridinyl anion (method IIIa) 
Several studies have been performed in order to synthesize 2-(carboxymethyl)aziridines 171 
via reactions of aziridinyl anions with α-haloacetates 170.93,94,95 
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A first attempt to synthesize β,γ-aziridino carboxylic ester 171 was made by treatment of 2-
sulfinylaziridine 168 with 3.5 equivalents of EtMgBr at -78 °C, followed by stirring at room 
temperature (Scheme 34).
93
 This reaction resulted in the formation of the 
aziridinylmagnesium species 169, which was found to be stable for several hours at room 
temperature, in quantitative yield. This compound 169 reacted easily with alkyl halides in the 
presence of catalytic CuI.
93
 However, reaction with ethyl iodoacetate 170 failed to give 2-
(carboxymethyl)aziridine 171 and resulted in desulfinated aziridine 172. 
 
 
 
 
 
Scheme 34 
In the next study, the functionalization of configurationally and chemically stable aziridine 
carboxylate anions has been performed by reaction with electrophiles with good to excellent 
retention of configuration.
94,95
 Aziridine ester (2S)-173,
96
 was deprotonated with LDA in THF 
at -78 °C and subsequently reacted with bromoacetate to afford 2-(carboxymethyl)aziridines 
(2S)-174 as single diastereomers after column chromatography (Scheme 35). Hereby, it has 
been stated that application of the less hindered methyl and ethyl aziridine esters only led to 
self-condensation. The use of 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU) 
as co-solvent resulted in improved chemical yields, but was not essential in contrast to 
previous observations on aziridine carbothioate anions.
97
 
When aziridine ester (2R)-173 was treated under analogous reaction conditions (LDA, THF,  
-78 °C), only self-condensation was observed.
94,95
 Since intramolecular stabilization appeared 
to be negligible in this compound, the highly reactive lithiated intermediate was stabilized by 
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N
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(R) OMe
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dr 95:5
COOtBu
COOtBu
(2R)-173
(2S)-173
intermolecular chelation in a more adequate solvent system. When a 5:1 mixture of 
DME:Et2O was used, a more stabilized aziridine carboxylate anion was formed, which 
reacted with bromoacetate towards aziridine (2R)-174 in a moderate yield (30%) but with 
excellent retention of conﬁguration (Scheme 35).94,95 
 
 
 
 
 
 
 
 
Scheme 35 
Besides the synthesis of 2-(carboxymethyl)aziridines via reactions of aziridinyl anions with α-
haloacetate electrophiles, also the application of glyoxylate 177 as electrophile has been 
evaluated.
98,99,100
 In the first step, N-tosyl-2-(trifluoromethyl)aziridine 175 was 
regioselectively deprotonated with n-BuLi in THF at -102 °C (Scheme 36). Hereby, it has 
been stated that the generation of the anion 176 was markedly influenced by the nature of the 
N-substituent. The N-(o-anisyl)- and N-(p-anisyl)aziridinyl anions could only be partially 
generated upon deprotonation with the stronger base sec-BuLi, whereas generation of the N-
benzylaziridinyl anion with sec-BuLi was unsuccessful. Subsequent reaction of the N-
tosylaziridinyl anion 176 with ethyl glyoxylate 177 in THF at -102 °C afforded (2S)-2-(1-
ethoxycarbonyl-1-hydroxymethyl)-2-(trifluoromethyl)-aziridine 178 in 27% yield as a 
mixture of two diastereomers (dr = 67:33). 
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Scheme 36 
Even though the following example falls out of the scope of nucleophilic addition of 
aziridinyl anions, it is interesting to report here the synthesis of 2-(carboxymethyl)aziridines 
181 via palladium-catalyzed hydrocarbonation of methyleneaziridine 179.
101,102
 The reaction 
of methyleneaziridines 179 with carbon pronucleophiles proceeded smoothly in the presence 
of a palladium catalyst to give the cyclic products in good yields. For example, optimization 
of different reaction conditions showed that in the presence of catalytic amounts of Pd(PPh3)4 
(5 mol%) and triphenylphosphine oxide (10 mol%), the reaction of 1-benzyl-2-
methyleneaziridine 179 with ethyl 2-cyanopropionate 180 as pronucleophile, in THF at 120 
°C for 15 h gave 181 in 63% yield as a 1:1-mixture of both diastereomers (Scheme 37). 
N
Bn Me
CN
H COOEt
5 mol% Pd(PPh3)4
10 mol% P(O)Ph3
THF, 120 °C, 15 h
+
N
Bn
Me
CN
Me
EtOOC
181 (63%)
dr 1:1
179 180 (0.67 equiv)
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2.3.2. Synthesis starting from 2H-azirines via the Reformatsky reaction 
(method IIIb) 
The utility of the Reformatsky reaction for the synthesis of 2-(carboxymethyl)aziridines 184 
starting from 2H-azirines 182 and α-bromoacetates 183 was demonstrated by several 
examples. 
103,104,105,106,107
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In the first example, α-bromoacetates 183 were reacted with a zinc-copper couple108 in a 1:1 
solvent mixture of benzene and diethyl ether to afford the corresponding Reformatsky 
reagents (Scheme 38).
103
 Addition of these Reformatsky reagents across 3,3-dimethyl-2-
phenyl-2H-azirine 182a resulted in the selective formation of β,γ-aziridino esters 184 in good 
yields (65-81%) upon reaction at 60 °C for 2-5 hours. Changing the solvent to toluene 
resulted in lower yields of the desired product 184 and the formation of 3-pyrrolidinones as 
side-products.
104
 Use of α-bromoacetates 183c (R1 = R2 = Me) under the given reaction 
conditions resulted as well in the formation of the corresponding 3-pyrrolidinone as side-
product (10% in benzene/Et2O; 26% in toluene). 
N
Me
Me Ph
183a (R1 = R2 = H)
183b (R1 = H,  R2 = Me)
183c (R1 = R2 = Me)
Et2O/PhH (1:1),
 ~60 °C, 2-5 h
H
N
Me
Me
Ph
R2
OEt
O
+
184a (65%)
184b (81%)
184c (66%)
R1
Br
O
OEt
Zn/Cu
R1
R2
182a
 
Scheme 38 
In the following study, the diastereoselectivity of the Reformatsky reaction with ethyl 2-
bromopropionate 183b and 2H-azirines 182 has been studied (Scheme 39).
105
 It has been 
proven that the formation of both diastereomers syn-184 and anti-184 was irreversible. As no 
isomerization of the formed compounds syn-184 and anti-184 was possible, the major isomer 
obtained by this reaction was the product of kinetic control.
105
 The structures of syn-184 and 
anti-184 have been deduced from those of the corresponding 4-aminolactones, obtained by 
treatment of both diastereomers separately with Olah’s reagent (pyridine-HF) or with aqueous 
hydrochloric acid.
105
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Scheme 39 
In addition, the Reformatsky reaction of α-bromophenylacetates 185 and 3,3-dimethyl-2-
phenyl-2H-azirine 182a in the presence of zinc was studied.
106,107
 Performing the reaction in 
dimethoxymethane at 40 °C for six hours afforded the 2-(carboxymethyl)aziridines 186 as a 
single diastereomer in 37-42% yield (Scheme 40). In this case, the formation of pyrrolinone 
187 was less than 5%, whereas the same reaction in toluene or THF resulted in pyrrolinone 
187, exclusively.
106
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Scheme 40 
Similarly to the Reformatsky reaction, also the Ivanov reaction
109
 was evaluated for the 
synthesis of 2-(carboxymethyl)aziridines 191 (Scheme 41).
107
 In the first step, arylacetic acids 
188 were treated with two equivalents of isopropylmagnesium chloride in dimethoxymethane, 
affording the corresponding organomagnesium compounds 189. Subsequent addition of 2H-
azirine 182a and heating at reflux temperature for six hours furnished β,γ-aziridino carboxylic 
acid salts 190 which were isolated as the corresponding zwitterions 191 as single 
diastereomers in good yields after an aqueous workup. Noteworthy, all attempts to synthesize 
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2-(carboxymethyl)aziridines 191 starting from arylacetic acids 188 with sodium 
naphthalenide were shown to be unsuccessful.
107
 
R
OH
O 2 equiv iPrMgCl
OMgCl
OMgClR
N
Me
Me Ph NMe
Me
Ph OMgCl
O
R
H2
N
Me
Me
Ph
O
O
R
 191 (56-66%)
R = Ph, 1-thienyl,
       4-MeOC6H4, 
       1-naphthyl,
       2-naphthyl
MgCl
dimethoxymethane
, 2.5 h
, 6 h
aq.
workup
188 189
182a
190
 
Scheme 41 
Besides, the nucleophilic addition of enolates, derived from the corresponding ethyl esters 
192 upon treatment with sodium hydride in DMSO, across 3,3-dimethyl-2-phenyl-2H-azirine 
182a, in order to synthesize the corresponding 2-(carboxymethyl)aziridines 193 has also been 
investigated (Scheme 42).
110
 This reaction resulted in multi-component reaction mixtures, 
from which the desired 2-(carboxymethyl)aziridine 193a was isolated in only 4% yield when 
ethyl phenylacetate 192 (R = Ph) was used. 
N
Me
Me Ph
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N
Me
Me
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OEt
O
+ R
O
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N O
RPh         192 
(R = H, Me, Ph)
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R
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2.4. Synthesis via addition of carbene equivalents across imines (method 
IV) 
The synthesis of aziridines via addition reactions of carbenes across imines has been already 
well explored in the past.
111
 In a first synthetic strategy, dichlorocarbene was used as a 
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carbenoid compound in addition reactions across imines 196 to afford 2-
(carboxymethyl)aziridines 197.
112
 Treatment of benzodiazepine 196 with sodium hydroxide in 
chloroform, in the presence of Et3BnNCl as a catalyst, resulted in the in situ formation of 
dichlorocarbene, which reacted with the imino moiety of benzodiazepines 196. This reaction 
led to the selective formation of the corresponding tricyclic dichloroaziridines 197 in 80-85% 
yield (Scheme 43).  
N
N
O
R
N
N
O
R
Cl Cl
50% NaOH
Et3BnNCl
CHCl3, rt, 3 h
R = Me, Et
197 (80-85%)196
 
Scheme 43 
The addition reaction with dichlorocarbene was also performed with bis-1,1’-(1,5-
benzodiazepin-1-yl)methane 198 under similar reaction conditions and afforded the 
corresponding polycyclic dichloroaziridine 199 in 45% yield (Scheme 44).
112
 
N
N
O
N
N
O
1.3 equiv Et3BnNCl
50% NaOH/CHCl3
rt, 3 h
N
N
O
N
N
O
Cl Cl
Cl Cl
199 (45%)
CH2 CH2
198  
Scheme 44 
In the next part, the synthesis of 2-(carboxymethyl)aziridines 204 via addition of sulfur ylides 
across imines 201 is described.
113,114,115
 Application of the well-known ylide chemistry in 
aziridination reactions
116
 resulted in the synthesis of N-tosyl-2-(carboxymethyl)aziridines 204 
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via reaction of N-tosylimines 201 and functionalized allyl bromides 200.
113,114
 Hereby, N-
tosylimines 201 and functionalized allyl bromides 200 reacted in the presence of 
dimethylsulfide and K2CO3 for five hours in acetonitrile at room temperature to afford the 
corresponding N-tosyl-2-(carboxymethyl)aziridines 204 in 60-70% yield as an inseparable 
mixture of cis- and trans-diastereomers (Scheme 45). 
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Scheme 45 
In the same manner, treatment of an E/Z-mixture of bromo compounds 205 with 
dimethylsulfide or tetrahydrothiophene as sulfur source, K2CO3 and N-tosylimines 206 for 2-4 
hours in acetonitrile at room temperature, furnished a 1:1 mixture of E/Z isomers of cis-
alkenylaziridines 207 and 208 in very good combined yields, which were separated by means 
of silica gel column chromatography (Scheme 46).
115
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2.5. Synthesis through reactions of nitrene equivalents with olefins (method 
V) 
2.5.1. Synthesis through addition of azides across alkenes 
The synthesis of aziridines via addition reactions of azides to olefins has gained a lot of 
interest the past decades.
117,118
 Several reports have described the synthesis of 2-
(carboxymethyl)aziridines 212 via reactions of azides with α,β-unsaturated esters 
209.
119,120,121,122,123,124,125,126,127,128,129,130
 Some examples are described in the following part. 
A first attempt to synthesize β,γ-aziridino carboxylic esters 212 started with the addition of 
phenylazide across alkene 209.
119
 Reaction of trimethyl ester 209 with phenylazide in ethyl 
acetate resulted in a separable mixture of regioisomers 210 and 211 (Scheme 47). Heating of 
both dihydrotriazoles 210 and 211 at 210 °C for 15 minutes afforded the corresponding β,γ-
aziridino carboxylic ester 212.  
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Scheme 47 
Efforts have been made in order to synthesize the bicyclic aziridine carboxylate 214.
124
 The 
photochemical reaction between cyclobutenedicarboxylate 213 and ethyl azidocarboxylate in 
dichloromethane for six hours at room temperature afforded the corresponding bicyclic 
aziridine 214 in 20% yield (Scheme 48). 
MeOOC
MeOOC
h
N3-COOEt MeOOC
MeOOC
N COOEt
214 (20%)
CH2Cl2, rt, 6 h
213  
Scheme 48 
The synthesis of β,γ-aziridino carboxylic amides 219 via additions of azides 216 across N-
protected 2-azabicyclo[2.2.1]hept-5-en-3-ones 215 has also been investigated.
126,127,128,129,130
 
First, bicyclic olefins 215 reacted with different azides 216 via an intermolecular [2+3] 
cycloaddition in toluene under high pressure (980 MPa) to afford a mixture of two 
regioisomeric triazolines 217 and 218, which could be separated via column chromatography 
in good yields (Scheme 49).
126
 However, irradiation of a mixture of both triazolines 217 and 
218 in acetonitrile afforded polycyclic 2-(carbamoylmethyl)aziridines 219 after nitrogen loss. 
Subsequent ring opening of the lactam functionality of aziridines 219 with methanol furnished 
the corresponding β,γ-aziridino carboxylic esters 220 in excellent yield. 
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Scheme 49 
In addition, the synthesis of 2-(carbamoylmethyl)aziridines 221 was also performed with 
tosylazide, as a prominent nitrene precursor, and bicyclic olefins 215 under thermal 
conditions.
128,129
 This thermal approach formed a good alternative to the previously described 
cycloaddition-photolysis reaction sequence.
126,127
  
Reaction of N-protected lactams 215 with tosylazide in toluene at 120 °C resulted in the 
formation of aziridines 221 as single isomers via the exo-cyclic addition of nitrene across the 
double bound of 215 (Scheme 50). Noteworthy, the reaction of N-Cbz-lactam 215a with 
tosylazide resulted also in the formation of triazolines 222 (6%) and 223 (2%) as minor 
products.
129
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Scheme 50 
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The synthesis of β,γ-aziridino carboxylic amides 224 via reaction of bicyclic olefins 215 with 
different azides was also effected under microwave conditions, with significantly reduced 
reaction times.
130
 After optimization of reaction conditions, microwave irradiation of a 
mixture of N-protected lactams 215 and electron-poor azides (R
2
 = Ts, P(O)(OPh)2) at 120-
140 °C for 30 minutes without solvent afforded the corresponding tricyclic 2-
(carbamoylmethyl)aziridines 224 through nitrene addition (Scheme 51). 
215b (R1 = Boc)
215d (R1 = TBDMS)
N
O
R1
N
O
R
neat, 120-140 °C, 30'
microwave
R2N3 N
R2
R2 = Ts, P(O)(OPh)2
224 (17-63%)
 
Scheme 51 
A final example of this synthetic approach comprised the aziridination reaction via an 
intramolecular 1,3-dipolar cycloaddition of azido dienone 225.
125
 Heating compound 225 in 
benzene at reflux temperature for two days resulted in a conversion towards tricyclic aziridine 
226 in 80% yield with complete regio- and stereocontrol (Scheme 52). The isolation of the 
fully characterized aziridine 226 rather than a triazoline product was probably due to the 
thermal triazoline instability, which accelerated the extrusion of nitrogen in the corresponding 
triazoline intermediate.
131
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2.5.2. Synthesis via in situ generated nitrenes 
Since several decades, aziridine synthesis via nitrene additions across olefins represents a well 
explored field in organic synthesis.
117,132
 In order to synthesize N-phthalimido-2-
(carboxymethyl)aziridines, the generation of singlet aminonitrenes for the application in 
cycloaddition reactions with olefins, has been already frequently 
reported.
133,134,135,136,137,138,139,140
 
A first approach of this methodology started with the generation of phthalimidonitrene via 
oxidation of N-aminophthalimide 229 with Pb(OAc)4.
133,141
 The addition of 
phthalimidonitrene across bicyclic lactone 227 (X = O) and lactam 228 (X = NH) proceeded 
by reacting bicyclic lactone 227 with N-aminophthalimide 229 and Pb(OAc)4 for one hour in 
dichloromethane at room temperature and furnished the corresponding tricyclic compound 
230 in 10% yield (Scheme 53).
134
 However, performing the reaction with bicyclic lactam 228 
under the same reaction conditions failed to deliver the desired tricyclic aziridino lactam 231 
(X = NH). Furthermore, the reaction of the bicyclic compounds 227 and 228 with the less 
nucleophilic ethoxycarbonylnitrene also did not result in aziridine formation. Where 
phthalimidonitrene had a distinct nucleophilic character, the strong electron-withdrawing 
group in ethoxycarbonylnitrene rendered an electrophilic species whose reactivity was 
diminished to the point that it would only add to electron-rich double bonds.
134
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Scheme 53 
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More recently, the diastereoselective synthesis of the 2,2-disubstituted N-phthalimidoaziridine 
233 via addition of in situ generated phthalimidonitrene across α-substituted α,β-unsaturated 
ester 232 has also been reported.
135
 The reaction of alkene 232 with N-aminophthalimide 229 
in the presence of lead(IV) acetate, provided the corresponding 2,2-disubstituted N-
phthalimidoaziridine 233 in 81% yield and excellent diastereoselectivity (Scheme 54). 
N
N
O Ph
O
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OPh
O H2NNPhth 229
Pb(OAc)4
N
N
O Ph
O
OH
OPh
O
NNPhth
233 (81%)
(>95% de)
232
 
Scheme 54 
In addition, the electrochemical aziridination of β,γ-unsaturated ester 234 with 
phthalimidonitrene has been explored.
136,137
 This study illustrated the possibility of a rational 
approach that bypasses the requirement for stoichiometric amounts of toxic oxidants and 
metal additives in organic redox reactions.
136
 The reaction was performed in an 
electrochemical cell, where the anodic compartment was charged with olefin 234, N-
aminophthalimide 229, acetic acid and triethylamine in acetonitrile (Scheme 55). Besides, the 
cathodic compartment contained a solution of acetic acid in acetonitrile. Implementation of 
the electrolysis at +1.80 V at ambient temperature delivered the N-phthalimido-2-
(carboxymethyl)aziridine 235 in good yield (55%), after the reaction was stopped when the 
cell current dropped to less than 5% of its original value.
137
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Scheme 55 
Furthermore, the in situ generation of nitrenes has been performed by using hypervalent 
iodine reagents such as iodosylbenzene and PIDA. 
138,139,140,142,143
 
In the first study, the aziridination of Z-alkylideneaziridine (Z)-236 via reaction with N-
aminophthalimide 229 in the presence of iodosylbenzene 237 as oxidant has been 
examined.
138,139,140
 Treatment of aziridine (Z)-236 with 1.5 equivalents of N-
aminophthalimide 229 in the presence of 1.6 equivalents of iodosylbenzene 237 and 3.5 
equivalents of potassium carbonate resulted in the formation of bisaziridino carboxylic ester 
238 in 58% yield as one single diastereomer when reacted in dichloromethane at 0 °C to room 
temperature (Scheme 56).
138
 
N O
O
H
H
EtOOC
1.5 equiv PhthNNH2 229
1.6 equiv PhIO 237
3.5 equiv K2CO3
CH2Cl2, 0 °C to rt
N O
O
H
H
EtOOC
N
PhthN
236 (Z) 238 (58%)  
Scheme 56 
Furthermore, the synthesis of bridged aziridine 240 starting from primary amine 239 via a 
modified Nagata intramolecular aziridination reaction has been investigated.
142
 After 
optimization of different reaction conditions, it has been shown that reaction of amine 239 in 
the presence of phenyliodine(III) diacetate (PIDA), potassium carbonate and silica gel in 1,2-
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dichloroethane at 55 °C for one hour gave the bridged aziridine 240 selectively in 72% yield 
(Scheme 57). This efficient intramolecular aziridination reaction proceeded via an 
iminoiodinane intermediate generated from the cycloalkenyl primary amine in the absence of 
a metal catalyst.
142
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Scheme 57 
Similarly, the application of the modified Nagata intramolecular aziridination method,
142
 
resulted also in the formation of aziridine 242 in 70% yield (Scheme 58).
143
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Scheme 58 
Along with aziridination reactions via in situ generated phthalimidonitrene and 
ethoxycarbonylnitrene across olefins, also the palladium(II)-mediated aziridination of olefins 
with bromamine-T 244 has been employed.
144
 Different reaction conditions were tested in 
order to synthesize 2-(carboxymethyl)aziridine 245 via a palladium(II)-mediated 
aziridination. Hereby, reaction of olefin 243 with bromamine-T 244 in the presence of PdCl2 
or Pd(MeCN)2Cl2 afforded the corresponding N-tosyl-2-(carboxymethyl)aziridine 245 in low 
yield (13-25%) after reaction for 2-24 hours in acetonitrile at room temperature (Scheme 59).  
COOMe
 TsNBrNa 244
 PdCl2 or Pd(MeCN)2Cl2
CH3CN, rt, 2-24 h, N2
N
COOMe
Ts
245 (13-25%)243  
Scheme 59 
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2.6. Functional group transformation starting from the chiral pool (method 
VI) 
In this part, the synthesis of 2-(carboxymethyl)aziridines via functional group transformation 
starting from products from the chiral pool will be described.
145,146
 Hereby, several 
transformations of the chiral skeletons were required to furnish the corresponding enantiopure 
bicyclic 2-(carboxymethyl)aziridines.  
In a first study, the use of (1R,6S)-cyclophellitol 246 in the synthesis of two enantiopure 
aziridines (1R,6R)-250 and (1S,6S)-250 with a 3,4,5-trihydroxy-7-azabicyclo[4.1.0]heptane-2-
carboxylic acid skeleton has been demonstrated.
145
 The synthesis of cyclophellitol carboxylic 
acid aziridine analog (1R,6R)-250 started with a two-step protection of the four hydroxyl 
groups of (1R,6S)-246, with TBDPSCl and benzylbromide, respectively (Scheme 60). The 
epoxide functionality of the resulting protected compound (1S,6S)-247 underwent subsequent 
ring-opening reaction with sodium azide in the presence of acetic acid and gave the diaxially 
opened azide as a sole product, which was directly subjected to reductive aziridination with 
triphenylphosphine in toluene to afford a single aziridine (1R,6R)-248 in good yield. 
Desilylation with TBAF, followed by Cbz-protection of the amino group resulted in 
compound (1R,6R)-249 in 85% yield. As direct oxidation of this compound (1R,6R)-249 with 
RuCl3-NaIO4 failed, a stepwise oxidation with Dess-Martin periodinane and NaClO2 was 
necessary to obtain the corresponding carboxylate. Subsequently, the resulting carboxylic acid 
was O-debenzylated to afford bicyclic 2-(carboxymethyl)aziridine (1R,6R)-250 in good yield. 
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Scheme 60 
Next, cyclophellitol carboxylic acid aziridine analog (1S,6S)-250 was prepared from the O-
protected epoxide (1S,6S)-247 (Scheme 61). Desilylation of compound (1S,6S)-247 with 
TBAF, followed by deoxygenation with KSeCN provided olefin 251 in 80% overall yield. 
Stereoselective epoxidation of 251 with mCPBA gave epoxide (1R,6R)-252 in 80% yield, 
after which ring opening with sodium azide and acetic acid afforded the diaxially opened 
azide (1R,6R)-253 in 81% yield as a sole product. Since direct aziridine formation, after 
silylation of (1R,6R)-253 with TBDPSCl was not successful, a stepwise procedure was 
required. Thus, mesylation with MsCl, reduction with triphenylphosphine and base-induced 
cyclization with sodium methoxide afforded the desired aziridine (1S,6S)-248 in 30% overall 
yield. By the same procedure used in the transformation of (1R,6R)-248 to (1R,6R)-250, 
(1S,6S)-248 was converted to bicyclic 2-(carboxymethyl)aziridine (1S,6S)-250 via (1S,6S)-
249 in 60% overall yield. 
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Scheme 61 
cis-Aziridino-L-proline 260, a bicyclic 2-(carboxymethyl)aziridine, has also been synthesized 
via functional group transformations starting from S-pyroglutamic acid 254.
146
 Azidoprolinol 
derivative 255, derived from S-pyroglutamic acid 254, has shown to be an ideal precursor in 
the synthesis of aziridinoproline 260 (Scheme 62). Hereto, the primary alcohol function was 
selectively protected as the TBDPS ether, which gave compound 256 upon hydrogenation in 
the presence of Boc2O. Subsequent reaction of alcohol 256 with mesyl chloride resulted in the 
formation of the corresponding mesylated product 257 in excellent yield. The cyclization to 
the fully protected cis-aziridinoprolinol derivative 258 was achieved with potassium 
carbonate in acetonitrile under reflux in 87% yield. After O-desilylation of 258 and oxidation 
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of the primary alcohol function with RuCl3/NaIO4, aziridinoproline 260 was obtained in low 
yield (35%).  
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Scheme 62 
In conclusion, it can be stated that the 2-(carboxymethyl)aziridines are a class of useful and 
attractive substrates in contemporary organic synthesis. Therefore, new synthetic approaches 
for the construction of 2-(carboxymethyl)aziridines are required, as the current available 
methodologies have often a limited scope or low yields or a limited chemoselectivity. 
Moreover, the application of more appropriate protecting groups at the nitrogen (and carbon) 
atom would be desirable to allow access to the corresponding unprotected amino acid 
derivatives. Further elaboration of asymmetric synthetic methods are also required, with 
special attention for the syntheses of all possible diastereo- and enantiomers. From this point 
of view, the further application of these 2-(carboxymethyl)aziridines as chemical probes, 
bioactive compounds and enzyme inhibitors is still largely uninvestigated. 
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3. Results and Discussion 
3.1. Synthesis of N-sulfinylimines 
3.1.1. Synthesis of N-(p-toluenesulfinyl)-α-functionalized aldimines 
As already mentioned in the introduction and goals, the synthesis of chiral N-(p-
toluenesulfinyl)aldimines has extensively been reported in the literature.
36,147,148
 Moreover, 
the synthesis of chiral N-sulfonyl-α-haloaldimines has also been reported as 
straightforward.
149
 Nevertheless, the synthesis of chiral N-(p-toluenesulfinyl)-α-
chloroaldimines or aliphatic N-(p-toluenesulfinyl)-α-aminoaldimines has not been reported so 
far. 
The synthesis of this new class of chiral N-(p-toluenesulfinyl)-α-chloroaldimines 266 started 
from α-chloroaldehydes 264 (Scheme 63). The preparation of the used α-chloroaldehydes 
264a-c,h proceeded via chlorination of the corresponding aldehydes 261a-c with SO2Cl2,
150
 
or via (in situ generated) Et3NHCl-catalysed loss of CO2 from 4-chloro-1,3-dioxolan-2-one 
262.
151
 
 
 
 
 
 
 
 
 
 
 
Scheme 63 
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α,α-Dichloroaldehydes 264d-g were available at the department and have been synthesized 
via direct chlorination of aldehydes 263d-g with chlorine in DMF.
152
 
Condensation of α-chlorinated aldehydes 264a-g with (S)-(+)-p-toluenesulfinamide 265 in the 
presence of Ti(OEt)4 in dichloromethane at room temperature,
147
 provided N-(p-
toluenesulfinyl)-α-chloroaldimines 266a-g (Scheme 64) in moderate to high yields and with 
excellent enantiomeric excess, as determined by chiral HPLC analysis of the N-(p-
toluenesulfinyl)-α-chloroaldimine derived (2S,3R)-trans-3-(N-tosylamino)azetidine-2-
carboxylate (ee > 98%) (vide infra). These imines 266a-g showed to be very stable during 
purification by column chromatography on silica gel to provide analytically pure samples. 
The synthesis of N-(p-toluenesulfinyl)-α-chloroaldimine 266h was, however, unsuccessful 
under the above-mentioned conditions and only led to decomposition. Performing the 
synthesis under milder conditions using anhydrous CuSO4 in dichloromethane,
153
 generated 
the desired imine 266h in high yield after 14 hours at room temperature. This highly unstable 
N-(p-toluenesulfinyl)imine 266h was used as such without further purification. 
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Scheme 64 
In addition, the synthesis of aliphatic N-(p-toluenesulfinyl)-α-aminoimine 268 was also 
pursued in order to obtain this polyaminated building block. Condensation of the 
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commercially available N-Boc-α-aminoacetaldehyde 267 with (S)-(+)-p-toluenesulfinamide 
265 in the presence of CuSO4 in dichloromethane at room temperature for eight hours did not 
result in a complete consumption of the starting aldehyde 267 (Scheme 65). Prolonging the 
reaction time for 22 hours gave complex reaction mixtures due to decomposition of the 
desired compound 268. No further efforts for the synthesis of the aliphatic N-(p-
toluenesulfinyl)-α-aminoimine 268 were made, while the synthesis of the corresponding 
aliphatic N-(tert-butanesulfinyl)-α-aminoimine was evaluated instead (vide infra). 
1) 3 equiv CuSO4
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H
O H2N
S
(S)
O
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BocHN
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3.1.2. Synthesis of N-(tert-butanesulfinyl)-α-functionalized aldimines 
Chiral N-(tert-butanesulfinyl)aldimines have proven to be valuable synthons for a wide 
variety of azaheterocyclic compounds and aliphatic amines via nucleophilic addition reactions 
across these activated imines.
38,35,40,148
  
In order to evaluate the unexplored reactivity of chiral N-(tert-butanesulfinyl)-α-
chloroaldimines 270 in Mannich-type additions, the chiral N-(tert-butanesulfinyl)-α-
chloroaldimine (RS)-270a,
150
 and the new imine (SS)-270a were efficiently prepared by 
condensation of α-chloroaldehyde 264a with the enantiopure tert-butanesulfinamides (RS)-269 
and (SS)-269, respectively, in the presence of Ti(OEt)4 in THF at reflux temperature (Scheme 
66). The chiral N-(tert-butanesulfinyl)-α-chloroacetaldimine (RS)-270b was prepared by 
condensation of α-chloroaldehyde 264h with (RS)-tert-butanesulfinamide (RS)-269 in the 
presence of anhydrous CuSO4 in dichloromethane,
153
 after 16 hours at room temperature in 
92% yield (Scheme 66). This unstable N-(tert-butanesulfinyl)imine (RS)-270b required no 
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further purification after filtration and solvent removal. Previously described results on the 
enantioselective synthesis of chiral N-(tert-butanesulfinyl)-α-chloroimines, starting from 
condensation reactions with the enantiopure tert-butanesulfinamides (RS)-269 (ee > 98%), 
have demonstrated that no racemization occurred at the sulphur atom, and it can be assumed 
that this is also valid for the synthesis of analogous N-(tert-butanesulfinyl)-α-chloroaldimines 
270, as the latter compounds 270a were synthesized under the same reaction conditions.
150b
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Scheme 66 
In addition, the synthesis of novel aliphatic N-(tert-butanesulfinyl)-α-aminoimines 271 was 
effectuated in order to obtain a valuable polyaminated building block suitable for addition 
reactions (Scheme 67).  
3 equiv CuSO4
1 equiv
H
O
H2N
S
O
CH2Cl2, rt, 24 h
H
N
S
O
BocHN
t-Bu
t-Bu
BocHN
(RS)-271 (99%)
(SS)-271 (96%)
*
*
267
(RS)-269
(SS)-269
(ee > 98%)
 
Scheme 67 
Condensation of N-Boc-α-aminoacetaldehyde 267 with the enantiopure tert-
butanesulfinamides (RS)-269 and (SS)-269, respectively, in the presence of CuSO4 in 
dichloromethane for 24 hours at room temperature resulted in the formation of the 
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corresponding N-(tert-butanesulfinyl)-α-aminoimines (RS)-271 and (SS)-271. Purification by 
filtration over silica gel afforded these stable imines (RS)-271 and (SS)-271 in excellent yields 
(96-99%). 
 
3.2. Asymmetric synthesis of α,β-diamino carboxylic acid derivatives via 
stereoselective Mannich-type additions across N-sulfinyl-α-
chloroimines 
 
The utility of α,β-diamino acids and γ-chloro-α-amino acids as building blocks for the 
synthesis of new heterocyclic compounds and peptides, has already extensively been 
demonstrated in the past.
10,17
 Preliminary results at the Department of Sustainable Organic 
Chemistry and Technology, Faculty of Bioscience-engineering, UGent, disclosed the 
successful racemic synthesis of γ-chloro-α,β-diamino acid derivatives via a Mannich-type 
addition of ‘benzophenone imine glycinates’ across N-(p-toluenesulfonyl)-α-
chloroaldimines.
91,92
 In this part, the first asymmetric synthesis of γ-chloro-α,β-diamino acid 
derivatives as new building blocks for heterocyclic scaffolds, incorporating the biologically 
interesting γ-chloro-α-amino acid moiety as well as the α,β-diamino acid moiety, will be 
discussed. 
The synthesis of γ-chloro-α,β-diamino acid derivatives 274 via Mannich-type additions of 
enolates derived from benzophenone imine glycinates 273 across enantiopure N-sulfinyl-α-
chloroaldimines 272 was investigated with special attention to the enantio- and 
diastereoselectivity of this reaction (Scheme 68). For this purpose, N-(p-toluenesulfinyl)-α-
chloroaldimines 266a,h and N-(tert-butanesulfinyl)-α-chloroaldimines (RS)-270a,b were used, 
as these compounds were known for their good reactivity and stereoselectivity in the 
Mannich-type reactions.
154
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Scheme 68 
3.2.1. Synthesis of alkyl N-(diphenylmethylene)glycinates 
Alkyl N-(diphenylmethylene)glycinates 273 were prepared, according to an established 
literature procedure,
91,92,155
 by reaction of glycinate hydrochloric acid salts 275a-c or 
glycinate p-toluenesulfonic acid salt 275d with one equivalent of benzophenone imine 276 for 
18 hours in dry dichloromethane at room temperature (Scheme 69). This gave rise to alkyl N-
(diphenylmethylene)glycinates 273a-b,d in almost quantitative yields (99%), while the tert-
butyl N-(diphenylmethylene)glycinate 273c was synthesized in a significantly lower yield 
(58%). 
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Scheme 69 
 
3.2.2. Synthesis and elaboration of γ-chloro-α-diphenylmethyleneamino-β-
p-toluenesulfinylamino carboxylic acid derivatives 
The stereoselective synthesis of chiral α,β-diamino acid derivatives 277 was achieved by a 
Mannich-type addition of N-(diphenylmethylene)glycine esters 273 across chiral N-p-
toluenesulfinyl-α-chloroaldimine 266a via systematically changing the reaction conditions 
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(Scheme 70, Table 1). It was found that the choice of base, LDA or LiHMDS, used for the 
deprotonation of the glycine ester 273a, had a dramatic influence on the syn- or anti-
selectivity of the reaction (Table 1).  
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Scheme 70 
In a first reaction (Table 1, entry 1), the Mannich-type addition of ethyl glycinate 273a across 
chiral  
N-p-toluenesulfinyl-α-chloroisobutyraldimine 266a was performed at -78 °C using five 
equivalents of LiHMDS. 
1
H NMR analysis of the crude reaction mixture indicated that the 
resulting syn-γ-chloro-α,β-diamino ester syn-277a was obtained with good syn-selectivity (dr 
= 93:7). The syn-adduct syn-277a was isolated in 63% yield (dr = 97:3) after purification by 
column chromatography and subsequent recrystallization. Repeating the reaction with 1.1 
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equivalents of LiHMDS (entry 2) led to the formation of syn-γ-chloro-α,β-diamino ester syn-
277a in an excellent syn-selectivity (dr = 99:1) after recrystallization. In this way, column 
chromatography to purify the syn-adduct syn-277a could be avoided, which resulted in an 
improved yield of 88%. Changing the solvent system to either methyl tert-butyl ether or 2-
methyltetrahydrofuran resulted in lower diastereoselectivities (entries 3-4). The use of methyl 
glycinate 273b using the optimal reaction conditions described in entry 2 resulted in a similar 
syn-selectivity (dr = 97:3) and yield (86%) (entry 5).  
 
Table 1. Addition of N-(diphenylmethylene)glycine esters 273 across N-p-
toluenesulfinylimine 266a producing syn- and anti-addition products 277 
Entry Ester Solvent Base X Time / Temp syn/anti ratio 
a
 Product Yield (%) 
1 273a THF LiHMDS 5 15’, -78 °C 93:7 syn-277a 63
 b
 
2 273a THF LiHMDS 1.1 15’, -78 °C 99:1
c
 syn-277a 88
 b
 
3 273a MTBE LiHMDS 1.1 15’, -78 °C 77:23 syn-277a - 
4 273a 2-Me-THF LiHMDS 1.1 15’, -78 °C 84:16 syn-277a - 
5 273b THF LiHMDS 1.1 15’, -78 °C 97:3
c
 syn-277b 86
 b
 
6 273a THF LDA 1.1 5’, -90 °C 13:87 anti-277a 79
d
 
7 273a THF LDA 1.6 5’, -90 °C .10:90. anti-277a 55
e
 
8 273c THF LDA 1.6 5’, -90 °C 28:72  anti-277c 52
f
 
9 273d THF LDA 1.1 5’, -90 °C 18:82 anti-277d - 
10 273a THF LiHMDS 1.1 
15’, -78 °C 
2 h, rt 
> 99:1 syn-278a 72
b
 
11 273a THF LDA 1.1 
5’, -90 °C 
2 h, rt 
> 99:1 syn-278a - 
 
a
 Determined via 
1
H NMR analysis of crude reaction mixtures with syn-277 or syn-278 as   
   standard 
b
 Isolated yield of single diastereomer (dr > 97:3) 
c
 Determined via 
1
H NMR after recrystallization of crude reaction mixtures 
d
 Isolated yield of anti- and syn-diastereomers (dr = 89:11) 
e
 Isolated yield of anti- and syn-diastereomers (dr = 90:10) 
f
 Isolated yield of anti- and syn-diastereomers (dr = 81:19) 
Performing the reaction with 1.1 equivalents of LDA, resulted in γ-chloro-α,β-diamino ester 
anti-277a with good anti-selectivity (dr = 87:13) (entry 6). The anti-γ-chloro-α,β-diamino 
ester anti-277a was obtained in 79% yield as a mixture of two diastereomers (dr = 89:11) 
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after purification by column chromatography. Unfortunately, the anti-adduct anti-277a was 
not crystalline and could not be obtained as a single diastereomer. In order to improve the 
diastereoselectivity, the reaction was conducted with 1.6 equivalents of LDA (entry 5), 
according to the procedure for the synthesis of anti-ethyl 2,3-diamino-3-phenylpropanoates 
from N-(benzylidene)-p-toluenesulfinamide and glycine enolates.
156
 These conditions led to a 
slightly better diastereoselectivity (dr = 90:10), but unfortunately the anti-γ-chloro-α,β-
diamino ester anti-277a was obtained in a lower yield (55%) as a mixture of two 
diastereomers (dr = 90:10) after purification by tedious column chromatography. When tert-
butyl glycinate 273c was subjected to the Mannich-type reaction conditions with N-p-
toluenesulfinyl-α-chloroisobutyraldimine 266a using 1.6 equivalents of LDA (entry 8), the 
resulting anti-γ-chloro-α,β-diamino ester anti-277c was obtained with moderate anti-
selectivity (dr = 72:28), and was isolated in 52% yield as a mixture of two diastereomers (dr = 
81:19) after purification by column chromatography. In addition, upon deprotonation of 
benzyl glycinate 273d with 1.1 equivalents of LDA and subsequent addition across N-p-
toluenesulfinyl-α-chloroisobutyraldimine 266a (entry 9), 1H NMR analysis of the crude 
reaction mixture showed that the expected anti-addition products were formed in good 
diastereoselectivity (dr = 82:18), yet purification by column chromatography failed to deliver 
pure compound anti-277d.  
Both the syn- and anti-addition products 277 were subsequently cyclized to the corresponding  
N-sulfinylaziridines 278 (Scheme 70) upon treatment with K2CO3 in acetone under reflux for 
20-48 hours, followed by column chromatography, which led to improved diastereomeric 
ratios in case of syn-278 and anti-278a (dr > 99:1).  
Hereby, the diastereomeric ratios were determined via 
1
H NMR analysis of the isolated 
products in which no other diastereomers were observed. Moreover, all the reported 
diastereomeric ratios were determined in this way.  
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N Ph
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The syn-N-sulfinylaziridine syn-278a could also be prepared directly in 72% yield via a 
single-step reaction starting from ethyl glycinate 273a, if the reaction mixture from the 
Mannich-type addition across imine 264a after 15 minutes at -78 °C was subsequently stirred 
for two hours at room temperature (Table 1, entry 10). This procedure was not applicable for 
the synthesis of anti-N-sulfinylaziridines anti-278 as the anti-adducts were the kinetically 
favored diastereomers which isomerize to the thermodynamically more stable syn-isomers 
(entry 11). The absolute stereochemistry of the anti-N-p-toluenesulfinylaziridine anti-278a 
and syn-adduct syn-277a were unambiguously determined by means of X-ray diffraction 
analysis (in collaboration with Prof. R. Sillanpää, Department of Chemistry, University of 
Jyväskylä, Finland) (Figure 7). 
 
 
 
 
 
  
 
 
 
                                               
 
 
 
 
 
 
 
Figure 7.  
X-ray diffraction analysis of anti-N-sulfinylaziridine anti-278a and syn-adduct syn-277a 
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The dramatic influence of the base, LDA or LiHMDS (Scheme 70), on the stereochemical 
outcome of the Mannich-type reaction across N-sulfinyl-α-chloroimine 266a under kinetic 
conditions (for example -90 °C, 5 min) was rationalized on the basis of the enolate geometry 
of the anions derived from the deprotonation of N-(diphenylmethylene)glycine esters 273.  
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Scheme 71 
As reported in the literature, the enolates obtained via deprotonation of N-
(diphenylmethylene)glycine esters 273 with LDA were expected to have the Z-geometry 
(Scheme 71), which was favoured by intramolecular chelation.
156,157,158
 As commonly 
performed in the assignment of enolate geometry, in contrast to conventional E/Z-
nomenclature, the highest priority designation was allocated to the O-metal group of the 
enolate substituents. Alternatively, it was proposed that upon deprotonation of N-
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(R)
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(S) O
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Ph
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OEt
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p-Tol 5 equiv TFA
acetone/H2O (2:1)
rt, 15 min
(R)
H
N
(S)
NH2
H
OEt
O
280 (78%)
1)
2) NH4OH
anti-278a
(dr > 99:1)
(diphenylmethylene)glycine esters 273 with the less basic LiHMDS in THF, a shift towards 
the formation of the E-enolate occurs (Scheme 71). Unfortunately, the enolate geometry could 
not be determined via trapping experiments with TMSCl.
159
 Reaction of the Z- and E-enolates 
via TS-279A and TS-279B results in the formation of anti-277 and syn-277, respectively.
156
 
The p-toluenesulfinyl group of anti-aziridine 278a (Scheme 72) was readily removed by 
treatment with five equivalents of trifluoroacetic acid in acetone/water (2:1) at room 
temperature for 15 minutes, resulting in the N-deprotected anti-β,γ-aziridino-α-amino ester 
280 in 78% yield after a basic workup with NH4OH.
160
 
 
 
 
 
Scheme 72 
The N-sulfinyl β,γ-aziridino moiety of aziridine anti-278a could be seen as functional 
equivalent to the γ-chloro substituent of natural γ-chloro-α-amino acids,3 or the adenosyl-S+-
CH3 cation of S-adenosylmethionine,
1
 in activating the γ-carbon as an electrophile. 
Eventually, this reactivity could be used in a ring transformation via intramolecular N-
alkylation to the corresponding trans-β-aminoazetidine-2-carboxylate 282. The N-
diphenylmethylene group of anti-N-sulfinylaziridine anti-278a (Scheme 73) was reduced by 
means of NaCNBH3 in the presence of acetic acid in MeOH, resulting in aziridine anti-281 
with a nucleophilic α-amino function (68% yield). Several attempts were made to achieve the 
ring transformation of N-sulfinylaziridine anti-281 into trans-β-aminoazetidine-2-carboxylate 
282, albeit without success (Scheme 73, Table 2). A possible explanation for this failure was 
the weaker electron-withdrawing character of the p-toluenesulfinyl group, with respect to the 
p-toluenesulfonyl group. Previously, the presence of the sulfonyl group has shown to promote 
an intramolecular ring opening towards the corresponding azetidines.
92
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Scheme 73 
Table 2. Different reaction conditions for the ring transformation of aziridine anti-281 
Entry Solvent Base/Acid Temperature Time Result Yield 
1 CH3CN 1 equiv Et3N Δ 20 h no reaction - 
2 CH3CN 5 equiv Et3N 100 °C
a
 22 h no reaction - 
3 EtOH 1 equiv Et3N Δ 96 h decomposition - 
4 DMSO 1 equiv Et3N 70 °C 28 h no reaction - 
5 DMSO 1 equiv Et3N Δ 20 h decomposition - 
6 CH2Cl2 1 equiv BF3.Et2O rt 20 h complex mixture - 
7 THF 1 equiv LiHMDS Δ 2.5 h complex mixture - 
8 THF 1 equiv KOtBu Δ 2.5 h 283 87%
b
 
9 THF 1 equiv NaH Δ 1 h 283 45%
c
 
10 EtOH 3 equiv K2CO3 Δ 22 h 283 98%
b
 
11 DMSO 3 equiv K2CO3 Δ 22 h complex mixture - 
12 DMSO 2.5 equiv NaH  80 °C  2 h 283 56%
c
 
13 Toluene 1 equiv DBU rt 24 h no reaction - 
14 CH3CN 2 equiv LiClO4 Δ 24 h complex mixture - 
15 CH3CN - 120 °C (MW) 10 min decomposition - 
16 CH3CN - 90 °C (MW) 5 min decomposition - 
17 CH3CN - 70 °C (MW) 5 min no reaction - 
18 CH3CN - 50 °C (MW) 30 min no reaction - 
19 CH3CN 1 equiv NaI rt 30 min no reaction - 
20 CH3CN 1 equiv NaI 50 °C (MW) 30 min no reaction - 
  
a
 The reaction was performed in a pressure vial 
  
b
 Yield after precipitation of dihydropyrrole-2-one 283 in diethyl ether 
  
c
 Yield after recrystallization from diethyl ether 
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An initial attempt using similar reaction conditions as in a previously reported ring 
transformation towards racemic anti-N-tosylazetidines, via heating in acetonitrile in the 
presence of one equivalent Et3N,
92
 did not result in the formation of trans-β-aminoazetidine-
2-carboxylate 282 (Table 2, entry 1). Also, use of more equivalents of triethylamine, other 
solvents (EtOH, DMSO), and/or increased reaction times and temperatures, did not lead to the 
desired conversion (entries 2-5). Reaction with one equivalent of BF3.Et2O at room 
temperature for 20 hours resulted in a complex reaction mixture, in which no trace of trans-β-
aminoazetidine-2-carboxylate 282 was detected (entry 6). Also the use of one equivalent 
LiHMDS led to a complex reaction mixture after heating at reflux for 2.5 hours (entry 7). 
When aziridine 281 was treated with one equivalent KOtBu in THF at reflux for 2.5 hours 
(entry 8), the selective formation of 3-amino-1,5-dihydropyrrole-2-one 283 was observed 
(87% yield).  
The proposed reaction mechanism, leading to this γ-lactam 283, begins with deprotonation at 
the α-position of the ester, which leads to an anti-periplanar elimination resulting in ring 
opening of the aziridine anti-281 (Scheme 74).  
283
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Scheme 74 
Chapter 3  Results and Discussion 
 
73 
 
The secondary amide group of alkenoate 284 then attacked the ester group leading to γ-lactam 
285. The p-toluenesulfinyl group of the ring-closed product 285 was subsequently cleaved by 
attack of the expelled ethoxide anion, resulting in dihydropyrrole-2-one 283. 
Using one equivalent of NaH for one hour instead (Table 2, entry 9), also afforded the 3-
amino-1,5-dihydropyrrole-2-one 283 however in a lower yield (45%). Performing the reaction 
in EtOH for 22 hours at reflux temperature in the presence of three equivalents of K2CO3 
(entry 10), afforded the 3-amino-1,5-dihydropyrrole-2-one 283 in an excellent yield of 98%. 
The same reaction in DMSO led to a complex reaction mixture (entry 11), whereas the use of 
2.5 equivalents of NaH in DMSO at 80 °C for two hours (entry 12), resulted in the 3-amino-
1,5-dihydropyrrole-2-one 283 in a yield of 56%. When aziridine anti-281 was treated with 
one equivalent of DBU in toluene for 24 hours at room temperature, no reaction was observed 
(entry 13). Reaction of aziridine anti-281 with two equivalents of LiClO4 in acetonitrile at 
reflux for 24 hours, resulted only in a complex reaction mixture (entry 14). In an additional 
series of attempts, a microwave reactor (200 W) was employed to promote ring 
transformation of aziridine anti-281 to trans-β-aminoazetidine-2-carboxylate 282, albeit 
without success. An initial reaction, performed in acetonitrile at 120 °C for 10 minutes, led to 
degradation of the starting material anti-281 (entry 15). Lowering reaction times and 
temperatures resulted in degradation or no reaction, without formation of the desired azetidine 
282 (entry 16-18). In a final attempt, NaI was added to the reaction mixture, but no 
conversion of the starting material into the envisaged product was achieved (entry 19-20). 
Since none of these attempts resulted in the intramolecular ring transformation to azetidine 
282, the p-toluenesulfinyl group of N-sulfinylaziridine anti-278a (Scheme 75) was selectively 
oxidized with 3-chloroperbenzoic acid (mCPBA), resulting in enantiomerically pure anti-N-
sulfonylaziridine 286 containing a strong electron-withdrawing activating group at the 
aziridine nitrogen. Based on the previously reported ring transformation of racemic anti-N-
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tosylaziridine 287 to racemic anti-N-tosylazetidine 288, the targeted ring transformation of 
aziridine 286 to optically pure azetidine 287 was expected to be straightforward.
92
 The N-
diphenylmethylene moiety of this anti-N-sulfonylaziridine 286 was subsequently reduced 
with NaCNBH3 in methanol in the presence of acetic acid, resulting in the formation of anti-
N-sulfonylaziridine 287 in 92% yield. It was shown that the anti-N-sulfonylaziridine 287 was 
an excellent precursor for an easy ring transformation towards trans-3-(N-
tosylamino)azetidine-2-carboxylate 288 via simple heating in acetonitrile at 120 °C for 10 
minutes under microwave (MW) conditions. Noteworthy, it has been reported that the latter 
transformation to prepare the racemic azetidine 288 has required heating at 70 °C in 
acetonitrile for 20 hours under conventional heating conditions.
92
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Scheme 75 
The enantiomeric excess of trans-3-(N-tosylamino)azetidine-2-carboxylate 288 (ee > 98%) 
was deduced from the analysis on chiral HPLC involving comparison to a racemic mixture of 
azetidine 288 (Figure 8). 
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In order to extend the potential applicability of the synthesized 3-aminoazetidine-2-carboxylic 
acid derivative 288 as building block for the synthesis of peptides, azetidine 288 (Scheme 76) 
was subjected to several deprotection reactions. In an initial reaction, the ester group was 
hydrolyzed under basic conditions in 2 M NaOH in aqueous methanol, resulting in trans-3-
(N-tosylamino)azetidine-2-carboxylic acid 289 in 69% yield after acidic workup with aqueous 
HCl. Subsequently, the N-(diphenylmethyl)amino group of the azetidine 289 was N-
deprotected by hydrogenolysis in the presence of Pd(OH)2/C.
161
 After precipitation in diethyl 
ether, the trans-3-(N-tosylamino)azetidine-2-carboxylic acid 290 was obtained in 92% yield. 
The hydrogenolysis of the N-(diphenylmethyl)amino group could be directly applied on the 
ethyl ester 288, affording ethyl 3-(N-tosylamino)azetidine-2-carboxylate 291 in 87% yield, 
also after precipitation from diethyl ether. 
Figure 8. Chiral HPLC chromatogram of racemic and (2S,3R)-trans-3-(N-tosylamino)- 
azetidine-2-carboxyla e 288 
N
(S)
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Ph
Ph
COOEt
NH
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(2S,3R)-288 
tR (2S,3R)-288 = 
65.91 min  
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43.91 min  
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Scheme 76 
Furthermore, some efforts were made to cleave the N-tosyl group from trans-3-(N-
tosylamino)azetidine-2-carboxylic ester 288 (Scheme 76, Table 3), unfortunately without 
success. In an initial attempt, treatment of azetidine 288 with Mg turnings in MeOH,
162,163
 
gave no reaction (Table 3, entry 1). When azetidine 288 was treated with sodium 
naphthalenide in THF at -78 °C (entry 2) or at -20 °C (entry 3),
164
 no reaction occurred and 
the starting material was completely recovered. Performing this reaction at room temperature 
for 30 minutes led to a complex mixture of unidentified products (entry 4). Also treatment of 
azetidine 288 with lithium naphthalenide instead of sodium naphthalenide did not afford the 
detosylated azetidine 292 (entry 5).
165
 The use of phenol and 48% HBr in H2O (entry 
6),
156,157,158,166
 or the use of sodium amalgam and disodium hydrogen phosphate in dry 
methanol (entry 7),
167
 both under reflux conditions gave rise to complex reaction mixtures. 
Application of conditions reported for the deprotection of tertiary sulfonamides using 
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trimethylsilyl chloride in the presence of sodium iodide (entry 8),
168
 failed also to deprotect 
azetidine 288. 
Table 3. Different attempts towards the synthesis of detosylated azetidine 292  
from azetidine 288 
Entry Solvent Reagent Temperature Time Result 
1 MeOH 10 equiv Mg rt 3 h no reaction 
2 THF 
4 equiv Na 
4.5 equiv naphthalene 
-78 °C 1 h no reaction 
3 THF 
4 equiv Na 
4.5 equiv naphthalene 
-78 °C -> -20 °C 1 h no reaction 
4 THF 
4 equiv Na 
4.5 equiv naphthalene 
rt 0.5 h decomposition 
5 THF 
14 equiv Li 
0.04 equiv naphthalene 
-78 °C 1 h no reaction 
6 
HBr  
(48 % in H2O) 
10 equiv phenol Δ 24 h decomposition 
7 MeOH 
110% mass Na/Hg 
5 equiv Na2HPO4 
Δ 1 h decomposition 
8 CH3CN 
1.5 equiv NaI 
1.5 equiv TMSCl 
Δ 3 h no reaction 
 
The procedure for the deprotection of tertiary sulfonamides using TMSCl in the presence of 
NaI was reported as straightforward.
168
 Following this strategy, azetidine 288 was N-
benzylated with benzyl bromide in the presence of K2CO3 in DMF to afford azetidine 293 in 
85% yield (Scheme 77).
169
 Next, the trans-N-benzyl-N-tosylazetidine 293 was stirred under 
reflux for 48 hours with 1.5 equivalents TMSCl in the presence of 1.5 equivalents NaI, yet 
without formation of the trans-(3-N-benzylamino)azetidine 294. 
In accordance with literature procedures,
162,163
 a final attempt was made by treatment of trans-
N-benzyl-N-tosylazetidine 293 with Mg turnings in MeOH via sonication for five hours at 40 
°C. This procedure afforded the detosylated trans-N-benzylazetidine 295 as the corresponding 
oxalate salt in diethyl ether (Scheme 77). Noteworthy, application of similar reaction 
conditions on the trans-N-tosylazetidine 288 failed to give any reaction. The fact that the 
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detosylation procedure with Mg turnings in MeOH was only suitable for tertiary sulfonamides 
and not for secondary sulfonamides could be explained by the presence of a moderately acidic 
proton in secondary sulfonamides that could be deprotonated by the produced methoxide 
anions, giving rise to the formation of the corresponding magnesium salts with a different 
reactivity. 
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Scheme 77 
As the synthesis of the racemic cis-isomer of azetidine 288 starting from the syn-isomer of 
aziridine 286 was not possible, but racemic syn-aziridine could be transformed into a racemic 
α,β-diamino-γ-butyrolactone,92 a similar ring transformation of syn-N-sulfinylaziridine syn-
278a to chiral α,β-diamino-γ-butyrolactones was evaluated (Scheme 78).  
Chapter 3  Results and Discussion 
 
79 
 
(R)
N
S
(S) O
(R)
N
H
Ph
Ph
OEt
O
p-Tol
(R)(R)
O O
HCl.H2N NH2.HCl
syn-278a
(dr > 99:1)
297 (94%)
0.5 M HCl in H2O/EtOAc (4:1)
 rt, 0.5 h
(R)
N
S(S)
O
(R) N
H
p-Tol
O O
Et
Ph
Ph (R)
N
(R)
NH2.HCl
H
O O
Et
H H
Cl
HCl
H2O
syn-281a 296  
Scheme 78 
By careful optimization of reaction conditions, (2R,3R)-2,3-diamino-4,4-dimethyl-
butyrolactone 297 was prepared by treatment of aziridine syn-278a in 0.5 M HCl in 
H2O/EtOAc for 30 minutes at room temperature in quantitative yield (Scheme 78). The 
optically pure lactone 297 could further be applied in the synthesis of new β-amino-
substituted analogues of N-acyl homoserine lactones acting as quorum sensing interfering 
compounds.
170,171,172
 
(2R,3R)-2,3-Diamino-4,4-dimethylbutyrolactone 297 was subsequently treated with different 
electrophiles. In a first reaction, the amino groups of the chiral α,β-diamino-γ-butyrolactone 
297 were protected by reaction with 2.6 equivalents of Boc2O in the presence of five 
equivalents of Et3N in THF for 18 hours at room temperature (Scheme 79). The resulting 
double Boc-protected α,β-diamino-γ-butyrolactone 298 was obtained in 60% yield after flash 
chromatography on silica gel. In order to synthesize a bicyclic α,β-diamino-γ-butyrolactone 
299, the (2R,3R)-2,3-diamino-4,4-dimethylbutyrolactone 297 was treated with 1.5 equivalents 
of 1,1'-carbonyldiimidazole (CDI) in the presence of five equivalents of Et3N for six hours in 
dry dichloromethane at reflux (Scheme 79). Unfortunately, application of these reaction 
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conditions failed to afford the desired bicyclic α,β-diamino-γ-butyrolactone 299 and only a 
complex reaction mixture was obtained according to 
1
H NMR analysis. 
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Scheme 79 
In order to prepare an α,β-diamino-γ-butyrolactone which can be selectively 
protected/deprotected, the synthesis of N-(diphenylmethylamino)aziridine syn-281 was 
performed as this was a potential precursor of the N
α
-protected α,β-diamino-γ-butyrolactone 
300. Therefore, the diphenylmethylene group of syn-N-sulfinylaziridine syn-278a was first 
reduced with NaCNBH3 in the presence of acetic acid in MeOH, which afforded the N-
(diphenylmethylamino)aziridine syn-281 in 71% yield after column chromatography on silica 
gel (Scheme 80). Unfortunately, the transformation of N-(diphenylmethylamino)aziridine syn-
281 towards N
α
-protected α,β-diamino-γ-butyrolactone 300 by treatment in a 1:1 solvent 
mixture of NH4Cl (sat.)/ethanol for 16 hours at reflux was not successful. 
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Scheme 80 
Additionally, syn-γ-chloro-α,β-diamino ester syn-277a was subjected to a deprotection 
reaction by treatment with TFA as previously described for the deprotection of the anti-N-
sulfinylaziridines anti-278a. Thus, syn-γ-chloro-α,β-diamino ester syn-277a was treated with 
five equivalents of trifluoroacetic acid in acetone/water (2:1) for 15 minutes (Scheme 81). 
Following basic workup with NH4OH, the syn-γ-chloro-α,β-diamino ester syn-301 was 
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isolated in 83% yield. The fact that the N-sulfinyl group was not removed under these 
conditions was remarkable, as the deprotection of anti-aziridine anti-278a under the same 
reaction conditions led to unprotected aziridine 280 (vide supra). 
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Next to the Mannich-type addition of N-(diphenylmethylene)glycine esters 273 across chiral 
N-sulfinyl-α-chloroisobutyraldimine 266a, the addition across N-sulfinyl-α-
chloroacetaldimine 266h was also investigated (Scheme 82).  
In a first reaction (Table 4, entry 1), the Mannich-type addition was performed by 
deprotonation of ethyl glycinate 273a for one hour at -78 °C using 1.1 equivalents of LDA 
followed by addition across chiral N-p-toluenesulfinyl-α-chloroacetaldimine 266h for five 
minutes at -90 °C. 
1
H NMR analysis of the crude reaction mixture indicated that the resulting 
γ-chloro-α,β-diamino ester major-302a was obtained with a moderate selectivity (dr = 74:26). 
After purification by tedious column chromatography, the Mannich-type adduct major-302a 
was isolated as one single diastereomer in 54% yield.  
In the following reaction (entry 2), the Mannich-type addition was performed by 
deprotonation of ethyl glycinate 273a for one hour at -78 °C using 1.1 equivalents of 
LiHMDS and subsequent reaction across chiral N-p-toluenesulfinyl-α-chloroacetaldimine 
266h for an additional hour at -90 °C. Based on the 
1
H NMR spectrum of the crude reaction 
mixture, the resulting γ-chloro-α,β-diamino ester major-302a had the same stereochemistry as 
this obtained by reaction with LDA (entry 1). γ-Chloro-α,β-diamino ester major-302a was 
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obtained in a similar selectivity (dr = 77:23), and was again isolated as one single 
diastereomer in 59% yield by tedious column chromatography. 
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Scheme 82 
Table 4. Addition of N-(diphenylmethylene)glycine esters 273 across N-p-
toluenesulfinylimine 266h producing syn- or anti-addition products 302 
Base Time R major/minor ratio 
a
 Yield (%)  
LDA 5 min Et 74:26 54 
b
 
LiHMDS 1 h Et 77:23 59 
b
 
LiHMDS 5 min Me 85:15 - 
c
 
 a
 Determined via 
1
H NMR of crude reaction mixtures 
 b 
Isolated yield of the single major-diastereomer 302a 
 
c 
Reaction mixture could not be purified  
 
Repeating the reaction by deprotonation of methyl glycinate 273b with 1.1 equivalents of 
LiHMDS for one hour at -78 °C (Table 4, entry 3) and subsequent reaction across chiral N-p-
toluenesulfinyl-α-chloroacetaldimine 266h for five minutes at -90 °C led to the formation of 
γ-chloro-α,β-diamino ester major-302b in a slightly improved diastereoselectivity (dr = 
85:15), but efforts to purify the crude reaction mixture by column chromatography on silica 
gel failed to give the pure γ-chloro-α,β-diamino ester major-302b. Moreover, there was no 
influence of the used base, LiHMDS or LDA, on the diastereoselectivity of the Mannich-type 
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additions across chiral N-sulfinyl-α-chloroacetaldimine 266h, in contrast to the great 
importance of the base in the synthesis of the γ-chloro-α,β-diamino pentanoates syn-277 and 
anti-277 (vide supra). 
Unfortunately, neither the absolute nor the relative stereochemistry could unambiguously be 
determined by comparison of the 
1
H NMR chemical shifts or the characteristic vicinal 
coupling constants of these γ-chloro-α,β-diamino esters major-302 with the previously 
synthesized γ-chloro-α,β-diamino esters syn-277 (vide supra). Furthermore, it was also 
impossible to determine the absolute stereochemistry of the major-adduct major-302a by 
means of an X-ray diffraction analysis as this compound was not crystalline. 
In order to determine the absolute stereochemistry of the γ-chloro-α,β-diamino esters major-
302, the direct preparation of the corresponding N-sulfinylaziridine 303 via a single-step 
reaction was investigated. The Mannich-type addition of the Li-enolate derived from ethyl 
glycinate 273a, across imine 266h was, after five minutes at -90 °C, stirred for an additional 
two hours at room temperature (Scheme 83). Unfortunately, this procedure, which was 
previously shown to afford syn-N-sulfinylaziridine syn-278a, gave only a complex reaction 
mixture.  
Therefore, further investigation will be necessary to assign the absolute stereochemistry of 
these compounds major-302 in order to use them as potential building blocks in asymmetric 
organic synthesis. 
 
 
 
 
Scheme 83 
 
Chapter 3  Results and Discussion 
 
84 
 
In conclusion, it was demonstrated that new chiral syn- and anti-γ-chloro-α,β-
diaminopentanoates were formed in high yield and excellent diastereomeric ratios via 
stereoselective Mannich-type reactions of N-(diphenylmethylene)glycine esters across a chiral 
N-p-toluenesulfinyl-α-chloroimine. The base used for the deprotonation of the glycine ester 
had a crucial influence on the diastereoselectivity of the Mannich-type reaction, with LDA 
leading selectively to anti-diastereomers, whereas the use of LiHMDS gave exclusively syn-
diastereomers. The γ-chloro-α,β-diaminopentanoates proved to be versatile building blocks in 
asymmetric synthesis as demonstrated by several selective transformations to new syn- and 
anti-β,γ-aziridino-α-amino esters, trans-3-aminoazetidine-2-carboxylates and α,β-diamino-γ-
butyrolactones. Unfortunately, the preparation of the corresponding γ-chloro-α,β-
diaminobutanoates occurred only in moderate diastereoselectivities and the absolute 
stereochemistry of these derivatives remained unknown. 
 
3.2.3. Synthesis and elaboration of γ-chloro-α-diphenylmethyleneamino-β-
tert-butanesulfinylamino carboxylic acid derivatives 
In addition to the stereoselective Mannich-type additions across (SS)-N-p-toluenesulfinyl-α-
chloroaldimine (SS)-266a (vide supra), the synthesis of chiral α,β-diamino acid derivatives 
with the enantiotopic stereochemistry has also been explored via addition of N-
(diphenylmethylene)glycine ester 273a across (RS)-N-tert-butanesulfinyl-α-chloroaldimines 
(RS)-270. The choice for the (RS)-N-tert-butanesulfinyl-α-chloroaldimines (RS)-270 was based 
on the high price of the (RS)-p-toluenesulfinamide (456 ₤/5 g) in comparison with the price of 
the (RS)-tert-butanesulfinamide (26 ₤/5 g),
173
 and also on the fact that the tert-butanesulfinyl 
group can be readily deprotected.  
The Mannich-type addition was performed by systematically changing the reaction conditions 
for the synthesis of γ-chloro-α,β-diamino esters 304 (Scheme 84, Table 5). It was found that 
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the base, LDA or LiHMDS, used for the deprotonation of the glycine ester 273a, had again a 
great influence on the syn- or anti-selectivity of this reaction (Table 5). In a first reaction 
(Table 5, entry 1), the Mannich-type addition of ethyl glycinate 273a across chiral N-tert-
butanesulfinyl-α-chloroisobutyraldimine (RS)-270a was performed for five minutes at -90 °C 
using 1.1 equivalents of LiHMDS. 
1
H NMR analysis of the crude reaction mixture indicated 
that the resulting syn-γ-chloro-α,β-diamino ester syn-304 was formed with a good syn-
selectivity, but no full conversion of the starting imine (RS)-270a was obtained (ratio (RS)-
270a/syn-304/anti-304 = 19:73:8). The syn-adduct syn-304 was isolated as a single 
diastereomer in a yield of 54% after purification by column chromatography and subsequent 
recrystallization in diethyl ether. Repeating the reaction with LiHMDS for prolonged reaction 
times (15 to 90 minutes) led again to the formation of syn-γ-chloro-α,β-diamino ester syn-304, 
but surprisingly more starting product was recovered at longer reaction times (entries 2 and 
4). Unfortunately, also performing the reaction with 1.6 equivalents of the Li-enolate for 15 
minutes at -90 °C (entry 3) did not result in higher conversions of the starting material. These 
remarkable results whereby prolonged reaction times were leading to lower conversions of the 
starting N-tert-butanesulfinyl-α-chloroisobutyraldimine (RS)-270a could be explained by the 
fact that Mannich-type addition across this N-tert-butanesulfinylimine (RS)-270a was 
probably more susceptible for a retro-Mannich-type reaction. Noteworthy, the 
diastereoselectivity of the reaction decreased also at prolonged reaction times (Table 5), 
which could be an indication that the syn-γ-chloro-α-diphenylmethyleneamino-β-tert-
butanesulfinylamino ester syn-304 was not the thermodynamically favoured reaction product, 
which was the case for the syn-γ-chloro-α-diphenylmethyleneamino-β-p-toluenesulfinylamino 
esters syn-277 (vide supra). 
In the following reaction (entry 5), the Mannich-type addition was performed for five minutes 
at -90 °C with 1.1 equivalents of LDA, resulting in a low conversion towards anti-γ-chloro-
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α,β-diamino ester anti-304 accompanied by a large recovery of the starting imine (RS)-270a 
(ratio (RS)-270a/syn-304/anti-304 = 64:7:29). In order to improve the conversion towards 
anti-304, the reaction was performed for 15 minutes at -90 °C using 1.1 equivalents of LDA 
(entry 6). These conditions led to a slightly better conversion (ratio (RS)-270a/syn-304/anti-
304 = 41:13:46), and anti-γ-chloro-α,β-diamino ester anti-304 was obtained in 22% yield as a 
single diastereomer (as partially characterized by 
1
H NMR analysis) after purification by 
column chromatography. Unfortunately, the prolongation of the reaction time to 90 minutes at 
-90 °C using 1.1 equivalents of LDA (entry 7), failed again to give a higher conversion 
towards the anti-adduct anti-304.  
Hereby, the assignment for the syn- and anti-stereochemistry of the Mannich-type addition 
products 304 was based on a comparison of analytical data with a combination of analogous 
1
H NMR chemical shifts (Hβ,syn:  = 4.12 ppm, Hβ,anti: = 3.69 ppm) and the characteristic 
vicinal coupling constants (
3
JHα-Hβ,syn = 0 Hz, 
3
JHα-Hβ,anti = 3.3 Hz) of the previously described 
syn- and anti-γ-chloro-α-diphenylmethyleneamino-β-p-toluenesulfinylamino esters 277 (vide 
supra). 
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Table 5. Addition of N-(diphenylmethylene)glycine ester 273a across N-tert-
butanesulfinylimine (RS)-270a producing syn- and anti-addition products 304 
Entry X Base Time (min) (RS)-270a/syn-304/anti-304
a
 Yield (Product) 
1 1.1 LiHMDS 5 19:73:8 54% (syn-304)
b
 
2 1.1 LiHMDS 15 24:57:19 - 
c
 
3 1.6 LiHMDS 15 23:54:23 - 
c
 
4 1.1 LiHMDS 90 34:29:37 - 
c
 
5 1.1 LDA 5 64:7:29 - 
c
 
6 1.1 LDA 15 41:13:46 22% (anti-304)
b
 
7 1.1 LDA 90 52:13:35 -
c
 
 a
 Ratio determined via 
1
H NMR of crude reaction mixtures 
 
b 
Isolated yield of the single diastereomer (dr > 99:1) 
 
c
 Reaction mixture was not purified 
 
The great influence of the used base, LDA or LiHMDS (Scheme 84), on the stereochemical 
outcome of the Mannich-type reaction across N-tert-butanesulfinyl-α-chloroimine (RS)-270a 
was again rationalized on the basis of the enolate geometry of the anions derived from the 
deprotonation of N-(diphenylmethylene)glycine ester 273a. As previously described, the 
enolates obtained via deprotonation of N-(diphenylmethylene)glycine ester 273a with LDA 
were expected to have the Z-geometry, whereas deprotonation with the less basic LiHMDS in 
THF would afford the E-enolate (vide supra). Reaction of the Z- and E-enolates via TS-305A 
and TS-305B (Scheme 85) resulted in the formation of anti-304 and syn-304, respectively.
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Scheme 85 
The syn-addition product syn-304 was subsequently cyclized to the corresponding N-
sulfinylaziridine anti-306 in excellent yield (97%) upon treatment with K2CO3 for 48 hours in 
acetone under reflux (Scheme 86). The fact that treatment of syn-addition product syn-304 
under the latter conditions did not afford the corresponding syn-N-sulfinylaziridine syn-306 
showed that a base-induced isomerization in α-position occurred, which resulted in the 
thermodynamically controlled formation of the anti-N-sulfinylaziridine anti-306. 
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Scheme 86 
The absolute stereochemistry of this N-tert-butanesulfinylaziridine anti-306 was elucidated by 
means of an X-ray diffraction analysis (in collaboration with Prof. R. Sillanpää, Department 
of Chemistry, University of Jyväskylä, Finland) (Figure 9),
171
 and showed that the aziridine 
anti-306 had an (RS,2R,2’S)-stereochemistry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
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(ref 170)
Figure 9. X-ray diffraction analysis of anti-N-sulfinylaziridine anti-306  
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In addition, this anti-N-sulfinylaziridine anti-306 could also be prepared directly in 79% yield 
via a single-step reaction starting from ethyl glycinate 273a, if the reaction mixture from the 
Mannich-type addition across imine (RS)-270a after five minutes at -90 °C was subsequently 
stirred for two hours at room temperature (Scheme 87). As this procedure resulted as well in 
the synthesis of anti-aziridine anti-306, it could be concluded that anti-306 was the 
thermodynamically controlled diastereomer. The fact that the N-p-toluenesulfinylaziridine 
278 did not gave the anti-isomers, but the syn-isomers as the thermodynamically favored 
diastereomers, could be explained by the stabilizing effect of the π-π-stacking between the N-
p-toluenesulfinyl group and a phenyl group of the benzophenone imine functionality. The 
characteristic 
1
H NMR chemical shift of the para-methyl group of the N-p-toluenesulfinyl 
functionality (CaromCH3,syn: = 1.95 ppm, CaromCH3,anti: = 2.33-2.36 ppm) suggested this as 
well, as the π-π-stacking induced a shielding effect at the para-methyl group, which was 
accompanied by a upfield shift of this group. 
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Next to the Mannich-type addition of N-(diphenylmethylene)glycine esters 273 across chiral 
N-tert-butanesulfinyl-α-chloroisobutyraldimine (RS)-270a, the addition across chiral N-tert-
butanesulfinyl-α-chloroacetaldimine (RS)-270b was also investigated (Scheme 88). 
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In a first reaction (Table 6, entry 1), the Mannich-type addition was performed by 
deprotonation of ethyl glycinate 273a for one hour at -78 °C using 1.1 equivalents of 
LiHMDS and subsequent reaction across N-tert-butanesulfinyl-α-chloroacetaldimine (RS)-
270b for five minutes at -90 °C. 
1
H NMR analysis of the crude reaction mixture indicated that 
the resulting γ-chloro-α,β-diamino ester major-307 was obtained with good selectivity (dr = 
84:16). After purification by column chromatography, the Mannich-type adduct major-307 
was isolated in 79% yield.  
In the following reaction (entry 2), the Mannich-type addition was performed by 
deprotonation of ethyl glycinate 273a for one hour at -78 °C using 1.1 equivalents of LDA 
and subsequent reaction across N-tert-butanesulfinylimine (RS)-270b for five minutes at -90 
°C. According to the 
1H NMR spectrum of the crude reaction mixture, the resulting γ-chloro-
α,β-diamino ester major-307 was the same product as that obtained by reaction with LiHMDS 
(entry 1), similar to the results obtained for the previously described γ-chloro-α-
diphenylmethyleneamino-β-p-toluenesulfinylamino esters 302 (vide supra). The γ-chloro-α,β-
diamino ester major-307 was obtained with a slightly lower diastereoselectivity (dr = 72:28), 
and was isolated in 56% yield after column chromatography. 
In accordance with the synthesis of γ-chloro-α-diphenylmethyleneamino-β-p-
toluenesulfinylamino esters 302 (vide supra), there was no influence of the used base, 
LiHMDS or LDA, on the diastereoselectivity of the Mannich-type additions across chiral N-
tert-butanesulfinylimine (RS)-270b. 
Furthermore, the absolute or the relative stereochemistry of major-307 could not be 
determined by analysis of the 
1
H NMR chemical shifts or the characteristic vicinal coupling 
constants and X-ray diffraction analysis was not possible, since this compound major-307 
was not crystalline.  
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Table 6. Addition of N-(diphenylmethylene)glycine ester 273a across N-tert-
butanesulfinylimine (RS)-270b producing syn- or anti-addition products 307 
Base major/anti ratio 
a
 Yield (%) 
b
 
LiHMDS 84:16 79 
LDA 72:28 56 
 a
 Determined via 
1
H NMR of crude reaction mixtures 
 b
 Isolated yield of single diastereomer (dr > 99:1) 
 
The major-addition product major-307 was subsequently cyclized to the corresponding N-
sulfinylaziridine 308 in 45% yield upon treatment with K2CO3 for 14 hours in acetone under 
reflux (Scheme 89). Unfortunately, the synthesis of this aziridine 308 did not offer the 
possibility to assign the absolute or relative stereochemistry. 
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Scheme 89 
In conclusion, it was demonstrated that new enantiopure syn- and anti-γ-chloro-α,β-diamino-
pentanoates were formed in moderate yields via stereoselective Mannich-type reactions of the 
ethyl N-(diphenylmethylene)glycine ester across a chiral N-tert-butanesulfinyl-α-chloroimine. 
These lower yields were caused by the low conversions of the chiral N-tert-butanesulfinyl-α-
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chloroimine to the corresponding syn- and anti-γ-chloro-α,β-diaminopentanoates, probably 
due to retro-Mannich-type addition. The base used for the deprotonation of the glycine ester 
had again a great influence on the diastereoselectivity of the Mannich-type reaction, with 
LDA leading selectively to anti-diastereomers, whereas the use of LiHMDS leads to syn-
diastereomers. Furthermore, the syn-γ-chloro-α,β-diaminopentanoate was selectively 
transformed into a new anti-β,γ-aziridino-α-amino ester, whose structure was unambiguously 
determined by means of X-ray diffraction analysis. The preparation of the corresponding γ-
chloro-α,β-diaminobutanoate occurred in better yield and good diastereoselectivity and this 
compound was also transformed into the corresponding β,γ-aziridino-α-amino ester. 
Unfortunately, the stereochemistry of these derivatives could not be revealed. 
 
3.3. Asymmetric synthesis of α,β-diaminoacylpyrrolidines and -piperidines 
via stereoselective Mannich-type additions across N-sulfinyl-α-
chloroimines 
 
Given the fact that α,γ-diamino carboxylic amides, as well as β-amino carboxylic amides, are 
known for their activity as dipeptidyl peptidase (DPP) inhibitors, there is an increasing 
interest to study the DPP inhibitory potency of analogous α,β-diamino carboxylic amides.31 
The synthesis of chiral α,β-diamino carboxylic acid derivatives via asymmetric Mannich-type 
addition of enolates across activated imines, e.g. N-sulfinylimines,
156,157,174,175
 is one of the 
most common and versatile methods in organic chemistry and has continuously been under 
development.
10,11
 The asymmetric synthesis of new chiral γ-chloro-α,β-diamino carboxylic 
esters via highly diastereoselective Mannich-type reactions across the chiral N-p-
toluenesulfinyl-α-chloroimine has previously been described (vide supra), however, 
transformation of these γ-chloro-α,β-diamino carboxylic esters into the corresponding 
carboxylic acids, en route to further coupling to carboxylic amides, has not been investigated 
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because these diamino acid derivatives are prone towards ring transformation to α,β-diamino-
γ-butyrolactones. 
In the following part, the synthesis and elaboration of chiral syn-γ-chlorinated-α,β-diamino 
carboxylic amide derivatives with excellent diastereoselectivity will be demonstrated. In order 
to develop potential DPP inhibitors, the ring closure and deprotection of the α-amino 
functionality of the synthesized γ-chloro-α,β-diamino carboxylic amides were explored as 
well. 
 
3.3.1. Synthesis of N-(diphenylmethylene)glycine amides 
The synthesis of N-(diphenylmethylene)glycine amides 313 was performed starting from N-
Boc-glycine 309, in accordance with literature procedures.
176
 Activation of N-Boc-glycine by 
N,N'-dicyclohexylcarbodiimide (DCC) and subsequent addition of a cyclic amine 310 resulted 
in the formation of the corresponding N-Boc-glycine amides 311 (Scheme 90).  
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Subsequent N-Boc-deprotection of the amides 311 by treatment with a saturated HCl/EtOAc 
solution afforded the glycine amide hydrochloric acid salts 312 (68-93% yield). Reaction of 
these glycine amide salts 312 with 0.95 equivalents of benzophenone imine for 16 hours in 
dichloromethane at room temperature resulted in the desired N-(diphenylmethylene)glycine 
amides 313 in high yields (77-99%). 
 
3.3.2. Synthesis and elaboration of γ-chloro-α,β-diamino carboxylic amide 
derivatives 
The stereoselective synthesis of chiral γ-chloro-α,β-diamino carboxylic amides was performed 
using a Mannich-type addition of glycine amides 313 across chiral N-sulfinyl-α-chloroimines 
266.  
Based on the previously reported Mannich-type addition of glycine esters across chiral N-p-
toluenesulfinyl-α-chloroaldimine 266a (vide supra), the influence of the base (LiHMDS or 
LDA) used for the deprotonation of glycine amides 313a-b on the syn- or anti-selectivity of 
the Mannich-type addition was investigated (Scheme 91).  
Initially, the Mannich-type addition of glycine amide 313b across chiral N-p-toluenesulfinyl-
α-chloroisobutyraldimine 266a was performed at -78 °C using 1.1 equivalents of LDA. 
According to the 
1
H NMR analysis of the crude reaction mixture, the resulting syn-γ-chloro-
α,β-diamino carboxylic amide syn-314b was formed with an excellent stereoselectivity (dr > 
99:1), yet in rather low conversion. After crystallization, the syn-adduct syn-314b was isolated 
in a low yield of 16%. Repeating the Mannich-type addition of glycine amides 313 across 
chiral N-p-toluenesulfinyl-α-chloroaldimines 266 with 1.1 equivalents of LiHMDS resulted 
also in the formation of syn-γ-chlorinated-α,β-diamino carboxylic amides syn-314 with an 
excellent stereoselectivity (dr > 99:1). The conversion of the substrates was complete under 
these reaction conditions (-78 °C, 15 minutes), and the syn-adducts syn-314 were isolated in 
12-76% yield after recrystallization. The diastereomeric ratio of these syn-γ-chlorinated-α,β-
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diamino carboxylic amides syn-314 (dr > 99:1) was determined by means of 
1
H NMR, 
13
C 
NMR and HPLC analysis where no signals from other diastereomers could be detected.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
 Yield in parentheses result from the use of LDA instead of LiHMDS 
Scheme 91 
In contrast to the Mannich-type addition of glycine esters 273 across chiral N-p-
toluenesulfinyl-α-chloroimine 266a (vide supra), the diastereoselectivity of the Mannich-type 
addition of glycine amides 313 across chiral N-p-toluenesulfinyl-α-chloroaldimines 266a-g 
was independent of the choice of the base used. The absolute stereochemistry of γ-chloro-α,β-
diamino carboxylic amides syn-314a-f and γ,γ-dichloro-α,β-diamino carboxylic amides syn-
314g-n was unambiguously determined by means of X-ray diffraction analysis of compounds 
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syn-314b and syn-314h (in collaboration with Prof. K. W. Törnroos, Department of 
Chemistry, University of Bergen, Norway), respectively (Figure 10). Additionally, analogous 
1
H NMR chemical shifts (Hα: -5.25 ppm, Hβ: -4.25 ppm) and the 
characteristic vicinal coupling constants (
3
JHα-Hβ = 0-1.1 Hz) of all derivatives syn-314a-n 
pointed out the (SS,2S,3S)-stereochemistry. 
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The vicinal coupling constant 
3
JHα-Hβ = 0-1.1 Hz for the syn-amides 314 had a comparable 
small value as the observed vicinal coupling constant 
3
JHα-Hβ of the closely related syn-γ-
Figure 10. Crystal structures of (SS,2S,3S)-γ-chlorinated-α,β-diamino carboxylic amides 
 syn-314b and syn-314h 
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chloro-α,β-diamino carboxylic esters (3JHα-Hβ = 1.1 Hz). Notably, the (SS,2S,3S)-γ-chlorinated-
α,β-diamino carboxylic amides syn-314 were obtained with the opposite enantioselectivity as 
compared to the (SS,2R,3R)-γ-chloro-α,β-diamino carboxylic esters syn-277 obtained via 
Mannich-type addition of E-enolates derived from glycine esters 273 across imine 266a (vide 
supra). The monosubstituted tertiary amide enolates obtained via deprotonation of N-
(diphenylmethylene)glycine amides 313 were expected to have the Z-geometry in which 
A(1,3) interactions were minimized and Li-chelation stabilizes the conformation (Scheme 92), 
regardless of the base used.
177
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Reaction of the Z-enolates via a cyclic chelated six-membered chairlike transition state model 
TS-315A, would have resulted in anti-addition products anti-314 in analogy with the 
previously obtained results on the synthesis of (SS,2S,3R)-γ-chloro-α,β-diamino carboxylic 
esters (vide supra). However, starting from glycine amides 313, due to the important 1,3-
diaxial interaction between the haloalkyl group (-CClR
1
R
2
) and the cyclic amine moiety  
[-N(CH2)n(CH2)3] in this transition state, TS-315A was highly disfavoured. The formation of 
the (SS,2S,3S)-γ-chlorinated-α,β-diamino carboxylic amides syn-314 could be explained by a 
boatlike transition state model TS-315B involving the (E)-N-p-toluenesulfinylaldimines 266a-
g.
91,178
 This less sterically hindered transition state TS-315B in which the haloalkyl group  
(-CClR
1
R
2
) occupied the less hindered pseudoequatorial position and the corresponding  
Li-adduct 316, were stabilized by the interaction between the Li-cation, the 
diphenylmethyleneamino group and the sulfinylimine nitrogen. 
The reversal of the enantiotopic face selectivity in the reaction of the N-sulfinyl imines 266a-
g with the glycine amides 313, as compared to the reaction with glycine esters 273, was 
attributed to the α-coordinating ability of the chlorine atom with the lithium of the incoming 
enolate as depicted in transition state TS-315B. The coordinating α-chloro atom in TS-315B 
overrode the chelation of the sulfinyl oxygen (e.g. TS-315A) and allowed the sulfinylimine to 
react in the conformation wherein the S=O bond and the lone pair of electrons on the nitrogen 
atom were anti-periplanar.
179
 This reversal of stereoselectivity was analogous to results 
obtained with other N-p-toluenesulfinyl imines containing an oxygen atom as α-coordinating 
group.
34,180
 
In a next attempt, the direct preparation of the corresponding N-sulfinyl-β,γ-aziridino-α-amino 
carboxylic amide 317b was evaluated via a single-step reaction. Thus, the reaction mixture 
from the Mannich-type addition of the Li-enolate derived from amide 313b, across imine 
266a was after 15 minutes at -78 °C additionally stirred for 90 minutes at room temperature 
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(Scheme 93). Unfortunately, this procedure proved to be unsuccessful for the preparation of 
syn-N-sulfinylaziridine 317b and afforded only a complex reaction mixture.  
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Scheme 93 
Next, the syn-addition products syn-314 were cyclized to the corresponding N-sulfinyl-β,γ-
aziridino-α-amino carboxylic amides 317 upon treatment with K2CO3 in acetone under reflux 
in a moderate to very good yield (36-90%) (Scheme 94).  
The conversion of the ring-closure reaction was always complete as determined by TLC 
analysis, but purification of these N-sulfinyl-β,γ-aziridino-α-amino carboxylic amides 317 by 
flash chromatography resulted in a considerable loss of product. 
In order to extend the potential applicability of the synthesized N-sulfinyl-β,γ-aziridino-α-
amino carboxylic amides 317 as building blocks in biomedicinal chemistry, some attempts 
were made to remove the N-protective groups of diamino carboxylic amides 317 under mild 
acidic conditions (Scheme 94). In analogy with the previously described results on the 
corresponding aziridino esters 280 (vide supra), amide 317b was treated with five equivalents 
of trifluoroacetic acid in acetone/water (2:1) at room temperature for 15 minutes. After a basic 
workup with NH4OH, it was concluded that the conversion towards the N-deprotected syn-
β,γ-aziridino-α-amino carboxylic amide 318b was complete, based on 1H NMR and LC-MS 
analysis of the crude reaction mixture. Unfortunately, all attempted purification techniques 
(column chromatography, preparative TLC, acid-base extraction) in order to remove 
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benzophenone and some other minor impurities from the crude reaction mixture, failed to 
provide the pure N-deprotected syn-β,γ-aziridino-α-amino carboxylic amide 318b. 
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Scheme 94 
Alternatively, the deprotection of the α-amino functionality of the synthesized syn-γ-
chlorinated-α,β-diamino carboxylic amides syn-314 was investigated en route towards the 
development of potential DPP inhibitors.
27
 For this purpose, syn-γ-chlorinated-α,β-diamino 
carboxylic amides syn-314a-d,f-g were treated with five equivalents of trifluoroacetic acid in 
acetone/water (2:1) for 15 minutes (Scheme 95). After a basic workup with NH4OH, the α-
deprotected syn-γ-chloro-α,β-diamino carboxylic amides 319 could be purified by 
crystallization or preparative TLC (21-91% yield). The obtained result was in accordance with 
the earlier reported selective deprotection of a benzophenone imine functionality of diamino 
esters, containing a N-p-toluenesulfinyl moiety, with H3PO4/H2O/THF.
175,181
 
In a next step, syn-γ-chloro-α,β-diamino carboxylic amide 319b was chemoselectively 
cyclized to the corresponding N-sulfinyl-β,γ-aziridino-α-amino carboxylic amide 320b upon 
treatment with K2CO3 in acetone under reflux in 86% yield. 
Chapter 3  Results and Discussion 
 
102 
 
(S)
R1
Cl
R2
(S)
N
O
NH
N Ph
Ph
S
(S)
O
p-Tol 1) 5 equiv TFA
    acetone/H2O (2:1) 
    rt, 15 min
2) NH4OH (S)
R1
Cl
R2
(S)
N
O
NH
NH2
S
(S)
O
p-Tol
syn-314
(dr > 99:1) 319a (70%)
319b (21%)
319c (91%)
319d (59%)
319f (78%)
319g (53%)
n
n
(S)
(S)
N
S
(S) Op-Tol
NH2
O
NH
3 equiv K2CO3
acetone, , 24 h
320b
(86%, dr > 99:1)
R1,R2 = Me
n = 2(dr > 99:1)
 
Scheme 95 
In order to provide access to the N
α
,N
β
-deprotected syn-γ-chloro-α,β-diamino carboxylic 
amides, syn-γ-chloro-α,β-diamino carboxylic amides syn-314 were subjected to some 
alternative acidic deprotection reactions (Scheme 96).  
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Scheme 96 
In a first reaction, syn-γ-chloro-α,β-diamino carboxylic amide syn-314b was treated with ten 
equivalents of trifluoroacetic acid in ethanol at room temperature.
156
 This resulted in trans-
imidazolidine 321b after basic workup with NH4OH. It was remarkable that the N-
(diphenylmethylene) group was not removed under these reaction conditions, but was trapped 
by the deprotected β-amino group, as the deprotection of analogous anti-substrates under the 
same reaction conditions led to unprotected anti-α,β-diamino carboxylic esters.156 This was 
possibly due to the fact that solvolysis of the imine functionality with ethanol was not 
favorable and an acid-catalyzed deprotection of the sulfinyl moiety would occur first.
182
 The 
resulting β-amino deprotected syn-γ-chloro-α,β-diamino carboxylic amide could subsequently 
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ring close further to trans-imidazolidine 321b, which was less sterically congested than an 
analogous cis-imidazolidine. In the literature, comparable non-halogenated trans-
imidazolidines have already been synthesized via 1,3-dipolar cycloaddition of N-
(diphenylmethylene)glycine ester enolates across N-sulfinyl aldimines in the presence of a 
Lewis acid.
183
 The trans-stereochemistry of imidazolidine 321b was confirmed by the vicinal 
coupling constant 
3
JH4-H5 = 7.2 Hz and the 
1
H NMR chemical shift of H4 (3.85 ppm) which 
were in the same range as for closely related trans-imidazolidines and trans-
oxazolidines.
183,184
 The trans-imidazolidine 321b could be a potential building block for 
foldamers, as the corresponding trans-oxazolidin-2-ones have already been applied for this 
purpose.
49
 Trans-imidazolidine 321b could also be used as precursor for the corresponding 
N
α
,N
β
-deprotected α,β-diamino carboxylic amide, obtained via hydrolysis under acidic 
conditions, as described for the deprotection of imidazolidines, imidazolines and oxazolines in 
the literature.
174,185
 However, in a second reaction, syn-γ-chloro-α,β-diamino carboxylic amide 
syn-314a was directly converted into the hydrochloride of the N
α
,N
β
-deprotected syn-γ-chloro-
α,β-diamino carboxylic amide 322a, by stirring in 0.5 M (aq.) HCl/EtOAc (2:1) for 30 
minutes at room temperature, in a yield of 83%. In this reaction, the acid-catalyzed hydrolysis 
of the benzophenone imine functionality proceeds readily and prevents the formation of the 
corresponding trans-imidazolidine. 
Furthermore, it was endeavored to use the synthesized syn-γ-chloro-α,β-diamino carboxylic 
amides syn-314 as building blocks for the synthesis of 1,2-diaminocyclopropanecarboxylic 
acid derivatives 324, which are structural analogues of 1-aminocyclopropane-1-carboxylic 
acid (α-ACC), the precursor of the plant hormone ethylene. Nature uses an imination/α-
deprotonation/ring closure strategy in the biosynthesis of α-ACC (not shown), and broadening 
of this approach delivered already new amino- and alkoxy-substituted cyclopropanes.
186
 For 
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this purpose, the synthesis of precursor 323 with a fully protected β-amino group via reaction 
with different electrophiles was envisioned (Scheme 97, Table 7). 
In accordance with the previously described N-benzylation of azetidine 288 (vide supra), γ-
chloro-α,β-diamino carboxylic amide syn-314d was treated with benzyl bromide in the 
presence of K2CO3 for three hours in DMF, which resulted in a complete recovery of the 
starting material syn-314d (Table 7, entry 1). A next attempt was made by reaction of syn-
314d with two equivalents of Boc2O in the presence of DMAP in dry CH2Cl2 at room 
temperature for 10 days, which gave again no conversion (entry 2). The reaction of syn-314d 
with three equivalents of methyl iodide in the presence of K2CO3 in a DMF/CH3CN-solvent 
mixture at room temperature for 16 hours afforded, next to unreacted starting material syn-
314d, 18% of aziridine 317d according to 
1
H NMR analysis of the crude reaction mixture 
(entry 3). Performing the reaction with 2.5 equivalents of trimethyloxonium tetrafluoroborate 
(Me3O
+
.BF4
-
) in the presence of 3.5 equivalents of DIPEA for 16 hours in dry CH2Cl2 at room 
temperature, did not result in the desired compound 323 (R = Me) (entry 4). In a final attempt, 
the reaction was conducted with five equivalents of diazomethane in dry CH2Cl2 for three 
hours at room temperature, but again no reaction occurred under these conditions (entry 5). 
No further attempts towards the synthesis of the fully protected syn-γ-chloro-α,β-diamino 
carboxylic amide 323 were made, as it was assumed that too many sterical interactions were 
present to obtain the desired compound 323. 
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Table 7. Different reaction conditions for the conversion of syn-314d towards compound 323 
Reagent 
(Equiv) 
Additive 
(Equiv) 
Solvent Time Temp. (°C) Result 
BnBr (1.1) K2CO3 (1.2) DMF 3 h rt No reaction 
Boc2O (2) DMAP (1.1) CH2Cl2 (dry) 10 d rt No reaction 
MeI (3) K2CO3 (3) DMF/CH3CN (2:1) 16 h rt 317d (18%)
 a
 
Me3O
+
.BF4
-
 (2.5) DIPEA (3.5) CH2Cl2 (dry) 16 h rt No reaction 
CH2N2 (5) - CH2Cl2 (dry) 3 h rt No reaction 
 a
 Determined via 
1
H NMR of crude reaction mixture 
In order to extend the scope of this synthetic strategy, the Mannich-type addition of N-
(diphenylmethylene)glycine amides 313 across N-sulfinyl-α-chloroacetaldimine 266h was 
also investigated (Scheme 98).  
Therefore, the Mannich-type addition was performed by deprotonation of glycine amide 313b 
for one hour at -78 °C using 1.1 equivalents of LiHMDS and subsequent reaction across chiral 
N-p-toluenesulfinyl-α-chloroacetaldimine 266h for 15 minutes at -78 °C. 1H NMR analysis of 
the crude reaction mixture indicated that the resulting γ-chloro-α,β-diamino amide 325 was 
obtained in high selectivity (dr = 90:10). However, upon purification by tedious column 
chromatography, the Mannich-type adducts 325 could not be isolated and only side product 
326 was obtained as one single diastereomer in 9% yield. The formation of side product 326 
could be explained by hydrolysis of the amide group of Mannich-type adduct 325, resulting in 
the corresponding carboxylic acid, which subsequently underwent ring closure to the 
corresponding γ-lacton.  
Unfortunately, the stereochemistry of compound 325 could not be assigned by comparison of 
the 
1
H NMR chemical shifts or the characteristic vicinal coupling constants of this γ-chloro-
α,β-diamino carboxylic amide 325 with the previously synthesized γ-chloro-α,β-diamino 
carboxylic amides syn-314 (vide supra). Furthermore, it was also impossible to determine the 
stereochemistry of compound 326 by means of an X-ray diffraction analysis as this compound 
was not crystalline.  
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Scheme 98 
In addition, some attempts were made to synthesize the syn-γ-chloro-α,β-diamino carboxylic 
amides 327 with the enantiotopic stereochemistry by means of stereoselective Mannich-type 
addition of N-(diphenylmethylene)glycine amide 313b across (RS)-N-tert-butanesulfinyl-α-
chloroimine (RS)-270a.  
The Mannich-type addition was performed by systematically changing the reaction conditions 
(Scheme 99, Table 8). In a first attempt (entry 1), the Mannich-type addition of glycine amide 
313b across chiral N-tert-butanesulfinyl-α-chloroisobutyraldimine (RS)-270a was performed 
for 15 minutes at -78 °C using 1.1 equivalents of LiHMDS. 
1
H NMR analysis of the crude 
reaction mixture indicated that the resulting γ-chloro-α,β-diamino carboxylic amide 327 was 
formed as one single diastereomer but only with 30% conversion of the starting imine (RS)-
270a. Performing the reaction with LiHMDS for a prolonged reaction time (180 minutes) led 
to 70% conversion of the starting imine (RS)-270a, yet the resulting γ-chloro-α,β-diamino 
carboxylic amide 327 was obtained as a mixture of three diastereomers (entry 2). In a 
following attempt, the reaction was performed with five equivalents of the Li-enolate for 15 
minutes at -78 °C (entry 3), which resulted in 50% conversion of the starting material and the 
formation of one single diastereomer of compound 327. In a final attempt, the Mannich-type 
addition of the Li-enolate derived from glycine amide 313b, across imine (RS)-270a was after 
15 minutes at -78 °C, additionally stirred for 90 minutes at room temperature (entry 4). 
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Unfortunately, this procedure afforded a complex mixture of different diastereomeric 
aziridines. 
As none of these adducts 327 could be isolated, it was impossible to assign the 
stereochemistry of these γ-chloro-α,β-diamino carboxylic amides 327. Therefore, further 
investigation is required to reveal the relative and absolute stereochemistry of compounds 327 
in order to use them as potential building blocks in asymmetric organic synthesis. 
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Scheme 99 
Table 8. Addition of N-(diphenylmethylene)glycine amide 313b across N-tert-
butanesulfinylimine (RS)-270a producing adducts 327 
Entry X Time (min) Temp. (°C) Result 
1 1.1 15 -78 30% conversion, 1 diastereomer 327 
2 1.1 180 -78 70% conversion, 3 diastereomers 327 
3 5 15 -78 50% conversion, 1 diastereomer 327 
4 1.1 15 + (90) -78 + (rt) complex mixture of aziridines 
 
In conclusion, it was demonstrated that new chiral syn-γ-chlorinated-α,β-diamino carboxylic 
amides were formed in acceptable to good yields with excellent diastereomeric ratios via 
stereoselective Mannich-type reactions of N-(diphenylmethylene)glycine amides across chiral 
N-p-toluenesulfinyl-α-chloroaldimines. Notably, a very high syn-diastereoselectivity was 
obtained in the synthesis of these (SS,2S,3S)-γ-chlorinated-α,β-diamino carboxylic amides 
with the opposite enantiotopic face selectivity as compared to the Mannich-type additions of 
N-(diphenylmethylene)glycine esters across chiral N-p-toluenesulfinyl-α-chloroaldimines. 
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The synthesized γ-chloro-α,β-diamino carboxylic amides were ring closed to the 
corresponding aziridines or selectively deprotected under acidic conditions, and the resulting 
α,β-diaminoacylpyrrolidines and -piperidines could have a potential applicability as 
dipeptidyl peptidase inhibitors which is currently under investigation. 
 
3.3.3. Biotesting results of α,β-diamino carboxylic amide derivatives 
A first small library of diamino amide derivatives 317 and 319 was screened by the research 
group of Prof. K. Augustyns and Prof. P. Van der Veken, Department of Medicinal 
Chemistry, University of Antwerp, Belgium for their FAP and DPP inhibitory activity (Table 
9). These biotesting results showed that only the deprotected α-amino pyrrolidine amide 319a 
had some selective inhibitor activity for DPP2 and that the presence of the benzophenone 
imine lowers the affinity for the enzymes. Therefore, the biotesting of a new library of N
α
-
unprotected γ-chloro-α,β-diamino amides 319, an α-deprotected β,γ-aziridino-α-amino amide 
320b, a fully deprotected γ-chloro-α,β-diamino amide 322a and some selectively or 
completely deprotected α,β,γ-triamino amides (vide infra) is currently under investigation for 
their activity as FAP- and DPP-inhibitors by the group of Prof. K. Augustyns and Prof. P. Van 
der Veken. 
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Table 9. IC50-values of diamino amide derivatives 317a-b and 319a-b tested for in vitro  
FAP and DPP inhibitory activity and literature values
28b
 of reference compounds  
UAMC 0039 (DPPIV) and (S)-2,4-diaminobutanoylpiperidine 10 (DPPII)  
Compound 
FAP 
IC50 (µM) 
DPPIV 
IC50 (µM) 
DPP9 
IC50 (µM) 
DPPII 
IC50 (µM) 
PO 
IC50 (µM) 
 
 
 
>12.5 >100 >100 >100 >100 
 
 
 
>12.5 >100 >100 >100 >100 
 
 
 
>100 >100 >100 37±5 >50 
 
 
 
>100 >100 >100 >50 >100 
 
 
 
- 
 
165 - 0.00048 - 
  
- 
 
>1000 - 0.130 - 
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3.4. Asymmetric synthesis of triamino carboxylic acid derivatives via 
stereoselective Mannich-type additions across N-sulfinylimines  
 
As mentioned in section 3.3, α,γ-diamino carboxylic amides and β-amino carboxylic amides 
have gained a lot of interest in studies on their activity as DPP inhibitors.
31,187
 In addition to 
the synthesis of γ-chloro-α,β-diamino carboxylic amides (vide supra), the library of diamino 
amides has been further expanded towards novel enantiopure α,β,γ-triamino amides 328. For 
this purpose, the synthesis of chiral α,β,γ-triamino carboxylic amides 328 was pursued via 
two possible synthetic approaches (Scheme 100). In a first synthetic strategy (A), the 
previously described syn-γ-chloro-α,β-diamino esters syn-277 and syn-β,γ-aziridino-α-amino 
esters syn-278, synthesized via diastereoselective Mannich-type reactions (vide supra), were 
reacted with different nitrogen-nucleophiles to access the corresponding α,β,γ-triamino esters 
329 which could subsequently be converted in the desired α,β,γ-triamino carboxylic amides 
328. A second approach (B) involved the synthesis of α,β,γ-triamino carboxylic amides 328 
via Mannich-type addition of glycine amides 313 across α-aminoimines 271. 
H2N
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N n
**
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3.4.1. Attempted synthesis of α,β,γ-triamino carboxylic acid derivatives via 
nucleophilic attack on α,β-diamino esters with a leaving group in γ-
position 
 
In the following part, the synthesis of chiral syn-α,β,γ-triamino carboxylic acid derivatives via 
substitution reactions of syn-γ-chloro-α,β-diamino esters syn-277 with different nucleophiles 
has been explored (Scheme 101, Table 10). 
syn-γ-Chloro-α,β-diamino ester syn-277b was heated in the presence of two equivalents of 
NaN3 in DMSO at 60 °C for two hours,
188
 without providing syn-α,β,γ-triamino ester 330 
(Table 10, entry 1). Repeating the reaction for a prolonged reaction time (five days), resulted 
in the formation of degradation products, next to the recovery of the starting material syn-
277b (entry 2).  
In analogy, an attempt was made to provide access to the corresponding potential syn-α,β,δ-
triamino carboxylic ester precursor 331 by reaction of syn-γ-chloro-α,β-diamino ester syn-
277b with one equivalent of KCN in DMSO at 60 °C for two hours, but no conversion was 
observed (entry 3). Prolongation of the reaction time to five days, also did not afford the 
desired compound 331 (entry 4). 
(R)
Cl
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NH
S (S)
O
p-Tol
N
OMe
Ph
Ph
O
R
(R)
NH
S (S)
O
p-Tol
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Ph
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(Table 10)
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Table 10. Different reaction conditions for the substitution reactions of  
syn-γ-chloro-α,β-diamino ester syn-277b 
Entry Nucleophile (Equiv) Time Result 
1 NaN3 (2 equiv) 2 h no reaction 
2 NaN3 (2 equiv) 5 d decomposition 
3 KCN (1 equiv) 2 h no reaction 
4 KCN (1 equiv) 5 d decomposition 
 
As substitution of chloride in syn-γ-chloro-α,β-diamino esters syn-277 failed to afford the 
desired esters 330 and 331, the synthesis of the same compounds 330 and 331 was 
investigated through selective aziridine ring opening of syn-β,γ-aziridino-α-amino esters syn-
278 with different nucleophiles (Scheme 102, Table 11). 
In a first attempt, treatment of aziridine syn-278 with two equivalents of NaN3 in DMSO at 70 
°C for two hours, gave no reaction (Table 11, entry 1). When aziridine syn-278 was treated 
under the same reaction conditions for a prolonged reaction time (five days), a degradation of 
the starting material was observed (entry 2). Performing the reaction in DMSO at 120 °C for 
10 minutes under microwave (MW) conditions, led to degradation of the starting material syn-
278 (entry 3). Lowering reaction time and temperature did not result in the formation of the 
desired α,β,γ-triamino ester 330 (entry 4). Furthermore, treatment of aziridine syn-278 with 
two equivalents of benzylamine in acetonitrile at reflux did not afford the desired compound 
332 and led only to a complex reaction mixture (entry 5). Performing the ring-opening 
reaction with one equivalent of KCN in DMSO at 70 °C for two hours, led to a complete 
recovery of syn-278 (entry 6). Repeating the reaction with prolonged reaction times (three 
days) gave rise to a complex reaction mixture (entry 7). In a final attempt, thiophenol was 
used as nucleophile to effect a ring-opening reaction, as this reagent is known for its good 
nucleophilicity. Treatment of aziridine syn-278 with two equivalents PhSH in acetonitrile at 
reflux for one hour, gave no reaction (entry 8). Performing this reaction for three days, 
unfortunately gave rise to a complex reaction mixture.  
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Scheme 102 
Table 11. Different reaction conditions for the ring opening of syn-β,γ-aziridino-α-amino 
ester syn-278b 
Entry Nucleophile (Equiv) Solvent Time Temp. (°C) Result 
1 NaN3 (2 equiv) DMSO 2 h 70 no reaction 
2 NaN3 (2 equiv) DMSO 5 d 70 decomposition 
3 NaN3 (2 equiv) DMSO 10' 120 (MW) decomposition 
4 NaN3 (2 equiv) DMSO 10' 70 (MW) no reaction 
5 BnNH2 (2 equiv) CH3CN 1 d  decomposition 
6 KCN (1 equiv) DMSO 2 h 70 no reaction 
7 KCN (1 equiv) DMSO 3 d 70 decomposition 
8 PhSH (2 equiv) CH3CN 1 h  no reaction 
9 PhSH (2 equiv) CH3CN 3 d  decomposition 
 
Given the fact that all efforts to perform the ring-opening reaction of aziridine syn-278 with 
different nucleophiles (NaN3, KCN, PhSH, BnNH2) failed, no further attempts were made to 
synthesize chiral functionalized diamino carboxylic acid derivatives via this synthetic route. 
 
3.4.2. Asymmetric synthesis of α,β,γ-triamino carboxylic acid derivatives via 
stereoselective Mannich-type additions across N-sulfinyl-α-
aminoimines 
 
Since the synthesis of enantiopure α,β,γ-triamino carboxylic amides 328 could not be realized 
via nucleophilic attack on α,β-diamino esters with a leaving group in γ-position, the second 
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approach comprising Mannich-type addition of glycine amides 313 across N-sulfinyl-α-
aminoimines (RS)-271 and (SS)-271 was envisioned (Scheme 103, Table 12).  
Initially, the Mannich-type addition was performed by deprotonation of glycine amide 313a 
for one hour at -78 °C using 1.1 equivalents of LiHMDS and subsequent reaction across (RS)-
N-tert-butanesulfinyl-α-N-Boc-aminoacetaldimine (RS)-271 for 15 minutes at -78 °C (Table 
12, entry 1). 
1
H NMR analysis of the crude reaction mixture indicated that the resulting syn-
α,β,γ-triamino carboxylic amide (RS)-syn-334a was obtained with excellent syn-selectivity (dr 
> 99:1). After purification by tedious column chromatography, the Mannich-type adduct (RS)-
syn-334a was isolated in 22% yield.  
When glycine amide 313b was used in the Mannich-type addition under the same reaction 
conditions (entry 2), this resulted in the formation of syn-α,β,γ-triamino carboxylic amide 
(RS)-syn-334b as one single diastereomer (dr > 99:1) in 60% yield after column 
chromatography. 
In the following reaction (entry 3), the Mannich-type addition was performed by 
deprotonation of glycine amide 313a for one hour at -78 °C using 1.1 equivalents of LiHMDS 
and subsequent reaction across (SS)-N-tert-butanesulfinyl-α-N-Boc-aminoacetaldimine (SS)-
271 for 15 minutes at -78 °C. The resulting syn-α,β,γ-triamino carboxylic amide (SS)-syn-334a 
was obtained in 69% yield and again with excellent syn-selectivity (dr > 99:1). 
In addition, the Mannich-type reaction was also performed with glycine amide 313b under the 
same reaction conditions (entry 4), which afforded the syn-α,β,γ-triamino carboxylic amide 
(SS)-syn-334b in 74% yield with excellent diastereoselectivity (dr > 99:1) after column 
chromatography. 
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Scheme 103 
Table 12. Addition of N-(diphenylmethylene)glycine amides 313 across N-sulfinyl-α-
aminoimines (RS)-271 and (SS)-271 producing syn-addition products (RS)-syn-334 and (SS)-
syn-334 
Entry imine n anti/syn ratio
 a
 Yield (%) 
b
 Product 
1 (RS)-271 1 > 99:1 22 (RS)-syn-334a 
2 (RS)-271 2 > 99:1 60 (RS)-syn-334b 
3 (SS)-271 1 > 99:1 69 (SS)-syn-334a 
4 (SS)-271 2 > 99:1 74 (SS)-syn-334b 
 a
 Determined via 
1
H NMR of crude reaction mixtures 
 b
 Isolated yield of single diastereomer dr > 99:1 
 
The absolute stereochemistry of syn-α,β,γ-triamino carboxylic amides syn-334 was 
unambiguously determined by means of an X-ray diffraction analysis of compound (SS)-syn-
334b (in collaboration with Prof. K. Van Hecke, Inorganic and Physical Chemistry, Ghent 
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University, Belgium) (Figure 11), in combination with the comparable 
1
H NMR chemical 
shifts (Hα: -4.33 ppm, Hβ: -3.71 ppm) and the characteristic vicinal coupling 
constants (
3
JHα-Hβ = 2.8 Hz) of all derivatives syn-334. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The formation of syn-α,β,γ-triamino carboxylic amides syn-334 could be explained via 
transition state model TS-335 (Scheme 104), which was analogous to TS-315B for the 
formation of (SS,2S,3S)-γ-chlorinated-α,β-diamino carboxylic amides syn-314 (vide supra). In 
accordance with the literature,
34-180,189,190,35
 the α-heteroatom effect in this type of reactions 
can be considered as generally applicable as the nature of the heteroatom (chloro or N-Boc-
amino) did not have an influence on the observed diastereoselectivity.  
(R)
BocHN (S)
NH
S
(S)
N
O
N
Ph
Ph
O
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Figure 11. X-ray diffraction analysis of (SS)-syn-α,β,γ-triamino carboxylic amide (SS)-syn-334b 
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Scheme 104 
Bearing this in mind, the monosubstituted tertiary amide enolates obtained via deprotonation 
of N-(diphenylmethylene)glycine amides 313 were expected to have again a Z-geometry 
(Scheme 104). The formation of the (SS,2S,3R)-α,β,γ-triamino carboxylic amides (SS)-syn-334 
could be explained by a boat-like transition state model TS-335 in which the (E)-N-tert-
butanesulfinylaldimine (SS)-271 participated in the reaction (vide supra). This less sterically 
hindered transition state TS-335, in which the aminoalkyl group (-CH2NHBoc) occupied the 
less hindered pseudoequatorial position, and the corresponding Li-adduct 336, were stabilized 
by the interaction between the Li-cation, the diphenylmethyleneamino group and the 
sulfinylimine nitrogen. 
In addition, the use of the enantiomeric (RS)-N-tert-butanesulfinyl-α-N-Boc-
aminoacetaldimine (RS)-271 induced a reversal of the enantiotopic face selectivity in this 
reaction as compared to the reaction with (SS)-imine (SS)-271. 
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In order to extend the potential applicability of the synthesized enantiopure α,β,γ-triamino 
carboxylic amides syn-334 as building blocks in biomedicinal chemistry, some attempts were 
made to remove the N-protective groups under mild acidic conditions (Scheme 105). 
In analogy with the previously described results on the syn-γ-chloro-α,β-diamino carboxylic 
amide syn-314a (vide supra), (RS,2R,3S)-α,β,γ-triamino carboxylic amide (RS)-syn-334b was 
directly converted into the corresponding hydrochloride salt of the N
α
,N
β
,N
γ
-deprotected 
(2R,3S)-α,β,γ-triamino carboxylic amide syn-337b, by stirring in 0.5 M (aq.) HCl/EtOAc (2:1) 
for 30 minutes at room temperature, providing the product in 64% yield. 
Alternatively, the deprotection of the α-amino functionality of the (RS,2R,3S)-α,β,γ-triamino 
carboxylic amide (RS)-syn-334b was investigated en route towards the development of 
potential DPP and FAP inhibitors.
27
 According to the previously described selective 
deprotection of the α-amino functionality of the syn-γ-chloro-α,β-diamino ester syn-277a 
(vide supra), the (RS,2R,3S)-α,β,γ-triamino carboxylic amide (RS)-syn-334b was treated with 
five equivalents of trifluoroacetic acid in acetone/water (2:1) for 15 minutes, resulting in the 
N
α
-deprotected (RS,2R,3S)-α,β,γ-triamino carboxylic amide (RS)-syn-338b in 77% yield after a 
basic workup with NH4OH (Scheme 105).  
 
 
 
 
 
 
 
 
Scheme 105 
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Similarly, the selective N
α
-deprotection of the (SS,2S,3R)-α,β,γ-triamino carboxylic amide 
(SS)-syn-334a was also performed and afforded the corresponding (SS,2S,3R)-α,β,γ-triamino 
carboxylic amide (SS)-syn-338a in 81% yield (Scheme 106).  
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(SS)-syn-334a
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Scheme 106 
In conclusion, it was demonstrated that new chiral α,β,γ-triamino carboxylic amides were 
formed in moderate to good yields and excellent diastereomeric ratios via stereoselective 
Mannich-type reactions of N-(diphenylmethylene)glycine amides across chiral N-tert-
butanesulfinyl-α-N-Boc-aminoacetaldimines. Notably, a very high syn-diastereoselectivity 
was obtained in the synthesis of these compounds, which were formed via the same transition 
state model as the previously described (SS,2S,3S)-γ-chlorinated-α,β-diamino carboxylic 
amides. The synthesized α,β,γ-triamino carboxylic amides were selectively deprotected under 
acidic conditions, and the resulting α,β,γ-triaminoacylpyrrolidines and -piperidines could have 
again a potential applicability as dipeptidyl peptidase inhibitors or as fibroblast activation 
protein inhibitors. This applied topic is currently under investigation. 
 
3.5. Asymmetric synthesis of α-halo-β,γ-diamino carboxylic acid 
derivatives via stereoselective Mannich-type additions across N-
sulfinyl-α-aminoimines 
 
In extention to this methodology, the synthesis of the unsubstituted trans-3-amino-azetidine-
2-carboxylate 339 was envisioned. The chiral azetidine 339 belongs to a very interesting class 
of molecules (vide supra) and could be used as a building block for the synthesis of 
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oligopeptides. The suggested synthetic approach comprised a Mannich-type addition of the 
enolate derived from an α-haloacetic acid derivative 341 across the chiral N-tert-
butanesulfinyl-α-N-Boc-aminoacetaldimine 271 (Scheme 107). Regioselective cyclization of 
the resulting Mannich-type addition product 340 could subsequently afford the desired chiral 
trans-3-aminoazetidine-2-carboxylate 339. 
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Scheme 107 
In a first reaction, the Mannich-type addition was performed by deprotonation of one 
equivalent of methyl bromoacetate 342 with LiHMDS for one hour at -78 °C and subsequent 
reaction with (SS)-N-tert-butanesulfinyl-α-N-Boc-aminoacetaldimine (SS)-271 for 30 minutes 
at -78 °C (Scheme 108). 
1
H NMR analysis of the crude reaction mixture indicated the 
formation of a complex reaction mixture, containing all four different diastereomers of the 
desired α-bromo-β,γ-diamino ester 343. As purification of this reaction mixture by column 
chromatography on silica gel failed, another pathway towards the desired Mannich-type 
addition product 340 was investigated. 
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Scheme 108 
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In order to synthesize the enantiopure α-halo-β,γ-diamino carboxylic acid derivative 340, the 
Mannich-type addition across the chiral N-tert-butanesulfinyl-α-N-Boc-aminoacetaldimine 
271 was performed using the Li-enolate of the α-chloro-N-tert-butanesulfinyl imidate (RS)-
344 (Scheme 109). This chiral N-sulfinyl imidate 344, which was available at the Department 
of Sustainable Organic Chemistry and Technology, Faculty of Bioscience Engineering, 
UGent, has already been successfully used for the chiral synthesis of many heterocyclic 
compounds.
191
 
In this case, the Mannich-type addition was performed by deprotonation of 1.8 equivalents of 
α-chloro-N-tert-butanesulfinyl imidate (RS)-344 with LiHMDS for one hour at -78 °C and 
subsequent reaction with (RS)-N-tert-butanesulfinyl-α-N-Boc-aminoacetaldimine (RS)-271 for 
30 minutes at -78 °C (Scheme 109). 
1
H NMR analysis of the crude reaction mixture indicated 
that the α-chloro-β,γ-diamino imidate 345 was formed as one single diastereomer (dr > 99:1). 
Subsequent purification by column chromatography on silica gel afforded the desired 
compound 345 in 83% yield.  
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Scheme 109 
Unfortunately, neither the absolute nor the relative stereochemistry could be determined by 
comparison of the 
1
H NMR chemical shifts or the vicinal coupling constants of this α-chloro-
β,γ-diamino imidate 345 with previously synthesized analogous compounds (vide supra). It 
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was also impossible to determine the absolute stereochemistry of α-chloro-β,γ-diamino 
imidate 345 by means of an X-ray diffraction analysis as this compound was not crystalline.  
 
In conclusion, it was demonstrated that a new chiral α-chloro-β,γ-diamino imidate was 
formed in high yield and excellent diastereoselectivity via a stereoselective Mannich-type 
reaction of an α-chloro-N-tert-butanesulfinyl imidate across the chiral N-tert-butanesulfinyl-
α-N-Boc-aminoacetaldimine. Further efforts are required to determine the absolute 
stereochemistry of this representative of this new class of compounds and to use this 
compound as potential building block in heterocyclic chemistry. 
 
3.6. Asymmetric synthesis of γ-chloro-α-hydroxy-β-amino acid derivatives 
via stereoselective Mannich-type additions across N-sulfinyl-α-
chloroimines 
In this part, the synthesis of γ-chloro-α-hydroxy-β-amino acid derivatives 348 via Mannich-
type additions across enantiopure N-sulfinyl-α-chloroaldimines 266a and 270a was 
investigated. This Mannich-type addition concerned an enantio- and diastereoselective 
reaction of enolates derived from O-protected alkyl α-hydroxyacetates 347 across chiral α-
chloroaldimines 346 (Scheme 110).  
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Scheme 110 
In this study, N-sulfinylaldimines 266a and 270a were used as starting products as these 
imines were known for their good reactivity and stereoselectivity by incorporation of chiral 
directing groups.
154
 In this context, analogous reactions across non-halogenated N-
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sulfinylimines were already performed for the asymmetric synthesis of β-amino acid 
derivatives.
156,192,193,194,195
 
It has already been reported that the addition of enolates, derived from O-protected alkyl α-
hydroxyacetates 347, across non-functionalized (SS)-N-(tert-butanesulfinyl)imines led to the 
diastereoselective synthesis of α-hydroxy-β-amino acid derivatives, when the reactions were 
performed at -78 °C in THF by using five equivalents of O-protected alkyl α-hydroxyacetates 
and LiHMDS as a base.
193
 According to these good results, the addition of O-protected alkyl 
α-hydroxyacetates 347 across N-sulfinyl-α-chloroimines 346 was investigated under similar 
reaction conditions. 
 
3.6.1. Synthesis of O-protected alkyl α-hydroxyacetates 
At first, the used O-protected alkyl α-hydroxyacetates 347 were synthesized according to 
literature procedures.
154,196
  
Benzyl α-hydroxyacetate 350a was efficiently prepared (89% yield) by reaction of glycolic 
acid 349 with one equivalent benzyl bromide in the presence of an equimolar amount of 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) for one hour in acetonitrile at 35 °C (Scheme 111).
196
 
350a (89%)
1 equiv DBU
1 equiv BnBr
CH3CN, 35 °C, 1 h
HO
O
OH
HO
O
OBn
349 (ref 196)  
Scheme 111 
In a next step, the hydroxy group of benzyl α-hydroxyacetate 350a and the commercially 
available methyl and ethyl ester derivatives 350b-c was protected by reaction with 1.3 
equivalents of di-tert-butyl dicarbonate in the presence of a catalytic amount of DMAP to 
afford the corresponding O-Boc alkyl α-hydroxyacetates 347a-c in high yields (Scheme 
112).
154,196
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Scheme 112 
  
3.6.2. Synthesis and elaboration of syn-alkyl 2-(tert-butoxycarbonyloxy)-4-
chloro-4-methyl-3-(tert-butanesulfinylamino)pentanoates 
 (RS)-N-(tert-Butanesulfinyl)-α-chloroaldimine (RS)-270a was subjected to a Mannich-type 
addition by reaction with the Li-enolates derived from the O-Boc alkyl α-hydroxyacetates 
347a-c. The reaction started with deprotonation of five equivalents of O-Boc alkyl α-
hydroxyacetate 347a-c with five equivalents of LiHMDS for one hour in THF at -78 °C and 
subsequent addition of (RS)-N-(tert-butanesulfinyl)-α-chloroaldimine (RS)-270a (Scheme 
113). The reaction mixture was stirred for three hours at -78 °C and quenched with a saturated 
NH4Cl-solution (aq.). 
1
H NMR analysis of the crude reaction mixtures showed that the 
corresponding Mannich-type addition products (RS)-351a-c were formed in good to excellent 
diastereomeric ratios high yields after purification via column chromatography on silica gel 
(Table 13).
154
  
5  equiv BocO
O
OR
1) 5 equiv LiHMDS
    THF, -78 °C, 1 h, N2
2) 1 equiv H
N
S
(R)
O
Cl
Cl
O
OR
NH
S
(R)
O
OBoc
t-Bu
t-Bu
(ref 153)
(RS)-351a-c
(RS)-270a
347a (R = Bn)
347b (R = Me)
347c (R = Et)
THF, -78 °C, 3 h, N2
 
 
Scheme 113 
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Table 13. Overview of the Mannich-type reaction of (RS)-N-(tert-butanesulfinyl)-α-
chloroaldimine (RS)-270a with α-hydroxy esters 347 at -78 ° C. 
R dr 
a
 Yield (%) 
b
  
Bn 80:20:0:0 75 
Me 98:2:0:0 86 
Et 89:11:0:0 88 
 a
 Determined via 
1
H NMR of crude reaction mixtures 
 b
 Isolated yield of single diastereomer (dr > 99:1)  
 
Based on the 
1
H NMR analysis, it was determined that the isolated major diastereomers were 
syn-adducts, as the typical doublet times doublet signals ascribed to H-3 were readily 
observed, whereas the corresponding anti-adducts have a typical triplet signal.
193
 
Unfortunately, it was impossible to determine the absolute stereochemistry of these syn-
adducts (RS)-351a-c by means of an X-ray diffraction analysis as none of these compounds 
were crystalline. Therefore, the corresponding (SS)-γ-chloro-α-hydroxy-β-amino ester (SS)-
351a was synthesized by Mannich-type addition of the Li-enolate derived from the O-Boc 
benzyl α-hydroxyacetate 347a across (SS)-N-(tert-butanesulfinyl)-α-chloroaldimine (SS)-270a 
under the same reaction conditions (Scheme 114).  
As the optical rotation of the corresponding dehalogenated (SS,2R,3S)-α-hydroxy-β-amino 
ester (SS,2R,3S)-352a’ was known in the literature,
196
 the reaction of compound (SS)-351a 
with Bu3SnH and AIBN was performed. Unfortunately, this reaction failed to provide the 
desired dechlorinated compound 352a or 352a’, which would have allowed the determination 
of the absolute stereochemistry of 351a by comparison of the optical rotation. 
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Scheme 114 
The absolute stereochemistry of (RS)-γ-chloro-α-hydroxy-β-amino acid derivative (RS)-351c 
was determined by means of an X-ray diffraction analysis (in collaboration with Prof. K. W. 
Törnroos, Department of Chemistry, University of Bergen, Norway) (Figure 12) of the 
crystalline (RS,2R,3R)-Boc-deprotected derivative (RS,2R,3R)-356c (vide infra). The 
(RS,2R,3R)-stereochemistry of the other synthesized (RS)-γ-chloro-α-hydroxy-β-amino esters 
(RS)-351a-b was deduced from the vicinal coupling constant 
3
JH2-H3 = 1.10 Hz and the 
1
H 
NMR chemical shift of H3 (4.01 ppm),
154
 which were in the same range as for the (RS)-γ-
chloro-α-hydroxy-β-amino ester (RS)-351c. 
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Figure 12. X-ray diffraction analysis of (RS,2R,3R)-γ-chloro-α-hydroxy-β-amino ester 
(RS,2R,3R)-356c 
The stereochemical outcome of the Mannich-type reaction across (RS)-N-(tert-butanesulfinyl)-
α-chloroaldimine (RS)-270a was rationalized on the basis of the enolate geometry of the 
anions derived from the deprotonation of O-Boc alkyl α-hydroxyacetates 347. As reported in 
the literature,
193,197
 the enolates obtained via deprotonation of O-Boc alkyl α-hydroxyacetates 
347 with LiHMDS in THF were expected to have the E-geometry (Scheme 115). As 
commonly performed in the assignment of enolate geometry, in contrast to conventional E/Z-
nomenclature, the highest priority designation was allocated to the O-metal group of the 
enolate substituents. The stereoselective formation of the E-enolates has been rationalized 
with the Ireland model,
197
 which showed that deprotonation of O-Boc alkyl α-hydroxyacetates 
347 with LiHMDS via transition state TS-353A, induced adverse sterical interactions of the 
axial TMS group and the O-Boc group. For this reason, the deprotonation proceeds via 
transition state TS-353B and afforded the corresponding E-enolate. 
(R)
Cl
(R)
NH
S(R)
O
t-Bu
OH
O
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Scheme 115 
Reaction of the E-enolates via a six/four-membered Li-chelated bicyclic chairlike transition 
state model TS-354A, which was valid for Mannich-type additions across non-functionalized 
N-sulfinyl imines,
193
 would have resulted in the formation of (RS,2S,3S)-γ-chloro-α-hydroxy-
β-amino esters (RS,2S,3S)-351 (Scheme 116). However, this transition state model TS-354A, 
which proceeded via a Si-face attack, lacked the important chelation between the α-
coordinating chlorine atom and the lithium atom.  
The formation of the (RS,2R,3R)-γ-chloro-α-hydroxy-β-amino esters (RS,2R,3R)-351 could be 
explained by a six/six-membered di-metal-chelated bicyclic chairlike transition state model 
TS-354B,
198,199
 or by a six-membered Li-chelated cyclic chairlike transition state model TS-
354C which proceeded both via a Re-face attack of the E-enolate (Scheme 116). In a first 
possible transition state model TS-354B, the α-coordinating ability of the chlorine atom 
overrode the chelation of the sulfinyl oxygen with the lithium ion of the incoming E-enolate 
and induced chelation of the sulfinyl oxygen with an extra Li-cation to form a six/six-
membered di-Li-chelated bicyclic chairlike transition state model. In an alternative transition 
state model TS-354C, the coordinating ability of the chlorine atom overruled the chelation of 
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the sulfinyl oxygen as well and an extra stabilizing effect was attained by the fact that the N-
sulfinyl imine (RS)-270a in this transition state was present in the energetically favoured s-cis 
configuration.
35
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Scheme 116 
The resulting (RS,2R,3R)-γ-chloro-α-hydroxy-β-amino esters (RS,2R,3R)-351 were 
subsequently cyclized to the corresponding N-sulfinyl-β,γ-aziridino-α-hydroxy esters 355 
upon treatment with K2CO3 in acetone under reflux in good yields (67-88%) (Scheme 117).
154
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Scheme 117 
In order to extend the potential applicability of the synthesized (RS,2R,3R)-γ-chloro-α-
hydroxy-β-amino esters (RS,2R,3R)-351 as building blocks in biomedicinal chemistry, a 
number of attempts was made to remove the protective groups of (RS,2R,3R)-351 under acidic 
conditions (Scheme 118). In a first reaction, (RS,2R,3R)-γ-chloro-α-hydroxy-β-amino ester 
(RS,2R,3R)-351 was dissolved in dichloromethane and treated with trifluoroacetic acid (30% 
v/v) at room temperature for one hour. After a basic workup with K2CO3, the α-deprotected 
syn-γ-chloro-α-hydroxy-β-amino esters 356 could be purified by crystallization in Et2O or by 
column chromatography on silica gel (75-86% yield). The obtained result was in accordance 
with the previously reported selective deprotection of a O-Boc-protected group, in the 
presence of an N-tert-butanesulfinyl moiety, of α-hydroxy-β-amino esters with TFA.196 
Moreover, the O-deprotected (RS,2R,3R)-γ-chloro-α-hydroxy-β-amino ester (RS,2R,3R)-356c 
was isolated as a crystalline product which allowed the implementation of an X-ray 
diffraction analysis (vide infra). 
In a next step, the N-(tert-butanesulfinyl) group of the O-deprotected (RS,2R,3R)-γ-chloro-α-
hydroxy-β-amino esters (RS,2R,3R)-356a-b was deprotected by reaction in a saturated HCl-
solution in dioxane for one hour at room temperature (Scheme 118). After evaporation of the 
solvent, it was concluded that the conversion towards the N,O-deprotected (RS,2R,3R)-γ-
chloro-α-hydroxy-β-amino esters (RS,2R,3R)-357a-b was complete based on 
1
H NMR 
analysis of the crude reaction mixture. Unfortunately, attempting different purification 
techniques (crystallization, preparative TLC, acid-base extraction) in order to improve the 
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yield of the pure N,O-deprotected (RS,2R,3R)-γ-chloro-α-hydroxy-β-amino esters (RS,2R,3R)-
357a-b, was shown to be only partially successful, giving 27-36% yield of (RS,2R,3R)-357a-b 
after crystallization in dichloromethane. Therefore, another route towards the N,O-deprotected 
(RS,2R,3R)-γ-chloro-α-hydroxy-β-amino esters (RS,2R,3R)-364 was envisioned (vide infra). 
In order to synthesize new heterocyclic derivatives 358a and 359c, the N,O-deprotected 
(RS,2R,3R)-γ-chloro-α-hydroxy-β-amino esters (RS,2R,3R)-357a,c were treated with different 
cyclizing agents in accordance to literature procedures (Scheme 118).
200,201
 In a first attempt, 
the amino alcohol (RS,2R,3R)-357a was treated with 1.1 equivalents of 1,1'-
carbonyldiimidazole (CDI) in the presence of 1.5 equivalents of Et3N for two hours in 
dichloromethane at room temperature. Unfortunately, application of these reaction conditions 
failed to afford the desired oxazolidinone 358a as only a complex reaction mixture was 
obtained according to 
1
H NMR analysis. In addition, reaction of amino alcohol (RS,2R,3R)-
357c with 1.1 equivalents of oxalyl chloride in the presence of three equivalents of Et3N for 
two hours in dichloromethane at room temperature gave again a complex reaction mixture 
with no traces of the corresponding morpholine-2,3-dione 359c. 
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Scheme 118 
Next to the attempts to synthesize oxazolidinone 358a and morpholine-2,3-dione 359c via 
reaction of the unprotected amino alcohols 357a,c with the cyclizing agents CDI and oxalyl 
chloride, these reactions were also performed with the N-(tert-butanesulfinyl)-protected 
(RS,2R,3R)-γ-chloro-α-hydroxy-β-amino esters (RS,2R,3R)-356a and (RS,2R,3R)-356c 
(Scheme 119). However, reaction of the N-protected compound (RS,2R,3R)-356c with CDI 
also resulted in the formation of a complex reaction mixture. Furthermore, a complex reaction 
mixture was observed when N-protected compound (RS,2R,3R)-356a was treated with oxalyl 
chloride. 
  
 
 
 
Scheme 119 
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In addition, some attempts were made to synthesize new 3-aminooxetane-2-carboxylic acid 
derivatives 362 via intramolecular nucleophilic substitution reactions (Scheme 120). In 
accordance with a literature procedure,
202
 the reaction of the O-deprotected amino alcohol 
(RS,2R,3R)-356b with one equivalent of AgBF4 in the presence of one equivalent of pyridine 
in toluene at reflux temperature for two hours (Table 14, entry 1) resulted in a complex 
reaction mixture, which could not be purified. In a next attempt, a similar reaction without 
pyridine gave also a complex reaction mixture (entry 2). Alternatively, performing the 
reaction for two hours in toluene at reflux temperature without additives, did not afford the 
desired oxetane derivative 362 (entry 3). In a final attempt, the reaction was conducted in 
pyridine for two hours at room temperature. However, no reaction occurred under these 
conditions (entry 4). No further attempts towards the synthesis of cis-3-aminooxetane-2-
carboxylic acid derivatives cis-362 were made, as it was assumed that the cis-configuration of 
the 3-amino- and the 2-alkoxycarbonyl group caused too much sterical interactions to allow 
the synthesis of oxetane 362. 
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362b
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356b
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Table 14
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Scheme 120 
Table 14. Different reaction conditions for the ring transformation towards oxetane 362b 
Entry Additive Solvent Time (h) Temperature Result 
1 
1 equiv AgBF4 
1 equiv 
pyridine 
toluene 2 
complex reaction 
mixture 
2 1 equiv AgBF4 toluene 2 
complex reaction 
mixture 
3 - toluene 2  no reaction 
4 - pyridine 2 rt no reaction 
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Alternatively, the deprotection of the (RS,2R,3R)-γ-chloro-α-hydroxy-β-amino esters 
(RS,2R,3R)-351 could also be effected starting with the initial synthesis of the N-deprotected 
(2R,3R)-γ-chloro-α-hydroxy-β-amino esters (2R,3R)-363 (Scheme 121).154 The N-(tert-
butanesulfinyl) group of Mannich-type adducts (RS,2R,3R)-351 was easily deprotected under 
mild conditions via acidic hydrolysis.
154,182a
 Treatment of compounds (RS,2R,3R)-351 with a 
saturated HCl-solution in dioxane for one hour at room temperature afforded the N-
deprotected esters (2R,3R)-363 in high yields (79-93%) upon evaporation of the solvent and 
subsequent precipitation in Et2O. The subsequent deprotection of the O-Boc protective group 
of (2R,3R)-363 was realized by stirring in dichloromethane/trifluoroacetic acid (30% v/v) at 
room temperature for one hour. After evaporation of the solvent in vacuo, the O
α
,N
β
-
deprotected (2R,3R)-γ-chloro-α-hydroxy-β-amino ester salts (2R,3R)-364 were obtained as 
pure products in excellent yields (84-97% yield). In this way, the synthesis of the O
α
,N
β
-
deprotected esters (2R,3R)-364 starting from the (RS,2R,3R)-γ-chloro-α-hydroxy-β-amino 
esters (RS,2R,3R)-351 proceeded in higher overall yields, than via the synthetic route that first 
involved the deprotection of O-Boc protective group (vide supra). 
Furthermore, some additional reactions were performed in order to synthesize oxazolidinones 
358. In accordance with a literature procedure,
203
 the N,O-deprotected (2R,3R)-γ-chloro-α-
hydroxy-β-amino ester salts (2R,3R)-364 were treated with four equivalents of N,N-
diisopropylethylamine (DIPEA) in dichloromethane for 15 minutes at 0 °C to neutralize the 
trifluoroacetic acid salt (Scheme 121). Dropwise addition of 1.2 equivalents of triphosgene 
dissolved in dichloromethane, resulted in the formation of the corresponding oxazolidinones 
358 in high yields (64-82%) after one hour at room temperature followed by aqueous workup. 
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Scheme 121 
Finally, some efforts were made to synthesize new morpholine-2,3-diones 359 and 
oxazolidines 365 via reaction with different cyclizing reagents (Scheme 122). In analogy with 
the previously described successful synthesis of oxazolidinones 358 (vide supra), the N,O-
deprotected (2R,3R)-γ-chloro-α-hydroxy-β-amino ester salt (2R,3R)-364 was treated with four 
equivalents of N,N-diisopropylethylamine (DIPEA) and 1.2 equivalents of oxalyl chloride. 
Unfortunately, after aqueous workup, the desired morpholine-2,3-dione 359b was not 
detected based on 
1
H NMR and LC-MS analysis of the crude reaction mixture. In addition, 
neat reaction of N,O-deprotected (2R,3R)-γ-chloro-α-hydroxy-β-amino ester salt (2R,3R)-
364a with diethyl oxalate,
204
 for 16 hours at room temperature did not result in the 
corresponding morpholine-2,3-dione 359a. Reaction of TFA-salt (2R,3R)-364b with 0.95 
equivalents of benzophenone imine for 18 hours in dry dichloromethane at room temperature 
was also attempted to synthesize the corresponding oxazolidine 365b. However, this reaction 
did not give any transformation. 
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Scheme 122 
 
3.6.3. Synthesis and elaboration of syn-alkyl 2-(tert-butoxycarbonyloxy)-4-
chloro-4-methyl-3-(p-toluenesulfinylamino)pentanoates 
 
 The high reactivity and diastereoselectivity observed in the Mannich-type addition reaction 
of Li-enolates derived from O-Boc alkyl α-hydroxyacetates 347a-c across N-(tert-
butanesulfinyl)-α-chloroaldimines 270a prompted the further investigation of the Mannich-
type additions across N-(p-toluenesulfinyl)-α-chloroaldimine 266a.154  
The N-(p-toluenesulfinyl)-α-chloroaldimine 266a was subjected to a Mannich-type addition 
under similar reaction conditions. The reaction started with deprotonation of five equivalents 
of the O-Boc alkyl α-hydroxyacetates 347a-c with five equivalents of LiHMDS for one hour 
in THF at -78 °C and subsequent addition of the (SS)-N-(p-toluenesulfinyl)-α-chloroaldimines 
(SS)-266a (Scheme 123). After stirring the reaction mixture for five hours at -78 °C and 
quenching with a saturated NH4Cl-solution (aq.), 
1
H NMR analysis of the crude reaction 
mixtures showed that the corresponding Mannich-type addition products (SS)-366a-c were 
formed in good to excellent diastereomeric ratios. Purification of (SS)-366a-c via column 
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chromatography on silica gel afforded the pure esters (SS)-366a-c in moderate to high yields 
(Table 15).
154
 
The diastereoselectivity and the efficiency of these Mannich-type additions was similar to the 
addition across N-(tert-butanesulfinyl)-α-chloroaldimines 270a, leading to the conclusion that 
these addition products (SS)-366a-c also have potential for the synthesis of chiral aziridines. 
The reaction of benzyl ester 347a with aldimine (SS)-266a afforded the syn-adduct (SS)-366a 
in the lowest yield, although the addition proceeded with a high stereoselectivity. The ethyl 
ester (SS)-366c was in the most efficient way synthesized via this approach.
154
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Scheme 123 
Table 15. Overview of the Mannich-type reaction of (SS)-N-(tert-butanesulfinyl)-α-
chloroaldimine (SS)-266a with α-hydroxy esters 347 at -78 ° C. 
R dr
 a
 Yield (%) 
b
 
Bn 95:5:0:0 51 
Me 87:13:0:0 83 
Et 82:18:0:0 75 
 
a
 Determined via 
1
H NMR of crude reaction mixtures 
 b
 Isolated yield of single diastereomer (dr > 99:1) 
 
Based on 
1
H NMR analysis, it was determined that the isolated major diastereomers were 
again the syn-adducts (vide supra). In analogy with the transition state models TS-354B and 
TS-354C (vide supra), which were proposed for the synthesis of (RS,2R,3R)-γ-chloro-α-
hydroxy-β-amino esters (RS,2R,3R)-351, it was assumed that the Mannich-type addition 
Chapter 3  Results and Discussion 
 
138 
 
products (SS)-366a-c would have an (SS,2S,3S)-stereochemistry. Indeed, determination of the 
absolute stereochemistry of the crystalline (SS)-γ-chloro-α-hydroxy-β-amino acid derivative 
(SS)-366b by means of an X-ray diffraction analysis (in collaboration with Prof. K. W. 
Törnroos, Department of Chemistry, University of Bergen, Norway) proved this assumption 
(Figure 13). The (SS,2S,3S)-stereochemistry of the other (SS)-γ-chloro-α-hydroxy-β-amino 
esters (SS)-366a,c was again confirmed by comparison of the vicinal coupling constant 
3
JH2-H3 
= 1.10 Hz and the 
1
H NMR chemical shift of H3 (4.00 ppm),
154
 which were in the same range 
as for the (SS)-γ-chloro-α-hydroxy-β-amino ester (SS)-366b. 
 
Figure 13. X-ray diffraction analysis of (SS,2S,3S)-γ-chloro-α-hydroxy-β-amino ester 
(SS,2S,3S)-366b 
The (SS,2S,3S)-γ-chloro-α-hydroxy-β-amino esters (SS,2S,3S)-366 were cyclized to the 
corresponding N-sulfinyl-β,γ-aziridino-α-hydroxy esters 367 upon treatment with K2CO3 in 
acetone under reflux in good yields (68-96%) (Scheme 124).  
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In conclusion, it was demonstrated that new (RS,2R,3R)- and (SS,2S,3S)-N-sulfinyl-γ-chloro-α-
hydroxy-β-amino esters could be synthesized in high yields and excellent diastereomeric 
ratios via stereoselective Mannich-type reactions of O-Boc glycolic esters across chiral N-
sulfinyl-α-chloroimines. In these reactions, the influence of the used imine in the Mannich-
type addition, i.e. N-(tert-butanesulfinyl)-α-chloroaldimines or N-(p-toluenesulfinyl)-α-
chloroaldimines, did not cause significant differences in the obtained yields and 
diastereoselectivities. Furthermore, the γ-chloro-α-hydroxy-β-amino esters proved to be 
versatile building blocks in asymmetric synthesis of novel syn-β,γ-aziridino-α-hydroxy esters 
and trans-alkyl oxazolidinonecarboxylates. 
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4. Perspectives 
In this PhD thesis, the efficient and enantioselective synthesis of the α-chloro-β,γ-diamino 
imidate 345 (Scheme 109) has been reported. In light of the synthetic potential of this 
compound 345, belonging to the class of α-chloro-β,γ-diamino carboxylic acid derivatives, 
some straightforward transformations can be foreseen which could provide the desired 4,4-
unsubstituted 3-aminoazetidine-2-carboxylic derivatives 339 (Scheme 107), constituting 
interesting building blocks for the synthesis of oligopeptides. 
In analogy with the preparation of α-chloro-β,γ-diamino imidate 345, the synthesis of β-
alkylamino imidates 368 could be performed via Mannich-type addition of the enolate 
obtained by deprotonation of a chiral α-chloro-N-tert-butanesulfinyl imidate 344 (Scheme 
109) with an appropriate base (LiHMDS, LDA,...), across chiral N-tert-butanesulfinyl-α-N-
Boc-aminoacetaldimine 271 (Scheme 67) and subsequent quenching with an alkyl halide 
(Scheme 125). Using different combinations of enantiomeric α-chloro-N-tert-butanesulfinyl 
imidates 344 and chiral N-tert-butanesulfinyl-α-N-Boc-aminoacetaldimines 271, it should be 
possible to obtain an α-chloro-β,γ-diamino imidate syn-345 with a syn-stereochemistry. Base-
induced cyclization of compounds syn-345 could provide access to the protected methyl 3-
aminoazetidine-2-imidates 368, which can be transformed into the corresponding 3-
aminoazetidine-2-carboxylates 369 by deprotection of the Boc- and sulfinyl groups with 
methanolic HCl.
191
 Selective transformations of these 3-aminoazetidine-2-carboxylates 369, 
by hydrolysis of the ester moiety or debenzylation of the 3-benzylamino group could give 
access to 3-aminoazetidine-2-carboxylic acids 371 and totally N-deprotected methyl 3-amino-
azetidine-2-carboxylate 370, respectively. These target compounds could be used as valuable 
building blocks in the synthesis of oligopeptides. 
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Scheme 125 
As mentioned before, the α-hydroxy-β-amino carboxylic acid unit is present in a wide range 
of biologically active molecules, such as paclitaxel 13a and docetaxel 13b, which are both 
known for their anti-mitotic activity (Figure 5). For this reason, α-hydroxy-β-amino 
carboxylic acid derivatives represent versatile building blocks for the synthesis of novel 
taxoids with potential antitumor activity,
205,206,207
 via a well-studied coupling reaction with the 
trimethylsilyl ether of baccatine III (373).
208
  
As hydrolysis of syn-γ-chloro-α-functionalized-β-amino esters resulted consistently in the 
synthesis of the corresponding trans-α,β-disubstituted γ-lactones, a new strategy could be 
developed (Scheme 126), starting from the trans-4-alkyl oxazolidin-2-one-5-carboxylic esters 
358, derived from the corresponding syn-γ-chloro-α-hydroxy-β-amino esters 364 (Scheme 
121). O-Debenzylation of benzyl trans-4-alkyl oxazolidin-2-one-5-carboxylic ester 358a via 
Pd/C-catalyzed hydrogenolysis, could provide the corresponding carboxylic acid 372, which 
will not rearrange to the corresponding γ-lactone due to configurational constraints. 
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Subsequent (Steglich-)coupling with the trimethylsilyl ether of baccatine III (373) and acid-
mediated cleavage of the protective groups would afford taxoid compounds 374.  
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Scheme 126 
In an extent of this methodology, also some new trans-substituted oxazolines 375 could be 
synthesized starting from syn-γ-chloro-α-hydroxy-β-amino esters 364’ (Scheme 127). 
Treatment of amino alcohols 364’ with thionyl chloride, an acyl chloride and a base could 
provide the desired oxazolines 375,
209,210
 which can afford new taxoid compounds via the 
previously described coupling reaction with the trimethylsilyl ether of baccatine III (373). 
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Scheme 127 
In order to provide an efficient access to a novel class of enantiopure δ-chloro-α,β-diamino 
esters 378, a stereoselective Mannich-type addition of the enolates derived from 
deprotonation of N-protected glycine esters 376 with an appropriate base (LiHMDS, LDA,...), 
across chiral N-sulfinyl-β-haloaldimines 377 could be developed (Scheme 128). In this way, 
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2-azetidinylglycinates 379 could be synthesized as analogs of 2-(aminomethyl)azetidines, 
from which Pt-complexes have been derived, known for their anti-cancer activity.
211
 In 
addition, 2-azetidinylglycinates 379 have also potential as building blocks for the synthesis of 
α,β-diamino-δ-valerolactones 380 and 3-aminopyrrolidine-2-carboxylic acid derivatives 381. 
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Scheme 128 
Furthermore, the synthesized β,γ-aziridino-α-amino carboxylic acid derivatives and 3-
aminoazetidine-2-carboxylates can be used as α- or β-amino acid building blocks for the 
synthesis of short synthetic peptides 382 and 383 (Figure 14) or foldamers, by coupling 
reactions with other (non-)natural amino acid residues.
212,213
 These conformationally 
constrained α- and β-amino acids have become very interesting in biologically active peptides 
due to their ability as synthons in the preparation of peptide-based drug molecules. Moreover, 
these (non-)natural amino acid residues can influence the principal secondary structural motifs 
adopted by the assembled peptides, such as the occurrence of 14-, 12-, 10-, 12/10-, and 8-
helices, as well as the hairpin turn, extended structures, stacks, and sheets.
214
 In recent years, 
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the chemistry of foldamers gained also a lot of attention, since these compounds are useful 
tools for studying different chemical, physico-chemical and biological problems.
49,215,216,217,218
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5. Experimental  part 
5.1. General methods 
Flame-dried glassware was used for all non-aqueous reactions. Commercially available 
solvents and reagents were purchased from common chemical suppliers and used without 
further purification, unless stated otherwise. The enantiopure reagents (SS)-p-
toluenesulfinamide and (RS)- and (SS)-tert-butanesulfinamide were commercially available (ee 
> 98%). 
Tetrahydrofuran (THF), diethyl ether (Et2O) and toluene (PhMe) were freshly distilled under 
a nitrogen atmosphere from sodium and sodium/benzophenone ketyl prior to use, whereas 
dichloromethane (CH2Cl2) was distilled from calcium hydride. Methanol (MeOH) and ethanol 
(EtOH) were reacted in the presence of magnesium metal and iodine, distilled and kept over 
molecular sieves. Petroleum ether refers to the 40-60 °C boiling fraction.  
The purification of the reaction mixtures was performed by column chromatography with 
silica gel (Acros, particle size 0.035-0.070 mm, pore diameter ca. 6 nm). Thin layer 
chromatography (TLC) was performed on glass plates coated with silica gel (Merck, 
Kieselgel 60 F254, precoated 0.25 mm) using standard visualization techniques or agents: UV 
fluorescence (254 nm and 366 nm), coloring with iodine vapors or with potassium 
permanganate solution.  
High resolution 
1
H NMR (300 MHz), 
13
C NMR (75 MHz) spectra were recorded on a Jeol 
Eclipse FT 300 NMR spectrometer at room temperature. Peak assignments were obtained 
with the aid of DEPT, COSY and/or HSQC spectra. The compounds were diluted in 
deuterated solvents, quoted in parts per million (ppm) with tetramethylsilane (TMS, = 0 
ppm) as internal standard unless specified otherwise.  
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IR spectra were recorded on a Perkin Elmer Spectrum BX FT-IR Spectrometer. All 
compounds were analyzed in neat form with an ATR (Attenuated Total Reflectance) 
accessory. Only selected absorbances (νmax/cm
-1
) were reported.  
LC-MS analysis was performed with Agilent 1100 series SL (ES, 4000 V) equipment, 
preceded by a reverse phase LC-column (Eclipse plus C18 column). The LC column has 
dimensions of 50x4.6 mm and has a particle size of 3.5 μm. Gradient elution was used (30% 
acetonitrile in water to 100% acetonitrile over 6 minutes) and the MS analysis was performed 
via electron-spray ionization at 4 kV (positive mode) or 3.5 kV (negative mode) and 
fragmentation at 70 eV, with only molecular ions (M + H
+
) and major peaks being reported 
with intensities quoted as percentage of the base peak, using either an LC-MS coupling or a 
direct inlet system.  
Chiral HPLC analysis was performed using a Daicel Chiralcel OD-(R)H column [cellulose 
tris (3,5-dimethylphenylcarbamate) coated on 5 μm silica gel] or OJ-RH column [cellulose 
tris (4-methylbenzoate) coated on 5 μm silica gel] and with a solvent mixture of 
hexane/ethanol 99:1 as the mobile phase.  
HRMS analysis was performed using an Agilent 1100 series HPLC coupled to an Agilent 
6210 TOF-Mass Spectrometer, equipped with ESI/APCI-multimode source.  
Elementary analyses were obtained by means of a Perkin Elmer series II CHNS/O elementary 
analyzer 2400.  
Melting points of crystalline compounds were determined using a Büchi B-540 apparatus or a 
Kofler bench, type WME Heizbank of Wagner & Munz. 
Optical rotations were determined using a JASCO P-2000 Series Polarimeter at a wavelength 
of 589 nm. 
All microwave reactions were performed in a CEM Discover Benchmate with a continuous 
power output from 0 to 300 watt and a self-adjusting, single mode MW cavity. The reactions 
Chapter 5   Experimental part 
 
149 
 
were performed in 10 mL thick-walled Pyrex reaction vessels, closed with a ‘snap-on’ septa 
cap and equipped with a small stirring bar. A ramp time of maximum five minutes was used 
whereby the temperature was increased from room temperature to the desired one. This 
temperature was maintained during the course of the reaction for the indicated time. The 
temperature control system used a non-contact infrared sensor to measure the temperature on 
the bottom of the vessel and was used in a feedback loop with the on-board computer to 
regulate the temperature from 25 to 250 °C by adjusting the power output (1 Watt 
increments). The pressure control, IntelliVent™ Pressure Control system, used an indirect 
measurement of the pressure by sensing changes in the external deflection of the septa on the 
top of the sealed pressure vessel. Stirring was performed by a rotating magnetic plate, located 
below the floor of the microwave cavity. When the reaction was done, cooling of the vial was 
performed by a stream of clean air onto the vial, which decreased the temperature of a 2 mL 
solution from approximately 150 °C to 40 °C in less than 120 seconds.  
 
5.2. Synthesis of (SS)-N-p-toluenesulfinyl-α-chloroaldimines 266a-c and 
(SS)-N-p-toluenesulfinyl-α,α-dichloroaldimines 266d-g 
The synthesis of (SS)-N-(2-chloro-2-methylpropylidene)-p-toluenesulfinamide 266a is 
representative. To a flame dried round-bottomed flask, charged with α-
chloroisobutyraldehyde 264a (3.43 g, 32.21 mmol) in dry CH2Cl2 (100 mL), was added 
Ti(OEt)4 (2 equiv, 14.70 g, 64.42 mmol) and (SS)-p-toluenesulfinamide 265 (5.00 g, 32.21 
mmol) under nitrogen atmosphere. The reaction mixture was stirred for 18 hours at room 
temperature. The reaction mixture was then poured into H2O/CH2Cl2 (1:1) (200 mL) while 
rapidly stirring. The suspension was filtered over Celite
®
 and the solids were washed with 
CH2Cl2 (2 x 50 mL). Subsequently, the combined organic phases were dried (MgSO4), 
filtered and evaporated in vacuo. The crude product was purified by column chromatography 
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to yield 7.25 g (29.74 mmol) of pure (SS)-N-(2-chloro-2-methylpropylidene)-p-toluene-
sulfinamide 266a.  
 
(SS)-N-(2-Chloro-2-methylpropylidene)-p-toluenesulfinamide 266a. Rf = 0.25 (petroleum 
ether/EtOAc : 5/1). White crystals, yield 92%. [α]D +326.2 (c 0.3, MeOH). Mp 
54.6 ± 1.0 °C. IR (cm
-1
): max 816, 1086, 1071, 1621. 
1
H NMR (300 MHz, 
CDCl3):  1.70 (3H, s, CCH3(CH3)), 1.77 (3H, s, CCH3(CH3)), 2.41 (3H, s, 
CH3Carom), 7.31 (2H, d, J = 8.0 Hz, CHarom), 7.55 (2H, d, J = 8.0 Hz, CHarom), 
8.17 (1H, s, CH=N). 
13
C NMR (75 MHz, CDCl3):  21.5 (CH3Carom), 29.0 (CCH3(CH3)), 29.1 
(CCH3(CH3)), 66.6 (C(CH3)2), 124.7 (2 x CHarom), 129.9 (2 x CHarom), 141.0 (Carom), 142.0 
(Carom), 165.9 (CH=N). MS (ES, pos. mode) m/z (%): 288/290 (100), 244/246 (M + H
+
, 80). 
HRMS (ES) calcd for C11H14ClNOS: 244.0557 MH
+
; found: 244.0548. 
 
(SS)-N-(2-Chloro-2-ethylbutylidene)-p-toluenesulfinamide 266b. Rf = 0.35 (petroleum 
ether/EtOAc : 9/1). Yellow oil, yield 66% (5.27 g). [α]D +264.4 (c 1.1, 
CHCl3). IR (cm
-1
): max 808, 1075, 1099, 1144, 1617. 
1
H NMR (300 MHz, 
CDCl3):  0.87 (3H, t, J = 7.2 Hz, CCH2CH3), 0.97 (3H, t, J = 7.2 Hz, 
CCH2CH3), 1.89-2.13 (4H, m, C(CH2CH3)2), 2.40 (3H, s, CH3Carom), 7.30 
(2H, d, J = 8.3 Hz, CHarom), 7.55 (2H, d, J = 8.3 Hz, CHarom), 8.11 (1H, s, CH=N). 
13
C NMR 
(75 MHz, CDCl3):  8.7 (CCH2CH3), 8.8 (CCH2CH3), 21.5 (CH3Carom), 32.0 (CCH2CH3), 
32.1 (CCH2CH3), 76.1 (CCl), 124.7 (2 x CHarom), 130.0 (2 x CHarom), 141.3 (Carom), 142.1 
(Carom), 166.2 (C=N). MS (ES, pos. mode) m/z (%): 263 (100), 272/274 (M + H
+
, 60). HRMS 
(ES) calcd for C13H18ClNOS: 272.0870 MH
+
; found: 272.0864. 
 
(SS)-N-(1-Chlorocyclohexylmethylidene)-p-toluenesulfinamide 266c. Rf = 0.31 (petroleum 
ether/EtOAc : 9/1). Colorless oil, yield 30% (0.80 g). [α]D +251.0 (c 1.2, 
CHCl3). IR (cm
-1
): max 809, 1075, 1098, 1144, 1618. 
1
H NMR (300 MHz, 
CDCl3):  1.18-1.35 (1H, m) and 1.49-2.13 (9H, m) ((CH2)5), 2.41 (3H, s, 
CH3Carom), 7.31 (2H, d, J = 8.3 Hz, CHarom), 7.55 (2H, d, J = 8.3 Hz, 
CHarom), 8.15 (1H, s, CH=N). 
13
C NMR (75 MHz, CDCl3):  21.5 (CH3Carom), 22.0 (2 x CH2), 
25.0 (CH2), 36.6 (2 x CH2), 71.6 (CCl), 124.8 (2 x CHarom), 130.0 (2 x CHarom), 141.3 (Carom), 
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142.0 (Carom), 166.0 (C=N). MS (ES, pos. mode) m/z (%): 177 (100), 284/286 (M + H
+
, 40). 
HRMS (ES) calcd for C14H18ClNOS: 284.0870 MH
+
; found: 284.0861. 
 
(SS)-N-(2,2-Dichloropropylidene)-p-toluenesulfinamide 266d. Rf = 0.38 (petroleum 
ether/EtOAc : 9/1). Colorless oil, yield 40% (1.67 g). [α]D +500.7 (c 1.0, 
CHCl3). IR (cm
-1
): max 808, 1072, 1102, 1619. 
1
H NMR (300 MHz, CDCl3): 
 2.27 (3H, s, CH3CCl2), 2.40 (3H, s, CH3Carom), 7.32 (2H, d, J = 8.1 Hz, 
CHarom), 7.55 (2H, d, J = 8.1 Hz, CHarom), 8.22 (1H, s, CH=N). 
13
C NMR (75 
MHz, CDCl3):  21.5 (CH3Carom), 32.5 (CH3CCl2), 82.9 (CCl2), 124.7 (2 x CHarom), 130.1 (2 x 
CHarom), 140.1 (Carom), 142.4 (Carom), 160.5 (C=N). MS (ES, pos. mode) m/z (%): 139 (100), 
264/266/268 (M + H
+
, 20). 
 
(SS)-N-(2,2-Dichlorobutylidene)-p-toluenesulfinamide 266e. Rf = 0.43 (petroleum 
ether/EtOAc : 9/1). Colorless oil, yield 59% (2.30 g). [α]D +405.0 (c 1.3, 
CHCl3). IR (cm
-1
): max 808, 1074, 1101, 1619. 
1
H NMR (300 MHz, CDCl3): 
 1.15 (3H, t, J = 7.2 Hz, CH3CH2), 2.39 (3H, s, CH3Carom), 2.40 (1H, dxq, J 
= 14.5 Hz, 7.2 Hz, CH(H)CH3), 2.43 (1H, dxq, J = 14.5 Hz, 7.2 Hz, 
CH(H)CH3), 7.30 (2H, d, J = 8.1 Hz, CHarom), 7.55 (2H, d, J = 8.1 Hz, CHarom), 8.20 (1H, s, 
CH=N). 
13
C NMR (75 MHz, CDCl3):  9.3 (CH3CH2), 21.5 (CH3Carom), 37.2 (CH3CH2), 88.5 
(CCl2), 124.7 (2 x CHarom), 130.0 (2 x CHarom), 140.3 (Carom), 142.3 (Carom), 160.5 (C=N). MS 
(ES, pos. mode) m/z (%): 139 (100), 278/280/282 (M + H
+
, 10). 
 
(SS)-N-(2,2-Dichloropentylidene)-p-toluenesulfinamide 266f. Rf = 0.44 (petroleum 
ether/EtOAc : 9/1). Colorless oil, yield 47% (1.77 g). [α]D +352.5 (c 1.1, 
CHCl3). IR (cm
-1
): max 808, 1076, 1102, 1619. 
1
H NMR (300 MHz, 
CDCl3):  0.96 (3H, t, J = 7.4 Hz, CH3CH2), 1.53-1.73 (2H, m, CH3CH2), 
2.29-2.43 (2H, m, CH2CCl2), 2.40 (3H, s, CH3Carom), 7.31 (2H, d, J = 7.7 
Hz, CHarom), 7.55 (2H, d, J = 7.7 Hz, CHarom), 8.18 (1H, s, CH=N). 
13
C NMR (75 MHz, 
CDCl3):  13.5 (CH3CH2), 18.3 (CH3CH2), 21.5 (CH3Carom), 45.7 (CH2CCl2), 87.5 (CCl2), 
124.7 (2 x CHarom), 130.0 (2 x CHarom), 140.2 (Carom), 142.4 (Carom), 160.6 (C=N). MS (ES, 
pos. mode) m/z (%): 139 (100), 292/294/296 (M + H
+
, 10). 
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(SS)-N-(2,2-Dichloro-3-methylbutylidene)-p-toluenesulfinamide 266g. Rf = 0.57 
(petroleum ether/EtOAc : 9/1). Colorless oil, yield 56% (2.10 g). [α]D +314.8 
(c 1.1, CHCl3). IR (cm
-1
): max 808, 1075, 1103, 1622. 
1
H NMR (300 MHz, 
CDCl3):  1.10 (3H, d, J = 6.6 Hz, (CH3(CH3)CH), 1.12 (3H, d, J = 6.6 Hz, 
(CH3(CH3)CH), 2.39 (3H, s, CH3Carom), 2.61 (1H, sept, J = 6.6 Hz, 
(CH3)2CH), 7.31 (2H, d, J = 7.8 Hz, CHarom), 7.56 (2H, d, J = 7.8 Hz, CHarom), 8.15 (1H, s, 
CH=N). 
13
C NMR (75 MHz, CDCl3):  17.9 (CH3(CH3)CH), 18.0 (CH3(CH3)CH), 21.5 
(CH3Carom), 40.6 (CH3)2CH), 93.3 (CCl2), 124.7 (2 x CHarom), 130.0 (2 x CHarom), 140.3 
(Carom), 142.3 (Carom), 161.0 (C=N). MS (ES, pos. mode) m/z (%): 139 (100), 292/294/296 (M 
+ H
+
, 5). 
 
5.3. Synthesis of (SS)-N-p-toluenesulfinyl-α-chloroaldimine 266h 
To a flame dried round-bottomed flask, charged with α-chloroacetaldehyde 264h (1.63 g, 
20.76 mmol) in dry CH2Cl2 (30 mL), was added CuSO4 (3 equiv, 9.94 g, 62.30 mmol) and 
(SS)-p-toluenesulfinamide 265 (3.22 g, 20.76 mmol) under nitrogen atmosphere. The reaction 
mixture was stirred for 14 hours at room temperature. The reaction mixture was then filtered 
over Celite
®
 and the filter cake was washed with CH2Cl2 (2 x 15 mL). Evaporation of the 
solvent in vacuo afforded 4.15 g (19.93 mmol) of the (SS)-N-(2-chloroethylidene)-p-
toluenesulfinamide 266h as a pale yellow oil. The crude product thus obtained, 90% pure by 
1
H-NMR analysis, was used without further purification or characterization, due to the 
instability of compound 266h.  
 
(SS)-N-(2-Chloroethylidene)-p-toluenesulfinamide 266h. Pale yellow oil, yield 96%. 
1
H 
NMR (300 MHz, CDCl3):  2.41 (3H, s, CH3Carom), 4.25 (1H, dxd, J = 13.8 
Hz, 4.4 Hz, CH(H)Cl), 4.30 (1H, dxd, J = 13.8 Hz, 4.4 Hz, CH(H)Cl), 7.33 
(2H, d, J = 8.3 Hz, CHarom), 7.56 (2H, d, J = 8.3 Hz, CHarom), 8.18 (1H, t, J = 
4.4 Hz, CH=N).  
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5.4. Synthesis of (RS)- and (SS)-N-tert-butanesulfinyl-α-chloroaldimines 
270a  
The synthesis of (SS)-N-(2-chloro-2-methylpropylidene)-tert-butanesulfinamide (SS)-270a is 
representative. To a flame dried round-bottomed flask, charged with α-
chloroisobutyraldehyde 264a (2.13 g, 20.00 mmol) in dry THF (75 mL), was added Ti(OEt)4 
(2 equiv, 9.13 g, 40.00 mmol) and (SS)-tert-butanesulfinamide (SS)-269 (2.42 g, 20.00 mmol) 
under nitrogen atmosphere. The reaction mixture was stirred for four hours at reflux 
temperature. The reaction mixture was then poured into brine/EtOAc (1:1) (150 mL) while 
rapidly stirring. The suspension was filtered over Celite
®
 and the solids were washed with 
EtOAc (2 x 30 mL). Subsequently, the combined organic phases were dried (MgSO4), filtered 
and evaporated in vacuo. The crude product was purified by column chromatography to yield 
2.90 g (13.80 mmol) of pure (SS)-N-(2-chloro-2-methylpropylidene)-tert-butanesulfinamide 
(SS)-270a. 
 
(SS)-N-(2-Chloro-2-methylpropylidene)-tert-butanesulfinamide (SS)-270a. Rf = 0.25 
(petroleum ether/EtOAc : 5/1). Colorless oil, yield 69%. [α]D +365.2 (c 1.2, 
CHCl3). IR (cm
-1
): max 1089, 1365, 1622. 
1
H NMR (300 MHz, CDCl3):  1.22 
(9H, s, tBu), 1.77 (3H, s, CCH3(CH3)), 1.78 (3H, s, CCH3(CH3)), 8.02 (1H, s, 
CH=N). 
13
C NMR (75 MHz, CDCl3):  22.4 (C(CH3)3), 29.1 (CCH3(CH3)), 
29.3 (CCH3(CH3)), 57.6 (C(CH3)3), 66.7 (C(CH3)2), 168.2 (CH=N). MS (ES, pos. mode) m/z 
(%): 210/212 (M + H
+
, 100).  
 
(RS)-N-(2-Chloro-2-methylpropylidene)-tert-butanesulfinamide (RS)-270a. Viscous white 
oil, yield 77%. All spectroscopic data were in good agreement with reported 
data of (RS)-270a.
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5.5. Synthesis of (RS)- and (SS)-N-tert-butanesulfinyl-α-functionalized 
aldimines 270b and 271 
The synthesis of (RS)-N-(2-tert-butoxycarbonylaminoethylidene)-tert-butanesulfinamide (RS)-
271 is representative. To a flame dried round-bottomed flask, charged with N-Boc-α-
aminoacetaldehyde 267 (0.10 g, 0.63 mmol) in dry CH2Cl2 (5 mL), was added CuSO4 (3 
equiv, 0.30 g, 1.89 mmol) and (RS)-tert-butanesulfinamide (RS)-269 (0.08 g, 0.63 mmol) 
under nitrogen atmosphere. The reaction mixture was stirred for 24 hours at room 
temperature. The reaction mixture was then filtered over Celite
®
 and the filter cake was 
washed with CH2Cl2 (2 x 2 mL). Evaporation of the solvent in vacuo and subsequent filtration 
over silica gel afforded 0.16 g (0.62 mmol) of the pure (RS)-N-(2-tert-
butoxycarbonylaminoethylidene)-tert-butanesulfinamide (RS)-271.  
 
(RS)-N-(2-tert-Butoxycarbonylaminoethylidene)-tert-butanesulfinamide (RS)-271. Yellow 
oil, yield 99%. IR (cm
-1
): max 752, 1064, 1164, 1365, 1634, 1699, 3322. 
1
H NMR (300 MHz, CDCl3):  1.21 (9H, s, StBu), 1.46 (9H, s, OtBu), 
4.15 (1H, dxdxd, J = 19.8 Hz, 4.7 Hz, 2.2 Hz, CH(H)NH), 4.26 (1H, 
dxdxd, J = 19.8 Hz, 6.1 Hz, 2.2 Hz, CH(H)NH), 5.18 (1H, br s, NH), 8.07 (1H, t, J = 2.2 Hz, 
CH=N). 
13
C NMR (75 MHz, CDCl3):  22.3 (SC(CH3)3), 28.3 (OC(CH3)3), 45.4 (CH2NH), 
57.1 (SC(CH3)3), 79.8 (OC(CH3)3), 155.7 (N(C=O)O), 165.3 (CH=N). MS (ES, pos. mode) 
m/z (%): 207 (M + H
+ 
- isobutene, 100). HRMS (ES) calcd for C7H14N2O3S: 207.0798 MH
+ 
- 
isobutene; found: 207.0802. 
 
(SS)-N-(2-tert-Butoxycarbonylaminoethylidene)-tert-butanesulfinamide (SS)-271. Yellow 
oil, yield 96%. [α]D +86.1 (c 2.5, CHCl3). IR (cm
-1
): max 754, 1064, 1163, 
1365, 1633, 1696, 3331. 
1
H NMR (300 MHz, CDCl3):  1.21 (9H, s, 
StBu), 1.46 (9H, s, OtBu), 4.10-4.20 (1H, m, CH(H)NH), 4.26 (1H, dxd, J 
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= 19.8 Hz, 5.0 Hz, CH(H)NH), 5.20 (1H, br s, NH), 8.05-8.08 (1H, m CH=N). 
13
C NMR (75 
MHz, CDCl3):  22.4 (SC(CH3)3), 28.4 (OC(CH3)3), 45.5 (CH2NH), 57.2 (SC(CH3)3), 80.0 
(OC(CH3)3), 155.7 (N(C=O)O), 165.1 (CH=N). MS (ES, pos. mode) m/z (%): 261 (M - H
+
). 
 
(RS)-N-(2-Chloroethylidene)-tert-butanesulfinamide (RS)-270b. Pale yellow oil, yield 92%. 
All spectroscopic data were in good agreement with reported data of (RS)-
270b.
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5.6. Synthesis of (SS,2S,3R)-alkyl 2-diphenylmethyleneamino-4-chloro-4-
methyl-3-(p-toluenesulfinylamino)pentanoates anti-277 
The synthesis of (SS,2S,3R)-alkyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(p-
toluenesulfinylamino)pentanoate anti-277a is representative. To a flame dried round-
bottomed flask with freshly distilled diisopropylamine (1.1 equiv, 6.76 mmol, 0.67 g) in dry 
THF (15 mL) was added n-BuLi (1.21 equiv, 7.43 mmol, 2.5M in hexane, 2.97 mL) under 
nitrogen atmosphere. The reaction mixture was stirred for five minutes at 0 °C and was 
subsequently cooled to -78 °C. After five minutes, a solution of N-
(diphenylmethylene)glycine ethyl ester 273a (1.1 equiv, 6.76 mmol, 1.81 g) in dry THF (5 
mL) was slowly added and the resulting solution was stirred for one hour at -78 °C. After 
deprotonation, the reaction mixture was cooled to -90 °C and a solution of (SS)-N-p-
toluenesulfinyl-α-chloroisobutyraldimine 266a (1.0 equiv, 6.14 mmol, 1.50 g), in dry THF 
(20 mL) was added dropwise and the reaction mixture was stirred at -90 °C for five minutes. 
To the reaction mixture was added a saturated solution of NH4Cl (40 mL) while stirring was 
continued at -90 °C for two minutes. The reaction mixture was brought to room temperature, 
followed by an extraction with EtOAc (3 x 40 mL). The combined organic phases were dried 
(MgSO4), filtered and evaporated in vacuo. The crude product was purified by column 
chromatography to yield 2.48 g (4.85 mmol) of (SS,2S,3R)-ethyl 2-diphenylmethyleneamino-
H
N
S
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4-chloro-4-methyl-3-(p-toluenesulfinylamino)-pentanoate anti-277a as a 89:11 mixture with 
syn-adduct syn-277a.  
 
(SS,2S,3R)-Ethyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(p-toluenesulfinyl-
amino)pentanoate anti-277a. Rf = 0.23 (petroleum ether/EtOAc : 3/1). 
White crystals, yield 79%, dr 89:11. Mp 52.7 ± 0.3 °C. IR (cm
-1
): max 
1624, 1731, 3280. 
1
H NMR (300 MHz, CDCl3):  1.19 (3H, t, J = 7.2 
Hz, CH2CH3), 1.62 (3H, s, CCH3(CH3)), 1.64 (3H, s, CCH3(CH3)), 2.37 
(3H, s, CaromCH3), 3.90 (1H, dxd, J = 8.8 Hz, 3.3 Hz, NHCH), 3.99-
4.16 (2H, m, OCH2CH3), 4.58 (1H, d, J = 3.3 Hz, CHN), 5.47 (1H, d, J = 8.8 Hz, NHCH), 
7.14-7.77 (14H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  14.0 (CH2CH3), 21.5 (CaromCH3) 
30.6 (CCH3(CH3)), 30.8 (CCH3(CH3)), 61.5 (OCH2CH3), 66.4 and 67.2 (NHCH and CHN), 
73.0 (C(CH3)2), 125.6, 127.8, 128.2, 128.7, 128.9, 129.4, 129.6, 130.8 (14xCHarom), 136.0, 
139.3, 141.3, 142.9 (4xCarom), 170.7 and 172.6 (C=N and C=O). MS (ES, pos. mode) m/z (%): 
511/513 (M + H
+
, 100). HRMS (ES) calcd for C28H31ClN2O3S: 511.1817 MH
+
; found: 
511.1825. 
 
(SS,2S,3R)-tert-Butyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(p-toluenesulfinyl-
amino)pentanoate anti-277c. Rf = 0.29 (petroleum ether/EtOAc : 
3/1). White crystals, yield 52%, dr 81:19. Mp 57.2 ± 0.5 °C. IR (cm
-
1
): max 1624, 1725, 3284. 
1
H NMR (300 MHz, CDCl3):  1.35 (9H, 
s, C(CH3)3), 1.64 (3H, s, CCH3(CH3)), 1.69 (3H, s, CCH3(CH3)), 
2.37 (3H, s, CaromCH3), 3.82 (1H, dxd, J = 8.8 Hz, 2.2 Hz, NHCH), 
4.44 (1H, d, J = 2.2 Hz, CHN), 5.62 (1H, d , J = 8.8 Hz, NH), 7.15-7.78 (14H, m, CHarom). 
13
C 
NMR (75 MHz, CDCl3):  21.3 (CaromCH3), 27.8 (C(CH3)3), 30.4 (CCH3(CH3)), 30.8 
(CCH3(CH3)), 66.6 and 67.3 (NHCH and CHN), 73.0 (C(CH3)2), 82.2 (OC(CH3)3), 125.7, 
127.9, 128.0, 128.5, 128.7, 129.3, 129.4, 130.5 (14xCHarom), 136.0, 139.4, 141.0, 142.5 
(4xCarom), 169.5 and 172.3 (C=N and C=O). MS (ES, pos. mode) m/z (%): 539/541 (M + H
+
, 
100). HRMS (ES) calcd for C30H35ClN2O3S: 539.2130 MH
+
; found: 539.2114. 
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5.7. Synthesis of (SS,2R,3R)-alkyl 2-diphenylmethyleneamino-4-chloro-4-
methyl-3-(p-toluenesulfinylamino)pentanoates syn-277 
 The synthesis of (SS,2R,3R)-ethyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(p-
toluenesulfinylamino)pentanoate syn-277a is representative. A solution of N-
(diphenylmethylene)glycine ethyl ester 273a (1.1 equiv, 6.76 mmol, 1.81 g) in THF (20 mL) 
was cooled to -78 °C under nitrogen atmosphere. A 1.0M solution of LiHMDS (1.1 equiv, 
6.76 mL, 6.76 mmol) in THF was slowly added and the resulting solution was stirred for one 
hour at -78 °C. After deprotonation, a solution of (SS)-N-p-toluenesulfinyl-α-
chloroisobutyraldimine 266a (1.0 equiv, 6.14 mmol, 1.50 g) in THF (20 mL) was added 
dropwise and the reaction mixture was stirred at -78 °C for 15 minutes. To the reaction 
mixture was added a saturated solution of NH4Cl (40 mL) while stirring at -78 °C for two 
minutes. The reaction mixture was brought to room temperature followed by an extraction 
with EtOAc (3 x 100 mL). The combined organic phases were dried (MgSO4), filtered and 
evaporated in vacuo. The crude product was purified by recrystallization from diethyl ether to 
yield 2.76 g (5.40 mmol) of pure (SS,2R,3R)-ethyl 2-diphenylmethyleneamino-4-chloro-4-
methyl-3-(p-toluenesulfinylamino)pentanoate syn-277a. 
 
(SS,2R,3R)-Ethyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(p-toluenesulfinyl-
amino)pentanoate syn-277a. Rf = 0.21 (petroleum ether/EtOAc : 3/1). 
White crystals, yield 88%. [α]D +193.8 (c 0.6, CHCl3). Mp 144.2 ± 1.0 
°C. IR (cm
-1
): max 815, 1070, 1088, 1259, 1621, 1721, 3312. 
1
H NMR 
(300 MHz, CDCl3):  1.30 (3H, t, J = 7.2 Hz, CH2CH3), 1.51 (3H, s, 
CCH3(CH3)), 1.63 (3H, s, CCH3(CH3)), 2.45 (3H, s, CaromCH3), 4.21-
4.38 (3H, m, NHCH and OCH2CH3), 4.66 (1H, d, J = 1.1 Hz, CHN), 5.83 (1H, d , J = 8.3 Hz, 
NHCH), 7.13-7.19 (2H, m, CHarom), 7.26-7.46 (8H, m, CHarom), 7.51-7.54 (2H, m, CHarom), 
7.74 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  14.1 (CH2CH3), 21.4 
(CaromCH3), 29.0 (CCH3(CH3)), 30.6 (CCH3(CH3)), 62.2 (OCH2CH3), 65.6 and 67.1 (NHCH 
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and CHN), 72.6 (C(CH3)2), 125.7, 127.1, 128.1, 128.6, 128.9, 129.0, 129.6, 130.7 
(14xCHarom), 136.4, 138.8, 141.3, 143.6 (4xCarom), 169.6 and 171.7 (C=N and C=O). MS (ES, 
pos. mode) m/z (%): 511/513 (M + H
+
, 100). HRMS (ES) calcd for C28H31ClN2O3S: 511.1817 
MH
+
; found: 511.1838. 
 
 (SS,2R,3R)-Methyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(p-toluenesulfinyl-
amino)pentanoate syn-277b. Rf = 0.08 (petroleum ether/EtOAc : 
4/1). White crystals, yield 86%. [α]D +224.1 (c 1.6, CHCl3). Mp 
136.4 ± 0.5 °C. IR (cm
-1
): max 1071, 1092, 1261, 1727, 3319. 
1
H 
NMR (300 MHz, CDCl3):  1.51 (3H, s, CCH3(CH3)), 1.63 (3H, s, 
CCH3(CH3)), 2.45 (3H, s, CaromCH3), 3.83 (3H, s, OCH3), 4.30 (1H, 
dxd, J = 8.3 Hz, 1.7 Hz, NHCH), 4.70 (1H, d, J = 1.7 Hz, CHN), 5.83 (1H, d , J = 8.3 Hz, 
NHCH), 7.13-7.16 (2H, m, CHarom), 7.28-7.45 (8H, m, CHarom), 7.50-7.53 (2H, m, CHarom), 
7.74 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  21.4 (CaromCH3), 29.0 
(CCH3(CH3)), 30.6 (CCH3(CH3)), 53.1 (OCH3), 65.6 and 67.2 (NHCH and CHN), 72.4 
(C(CH3)2), 125.7, 127.0, 128.1, 128.7, 128.9, 129.0, 129.6, 130.8 (14xCHarom), 136.4, 138.7, 
141.3, 143.5 (4xCarom), 170.2 and 171.8 (C=N and C=O). MS (ES, pos. mode) m/z (%): 
497/499 (M + H
+
, 100). HRMS (ES) calcd for C27H29ClN2O3S: 497.1660 MH
+
; found: 
497.1658. 
 
5.8. Synthesis of (SS,2’R)-alkyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-
1-(p-toluenesulfinyl)aziridin-2-yl]acetates 278 
 The synthesis of (SS,2S,2’R)-ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-
toluenesulfinyl)aziridin-2-yl]acetate anti-278a is representative. To a solution of (SS,2S,3R)-
ethyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(p-toluenesulfinylamino)pentanoate 
anti-277a (1.50 g, 2.93 mmol) in acetone (35 mL) was added K2CO3 (3.0 equiv, 8.80 mmol, 
1.22 g) at room temperature. The reaction mixture was allowed to stir for 24 hours at reflux 
temperature. After 24 hours, the K2CO3 was filtered off and the solvent was evaporated in 
vacuo. The resulting oil was redissolved in EtOAc (40 mL) and washed with water (2 x 15 
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mL). The organic phase was dried (MgSO4), filtered and evaporated in vacuo. The crude 
product was purified by column chromatography to yield 1.02 g (2.14 mmol) of (SS,2S,2’R)-
ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)aziridin-2-yl]acetate 
anti-278a. 
 
(SS,2S,2’R)-Ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)-
aziridin-2-yl]acetate anti-278a. Rf = 0.25 (petroleum ether/EtOAc : 3/1). 
White crystals, yield 73%. [α]D - 24.1 (c 0.4, CHCl3). Mp 103.8 ± 0.2 °C. 
IR (cm
-1
): max 1613, 1732. 
1
H NMR (300 MHz, CDCl3):  1.01 (3H, t, J = 
7.2 Hz, CH2CH3), 1.06 (3H, s, CCH3(CH3)), 1.60 (3H, s, CCH3(CH3)), 
2.36 (3H, s, CaromCH3), 3.50 (1H, d, J = 8.3 Hz, NCHazirCHN), 3.53-3.66 
(2H, m, CH2CH3), 3.84 (1H, d, J = 8.3 Hz, NCHazirCHN), 7.02-7.05 (2H, m, CHarom), 7.22 
(2H, d, J = 8.26 Hz, CHarom), 7.30-7.41 (6H, m, CHarom), 7.55 (2H, d, J = 8.26 Hz, CHarom), 
7.59-7.63 (2H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  13.8 (CH2CH3), 20.9 
(CCH3(CH3)), 21.3 (CaromCH3), 21.7 (CCH3(CH3)), 42.0 (NCHazirCHN), 44.6 (C(CH3)2), 60.8 
(CH2CH3), 65.4 (NCHazirCHN), 125.6, 128.0, 128.3, 128.9, 129.0, 129.2, 130.6 (14xCHarom), 
135.8, 139.4, 140.8, 143.1 (4xCarom), 170.1 and 170.9 (C=N and C=O). MS (ES, pos. mode) 
m/z (%): 475 (M + H
+
, 100). Anal. calcd for C28H30N2O3S: C 70.86; H 6.37; N 5.90; found: C 
71.00; H 6.21; N 5.85. 
 
(SS,2S,2’R)-tert-Butyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)-
aziridin-2-yl]acetate anti-278c. Rf = 0.38 (petroleum ether/EtOAc : 
3/1). White crystals, yield 79%, dr 81:19. Mp 92.2 ± 0.1 °C. IR (cm
-1
): 
max 1149, 1619, 1741. 
1
H NMR (300 MHz, CDCl3):  1.23 (3H, s, 
CCH3(CH3)), 1.25 (9H, s, C(CH3)3), 1.60 (3H, s, CCH3(CH3)), 2.33 (3H, 
s, CaromCH3), 3.41 (1H, d, J = 8.3 Hz, NCHazirCHN), 3.86 (1H, d, J = 8.3 
Hz, NCHazirCHN), 6.91-7.61 (14H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  21.25 
(CCH3(CH3)), 21.28 (CaromCH3), 21.8 (CCH3(CH3)), 27.8 (C(CH3)3), 42.2 (NCHazirCHN), 
44.5 (C(CH3)2), 65.5 (NCHazirCHN), 81.5 (OC(CH3)3), 125.9, 127.9, 128.1, 128.7, 128.9, 
129.2, 130.3 (14xCHarom), 135.8, 139.7, 140.7, 143.3 (4xCarom), 168.9 and 170.1 (C=N and 
C=O). MS (ES, pos. mode) m/z (%): 503 (M + H
+
, 100). Anal. calcd for C30H34N2O3S: C 
71.68; H 6.82; N 5.57; found: C 72.05; H 6.79; N 5.57. 
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(SS,2R,2’R)-Ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)-
aziridin-2-yl]acetate syn-278a. Rf = 0.23 (petroleum ether/EtOAc : 3/1). 
Colourless oil, yield 99%. [α]D +117.8 (c 0.7, CHCl3). IR (cm
-1
): max 695, 
1072, 1092, 1624, 1735. 
1
H NMR (300 MHz, CDCl3):  1.07 (3H, s, 
CCH3(CH3)), 1.24 (3H, t, J = 6.9 Hz, CH2CH3), 1.60 (3H, s, CCH3(CH3)), 
1.95 (3H, s, CaromCH3), 3.53 (1H, d, J = 9.4 Hz, NCHazirCHN), 3.77 (1H, d, 
J = 9.4 Hz, NCHazirCHN), 4.07-4.22 (2H, m, CH2CH3), 6.54-6.72 (4H, m, CHarom), 7.25-7.33 
(5H, m, CHarom), 7.39-7.50 (5H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  14.1 (CH2CH3), 
20.4 (CCH3(CH3)), 21.2 (CaromCH3), 22.6 (CCH3(CH3)), 42.2 (NCHazirCHN), 45.4 (C(CH3)2), 
61.2 (CH2CH3), 64.4 (NCHazirCHN), 124.6, 127.7, 128.0, 128.3, 129.1, 129.2, 130.2 
(14xCHarom), 135.6, 138.9, 141.0, 143.2 (4xCarom), 169.8 and 170.5 (C=N and C=O). MS (ES, 
pos. mode) m/z (%): 475 (M + H
+
, 100). HRMS (ES) calcd for C28H30N2O3S: 475.2050 MH
+
; 
found: 475.2071. 
 
(SS,2R,2’R)-Methyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)-
aziridin-2-yl]acetate syn-278b. Rf = 0.26 (petroleum ether/EtOAc : 3/1). 
White crystals, yield 83%. [α]D +178.9 (c 1.6, CHCl3). Mp 108.0 ± 0.3 
°C. IR (cm
-1
): max 698, 1070, 1091, 1622, 1741. 
1
H NMR (300 MHz, 
CDCl3):  1.07 (3H, s, CCH3(CH3)), 1.60 (3H, s, CCH3(CH3)), 1.95 (3H, 
s, CaromCH3), 3.53 (1H, d, J = 8.8 Hz, NCHazirCHN), 3.70 (3H, s, OCH3), 
3.80 (1H, d, J = 8.8 Hz, NCHazirCHN), 6.54-6.86 (4H, m, CHarom), 7.25-7.35 (5H, m, CHarom), 
7.39-7.50 (5H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  20.4 (CCH3(CH3)), 21.2 
(CaromCH3), 22.5 (CCH3(CH3)), 42.2 (NCHazirCHN), 45.4 (C(CH3)2), 52.4 (OCH3), 64.3 
(NCHazirCHN), 124.5, 127.7, 128.0, 128.3, 129.1, 129.2, 130.3 (14xCHarom), 135.5, 138.8, 
141.0, 143.2 (4xCarom), 170.4 and 170.6 (C=N and C=O). MS (ES, pos. mode) m/z (%): 461 
(M + H
+
, 100). HRMS (ES) calcd for C27H28N2O3S: 461.1893 MH
+
; found: 461.1894. 
 
5.9. Synthesis of (2S,2’R)-ethyl amino-(3,3-dimethylaziridin-2-yl)acetate 
280  
To a solution of (SS,2S,2’R)-ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluene-
sulfinyl)aziridin-2-yl]acetate anti-278a (0.50 g, 1.05 mmol) in acetone/H2O (2:1) (30 mL) 
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was added dropwise trifluoroacetic acid (5 equiv, 5.27 mmol, 0.41 mL) at room temperature. 
The reaction mixture was stirred for 15 minutes at room temperature and subsequently 
quenched with NH4OH in H2O until pH = 10 and concentrated in vacuo. The residue was 
redissolved in water (10 mL) and NH4OH was added until pH = 10. The aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic phases were dried (MgSO4), 
filtered and evaporated in vacuo. The crude product was purified by rapid filtration over a 
short silica column with petroleum ether and the silica was subsequently extracted with 
CH2Cl2/MeOH (4:1). The latter phase was filtered and evaporated in vacuo to yield 0.14 g 
(0.82 mmol) of (2S,2’R)-ethyl amino-(3,3-dimethylaziridin-2-yl)acetate 280. 
 
(2S,2’R)-Ethyl amino-(3,3-dimethylaziridin-2-yl)acetate 280. Yellowish oil, yield 78%. 
[α]D + 131.5 (c 0.9, CHCl3). IR (cm
-1
): max 831, 1027, 1187, 1382, 1729, 
2957. 
1
H NMR (300 MHz, CDCl3):  1.21 (3H, s, CCH3(CH3)), 1.23 (3H, 
t, J = 7.2 Hz, CH2CH3), 1.25 (3H, s, CCH3(CH3)), 1.39 (3H, br s, NH and 
NH2), 1.91 (1H, d, J = 8.8 Hz, NCHazirCHN), 3.08 (1H, d, J = 8.8 Hz, NCHazirCHN), 4.16 
(2H, q, J = 7.2 Hz, CH2CH3). 
13
C NMR (75 MHz, CDCl3):  14.3 (CH2CH3), 19.7 
(CCH3(CH3)), 27.2 (CCH3(CH3)), 35.6 (C(CH3)2), 45.8 (NCHazirCHN), 55.6 (CH2CH3), 61.2 
(CHNH2), 174.6 (C=O). MS (ES, pos. mode) m/z (%): 173 (M + H
+
, 100). HRMS (ES) calcd 
for C8H16N2O2: 173.1285 MH
+
; found: 173.1282. 
 
5.10. Synthesis of (SS)-ethyl 2-diphenylmethylamino-2-[3,3-dimethyl-1-(p-
toluenesulfinyl)aziridin-2-yl]acetate 281 
The synthesis of (SS,2S,2’R)-ethyl 2-diphenylmethylamino-2-[3,3-dimethyl-1-(p-
toluenesulfinyl)aziridin-2-yl]acetate anti-281 is representative. To a solution of (SS,2S,2’R)-
ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)aziridin-2-yl]acetate 
anti-278a (0.37 g, 0.78 mmol) in methanol (4 mL) was added dropwise acetic acid (1 equiv, 
0.78 mmol, 0.05 g) at room temperature. Subsequently, NaCNBH3 (2 equiv, 1.56 mmol, 0.10 
(R)
H
N
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g) was added in portions during five minutes. The reaction mixture was allowed to stir for six 
hours at room temperature. The reaction was then quenched with H2O (100 equiv, 78 mmol, 
1.4 mL) and concentrated in vacuo. The resulting precipitate was redissolved in EtOAc (4 
mL) and washed with H2O (3 x 2 mL). The organic phase was dried (MgSO4), filtered and 
evaporated in vacuo. The crude product was purified by column chromatography to yield 0.25 
g (0.53 mmol) of (SS,2S,2’R)-ethyl 2-diphenylmethylamino-2-[3,3-dimethyl-1-(p-
toluenesulfinyl)aziridin-2-yl]acetate anti-281.  
 
(SS,2S,2’R)-Ethyl 2-diphenylmethylamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)aziridin-
2-yl]acetate anti-281. Rf = 0.28 (hexane/Et2O : 10/1). White crystals, 
yield 68%. [α]D +80.6 (c 1.9, CHCl3). Mp 99.8 ± 0.5 °C. IR (cm
-1
): max 
1742, 3287. 
1
H NMR (300 MHz, CDCl3):  0.99 (3H, t, J = 7.2 Hz, 
CH2CH3), 1.21 (3H, s, CCH3(CH3)), 1.61 (3H, s, CCH3(CH3)), 2.22 
(1H, br s, NH), 2.37 (3H, s, CaromCH3), 2.88 (1H, d, J = 9.4 Hz, ) and 
2.91 (1H, d , J = 9.4 Hz) (NCHazirCHN and NCHazirCHN), 3.26 (1H, dxq, J = 11.0 Hz, 7.2 Hz, 
CH(H)CH3), 3.61 (1H, dxq, J = 11.0 Hz, 7.2 Hz, CH(H)CH3), 4.63 (1H, s, CHPh2), 7.16-7.33 
(12H, m, CHarom), 7.50 (2H, d , J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  14.0 
(CH2CH3), 20.7 (CCH3(CH3)), 21.3 (CaromCH3), 21.8 (CCH3(CH3)), 41.1 and 58.5 
(NCHazirCHN and NCHazirCHN), 45.3 (C(CH3)2), 60.4 (OCH2CH3), 65.2 (CHPh2), 125.3, 
127.0, 127.3, 127.4, 127.7, 128.4, 128.5, 129.2 (14xCHarom), 140.9, 142.1, 142.8, 143.5 
(4xCarom), 172.7 (CHCOO). MS (ES, pos. mode) m/z (%): 477 (M + H
+
, 100). HRMS (ES) 
calcd for C28H32N2O3S: 477.2206 MH
+
; found: 477.2210. 
 
(SS,2R,2’R)-Ethyl 2-diphenylmethylamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)aziridin-
2-yl]acetate syn-281. White crystals, yield 71%. [α]D +112.0 (c 0.8, 
CHCl3). Mp 144.0 ± 0.5 °C. IR (cm
-1
): max 1725, 2970. 
1
H NMR (300 
MHz, CDCl3):  1.22 (3H, s, CCH3(CH3)), 1.25 (3H, t, J = 7.2 Hz, 
CH2CH3), 1.53 (3H, s, CCH3(CH3)), 1.78 (1H, br s, NH), 2.35 (3H, s, 
CaromCH3), 2.82 (1H, d, J = 8.8 Hz, ) and 2.89 (1H, d , J = 8.8 Hz) 
(NCHazirCHN and NCHazirCHN), 4.11 (1H, dxq, J = 10.6 Hz, 7.2 Hz, CH(H)CH3), 4.21 (1H, 
dxq, J = 10.6 Hz, 7.2 Hz, CH(H)CH3), 4.61 (1H, s, CHPh2), 6.84-6.90 (2H, m, CHarom), 6.92-
(R)
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6.98 (2H, m, CHarom), 7.11-7.23 (4H, m, CHarom), 7.25-7.32 (2H, m, CHarom), 7.71 (2H, d, J = 
8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  14.3 (CH2CH3), 20.5 (CCH3(CH3)), 21.5 
(CaromCH3), 22.6 (CCH3(CH3)), 41.7 and 57.8 (NCHazirCHN and NCHazirCHN), 45.8 
(C(CH3)2), 60.9 (OCH2CH3), 64.5 (CHPh2), 125.3, 126.8, 127.0, 127.3, 127.4, 128.1, 128.2, 
129.4 (14xCHarom), 141.3, 142.1, 143.1, 143.9 (4xCarom), 172.6 (CHCOO). MS (ES, pos. 
mode) m/z (%): 477 (M + H
+
, 100). HRMS (ES) calcd for C28H32N2O3S: 477.2206 MH
+
; 
found: 477.2217. 
 
5.11. Synthesis of 3-(diphenylmethylamino)-5,5-dimethyl-1,5-
dihydropyrrole-2-one 283 
To a solution of (SS,2S,2’R)-ethyl 2-diphenylmethylamino-2-[3,3-dimethyl-1-(p-toluene-
sulfinyl)aziridin-2-yl]acetate anti-281 (0.10 g, 0.21 mmol) in ethanol (2 mL) was added 
K2CO3 (3.0 equiv, 0.63 mmol, 0.09 g) at room temperature. The reaction mixture was stirred 
for 22 hours at reflux. Subsequently, the K2CO3 was filtered off and the solvent was 
evaporated in vacuo. Precipitation in diethyl ether afforded 0.06 g (0.20 mmol) of 3-
(diphenylmethylamino)-5,5-dimethyl-1,5-dihydropyrrole-2-one 283. 
 
3-(Diphenylmethylamino)-5,5-dimethyl-1,5-dihydropyrrole-2-one 283. White crystals, 
yield 98%. Mp 213.2 ± 1.0 °C. IR (cm
-1
): max 704, 1344, 1650, 1697, 3181, 
3359. 
1
H NMR (300 MHz, CDCl3):  1.24 (6H, s, C(CH3)2), 4.52 (1H, br d, 
J = 3.6 Hz, NHCH), 4.91 (1H, d, J = 1.65 Hz, CH=C), 5.25 (1H, d  , J = 3.6 
Hz, CHPh2), 6.21 (1H, br s, NHCO), 7.21-7.34 (10H, m, CHarom). 
13
C NMR (75 MHz, 
CDCl3):  27.6 (C(CH3)2), 57.5 (C(CH3)2), 63.7 (CHPh2), 115.2 (CH=C), 127.3, 127.4, 128.6 
(10xCHarom), 136.6 (CH=C), 141.8 (2xCarom), 169.0 (C=O). MS (ES, pos. mode) m/z (%): 293 
(M + H
+
, 100). HRMS (ES) calcd for C19H20N2O: 293.1648 MH
+
; found: 293.1651. 
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5.12. Synthesis of (2S,2’R)-ethyl 2-diphenylmethyleneamino-2-[3,3-
dimethyl-1-(p-toluenesulfonyl)aziridin-2-yl]acetate 286 
To a solution of (SS,2S,2’R)-ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluene-
sulfinyl)aziridin-2-yl]acetate anti-278a (1.10 g, 2.32 mmol) in dry CH2Cl2 (40 mL) was added 
mCPBA (1.1 equiv, 2.55 mmol, 0.44 g) at room temperature. The reaction mixture was 
allowed to stir for two minutes at room temperature and was subsequently quenched with a 
saturated solution of NaHCO3 (20 mL). The organic phase was dried (MgSO4), filtered and 
evaporated in vacuo. The crude product was purified by recrystallization from EtOAc to yield 
1.02 g (2.09 mmol) of (2S,2’R)-ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-
toluene-sulfonyl)aziridin-2-yl]-acetate 286. All spectroscopic data were in good agreement 
with reported data of the racemate of 286.
92
 White crystals, yield 90%. [α]D -137.1 (c 0.4, 
CHCl3). Mp 128.4 ± 0.5 °C. 
 
5.13. Synthesis of (2S,2’R)-ethyl 2-diphenylmethylamino-2-[3,3-dimethyl-1-
(p-toluenesulfonyl)aziridin-2-yl]acetate 287 
To a solution of (2S,2’R)-ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluene-
sulfonyl)aziridin-2-yl]acetate 286 (1.33 g, 2.71 mmol) in methanol (15 mL) was added 
dropwise acetic acid (1 equiv, 2.71 mmol, 0.16 g) at room temperature. Subsequently, 
NaCNBH3 (2 equiv, 5.42 mmol, 0.34 g) was added in portions during five minutes. The 
reaction mixture was stirred for six hours at room temperature. The reaction was then 
quenched with H2O (100 equiv, 271 mmol, 4.9 mL) and concentrated in vacuo. The resulting 
precipitate was redissolved in EtOAc (15 mL) and washed with water (3 x 10 mL). The 
organic phase was dried (MgSO4), filtered and evaporated in vacuo. The crude product was 
purified by recrystallization from EtOAc/Et2O (1:1) to yield 1.23 g (2.50 mmol) of (2S,2’R)-
ethyl 2-diphenylmethylamino-2-[3,3-dimethyl-1-(p-toluenesulfonyl)aziridin-2-yl]acetate 287. 
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All spectroscopic data were in good agreement with reported data of the racemate of 287.
92
 
White crystals, yield 92%. [α]D -45.3 (c 0.9, CHCl3). Mp 95.8 ± 1.0 °C. 
 
5.14. Synthesis of (2S,3R)-ethyl 1-diphenylmethyl-4,4-dimethyl-3-(p-
toluenesulfonylamino)azetidine-2-carboxylate 288 
In a 10 mL microwave vial containing (2S,2’R)-ethyl 2-diphenylmethylamino-2-[3,3-
dimethyl-1-(p-toluenesulfonyl)aziridin-2-yl]acetate 287 (0.40 g, 0.81 mmol) was added 
acetonitrile (3 mL). The reaction mixture was stirred vigorously at 120 °C for 10 minutes. 
Subsequently, the reaction mixture was concentrated in vacuo and the residue was 
recrystallized from Et2O to afford 0.25 g (0.51 mmol) of (2S,3R)-ethyl 1-diphenylmethyl-4,4-
dimethyl-3-(p-toluenesulfonylamino)azetidine-2-carboxylate 288. All spectroscopic data were 
in good agreement with reported data of the racemate of 288 (ee > 98%). White crystals, yield 
63%. [α]D +15.6 (c 0.2, CHCl3). Mp 188.1 ± 0.5 °C. 
 
5.15. Synthesis of (2S,3R)-1-diphenylmethyl-4,4-dimethyl-3-(p-toluene-
sulfonylamino)azetidine-2-carboxylic acid 289 
(2S,3R)-Ethyl 1-diphenylmethyl-4,4-dimethyl-3-(p-toluenesulfonylamino)azetidine-2-
carboxylate 288 (0.37 g, 0.80 mmol) was dissolved in 2 M NaOH/MeOH (1:1) (40 mL). The 
reaction mixture was stirred for 24 hours at reflux temperature and subsequently washed with 
EtOAc (1 x 20 mL). The aqueous phase was brought to pH = 4 with 2 M HCl and extracted 
with EtOAc (3 x 20 mL). The combined organic phases were dried (MgSO4), filtered and 
evaporated in vacuo. Recrystallization from diethyl ether/hexane (1:1) afforded 0.24 g (0.52 
mmol) of (2S,3R)-1-diphenylmethyl-4,4-dimethyl-3-(p-toluenesulfonylamino)azetidine-2-
carboxylic acid 289. 
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(2S,3R)-1-Diphenylmethyl-4,4-dimethyl-3-(p-toluenesulfonylamino)azetidine-2-
carboxylic acid 289. White crystals, yield 69%. [α]D +61.0 (c 0.5, 
MeOH). Mp 121.0 ± 0.2 °C. IR (cm
-1
): max 705, 1092, 1153, 1321, 1454, 
1643, 1714, 3062. 
1
H NMR (300 MHz, CDCl3):  1.19 (3H, s, 
CCH3(CH3)), 1.24 (3H, s, CCH3(CH3)), 2.36 (3H, s, CaromCH3), 3.65-3.73 
(2H, m, CHNH and CHCOOH), 4.88 (1H, s, CHPh2), 6.33 (2H, br s, NH), 7.14-7.36 (10H, m, 
CHarom), 7.53 (2H, d, J = 7.7 Hz, CHarom), 7.70 (2H, d, J = 7.7 Hz, CHarom). 
13
C NMR (75 
MHz, CDCl3):  16.5 (CCH3(CH3)), 21.6 (CaromCH3), 29.7 (CCH3(CH3)), 56.0 (CHNH), 66.7 
(CHCOOH), 69.3 (CHPh2), 70.3 (C(CH3)2), 127.0, 127.7, 128.0, 128.6, 128.8, 129.1, 129.9 
(14xCHarom), 136.8, 137.4, 140.2, 143.9 (4xCarom), 170.7 (COOH). MS (ES, pos. mode) m/z 
(%): 465 (M + H
+
, 100). HRMS (ES) calcd for C26H28N2O4S: 465.1843 MH
+
; found: 
465.1848. 
 
5.16. Synthesis of (2S,3R)-4,4-dimethyl-3-(p-toluenesulfonylamino)-
azetidine-2-carboxylic acid derivatives 290 and 291 
The synthesis of (2S,3R)-4,4-dimethyl-3-(p-toluenesulfonylamino)azetidine-2-carboxylic acid 
290 is representative. To a solution of (2S,3R)-1-diphenylmethyl-4,4-dimethyl-3-(p-
toluenesulfonyl-amino)azetidine-2-carboxylic acid 289 (0.060 g, 0.13 mmol) in methanol (5 
mL) was added Pd(OH)2/C (30% mass fraction, 0.018 g) at room temperature. The mixture 
was stirred for 64 hours at room temperature under H2-atmosphere (3 bar) and subsequently 
filtered through a short pad of Celite
®
. The Celite
®
 pad was washed exhaustively with CH2Cl2 
and the collected organic fractions were evaporated in vacuo. Precipitation in diethyl ether 
afforded 0.035 g (0.12 mmol) of (2S,3R)-4,4-dimethyl-3-(p-toluenesulfonylamino)azetidine-
2-carboxylic acid 290. 
 
(2S,3R)-4,4-Dimethyl-3-(p-toluenesulfonylamino)azetidine-2-carboxylic acid 290. White 
crystals, yield 92%. [α]D +66.9 (c 0.4, MeOH). Mp 171.0 ± 1.0 °C. IR (cm
-1
): 
max 665, 1094, 1159, 1326, 1620, 3063. 
1
H NMR (300 MHz, CD3OD):  
1.47 (6H, s, C(CH3)2), 2.42 (3H, s, CaromCH3), 3.87 (1H, d, J = 8.0 Hz, 
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CHNH), 4.27 (1H, d, J = 8.0 Hz, CHCOO), 7.38 (2H, d, J = 7.7 Hz, CHarom), 7.76 (2H, d, J = 
7.7 Hz, CHarom). 
13
C NMR (75 MHz, CD3OD):  21.3 (CCH3(CH3)), 21.5 (CaromCH3), 26.5 
(CCH3(CH3)), 59.4 (CHNH), 60.4 (CHCOO), 69.8 (C(CH3)2), 128.2, 130.9 (4xCHarom), 
138.9, 145.2 (2xCarom), 171.4 (C=O, tentative assignment). MS (ES, pos. mode) m/z (%): 299 
(M + H
+
, 100). HRMS (ES) calcd for C13H18N2O4S: 299.1060 MH
+
; found: 299.1066. 
 
(2S,3R)-Ethyl 4,4-dimethyl-3-(p-toluenesulfonylamino)azetidine-2-carboxylate 291. 
White crystals, yield 87%. [α]D +54.2 (c 0.9, MeOH). Mp 183.6 ± 1.5 °C. IR 
(cm
-1
): max 664, 907, 1095, 1167, 1228, 1338, 1732, 2771. 
1
H NMR (300 
MHz, CDCl3):  1.10 (3H, t, J = 6.9 Hz, CH2CH3), 1.65 (3H, s, CCH3(CH3)), 
1.68 (3H, s, CCH3(CH3)), 1.65-1.68 (1H, br s, NH), 2.42 (3H, s, CaromCH3), 3.99-4.13 (3H, m, 
CH2CH3 and CHNH), 5.36 (1H, d, J = 7.7 Hz, CHCOO), 7.29 (2H, d, J = 8.0 Hz, CHarom), 
7.80 (2H, d, J = 8.0 Hz, CHarom), 8.16 (1H, d, J = 8.81 Hz, NH). 
13
C NMR (75 MHz, 
CD3OD):  14.2 (CH2CH3), 20.8 (CCH3(CH3)), 21.5 (CaromCH3), 26.0 (CCH3(CH3)), 57.9 
(CHNH), 59.1 (CHCOO), 64.0 (CH2CH3), 72.0 (C(CH3)2), 128.2, 131.0 (4xCHarom), 139.2, 
145.4 (2xCarom), 167.5 (C=O). MS (ES, pos. mode) m/z (%): 327 (M + H
+
, 100). HRMS (ES) 
calcd for C15H22N2O4S: 327.1373 MH
+
; found: 327.1379. 
 
5.17. Synthesis of (2S,3R)-ethyl 1-diphenylmethyl-4,4-dimethyl-3-[benzyl-
(p-toluenesulfonyl)amino]azetidine-2-carboxylate 293 
To a solution of (2S,3R)-ethyl 1-diphenylmethyl-4,4-dimethyl-3-(p-toluenesulfonylamino)-
azetidine-2-carboxylate 288 (0.22 g, 0.45 mmol) in DMF (4 mL) was added K2CO3 (3 equiv, 
1.35 mmol, 0.19 g) at room temperature. Subsequently, benzyl bromide (1.4 equiv, 0.63 
mmol, 0.11 g) was added dropwise and the reaction mixture was stirred for 3.5 hours at room 
temperature. The reaction mixture was poured in diethyl ether (5 mL) and washed with NH4Cl 
in H2O (2 mL) and brine (3 x 2 mL). The organic phase was dried (MgSO4), filtered and 
evaporated in vacuo. The crude product was purified by column chromatography to yield 0.22 
g (0.38 mmol) of (2S,3R)-ethyl 1-diphenylmethyl-4,4-dimethyl-3-[benzyl-(p-toluene-
sulfonyl)amino]azetidine-2-carboxylate 293.  
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(2S,3R)-Ethyl 1-diphenylmethyl-4,4-dimethyl-3-[benzyl-(p-toluenesulfonyl)amino]-
azetidine-2-carboxylate 293. Rf = 0.18 (petroleum ether/EtOAc : 5/1). 
White crystals, yield 85%. [α]D +54.0 (c 0.2, CHCl3). Mp 165.5 ± 0.5 °C. 
IR (cm
-1
): max 671, 695, 706, 1157, 1216, 1332, 1720. 
1
H NMR (300 
MHz, CDCl3):  0.81 (3H, t, J = 7.2 Hz, CH2CH3), 0.93 (3H, s, 
CCH3(CH3)), 1.18 (3H, s, CCH3(CH3)), 2.39 (3H, s, CaromCH3), 3.38-3.49 (1H, m, 
CH(H)CH3), 3.54-3.65 (1H, m, CH(H)CH3), 3.74 (1H, d, J = 7.7 Hz, CHNBn), 3.90 (1H, d, J 
= 16.2 Hz, NCH(H)Ph), 3.93 (1H, d, J = 7.7 Hz, CHCOO), 4.40 (1H, s, CHPh2), 4.64 (1H, d, 
J = 16.2 Hz, CH(H)Ph), 7.06-7.37 (15H, m, CHarom), 7.49 (2H, d, J = 7.2 Hz, CHarom), 7.64 
(2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  13.6 (CH2CH3), 17.1 
(CCH3(CH3)), 21.5 (CaromCH3), 29.6 (CCH3(CH3)), 51.4 (CH2Ph), 60.4 (CH2CH3), 62.0 
(CHCOO), 63.6 (CHNH), 68.6 (C(CH3)2), 69.9 (CHPh2), 127.2, 127.4, 127.5, 127.7, 128.0, 
128.1, 128.3, 128.4, 128.9, 129.7 (19xCHarom), 135.5, 137.7, 140.7, 142.8, 143.6 (5xCarom), 
171.4 (C=O). MS (ES, pos. mode) m/z (%): 583 (M + H
+
, 100). HRMS (ES) calcd for 
C35H38N2O4S: 583.2625 MH
+
; found: 583.2620. 
 
5.18. Synthesis of bis-[(2S,3R)-ethyl 1-diphenylmethyl-4,4-dimethyl-3-
(benzylamino)azetidine-2-carboxylate] oxalic acid salt 295 
A mixture of magnesium powder (83 mg, 3.4 mmol) in dry MeOH (1 mL) was sonicated at 
40 °C for one minute. Subsequently, a solution of (2S,3R)-ethyl 1-diphenylmethyl-4,4-
dimethyl-3-[benzyl-(p-toluenesulfonyl)amino]azetidine-2-carboxylate 293 (100 mg, 0.2 
mmol) in MeOH (0.4 mL) was added dropwise and the resulting suspension was sonicated for 
five hours at 40 °C. Next, the reaction mixture was concentrated under reduced pressure to 
afford a white powder which was redissolved in an aqueous solution of NH4Cl (sat.), which 
was immediatly extracted with CHCl3 (3 x 5 mL). Drying of the combined organic phases 
with MgSO4, filtration of the drying agent and evaporation of the solvent in vacuo afforded a 
crude mixture containing the detosylated compound. This crude mixture was redissoved in 
Et2O (1.0 ml), and addition, under sonication, of a solution of anhydrous oxalic acid (8 mg, 
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0.1 mol) in EtOH (0.2 ml) resulted immediately in the formation of a precipitate. The solid 
was filtered and dried under reduced pressure to give the pure title compound 295. 
 
Bis-[(2S,3R)-ethyl 1-diphenylmethyl-4,4-dimethyl-3-(benzylamino)azetidine-2-
carboxylate] oxalic acid salt 295. White powder, yield 
37%. [α]D +32.7 (c 0.5, CHCl3). Mp 168.0 ± 1.0 °C. IR 
(cm
-1
): max 695, 706, 1192, 1271, 1599, 1740. 
1
H NMR 
(300 MHz, CDCl3):  0.94 (3H, t, J = 7.2 Hz, CH2CH3), 
1.13 (3H, s, CCH3(CH3)), 1.22 (3H, s, CCH3(CH3)), 
1.26 (2H, br s, NH2) 3.44-3.91 (6H, m, CH2CH3 and CHNBn and NCH2Ph and CHCOO), 
4.74 (1H, s, CHPh2), 7.06-7.31 (11H, m, 11xCHarom), 7.36 (2H, d, J = 6.1 Hz, 2xCHarom), 7.57 
(2H, d, J = 7.2 Hz, 2xCHarom). 
13
C NMR (75 MHz, CDCl3):  13.9 (CH2CH3), 16.0 
(CCH3(CH3)), 30.5 (CCH3(CH3)), 50.6 (CH2Ph), 59.6 (CHNH2), 60.8 (CH2CH3), 65.7 
(CHCOO), 65.9 (C(CH3)2), 70.1 (CHPh2), 127.4, 127.6, 128.0, 128.3, 128.8, 129.1, 129.5 
(15xCHarom), 140.8, 142.8 (3xCarom), 163.3 (O(C=O)2O), 171.5 (CHC=O). MS (ES, pos. 
mode) m/z (%): 429 (M + H
+ 
- oxalic acid, 100). HRMS (ES) calcd for C28H32N2O2: 429.2537 
(MH
+
- oxalic acid); found: 429.2540. 
 
5.19. Synthesis of (R,R)-2,3-diamino-4,4-dimethylbutyrolactone 
dihydrochloride 297 
(SS,2R,2’R)-Ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)aziridin-
2-yl]-acetate syn-278a (0.14 g, 0.29 mmol) was dissolved in a mixture of 0.5 M HCl 
(aq.)/EtOAc (4:1) (10 mL) and the mixture was stirred for 30 minutes at room temperature. 
Subsequently, the reaction mixture was concentrated in vacuo. Precipitation from diethyl 
ether afforded 0.06 g (0.28 mmol) of (2R,3R)-2,3-diamino-4,4-dimethylbutyrolactone 
dihydrochloride 297. 
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(2R,3R)-2,3-Diamino-4,4-dimethylbutyrolactone dihydrochloride 297. White crystals, 
yield 94%. [α]D +12.5 (c 0.3, MeOH). Mp 243.8 ± 1.5 °C. IR (cm
-1
): 
max 1042, 1070, 1136, 1273, 1500, 1763, 1787, 2857. 
1
H NMR (300 
MHz, CD3OD, int. ref. H2O):  1.48 (3H, s, CCH3(CH3)), 1.59 (3H, s, 
CCH3(CH3)), 3.97 (1H, d, J = 10.46 Hz) and 4.61 (1H, d, J = 10.46 Hz) (C(CH3)2CH and 
CHCO). 
13
C NMR (75 MHz, D2O, int. ref. CH3CN):  21.7 (CCH3(CH3)), 26.5 (CCH3(CH3)), 
52.3 and 57.2 (CHCO and C(CH3)2CH), 84.9 (C(CH3)2), 168.1 (C=O). MS (ES, pos. mode) 
m/z (%): 145 (M + H
+
 - 2xHCl, 100). Anal. calcd for C6H14Cl2N2O2: C 33.19; H 6.50; N 
12.90; found: C 33.55; H 6.51; N 12.66. 
 
5.20. Synthesis of (R,R)-2,3-(di-tert-butoxycarbonylamino)-4,4-dimethyl-
butyrolactone 298 
A mixture of (2R,3R)-2,3-diamino-4,4-dimethylbutyrolactone hydrochloride 297 (0.10 g, 0.46 
mmol), Et3N (0.23 g, 2.30 mmol) and Boc2O (0.26 g, 1.20 mmol) was dissolved in THF (10 
mL) and the mixture was stirred for 18 hours at room temperature. Subsequently, the 
precipitate was filtered over Celite® and the filtrate was concentrated in vacuo. Precipitation 
in diethyl ether afforded 0.09 g (0.28 mmol) of (R,R)-2,3-(di-tert-butoxycarbonylamino)-4,4-
dimethylbutyrolactone 298. 
 
(R,R)-2,3-(Di-tert-butoxycarbonylamino)-4,4-dimethylbutyrolactone 298. White powder, 
yield 60%. [α]D -18.2 (c 3.8, CHCl3). Mp 156.8 ± 1.0 °C. IR (cm
-1
): max 
1160, 1252, 1517, 1689, 1776, 3366. 
1
H NMR (300 MHz, CDCl3):  
1.36 (3H, s, CCH3(CH3)), 1.44 (9H, s, OC(CH3)3), 1.45 (9H, s, 
OCCH3)3), 1.55 (3H, s, CCH3(CH3)), 3.97-4.08 (1H, m) and 4.48-4.60 (1H, m) (C(CH3)2CH 
and CHCO), 5.02-5.17 (1H, m) and 5.28-5.41 (1H, m) (2xNH). 
13
C NMR (75 MHz, CDCl3): 
 21.6 (CCH3(CH3)), 27.2 (CCH3(CH3)), 27.7 (2xOC(CH3)3), 54.0 and 59.6 (CHCO and 
C(CH3)2CH), 78.7 and 79.1 (2xOC(CH3)3), 82.7 (C(CH3)2), 155.7 and 155.9 (2xNC=O), 
171.0 (OC=O). MS (ES, pos. mode) m/z (%): 233 (M + H
+
 - 2 x isobutene, 100). HRMS (ES) 
calcd for C7H12N2O4: 189.0870 (MH
+ 
- CO2 - 2 x isobutene); found: 189.0878. 
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5.21. Synthesis of (SS,2R,3R)-ethyl 2-amino-4-chloro-4-methyl-3-(p-toluene-
sulfinylamino)pentanoate syn-301 
To a solution of (SS,2R,3R)-ethyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(p-toluene-
sulfinylamino)pentanoate syn-277a (0.50 g, 0.98 mmol) in acetone/H2O (2:1) (30 mL) was 
added dropwise trifluoroacetic acid (5 equiv, 4.89 mmol, 0.38 mL) at room temperature. The 
reaction mixture was stirred for 15 minutes at room temperature and subsequently quenched 
with NH4OH in H2O until pH = 10 and concentrated in vacuo. The residue was redissolved in 
water (10 mL) and NH4OH in H2O was added until pH = 10. The aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic phases were dried (MgSO4), 
filtered and evaporated in vacuo. The crude product was purified by rapid filtration over a 
short silica column with petroleum ether and the silica was subsequently extracted with 
CH2Cl2/MeOH (4:1). The latter phase was filtered and evaporated in vacuo to yield 0.28 g 
(0.81 mmol) of (SS,2R,3R)-ethyl 2-amino-4-chloro-4-methyl-3-(p-toluenesulfinylamino)-
pentanoate syn-301. 
 
(SS,2R,3R)-Ethyl 2-amino-4-chloro-4-methyl-3-(p-toluenesulfinylamino)pentanoate syn-
301. Yellowish oil, yield 83%. [α]D +155.2 (c 0.5, CHCl3). IR (cm
-1
): 
max 811, 1064, 1090, 1224, 1734, 3208. 
1
H NMR (300 MHz, CDCl3): 
 1.36 (3H, t, J = 7.15 Hz, CH2CH3), 1.63 (3H, s, CCH3(CH3)), 1.69 
(2H, br s, NH2), 1.74 (3H, s, CCH3(CH3)), 2.41 (3H, s, CaromCH3), 4.07 
(1H, dxd, J = 9.1 Hz, 1.10 Hz, CHNH), 4.17 (1H, d, J = 1.10 Hz, CHNH2), 4.24-4.37 (2H, m, 
CH2CH3), 5.40 (1H, d, J = 9.1 Hz, NH), 7.30 (2H, d, J = 8.0 Hz, CHarom), 7.63 (2H, d, J = 8.0 
Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  14.2 (CH2CH3), 21.3 (CaromCH3), 29.2 
(CCH3(CH3)), 30.8 (CCH3(CH3)), 53.3 (CHNH2), 62.2 (CH2CH3), 65.3 (CHNH), 73.0 
(C(CH3)2), 125.4, 129.5 (4xCHarom), 141.4, 142.8 (2xCarom), 173.0 (C=O). MS (ES, pos. 
mode) m/z (%): 347/349 (M + H
+
, 100). HRMS (ES) calcd for C15H23ClN2O3S: 347.1191 
MH
+
; found: 347.1205. 
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5.22. Synthesis of (SS)-ethyl 2-diphenylmethyleneamino-4-chloro-3-(p-
toluenesulfinylamino)butanoate major-302a 
A solution of N-(diphenylmethylene)glycine ethyl ester 273a (1.1 equiv, 8.40 mmol, 2.25 g) 
in THF (20 mL) was cooled to -78 °C under nitrogen atmosphere. A 1.0M solution of 
LiHMDS (1.1 equiv, 8.40 mL, 8.40 mmol) in THF was slowly added and the resulting 
solution was stirred for 1 hour at -78 °C. After deprotonation, a solution of (SS)-N-p-
toluenesulfinyl-α-chloroacetaldimine 266h (1.0 equiv, 7.60 mmol, 1.65 g) in THF (20 mL) 
was added dropwise and the reaction mixture was stirred at -90 °C for one hour. To the 
reaction mixture was added a saturated solution of NH4Cl (40 mL) while stirring at -78 °C for 
two minutes. The reaction mixture was brought to room temperature followed by an 
extraction with EtOAc (3 x 100 mL). The combined organic phases were dried (MgSO4), 
filtered and evaporated in vacuo. The crude product was purified by column chromatography 
to yield 2.30 g (4.48 mmol) of pure (SS)-ethyl 2-diphenylmethyleneamino-4-chloro-3-(p-
toluenesulfinylamino)butanoate major-302a. 
 
(SS)-Ethyl 2-diphenylmethyleneamino-4-chloro-3-(p-toluenesulfinylamino)butanoate 
major-302a. Rf = 0.04 (petroleum ether/EtOAc : 4/1). Yellowish oil, 
yield 59%. [α]D +2.0 (c 1.2, CHCl3). IR (cm
-1
): max 697, 1064, 1090, 
1242, 1626, 1736, 3293. 
1
H NMR (300 MHz, CDCl3):  1.28 (3H, t, J 
= 7.2 Hz, CH2CH3), 2.41 (3H, s, CaromCH3), 3.44 (1H, t, J = 11.0 Hz, 
CH(H)Cl), 3.72 (1H, dxd, J = 11.0 Hz, 4.4 Hz, CH(H)Cl), 4.13-4.34 
(3H, m, CH2CH3 and CHNH), 4.54 (1H, d, J = 2.2 Hz, CHCOO), 5.36 (1H, d , J = 10.5 Hz, 
NH), 7.13-7.20 (2H, m, CHarom), 7.27-7.35 (4H, m, CHarom), 7.37-7.46 (4H, m, CHarom), 7.54-
7.62 (4H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  14.3 (CH2CH3), 21.4 (CaromCH3), 44.2 
(CH2Cl), 58.8 (CHNH), 61.5 (CH2CH3), 64.5 (CHCOO), 125.7, 127.5, 128.1, 128.5, 128.8, 
128.9, 129.7, 131.0 (14xCHarom), 135.9, 138.6, 141.6, 142.0 (4xCarom), 170.2 and 174.3 (C=N 
and C=O). MS (ES, pos. mode) m/z (%): 483/485 (M + H
+
, 100). HRMS (ES) calcd for 
C26H27ClN2O3S: 483.1504 MH
+
; found: 483.1500. 
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5.23. Synthesis of (RS,2S,3S)-ethyl 2-diphenylmethyleneamino-4-chloro-4-
methyl-3-(tert-butanesulfinylamino)pentanoate syn-304 
A solution of N-(diphenylmethylene)glycine ethyl ester 273a (1.1 equiv, 2.75 mmol, 0.74 g) 
in THF (15 mL) was cooled to -78 °C under nitrogen atmosphere. A 1.0M solution of 
LiHMDS (1.1 equiv, 2.75 mL, 2.75 mmol) in THF was slowly added and the resulting 
solution was stirred for one hour at -78 °C. After deprotonation, the reaction mixture was 
cooled to -90 °C and a solution of (RS)-N-tert-butanesulfinyl-α-chloroisobutyraldimine (RS)-
270a (1.0 equiv, 2.5 mmol, 0.52 g) in THF (5 mL) was added dropwise and the reaction 
mixture was stirred at -90 °C for five minutes. To the reaction mixture was added a saturated 
solution of NH4Cl (10 mL) while stirring at -78 °C for two minutes. The reaction mixture was 
brought to room temperature followed by an extraction with EtOAc (3 x 30 mL). The 
combined organic phases were dried (MgSO4), filtered and evaporated in vacuo. The crude 
product was purified by column chromatography to yield 0.64 g (1.35 mmol) of (RS,2S,3S)-
ethyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(tert-butanesulfinylamino)-pentanoate 
syn-304. 
 
(RS,2S,3S)-Ethyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(tert-butanesulfinyl-
amino)pentanoate syn-304. Rf = 0.05 (petroleum ether/EtOAc : 4/1). 
White crystals, yield 54%. Mp 97.3 ± 1.5 °C. IR (cm
-1
): max 691, 1076, 
1255, 1624, 1726, 3278. 
1
H NMR (300 MHz, CDCl3):  1.27 (3H, t, J = 
7.2 Hz, CH2CH3), 1.35 (9H, s, tBu), 1.45 (3H, s, CCH3(CH3)), 1.54 (3H, 
s, CCH3(CH3)), 4.12 (1H, d , J = 7.7 Hz, NHCH), 4.15-4.32 (2H, m, 
OCH2CH3), 4.69 (1H, s, CHCOO), 5.77 (1H, d  , J = 7.7 Hz, NHCH), 7.16-7.22 (2H, m, 
CHarom), 7.32-7.39 (2H, m, CHarom), 7.40-7.47 (4H, m, CHarom), 7.59-7.63 (2H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  13.8 (CH2CH3), 22.8 (C(CH3)3), 28.2 (CCH3(CH3)), 30.5 
(CCH3(CH3)), 56.3 (C(CH3)3), 61.7 (OCH2CH3), 64.9 (CHCOO), 66.0 (NHCH), 72.0 
(C(CH3)2), 126.8, 127.8, 128.2, 128.4, 128.6, 130.4 (10xCHarom), 136.1, 138.7 (2xCarom), 
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169.1 and 170.8 (C=N and C=O). MS (ES, pos. mode) m/z (%): 477/479 (M + H
+
, 100). 
HRMS (ES) calcd for C25H33ClN2O3S: 477.1973 MH
+
; found: 477.1977. 
 
5.24. Synthesis of (RS,2R,3S)-ethyl 2-diphenylmethyleneamino-4-chloro-4-
methyl-3-(tert-butanesulfinylamino)pentanoate anti-304  
To a flame dried round-bottomed flask with freshly distilled diisopropylamine (1.1 equiv, 
2.75 mmol, 0.27 g) in dry THF (15 mL) was added n-BuLi (1.21 equiv, 3.03 mmol, 2.5M in 
hexane, 1.21 mL) under nitrogen atmosphere. The reaction mixture was stirred for five 
minutes at 0 °C and was subsequently cooled to -78 °C. After five minutes, a solution of N-
(diphenylmethylene)glycine ethyl ester 273a (1.1 equiv, 2.75 mmol, 0.74 g) in dry THF (5 
mL) was slowly added and the resulting solution was stirred for one hour at -78 °C. After 
deprotonation, the reaction mixture was cooled to -90 °C and a solution of (RS)-N-tert-
butanesulfinyl-α-chloroisobutyraldimine (RS)-270a (1.0 equiv, 2.50 mmol, 0.52 g), in dry 
THF (5 mL) was added dropwise and the reaction mixture was stirred at -90 °C for 15 
minutes. To the reaction mixture was added a saturated solution of NH4Cl (8 mL) while 
stirring was continued at -90 °C for two minutes. The reaction mixture was brought to room 
temperature, followed by an extraction with EtOAc (3 x 15 mL). The combined organic 
phases were dried (MgSO4), filtered and evaporated in vacuo. The crude product was purified 
by column chromatography to yield 0.26 g (0.55 mmol) of (RS,2R,3S)-ethyl 2-
diphenylmethyleneamino-4-chloro-4-methyl-3-(tert-butanesulfinylamino)pentanoate anti-
304.  
 
(RS,2R,3S)-Ethyl 2-diphenylmethyleneamino-4-chloro-4-methyl-3-(tert-butanesulfinyl-
amino)-pentanoate anti-304. Rf = 0.10 (petroleum ether/EtOAc : 4/1). 
Yellow oil, yield 22%. 
1
H NMR (300 MHz, CDCl3):  1.22 (3H, t, J = 
7.2 Hz, CH2CH3), 1.31 (9H, s, tBu), 1.54 (6H, s, C(CH3)2), 3.69 (1H, 
dxd, J = 7.7 Hz, 3.3 Hz, NHCH), 4.01-4.21 (2H, m, OCH2CH3), 4.72 
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(1H, d, J = 3.3 Hz, CHN), 5.23 (1H, d, J = 7.7 Hz, NHCH), 7.19-7.24 (2H, m, CHarom), 7.31-
7.53 (6H, m, CHarom), 7.74-7.79 (2H, m, CHarom).  
 
5.25. Synthesis of (RS,2R,2’S)-ethyl 2-diphenylmethyleneamino-2-[3,3-
dimethyl-1-(tert-butanesulfinyl)aziridin-2-yl]acetate anti-306 
A solution of N-(diphenylmethylene)glycine ethyl ester 273a (1.1 equiv, 2.75 mmol, 0.74 g) 
in THF (15 mL) was cooled to -78 °C under nitrogen atmosphere. A 1.0M solution of 
LiHMDS (1.1 equiv, 2.75 mL, 2.75 mmol) in THF was slowly added and the resulting 
solution was stirred for one hour at -78 °C. After deprotonation, the reaction mixture was 
cooled to -90 °C and a solution of (RS)-N-tert-butanesulfinyl-α-chloroisobutyraldimine (RS)-
270a (1.0 equiv, 2.5 mmol, 0.52 g) in THF (5 mL) was added dropwise and the reaction 
mixture was stirred at -90 °C for five minutes. Subsequently, the reaction mixture was 
allowed to warm up to room temperature and the reaction continued for two hours at room 
temperature. To the reaction mixture was added a saturated solution of NH4Cl (10 mL) while 
stirring at room temperature for two minutes. Extraction with EtOAc (3 x 30 mL) was 
followed by drying (MgSO4), filtration and evaporation in vacuo of the combined organic 
phases. The crude product was purified by column chromatography to yield 0.87 g (1.98 
mmol) of (RS,2R,2’S)-ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(tert-
butanesulfinyl)aziridin-2-yl]acetate anti-306. 
 
(RS,2R,2’S)-Ethyl 2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(tert-butanesulfinyl)-
aziridin-2-yl]acetate anti-306. Rf = 0.10 (petroleum ether/EtOAc : 5/1). 
White crystals, yield 79%. [α]D +42.7 (c 1.0, CHCl3). Mp 137.1 ± 1.0 °C. 
IR (cm
-1
): max 1619, 1735. 
1
H NMR (300 MHz, CDCl3):  1.05 (3H, s, 
CCH3(CH3)), 1.14 (9H, s, tBu), 1.27 (3H, t, J = 7.2 Hz, CH2CH3), 1.49 
(3H, s, CCH3(CH3)), 3.29 (1H, d, J = 8.8 Hz, NCHazirCHN), 4.08 (1H, d, J 
= 8.8 Hz, NCHazirCHN), 4.19 (2H, q, J = 7.2 Hz, CH2CH3), 7.23-7.49 (8H, m, CHarom), 7.64-
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7.70 (2H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  14.1 (CH2CH3), 20.7 (CCH3(CH3)), 22.2 
(CCH3(CH3)), 22.5 (C(CH3)3), 43.3 (C(CH3)2), 44.4 (NCHazirCHN), 55.8 (C(CH3)3), 61.3 
(CH2CH3), 65.3 (NCHazirCHN), 127.9, 128.0, 128.3, 128.8, 129.1, 130.4 (10xCHarom), 135.8, 
139.1 (2xCarom), 169.7 and 171.3 (C=N and C=O). MS (ES, pos. mode) m/z (%): 441 (M + 
H
+
, 100). HRMS (ES) calcd for C25H32N2O3S: 441.2206 MH
+
; found: 441.2216. 
 
5.26. Synthesis of (RS)-ethyl 2-diphenylmethyleneamino-4-chloro-3-(tert-
butanesulfinylamino)butanoate major-307 
A solution of N-(diphenylmethylene)glycine ethyl ester 273a (1.1 equiv, 2.75 mmol, 0.74 g) 
in THF (10 mL) was cooled to -78 °C under nitrogen atmosphere. A 1.0M solution of 
LiHMDS (1.1 equiv, 2.75 mL, 2.75 mmol) in THF was slowly added and the resulting 
solution was stirred for one hour at -78 °C. After deprotonation, a solution of (RS)-N-tert-
butanesulfinyl-α-chloroacetaldimine (RS)-270b (1.0 equiv, 2.50 mmol, 0.45 g) in THF (5 mL) 
was added dropwise and the reaction mixture was stirred at -90 °C for five minutes. To the 
reaction mixture was added a saturated solution of NH4Cl (8 mL) while stirring at -90 °C for 
two minutes. The reaction mixture was brought to room temperature followed by an 
extraction with EtOAc (3 x 20 mL). The combined organic phases were dried (MgSO4), 
filtered and evaporated in vacuo. The crude product was purified by column chromatography 
to yield 0.89 g (1.98 mmol) of pure (RS)-ethyl 2-diphenylmethyleneamino-4-chloro-3-(tert-
butanesulfinylamino)butanoate major-307. 
 
(RS)-Ethyl 2-diphenylmethyleneamino-4-chloro-3-(tert-butanesulfinylamino)butanoate 
major-307. Rf = 0.10 (petroleum ether/EtOAc : 3/1). Yellowish viscous 
oil, yield 79%. [α]D +28.3 (c 1.3, CHCl3). IR (cm
-1
): max 696, 1073, 
1191, 1627, 1741, 3305. 
1
H NMR (300 MHz, CDCl3): δ 1.22 (3H, t, J = 
7.2 Hz, CH2CH3), 1.24 (9H, s, C(CH3)3), 3.48 (1H, t, J = 11.0 Hz, 
CHCl(H)), 3.97 (1H, dxd, J = 11.0 Hz, 3.9 Hz, CHCl(H)), 4.07-4.15 
(3H, m, OCH2CH3 and CHNH), 4.51 (1H, d, J = 2.2 Hz, CHN), 4.58 (1H, d , J = 11.0 Hz, 
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NHCH), 7.17-7.20 (2H, m, CHarom), 7.35-7.38 (2H, m, CHarom), 7.42-7.44 (4H, m, CHarom), 
7.61-7.64 (2H, m, CHarom). 
13
C NMR (75 MHz, CDCl3): δ 14.2 (CH2CH3), 22.6 (C(CH3)3), 
44.1 (CH2Cl), 56.6 (C(CH3)3), 60.9 and 61.3 (CHNH and OCH2CH3), 64.1 (CHCOO), 127.5, 
128.2, 128.5, 128.8, 128.9, 131.0 (10xCHarom), 135.8, 138.7 (2xCarom), 170.0 and 174.5 (C=N 
and C=O). MS (ES, pos. mode) m/z (%): 449/451 (M + H
+
, 100). HRMS (ES) calcd for 
C23H29ClN2O3S: 449.1660 MH
+
; found: 449.1659. 
 
5.27. Synthesis of (RS)-ethyl 2-diphenylmethyleneamino-2-[1-(tert-butane-
sulfinyl)aziridin-2-yl]acetate major-308 
To a solution of (RS)-ethyl 2-diphenylmethyleneamino-4-chloro-3-(tert-butanesulfinylamino)-
butanoate major-307 (1.37 g, 3.05 mmol) in acetone (30 mL) was added K2CO3 (3.0 equiv, 
9.15 mmol, 1.26 g) at room temperature. The reaction mixture was allowed to stir for 14 
hours at reflux temperature. After 14 hours, the K2CO3 was filtered off and the solvent was 
evaporated in vacuo. The resulting oil was redissolved in EtOAc (40 mL) and washed with 
water (2 x 15 mL). The organic phase was dried (MgSO4), filtered and evaporated in vacuo. 
The crude product was purified by column chromatography to yield 0.57 g (1.38 mmol) of 
(RS)-ethyl 2-diphenylmethyleneamino-2-[1-(tert-butanesulfinyl)aziridin-2-yl]acetate major-
308. 
 
(RS)-Ethyl 2-diphenylmethyleneamino-2-[1-(tert-butanesulfinyl)aziridin-2-yl]acetate 
major-308. Rf = 0.18 (petroleum ether/EtOAc : 3/1). Yellowish viscous oil, 
yield 45%. [α]D -29.7 (c 1.4, CHCl3). IR (cm
-1
): max 1660, 1736. 
1
H NMR 
(300 MHz, CDCl3):  1.20 (9H, s, C(CH3)3), 1.27 (3H, t, J = 7.2 Hz, 
CH2CH3), 1.91 (1H, d, J = 3.9 Hz, CH(H)N), 2.73 (1H, d, J = 7.7 Hz, 
CH(H)N), 2.83 (1H, txd, J = 7.7 Hz, 3.9 Hz, NCHazirCHN), 3.87 (1H, d, J = 
7.7 Hz, NCHazirCHN), 4.11-4.28 (2H, m, CH2CH3), 7.17-7.25 (2H, m, CHarom), 7.30-7.47 
(6H, m, CHarom), 7.63-7.69 (2H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  14.2 (CH2CH3), 
22.7 (C(CH3)3), 23.4 (CH2N), 35.5 (NCHazirCHN), 57.1 (C(CH3)3), 61.3 (CH2CH3), 67.7 
N
Ph
Ph
N
S
(R)O
H
OEt
O
t-Bu
**
Chapter 5   Experimental part 
 
178 
 
(NCHazirCHN), 128.1, 128.2, 128.8, 129.0, 130.6 (10xCHarom), 135.9, 139.4 (2xCarom), 169.6 
and 171.8 (C=N and C=O). MS (ES, pos. mode) m/z (%): 413 (M + H
+
, 100). HRMS (ES) 
calcd for C23H28N2O3S: 413.1893 MH
+
; found: 413.1783. 
 
5.28. Synthesis of (SS,2S,3S) N-[4-chloro-2-diphenylmethyleneamino-3-(p-
toluenesulfinylamino)alkanoyl]amines syn-314 
The synthesis of (SS,2S,3S) N-[4-chloro-2-diphenylmethyleneamino-4-methyl-3-(p-
toluenesulfinylamino)pentanoyl]piperidine syn-314b is representative. A solution of N-[2-
diphenylmethyleneaminoacetyl]piperidine 313b (1.1 equiv, 0.91 mmol, 0.28 g) in THF (10 
mL) was cooled to -78 °C under nitrogen atmosphere. A 1.0M solution of LiHMDS (1.1 
equiv, 0.91 mL, 0.91 mmol) in THF was slowly added and the resulting solution was stirred 
for one hour at -78 °C. After deprotonation, a solution of (SS)-N-p-toluenesulfinyl-α-
chloroisobutyraldimine 266a (1.0 equiv, 0.82 mmol, 0.20 g) in THF (5 mL) was added 
dropwise and the reaction mixture was stirred at -78 °C for 15 minutes. To the reaction 
mixture was added a saturated solution of NH4Cl (5 mL) while stirring at -78 °C for two 
minutes. The reaction mixture was brought to room temperature followed by an extraction 
with EtOAc (3 x 20 mL). The combined organic phases were dried (MgSO4), filtered and 
evaporated in vacuo. The crude product was purified by recrystallization from diethyl ether to 
yield 0.32 g (0.58 mmol, 71%) of pure (SS,2S,3S) N-[4-chloro-2-diphenylmethyleneamino-4-
methyl-3-(p-toluenesulfinylamino)pentanoyl]piperidine syn-314b. 
 
(SS,2S,3S) N-[4-Chloro-2-diphenylmethyleneamino-4-methyl-3-(p-toluenesulfinylamino)- 
pentanoyl]pyrrolidine syn-314a. White crystals, yield 57% (0.30 g). 
[α]D +64.7 (c 1.3, CHCl3). Mp 132.3 ± 2.0 °C. IR (cm
-1
): max 697, 703, 
1069, 1096, 1277, 1424, 1444, 1635, 3291 (weak). 
1
H NMR (300 MHz, 
CDCl3):  1.45 (3H, s, CCH3(CH3)), 1.53-1.86 (4H, m, 2xCH2(CH2)2), 
1.77 (3H, s, CCH3(CH3)), 2.25-2.35 (1H, m, CH(H)N), 2.41 (3H, s, 
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CaromCH3), 3.26-3.40 (3H, m, CH(H)N and CH2N), 3.77 (1H, d, J = 9.4 Hz, CHNH), 4.93 
(1H, s, CHCO), 6.16 (1H, d, J = 9.4 Hz, NH), 7.12-7.19 (2H, m, CHarom), 7.23-7.35 (4H, m, 
CHarom), 7.35-7.50 (4H, m, CHarom), 7.50-7.57 (2H, m, CHarom), 8.07 (2H, d, J = 8.3 Hz, 
CHarom). 
13
C NMR (75 MHz, CDCl3):  21.4 (CaromCH3), 24.0, 26.0 (2xCH2(CH2)2), 27.3 
(CCH3(CH3)), 32.4 (CCH3(CH3)), 46.1, 46.2 (2xCH2N), 62.5 (CHCO), 66.6 (CHNH), 73.6 
(C(CH3)2), 126.1 (2xCHarom), 126.8 (2xCHarom), 128.1 (2xCHarom), 128.5 (2xCHarom), 128.6 
(CHarom), 128.7 (2xCHarom), 129.6 (2xCHarom), 130.7 (CHarom), 137.8, 138.5, 141.2, 143.8 
(4xCarom), 169.5 and 170.1 (C=N and C=O). MS (ES, pos. mode) m/z (%): 536/538 (M + H
+
, 
100). HRMS (ES) calcd for C30H34ClN3O2S: 536.2133 MH
+
; found: 536.2146. 
 
(SS,2S,3S) N-[4-Chloro-2-diphenylmethyleneamino-4-methyl-3-(p-toluenesulfinylamino)-
pentanoyl]piperidine syn-314b. White crystals, yield 71% (0.32 g). 
[α]D +78.1 (c 0.9, CHCl3). Mp 125.4 ± 2.0 °C. IR (cm
-1
): max 700, 1070, 
1098, 1222, 1442, 1640, 3355 (weak). 
1
H NMR (300 MHz, CDCl3):  
0.83-0.97 (1H, m, CH(H)(CH2)2), 1.30-1.59 (5H, m, CH(H)(CH2)2 and 
2xCH2(CH2)2), 1.47 (3H, s, CCH3(CH3)), 1.76 (3H, s, CCH3(CH3)), 2.41 
(3H, s, CaromCH3), 3.08-3.36 (3H, m, CH(H)N and CH2N), 3.52-3.64 (1H, m, CH(H)N), 3.78 
(1H, d, J = 9.4 Hz, CHNH), 5.12 (1H, s, CHCO), 6.04 (1H, d  , J = 9.4 Hz, NH), 7.12-7.18 
(2H, m, CHarom), 7.23-7.50 (8H, m, CHarom), 7.53 (2H, d, J = 8.3 Hz, CHarom), 7.95 (2H, d, J = 
8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  21.4 (CaromCH3), 24.4, 25.4, 25.8 
(3xCH2(CH2)2), 27.5 (CCH3(CH3)), 32.6 (CCH3(CH3)), 43.3, 46.1 (2xCH2N), 61.3 (CHCO), 
66.5 (CHNH), 73.7 (C(CH3)2), 126.0 (2xCHarom), 127.1 (2xCHarom), 128.0 (2xCHarom), 128.57 
(3xCHarom), 128.63 (2xCHarom), 129.6 (2xCHarom), 130.6 (CHarom), 137.4, 138.7, 141.3, 143.6 
(4xCarom), 169.2 and 170.0 (C=N and C=O). MS (ES, pos. mode) m/z (%): 550/552 (M + H
+
, 
100). HRMS (ES) calcd for C31H36ClN3O2S: 550.2290 MH
+
; found: 550.2306.  
 
(SS,2S,3S) N-[4-Chloro-2-diphenylmethyleneamino-4-ethyl-3-(p-toluenesulfinylamino)- 
hexanoyl]pyrrolidine syn-314c. White crystals, yield 41% (0.71 g). 
[α]D +60.4 (c 2.7, CHCl3). Mp 143.3 ± 1.0 °C. IR (cm
-1
): max 699, 1073, 
1103, 1294, 1422, 1442, 1636, 3348 (weak). 
1
H NMR (300 MHz, 
CDCl3):  0.93 (3H, t, J = 7.2 Hz) and 1.12 (3H, t, J = 7.2 Hz) 
(C(CH2CH3)2), 1.51-2.20 (8H, m, 2xCH2CH3 and 2xCH2(CH2)2), 2.24-
2.35 (1H, m, CH(H)N), 2.41 (3H, s, CaromCH3), 3.24-3.38 (3H, m, CH(H)N and CH2N), 4.00 
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(1H, d, J = 9.4 Hz, CHNH), 4.91 (1H, s, CHCO), 6.12 (1H, d , J = 9.4 Hz, NH), 7.13-7.22 
(2H, m, CHarom), 7.23-7.35 (4H, m, CHarom), 7.36-7.58 (6H, m, CHarom), 8.12 (2H, d, J = 8.3 
Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  8.7 (CH2CH3), 8.9 (CH2CH3), 21.5 (CaromCH3), 
24.0, 26.1 (2xCH2(CH2)2), 29.4 and 30.2 (C(CH2CH3)2), 46.2, 46.3 (2xCH2N), 62.2 (CHCO), 
63.5 (CHNH), 83.0 (C(CH2CH3)2), 126.4 (2xCHarom), 126.9 (2xCHarom), 128.2 (2xCHarom), 
128.7 (3xCHarom), 128.8 (2xCHarom), 129.7 (2xCHarom), 130.8 (CHarom), 137.9, 138.7, 141.2, 
144.1 (4xCarom), 169.7 and 170.0 (C=N and C=O). MS (ES, pos. mode) m/z (%): 564/566 (M 
+ H
+
, 100). HRMS (ES) calcd for C32H38ClN3O2S: 564.2446 MH
+
; found: 564.2454. 
 
(SS,2S,3S) N-[4-Chloro-2-diphenylmethyleneamino-4-ethyl-3-(p-toluenesulfinylamino)-
hexanoyl]piperidine syn-314d. White crystals, yield 65% (0.33 g). [α]D 
+61.1 (c 0.9, CHCl3). Mp 138.5 ± 2.0 °C. IR (cm
-1
): max 701, 1074, 
1111, 1252, 1439, 1634, 3332 (weak). 
1
H NMR (300 MHz, CDCl3):  
0.83-1.04 (1H, m, CH(H)(CH2)2), 0.93 (3H, t, J = 7.15 Hz) and 1.12 
(3H, t, J = 7.15 Hz) (C(CH2CH3)2), 1.30-1.65 (5H, m, CH(H)(CH2)2 and 
2xCH2(CH2)2), 1.72-2.16 (4H, m, 2xCH2CH3), 2.40 (3H, s, CaromCH3), 2.98-3.09 (1H, m, 
CH(H)N), 3.20-3.31 (1H, m, CH(H)N), 3.39-3.47 (2H, m, CH2N), 4.05 (1H, d, J = 9.4 Hz, 
CHNH), 5.09 (1H, s, CHCO), 5.95 (1H, d , J = 9.4 Hz, NH), 7.12-7.17 (2H, m, CHarom), 7.24-
7.31 (4H, m, CHarom), 7.35-7.49 (4H, m, CHarom), 7.54 (2H, d, J = 8.3 Hz, CHarom), 8.00 (2H, 
d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  8.6 (CH2CH3), 8.9 (CH2CH3), 21.5 
(CaromCH3), 24.5, 25.6, 26.1 (3xCH2(CH2)2), 29.4 and 30.3 (C(CH2CH3)2), 43.4, 46.1 
(2xCH2N), 61.2 (CHCO), 63.1 (CHNH), 83.3 (C(CH2CH3)2), 126.2 (2xCHarom), 127.2 
(2xCHarom), 128.1 (2xCHarom), 128.7 (5xCHarom), 129.7 (2xCHarom), 130.7 (CHarom), 137.5, 
138.9, 141.3, 143.9 (4xCarom), 169.7 (C=N and C=O). MS (ES, pos. mode) m/z (%): 578/580 
(M + H
+
, 100). HRMS (ES) calcd for C33H40ClN3O2S: 578.2603 MH
+
; found: 578.2609.  
 
(SS,2S,3S) N-[3-(1-Chlorocyclohexyl)-2-diphenylmethyleneamino-3-(p-toluenesulfinyl-
amino)propanoyl]pyrrolidine syn-314e. White crystals, yield 59% 
(1.14 g). [α]D +83.5 (c 2.5, CHCl3). Mp 138.8 ± 2.0 °C. IR (cm
-1
): max 
696, 704, 1068, 1092, 1294, 1430, 1634, 3309 (weak). 
1
H NMR (300 
MHz, CDCl3):  1.05-1.21 (1H, m, CH(H)CH2), 1.48-1.94 (12H, m, 
2xCH(H)CH2 and 5xCH2CH2), 2.24-2.47 (2H, m, CH(H)CH2 and 
CH(H)N), 2.41 (3H, s, CaromCH3), 3.27-3.40 (3H, m, CH(H)N and CH2N), 3.74 (1H, d, J = 
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9.4 Hz, CHNH), 5.01 (1H, s, CHCO), 6.16 (1H, d , J = 9.4 Hz, NH), 7.12-7.18 (2H, m, 
CHarom), 7.24-7.35 (4H, m, CHarom), 7.36-7.56 (6H, m, CHarom), 8.10 (2H, d, J = 8.3 Hz, 
CHarom). 
13
C NMR (75 MHz, CDCl3):  21.5 (CaromCH3), 21.7, 22.1, 24.0, 24.8, 26.1, 33.7, 
37.2 (7xCH2CH2), 46.2, 46.3 (2xCH2N), 62.3 (CHCO), 67.7 (CHNH), 80.1 (CCl), 126.2 
(2xCHarom), 126.9 (2xCHarom), 128.2 (2xCHarom), 128.6 (3xCHarom), 128.8 (2xCHarom), 129.7 
(2xCHarom), 130.8 (CHarom), 137.9, 138.7, 141.3, 143.9 (4xCarom), 169.7 and 169.8 (C=N and 
C=O). MS (ES, pos. mode) m/z (%): 576/578 (M + H
+
, 100). HRMS (ES) calcd for 
C33H38ClN3O2S: 576.2446 MH
+
; found: 576.2436. 
 
(SS,2S,3S) N-[3-(1-Chlorocyclohexyl)-2-diphenylmethyleneamino-3-(p-toluenesulfinyl-
amino)propanoyl]piperidine syn-314f. White crystals, yield 73% (1.20 
g). [α]D +86.9 (c 2.9, CHCl3). Mp 132.2 ± 1.0 °C. IR (cm
-1
): max 701, 
1073, 1104, 1221, 1441, 1638, 3320 (weak). 
1
H NMR (300 MHz, 
CDCl3):  0.82-0.98 (1H, m, CH(H)CH2), 1.05-1.21 (1H, m, 
CH(H)CH2), 1.31-1.81 (13H, m, 3xCH(H)CH2 and 5xCH2CH2), 2.30-
2.45 (1H, m, CH(H)CH2), 2.41 (3H, s, CaromCH3), 3.06-3.16 (1H, m, CH(H)N), 3.18-3.38 
(2H, m, CH(H)N and CH(H)N), 3.48-3.59 (1H, m, CH(H)N), 3.76 (1H, dxd, J = 9.4 Hz, 1.1 
Hz, CHNH), 5.20 (1H, d , J = 1.1 Hz, CHCO), 6.03 (1H, d , J = 9.4 Hz, NH), 7.12-7.17 (2H, 
m, CHarom), 7.24-7.56 (10H, m, CHarom), 7.99 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, 
CDCl3):  21.5 (CaromCH3), 21.7, 22.1, 24.5, 24.8, 25.5, 25.9, 33.8, 37.4 (8xCH2CH2), 43.4, 
46.2 (2xCH2N), 61.1 (CHCO), 67.8 (CHNH), 80.4 (CCl), 126.1 (2xCHarom), 127.2 
(2xCHarom), 128.1 (2xCHarom), 128.7 (5xCHarom), 129.7 (2xCHarom), 130.6 (CHarom), 137.5, 
138.9, 141.4, 143.7 (4xCarom), 169.5 and 169.6 (C=N and C=O). MS (ES, pos. mode) m/z (%): 
590/592 (M + H
+
, 100). HRMS (ES) calcd for C34H40ClN3O2S: 590.2603 MH
+
; found: 
590.2609. 
 
(SS,2S,3S) N-[4,4-Dichloro-2-diphenylmethyleneamino-3-(p-toluenesulfinylamino)-
pentanoyl]pyrrolidine syn-314g. White crystals, yield 12% (0.44 g). 
[α]D +28.4 (c 1.2, CHCl3). Mp 181.8 ± 1.0 °C. IR (cm
-1
): max 696, 
1066, 1100, 1427, 1444, 1638, 3320 (weak). 
1
H NMR (300 MHz, 
CDCl3):  1.56-1.86 (4H, m, 2xCH2(CH2)2), 2.19-2.29 (1H, m, 
CH(H)N), 2.25 (3H, s, CCH3Cl2), 2.43 (3H, s, CaromCH3), 3.21-3.31 
(1H, m, CH(H)N), 3.34-3.44 (2H, m, CH2N), 4.04 (1H, d, J = 9.4 Hz, CHNH), 5.03 (1H, s, 
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CHCO), 6.48 (1H, d, J = 9.4 Hz, NH), 7.15-7.65 (12H, m, CHarom), 8.11 (2H, d, J = 8.3 Hz, 
CHarom). 
13
C NMR (75 MHz, CDCl3):  21.5 (CaromCH3), 24.0, 26.1 (2xCH2(CH2)2), 35.6 
(CH3CCl2), 46.2, 46.3 (2xCH2N), 62.5 (CHCO), 68.5 (CHNH), 92.5 (CH3CCl2), 126.3 
(2xCHarom), 126.9 (2xCHarom), 128.1 (2xCHarom), 128.8 (3xCHarom), 128.9 (2xCHarom), 129.7 
(2xCHarom), 130.8 (CHarom), 137.8, 138.6, 141.5, 143.6 (4xCarom), 168.8 and 170.0 (C=N and 
C=O). MS (ES, pos. mode) m/z (%): 556/558/560 (M + H
+
, 100). HRMS (ES) calcd for 
C29H31Cl2N3O2S: 556.1587 MH
+
; found: 556.1591. 
 
(SS,2S,3S) N-[4,4-Dichloro-2-diphenylmethyleneamino-3-(p-toluenesulfinylamino)-
pentanoyl]piperidine syn-314h. White crystals, yield 55% (0.43 g). 
[α]D +55.6 (c 0.9, CHCl3). Mp 186.2 ± 1.0 °C. IR (cm
-1
): max 700, 1067, 
1101, 1443, 1642, 3310 (weak). 
1
H NMR (300 MHz, CDCl3):  0.92-
1.06 (1H, m, CH(H)(CH2)2), 1.30-1.66 (5H, m, CH(H)(CH2)2 and 
2xCH2(CH2)2), 2.23 (3H, s, CCH3Cl2), 2.42 (3H, s, CaromCH3), 2.97-3.09 
(1H, m, CH(H)N), 3.16-3.29 (1H, m, CH(H)N), 3.37-3.60 (2H, m, CH2N), 4.04 (1H, d, J = 
9.4 Hz, CHNH), 5.20 (1H, s, CHCO), 6.36 (1H, d  , J = 9.4 Hz, NH), 7.14-7.63 (12H, m, 
CHarom), 7.99 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  21.5 (CaromCH3), 
24.5, 25.5, 26.0 (3xCH2(CH2)2), 35.4 (CH3CCl2), 43.5, 46.3 (2xCH2N), 61.0 (CHCO), 68.4 
(CHNH), 92.4 (CH3CCl2), 126.2 (2xCHarom), 127.2 (2xCHarom), 128.1 (2xCHarom), 128.80 
(3xCHarom), 128.83 (2xCHarom), 129.7 (2xCHarom), 130.8 (CHarom), 137.5, 138.8, 141.6, 143.4 
(4xCarom), 168.6 and 170.1 (C=N and C=O). MS (ES, pos. mode) m/z (%): 570/572/574 (M + 
H
+
, 100). HRMS (ES) calcd for C30H33Cl2N3O2S: 570.1743 MH
+
; found: 570.1747. 
 
(SS,2S,3S) N-[4,4-Dichloro-2-diphenylmethyleneamino-3-(p-toluenesulfinylamino)-
hexanoyl]pyrrolidine syn-314i. White crystals, yield 44% (0.77 g). 
[α]D +43.2 (c 1.0, CHCl3). Mp 187.8 ± 1.0 °C. IR (cm
-1
): max 696, 
1070, 1098, 1278, 1433, 1633, 3342 (weak). 
1
H NMR (300 MHz, 
CDCl3):  1.23 (3H, t, J = 7.2 Hz, CH2CH3), 1.53-1.86 (4H, m, 
2xCH2(CH2)2), 2.16-2.26 (1H, m, CH(H)N), 2.27-2.39 (1H, m, 
CH(H)CH3), 2.43 (3H, s, CaromCH3), 2.53-2.67 (1H, m, CH(H)CH3), 3.20-3.30 (1H, m, 
CH(H)N), 3.33-3.44 (2H, m, CH2N), 4.07 (1H, d, J = 9.4 Hz, CHNH), 5.08 (1H, s, CHCO), 
6.47 (1H, d, J = 9.4 Hz, NH), 7.16-7.55 (12H, m, CHarom), 8.16 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3): 9.4 (CH2CH3), 21.6 (CaromCH3), 24.0, 26.2 (2xCH2(CH2)2), 
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38.3 (CH2CCl2), 46.2, 46.3 (2xCH2N), 62.3 (CHCO), 68.0 (CHNH), 98.8 (CH2CCl2), 126.4 
(2xCHarom), 127.0 (2xCHarom), 128.1 (2xCHarom), 128.8 (3xCHarom), 128.9 (2xCHarom), 129.7 
(2xCHarom), 130.8 (CHarom), 137.9, 138.7, 141.5, 143.6 (4xCarom), 169.0 and 169.6 (C=N and 
C=O). MS (ES, pos. mode) m/z (%): 570/572/574 (M + H
+
, 100). HRMS (ES) calcd for 
C30H33Cl2N3O2S: 570.1743 MH
+
; found: 570.1746. 
 
(SS,2S,3S) N-[4,4-Dichloro-2-diphenylmethyleneamino-3-(p-toluenesulfinylamino)-
hexanoyl]piperidine syn-314j. White crystals, yield 70% (1.18 g). [α]D 
+54.5 (c 1.0, CHCl3). Mp 158.3 ± 1.0 °C. IR (cm
-1
): max 702, 1071, 
1102, 1217, 1433, 1643, 3322 (weak). 
1
H NMR (300 MHz, CDCl3):  
0.95-1.08 (1H, m, CH(H)(CH2)2), 1.22 (1H, t, J = 7.2 Hz, CH2CH3), 
1.29-1.65 (5H, m, CH(H)(CH2)2 and 2xCH2(CH2)2), 2.20-2.39 (1H, m, 
CH(H)CH3), 2.42 (3H, s, CaromCH3), 2.48-2.64 (1H, m, CH(H)CH3), 2.92-3.04 (1H, m, 
CH(H)N), 3.16-3.28 (1H, m, CH(H)N), 3.39-3.56 (2H, m, CH2N), 4.08 (1H, d, J = 9.4 Hz, 
CHNH), 5.25 (1H, s, CHCO), 6.34 (1H, d  , J = 9.4 Hz, NH), 7.15-7.56 (12H, m, CHarom), 8.05 
(2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  9.3 (CH2CH3), 21.5 (CaromCH3), 
24.5, 25.6, 26.1 (3xCH2(CH2)2), 38.3 (CH2CCl2), 43.5, 46.2 (2xCH2N), 60.9 (CHCO), 67.8 
(CHNH), 98.6 (CH2CCl2), 126.3 (2xCHarom), 127.3 (2xCHarom), 128.1 (2xCHarom), 128.8 
(3xCHarom), 128.9 (2xCHarom), 129.7 (2xCHarom), 130.7 (CHarom), 137.5, 138.9, 141.6, 143.4 
(4xCarom), 168.8 and 169.7 (C=N and C=O). MS (ES, pos. mode) m/z (%): 584/586/588 (M + 
H
+
, 100). HRMS (ES) calcd for C31H35Cl2N3O2S: 584.1900 MH
+
; found: 584.1903. 
 
(SS,2S,3S) N-[4,4-Dichloro-2-diphenylmethyleneamino-3-(p-toluenesulfinylamino)-
heptanoyl]pyrrolidine syn-314k. White crystals, yield 23% (0.41 g). 
[α]D +57.7 (c 1.0, CHCl3). Mp 165.3 ± 1.0 °C. IR (cm
-1
): max 696, 
1070, 1096, 1252, 1430, 1637, 3285. 
1
H NMR (300 MHz, CDCl3):  
0.98 (3H, t, J = 7.2 Hz, CH2CH3), 1.53-1.86 (7H, m, 2xCH2(CH2)2 and 
CH2CH3), 2.19-2.48 (3H, m, CH(H)N and CH2CCl2), 2.42 (3H, s, 
CaromCH3), 3.19-3.29 (1H, m, CH(H)N), 3.34-3.44 (2H, m, CH2N), 4.08 (1H, d, J = 9.4 Hz, 
CHNH), 5.06 (1H, s, CHCO), 6.47 (1H, d, J = 9.4 Hz, NH), 7.16-7.56 (12H, m, CHarom), 8.14 
(2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3): 13.5 (CH2CH3), 18.4 (CH2CH3), 
21.5 (CaromCH3), 24.0, 26.2 (2xCH2(CH2)2), 46.2, 46.4 (2xCH2N), 46.9 (CH2CCl2), 62.5 
(CHCO), 67.4 (CHNH), 97.7 (CH2CCl2), 126.5 (2xCHarom), 127.0 (2xCHarom), 128.1 
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(2xCHarom), 128.8 (3xCHarom), 128.9 (2xCHarom), 129.7 (2xCHarom), 130.8 (CHarom), 137.9, 
138.7, 141.4, 143.8 (4xCarom), 169.0 and 169.6 (C=N and C=O). MS (ES, pos. mode) m/z (%): 
584/586/588 (M + H
+
, 100). HRMS (ES) calcd for C31H35Cl2N3O2S: 584.1900 MH
+
; found: 
584.1904. 
 
(SS,2S,3S) N-[4,4-Dichloro-2-diphenylmethyleneamino-3-(p-toluenesulfinylamino)-
heptanoyl]piperidine syn-314l. White crystals, yield 39% (0.68 g). [α]D 
+52.6 (c 1.1, CHCl3). Mp 161.8 ± 1.0 °C. IR (cm
-1
): max 702, 1072, 
1102, 1431, 1645, 3362 (weak). 
1
H NMR (300 MHz, CDCl3):  0.96 
(3H, t, J = 7.2 Hz, CH2CH3), 1.00-1.10 (1H, m, CH(H)(CH2)2), 1.28-
1.82 (7H, m, CH(H)(CH2)2 and 2xCH2(CH2)2 and CH2CH3), 2.16-2.40 
(2H, m, CH2CCl2), 2.42 (3H, s, CaromCH3), 2.93-3.04 (1H, m, CH(H)N), 3.17-3.29 (1H, m, 
CH(H)N), 3.40-3.57 (2H, m, CH2N), 4.08 (1H, d, J = 9.4 Hz, CHNH), 5.23 (1H, s, CHCO), 
6.37 (1H, d , J = 9.4 Hz, NH), 7.15-7.59 (12H, m, CHarom), 8.03 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  13.5 (CH2CH3), 18.3 (CH2CH3), 21.5 (CaromCH3), 24.5, 25.6, 
26.1 (3xCH2(CH2)2), 43.5, 46.2 (2xCH2N), 46.9 (CH2CCl2), 61.1 (CHCO), 67.1 (CHNH), 
97.5 (CH2CCl2), 126.3 (2xCHarom), 127.3 (2xCHarom), 128.0 (2xCHarom), 128.7 (3xCHarom), 
128.9 (2xCHarom), 129.7 (2xCHarom), 130.7 (CHarom), 137.6, 138.9, 141.5, 143.6 (4xCarom), 
168.8 and 169.6 (C=N and C=O). MS (ES, pos. mode) m/z (%): 598/600/602 (M + H
+
, 100). 
HRMS (ES) calcd for C32H37Cl2N3O2S: 598.2056 MH
+
; found: 598.2060. 
 
(SS,2S,3S) N-[4,4-Dichloro-2-diphenylmethyleneamino-5-methyl-3-(p-toluenesulfinyl-
amino)hexanoyl]pyrrolidine syn-314m. White crystals, yield 43% 
(0.24 g). [α]D +41.9 (c 0.9, CHCl3). Mp 152.1 ± 1.0 °C. IR (cm
-1
): max 
698, 1072, 1102, 1427, 1641, 3288 (weak). 
1
H NMR (300 MHz, 
CDCl3):  1.22 (3H, d, J = 6.6 Hz, CHCH3(CH3)), 1.24 (3H, d, J = 6.6 
Hz, CHCH3(CH3)), 1.52-1.84 (4H, m, 2xCH2(CH2)2), 2.10-2.19 (1H, m, 
CH(H)N), 2.43 (3H, s, CaromCH3), 3.05 (1H, sept, J = 6.6 Hz, CH(CH3)2), 3.16-3.26 (1H, m, 
CH(H)N), 3.34-3.44 (2H, m, CH2N), 4.23 (1H, d, J = 9.4 Hz, CHNH), 5.05 (1H, s, CHCO), 
6.46 (1H, d, J = 9.4 Hz, NH), 7.17-7.55 (12H, m, CHarom), 8.22 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3): 18.3 (CH(CH3)2), 21.5 (CaromCH3), 24.0, 26.1 (2xCH2(CH2)2), 
38.8 (CHCCl2), 46.2, 46.3 (2xCH2N), 62.3 (CHCO), 65.9 (CHNH), 103.8 (CHCCl2), 126.5 
(2xCHarom), 127.0 (2xCHarom), 128.0 (2xCHarom), 128.7 (3xCHarom), 128.9 (2xCHarom), 129.7 
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(2xCHarom), 130.7 (CHarom), 138.0, 138.8, 141.4, 143.8 (4xCarom), 169.0 and 169.2 (C=N and 
C=O). MS (ES, pos. mode) m/z (%): 584/586/588 (M + H
+
, 100). HRMS (ES) calcd for 
C31H35Cl2N3O2S: 584.1900 MH
+
; found: 584.1909. 
 
(SS,2S,3S) N-[4,4-Dichloro-2-diphenylmethyleneamino-5-methyl-3-(p-toluenesulfinyl-
amino)hexanoyl]piperidine syn-314n. White crystals, yield 76% (1.28 
g). [α]D +44.9 (c 1.1, CHCl3). Mp 171.2 ± 1.0 °C. IR (cm
-1
): max 698, 
1070, 1103, 1441, 1641, 3288 (weak). 
1
H NMR (300 MHz, CDCl3):  
1.21 (3H, d, J = 6.6 Hz, CHCH3(CH3)), 1.23 (3H, d, J = 6.6 Hz, 
CHCH3(CH3)), 1.00-1.16 (1H, m, CH(H)(CH2)2), 1.27-1.64 (5H, m, 
CH(H)(CH2)2 and 2xCH2(CH2)2), 2.43 (3H, s, CaromCH3), 2.82-2.94 (1H, m, CH(H)N), 3.03 
(1H, sept, J = 6.6 Hz, CH(CH3)2), 3.18-3.38 (1H, m, CH(H)N and CH(H)N), 3.57-3.68 (1H, 
m, CH(H)N), 4.25 (1H, d, J = 9.4 Hz, CHNH), 5.23 (1H, s, CHCO), 6.30 (1H, d , J = 9.4 Hz, 
NH), 7.16-7.55 (12H, m, CHarom), 8.14 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, 
CDCl3):  18.3 (CH(CH3)2), 21.5 (CaromCH3), 24.5, 25.6, 26.2 (3xCH2(CH2)2), 38.9 
(CHCCl2), 43.5, 46.1 (2xCH2N), 60.9 (CHCO), 65.4 (CHNH), 103.4 (CH2CCl2), 126.4 
(2xCHarom), 127.3 (2xCHarom), 128.0 (2xCHarom), 128.77 (3xCHarom), 128.84 (2xCHarom), 
129.7 (2xCHarom), 130.6 (CHarom), 137.7, 139.0, 141.5, 143.6 (4xCarom), 169.1 (C=N and 
C=O). MS (ES, pos. mode) m/z (%): 598/600/602 (M + H
+
, 100). HRMS (ES) calcd for 
C32H37Cl2N3O2S: 598.2056 MH
+
; found: 598.2066. 
 
5.29. Synthesis of (SS,2S,2’S) N-{2-amino-2-[1-(p-toluenesulfinyl)aziridin-2-
yl]acetyl}amines 317 and 320b  
The synthesis of (SS,2S,2’S) N-{2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluene-
sulfinyl)aziridin-2-yl]acetyl}piperidine 317b is representative. To a solution of (SS,2S,3S) N-
[4-chloro-2-diphenylmethyleneamino-4-methyl-3-(p-toluenesulfinylamino)pentanoyl]-
piperidine syn-314b (2.10 g, 3.82 mmol) in acetone (40 mL) was added K2CO3 (3.0 equiv, 
11.45 mmol, 1.58 g) at room temperature. The reaction mixture was allowed to stir for 24 
hours at reflux temperature. After 24 hours, the K2CO3 was filtered off and the solvent was 
evaporated in vacuo. The resulting oil was redissolved in EtOAc (40 mL) and washed with 
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water (2 x 15 mL). The organic phase was dried (MgSO4), filtered and evaporated in vacuo. 
The crude product was purified by column chromatography to yield 1.75 g (3.41 mmol, 90%) 
of (SS,2S,2’S) N-[2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)aziridin-2-
yl]acetyl]piperidine 317b. 
 
(SS,2S,2’S) N-{2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)aziridin-
2-yl]acetyl}pyrrolidine 317a. Rf = 0.09 (petroleum ether/EtOAc : 1/1). 
Yellow oil, yield 59% (0.33 g). [α]D +37.4 (c 4.1, CHCl3). IR (cm
-1
): max 
697, 1072, 1093, 1278, 1444, 1638. 
1
H NMR (300 MHz, CDCl3):  1.15 
(3H, s, CCH3(CH3)), 1.60-1.78 (4H, m, 2xCH2(CH2)2), 1.69 (3H, s, 
CCH3(CH3)), 1.98 (3H, s, CaromCH3), 2.80 (2H, t, J = 6.6 Hz, NCH2), 
3.34-3.51 (2H, m, NCH2), 3.40 (1H, d, J = 8.3 Hz, NCHazirCHN), 4.05 (1H, d, J = 8.3 Hz, 
NCHazirCHN), 6.74 (2H, d, J = 8.3 Hz, CHarom), 7.07-7.15 (2H, m, CHarom), 7.28-7.49 (8H, m, 
CHarom), 7.57 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  20.8 (CCH3(CH3)), 
21.5 (CaromCH3), 22.7 (CCH3(CH3)), 23.8, 26.1 (2xCH2(CH2)2), 46.0, 46.4 (2xNCH2), 48.0 
(C(CH3)2), 50.7 (NCHazirCHN), 64.7 (NCHazirCHN), 124.9 (2xCHarom), 127.9 (2xCHarom), 
128.1 (2xCHarom), 129.05 (CHarom), 129.14 (2xCHarom), 129.4 (2xCHarom), 130.4 (CHarom), 
135.1, 139.4 (2xCarom), 141.8 (2xCarom), 168.2 and 169.6 (C=N and C=O). MS (ES, pos. 
mode) m/z (%): 500 (M + H
+
, 100). HRMS (ES) calcd for C30H33N3O2S: 500.2366 MH
+
; 
found: 500.2375. 
 
(SS,2S,2’S) N-{2-diphenylmethyleneamino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)aziridin-
2-yl]-acetyl}piperidine 317b. Rf = 0.10 (petroleum ether/EtOAc : 1/1). 
Yellow oil, yield 90% (1.75 g). [α]D +43.8 (c 2.7, CHCl3). IR (cm
-1
): max 
696, 726, 1076, 1102, 1216, 1443, 1639. 
1
H NMR (300 MHz, CDCl3):  
1.15 (3H, s, CCH3(CH3)), 1.17-1.31 (2H, m, CH2(CH2)2), 1.34-1.63 (4H, 
m, 2x CH2(CH2)2), 1.70 (3H, s, CCH3(CH3)), 1.99 (3H, s, CaromCH3), 
2.83 (2H, br s, NCH2), 3.19-3.31 (1H, m, NCH(H)), 3.43 (1H, d, J = 8.3 Hz, NCHazirCHN), 
3.66-3.78 (1H, m, NCH(H)), 4.15 (1H, d, J = 8.3 Hz, NCHazirCHN), 6.74 (2H, d, J = 7.7 Hz, 
CHarom), 7.11 (2H, d, J = 7.7 Hz, CHarom), 7.25-7.49 (8H, m, CHarom), 7.57 (2H, d, J = 7.7 Hz, 
CHarom). 
13
C NMR (75 MHz, CDCl3):  20.7 (CCH3(CH3)), 21.4 (CaromCH3), 22.4 
(CCH3(CH3)), 24.4, 25.6, 26.5 (3xCH2(CH2)2), 43.4, 46.0 (2xNCH2), 47.7 (C(CH3)2), 50.6 
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(NCHazirCHN), 63.0 (NCHazirCHN), 124.8 (2xCHarom), 127.7 (2xCHarom), 127.9 (2xCHarom), 
129.0 (2xCHarom), 129.15 (CHarom), 129.21 (2xCHarom), 129.3 (2xCHarom), 130.3 (CHarom), 
134.5, 139.4, 141.60, 141.64 (4xCarom), 167.8 and 169.3 (C=N and C=O). MS (ES, pos. 
mode) m/z (%): 514 (M + H
+
, 100). Anal. calcd for C31H35N3O2S: 514.2523 MH
+
; found: 
514.2513. 
 
(SS,2S,2’S) N-{2-diphenylmethyleneamino-2-[3,3-diethyl-1-(p-toluenesulfinyl)aziridin-2-
yl]-acetyl}pyrrolidine 317c. Rf = 0.07 (petroleum ether/EtOAc : 1/1). 
Yellow oil, yield 44% (0.12 g). [α]D +71.6 (c 1.9, CHCl3). IR (cm
-1
): max 
696, 1076, 1102, 1277, 1427, 1444, 1644. 
1
H NMR (300 MHz, CDCl3): 
 0.79 (3H, t, J = 7.2 Hz, CH2CH3), 1.04 (3H, t, J = 7.2 Hz, CH2CH3), 
1.08-1.22 (1H, m, C(H)HCH3), 1.32-1.45 (1H, m, C(H)HCH3), 1.53-1.70 
(4H, m, 2xCH2(CH2)2), 1.88 (3H, s, CaromCH3), 1.90-2.10 (2H, m, CH2CH3), 2.60-2.75 (2H, 
m, CH2N), 3.24-3.42 (2H, m, CH2N), 3.39 (1H, d, J = 8.3 Hz, NCHazirCHN), 4.03 (1H, d, J = 
8.3 Hz, NCHazirCHN), 6.65 (2H, d, J = 8.3 Hz, CHarom), 7.00-7.07 (2H, m, CHarom), 7.19-7.45 
(8H, m, CHarom), 7.49 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  9.3 
(CH2CH3), 10.6 (CH2CH3), 21.4 (CaromCH3), 23.8 (CH2(CH2)2), 24.0, 24.4 (2xCH2CH3), 26.0 
(CH2(CH2)2), 45.8, 46.2 (2xNCH2), 51.1 (NCHazirCHN), 56.1 (C(CH2CH3)2), 64.0 
(NCHazirCHN), 124.9 (2xCHarom), 127.7 (2xCHarom), 127.9 (2xCHarom), 129.0 (CHarom), 129.1 
(2xCHarom), 129.2 (2xCHarom), 129.3 (2xCHarom), 130.3 (CHarom), 135.2, 139.3, 141.6, 141.8 
(4xCarom), 168.2 and 169.4 (C=N and C=O). MS (ES, pos. mode) m/z (%): 528 (M + H
+
, 100). 
Anal. calcd for C32H37N3O2S: 528.2679 MH
+
; found: 528.2691. 
 
(SS,2S,2’S) N-{2-diphenylmethyleneamino-2-[3,3-diethyl-1-(p-toluenesulfinyl)aziridin-2-
yl]-acetyl}piperidine 317d. Rf = 0.08 (petroleum ether/EtOAc : 1/1). 
Yellow oil, yield 50% (0.07 g). [α]D +79.9 (c 2.8, CHCl3). IR (cm
-1
): max 
696, 1077, 1101, 1214, 1442, 1641. 
1
H NMR (300 MHz, CDCl3):  0.85 
(3H, t, J = 7.2 Hz, CH2CH3), 1.11 (3H, t, J = 7.2 Hz, CH2CH3), 1.15-1.30 
(3H, m, C(H)HCH3 and CH2(CH2)2), 1.37-1.60 (5H, m, C(H)HCH3 and 
2xCH2(CH2)2), 1.89-2.17 (2H, m, CH2CH3), 1.96 (3H, s, CaromCH3), 2.78-2.89 (2H, m, 
CH2N), 3.18-3.31 (1H, m, CH(H)N), 3.46 (1H, d, J = 8.3 Hz, NCHazirCHN), 3.63-3.74 (1H, 
m, CH(H)N), 4.19 (1H, d, J = 8.3 Hz, NCHazirCHN), 6.73 (2H, d, J = 7.7 Hz, CHarom), 7.12 
(2H, d, J = 7.2 Hz, CHarom), 7.27-7.45 (8H, m, CHarom), 7.56 (2H, d, J = 7.2 Hz, CHarom). 
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NMR (75 MHz, CDCl3):  9.4 (CH2CH3), 10.7 (CH2CH3), 21.5 (CaromCH3), 24.1, 24.3 
(2xCH2CH3), 24.5, 25.7, 26.7 (3xCH2(CH2)2), 43.5, 46.1 (2xNCH2), 51.1 (NCHazirCHN), 56.2 
(C(CH2CH3)2), 62.6 (NCHazirCHN), 124.9 (2xCHarom), 127.8 (2xCHarom), 128.0 (2xCHarom), 
129.1 (2xCHarom), 129.2 (CHarom), 129.3 (4xCHarom), 130.3 (CHarom), 134.8, 139.5, 141.7, 
141.8 (4xCarom), 167.9 and 169.3 (C=N and C=O). MS (ES, pos. mode) m/z (%): 542 (M + 
H
+
, 100). HRMS (ES) calcd for C33H39N3O2S: 542.2836 MH
+
; found: 542.2846. 
 
(SS,2S,2’S) N-{2-diphenylmethyleneamino-2-[1-(p-toluenesulfinyl)-1-azaspiro[2.5]oct-2-
yl]-acetyl}pyrrolidine 317e. Rf = 0.21 (petroleum ether/EtOAc : 2/1). 
Yellow oil, yield 36% (0.09 g). [α]D +53.9 (c 2.5, CHCl3). IR (cm
-1
): 
max 696, 751, 1075, 1096, 1260, 1431, 1444, 1638. 
1
H NMR (300 MHz, 
CDCl3):  1.14-1.77 (11H, m, CH(H)(CH2)2 and 4xCH2(CH2)2 and 
CCH2CH2), 1.80-1.92 (1H, m, CH(H)CH2), 1.94 (3H, s, CaromCH3), 2.05-
2.12 (2H, m, CCH2CH2), 2.60-2.76 (2H, m, CH2N), 3.32-3.50 (2H, m, CH2N), 3.46 (1H, d, J 
= 8.8 Hz, NCHazirCHN), 4.10 (1H, d, J = 8.8 Hz, NCHazirCHN), 6.70 (2H, d, J = 8.3 Hz, 
CHarom), 7.07-7.14 (2H, m, CHarom), 7.28-7.50 (8H, m, CHarom), 7.57 (2H, d, J = 8.3 Hz, 
CHarom). 
13
C NMR (75 MHz, CDCl3):  21.5 (CaromCH3), 23.9, 24.8, 25.3, 25.7, 26.1 
(5xCH2(CH2)2), 32.0, 33.0 (2xCCH2CH2), 45.8, 46.3 (2xCH2N), 51.0 (NCHazirCHN), 53.1 
(C(CH2)5), 63.9 (NCHazirCHN), 124.9 (2xCHarom), 127.8 (2xCHarom), 128.0 (2xCHarom), 129.0 
(CHarom), 129.2 (2xCHarom), 129.3 (2xCHarom), 129.4 (2xCHarom), 130.3 (CHarom), 135.1, 
139.4, 141.7, 141.8 (4xCarom), 168.3 and 169.4 (C=N and C=O). MS (ES, pos. mode) m/z (%): 
540 (M + H
+
, 100). HRMS (ES) calcd for C33H37N3O2S: 540.2679 MH
+
; found: 540.2681. 
 
(SS,2S,2’S) N-{2-diphenylmethyleneamino-2-[1-(p-toluenesulfinyl)-1-azaspiro[2.5]oct-2-
yl]-acetyl}piperidine 317f. Rf = 0.13 (petroleum ether/EtOAc : 2/1). 
Yellow oil, yield 43% (0.10 g). [α]D +49.1 (c 2.3, CHCl3). IR (cm
-1
): 
max 696, 751, 1075, 1099, 1218, 1443, 1639. 
1
H NMR (300 MHz, 
CDCl3):  1.10-1.75 (13H, m, CH(H)(CH2)2 and 5xCH2(CH2)2 and 
CCH2CH2), 1.80-1.92 (1H, m, CH(H)(CH2)2), 1.95 (3H, s, CaromCH3), 
2.04-2.14 (2H, m, CCH2CH2), 2.70-2.86 (2H, m, CH2N), 3.20-3.31 (1H, m, CH(H)N), 3.45 
(1H, d, J = 8.3 Hz, NCHazirCHN), 3.67-3.77 (1H, m, CH(H)N), 4.18 (1H, d, J = 8.3 Hz, 
NCHazirCHN), 6.70 (2H, d, J = 8.3 Hz, CHarom), 7.08-7.16 (2H, m, CHarom), 7.28-7.47 (8H, m, 
CHarom), 7.56 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  21.4 (CaromCH3), 
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24.4, 24.8, 25.2, 25.6, 26.6 (6xCH2(CH2)2), 31.9, 32.7 (2xCCH2CH2), 43.3, 46.0 (2xCH2N), 
50.8 (NCHazirCHN), 53.1 (C(CH2)5), 62.2 (NCHazirCHN), 124.8 (2xCHarom), 127.7 
(2xCHarom), 127.9 (2xCHarom), 129.08 (2xCHarom), 129.14 (CHarom), 129.2 (2xCHarom), 130.2 
(CHarom), 134.6, 139.4, 141.6, 141.7 (4xCarom), 167.9 and 169.1 (C=N and C=O). MS (ES, 
pos. mode) m/z (%): 554 (M + H
+
, 100). HRMS (ES) calcd for C34H39N3O2S: 554.2836 MH
+
; 
found: 554.2836. 
 
(SS,2S,2’S) N-{2-Amino-2-[3,3-dimethyl-1-(p-toluenesulfinyl)aziridin-2-yl]acetyl}-
piperidine 320b. Rf = 0.10 (petroleum ether/EtOAc : 1/1). Yellow oil, 
yield 86% (0.18 g). [α]D +52.0 (c 2.1, CHCl3). IR (cm
-1
): max 751, 813, 
1065, 1088, 1221, 1444, 1631, 3272. 
1
H NMR (300 MHz, CDCl3):  
1.07-1.36 (2H, m, CH2(CH2)2), 1.28 (3H, s, CCH3(CH3)), 1.40-1.71 (6H, 
m, NH2 and 2xCH2(CH2)2), 1.57 (3H, s, CCH3(CH3)), 2.42 (3H, s, CaromCH3), 2.63 (1H, d, J = 
8.3 Hz, NCHazirCHN), 3.32 (1H, d, J = 8.3 Hz, NCHazirCHN), 3.35-3.62 (4H, m, 2xCH2N), 
7.34 (2H, d, J = 8.3 Hz, CHarom), 7.72 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, 
CDCl3):  20.9 (CCH3(CH3)), 21.5 (CaromCH3), 22.0 (CCH3(CH3)), 24.4, 25.5, 26.6 
(3xCH2(CH2)2), 43.1, 46.5 (CH2N), 49.9 (C(CH3)2), 51.0 (NCHazirCHN), 51.3 (NCHazirCHN), 
125.3 (2xCHarom), 129.7 (2xCHarom), 142.7, 142.8 (2xCarom), 169.9 (C=O). MS (ES, pos. 
mode) m/z (%): 350 (M + H
+
, 100). HRMS (ES) calcd for C18H27N3O2S: 350.1897 MH
+
; 
found: 350.1892. 
 
5.30. Synthesis of (SS,2S,3S) N-[2-amino-4-chloro-3-(p-toluenesulfinyl-
amino)alkanoyl]amines 319 
The synthesis of (SS,2S,3S) N-[2-amino-4-chloro-4-methyl-3-(p-toluenesulfinylamino)-
pentanoyl]piperidine 319b is representative. To a solution of (SS,2S,3S) N-[4-chloro-2-
diphenylmethyleneamino-4-methyl-3-(p-toluenesulfinylamino)pentanoyl]piperidine syn-314b 
(0.82 g, 1.49 mmol) in acetone/H2O (2:1) (30 mL) was added dropwise trifluoroacetic acid  
(5 equiv, 7.45 mmol, 0.57 mL) at room temperature. The reaction mixture was stirred for 15 
minutes at room temperature and subsequently quenched with NH4OH in H2O until pH = 10 
and concentrated in vacuo. The residue was redissolved in water (10 mL) and NH4OH in H2O 
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was added until pH = 10. The aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The 
combined organic phases were dried (MgSO4), filtered and evaporated in vacuo. The crude 
product was purified by crystallization in diethyl ether to yield 0.12 g (0.31 mmol, 21%) of 
pure (SS,2S,3S) N-[2-amino-4-chloro-4-methyl-3-(p-toluenesulfinylamino)pentanoyl]-
piperidine 319b. 
 
(SS,2S,3S) N-[2-Amino-4-chloro-4-methyl-3-(p-toluenesulfinylamino)pentanoyl]-
pyrrolidine 319a. White crystals, yield 70% (0.26 g). [α]D +51.0 (c 2.9, 
CHCl3). Mp 125.4 ± 2.0 °C. IR (cm
-1
): max 892, 1062, 1083, 1343, 1451, 
1599, 1629, 3230. 
1
H NMR (300 MHz, CDCl3):  1.55 (3H, s, 
CCH3(CH3)), 1.68 (3H, s, CCH3(CH3)), 1.77 (2H, br s, NH2), 1.84-2.13 
(4H, m, 2xCH2(CH2)2), 2.41 (3H, s, CaromCH3), 3.44-3.66 (4H, m, 2xCH2N), 3.66 (1H, dxd, J 
= 9.4 Hz, 2.2 Hz, CHNH), 4.24 (1H, d, J = 2.2 Hz, CHCO), 4.89 (1H, d, J = 9.4 Hz, NH), 
7.32 (2H, d, J = 8.3 Hz, CHarom), 7.83 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, 
CDCl3):  21.4 (CaromCH3), 24.0, 26.3 (2xCH2(CH2)2), 29.2 (CCH3(CH3)), 31.9 (CCH3(CH3)), 
46.6, 46.8 (2xCH2N), 52.4 (CHCO), 65.0 (CHNH), 73.7 (CCl), 125.7 (2xCHarom), 129.6 
(2xCHarom), 141.6, 142.7 (2xCarom), 171.7 (C=O). MS (ES, pos. mode) m/z (%): 372/374 (M + 
H
+
, 100). HRMS (ES) calcd for C17H26ClN3O2S: 372.1507 MH
+
; found: 372.1513. 
 
(SS,2S,3S) N-[2-Amino-4-chloro-4-methyl-3-(p-toluenesulfinylamino)pentanoyl]-
piperidine 319b. White crystals, yield 21% (0.12 g). [α]D +67.5 (c 2.4, 
CHCl3). Mp 119.8 ± 2.0 °C. IR (cm
-1
): max 821, 854, 1066, 1092, 1244, 
1446, 1460, 1613, 3181. 
1
H NMR (300 MHz, CDCl3):  1.50-1.77 (6H, 
m, 3xCH2(CH2)2), 1.56 (3H, s, CCH3(CH3)), 1.69 (3H, s, CCH3(CH3)), 
1.81 (2H, br s, NH2), 2.41 (3H, s, CaromCH3), 3.46-3.58 (2H, m, CH2N), 3.61 (1H, dxd, J = 9.9 
Hz, 1.7 Hz, CHNH), 3.67-3.81 (2H, m, CH2N), 4.49 (1H, d, J = 1.7 Hz, CHCO), 4.93 (1H, d, 
J = 9.9 Hz, NH), 7.32 (2H, d, J = 8.3 Hz, CHarom), 7.79 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR 
(75 MHz, CDCl3):  21.4 (CaromCH3), 24.6, 25.6, 26.3 (3xCH2(CH2)2), 28.7 (CCH3(CH3)), 
32.3 (CCH3(CH3)), 44.0, 46.4 (2xCH2N), 50.4 (CHCO), 65.6 (CHNH), 73.8 (CCl), 125.8 
(2xCHarom), 129.6 (2xCHarom), 141.5, 142.7 (2xCarom), 171.5 (C=O). MS (ES, pos. mode) m/z 
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(%): 386/388 (M + H
+
, 100). HRMS (ES) calcd for C18H28ClN3O2S: 386.1664 MH
+
; found: 
386.1676. 
 
(SS,2S,3S) N-[2-Amino-4-chloro-4-ethyl-3-(p-toluenesulfinylamino)hexanoyl]pyrrolidine 
319c. White crystals, yield 91% (0.16 g). [α]D +49.4 (c 2.6, CHCl3). Mp 
127.3 ± 2.0 °C. IR (cm
-1
): max 637, 811, 1056, 1086, 1324, 1440, 1612, 
1630, 3282. 
1
H NMR (300 MHz, CDCl3):  0.90 (3H, t, J = 7.2 Hz, 
CH2CH3), 1.06 (3H, t, J = 7.15 Hz, CH2CH3), 1.76 (2H, br s, NH2), 1.82-
2.10 (8H, m, 2xCH2(CH2)2 and 2xCH2CH3), 2.41 (3H, s, CaromCH3), 3.42-3.70 (4H, m, 
2xCH2N), 3.90 (1H, dxd, J = 9.4 Hz, 2.2 Hz, CHNH), 4.17 (1H, d, J = 2.2 Hz, CHCO), 4.78 
(1H, d , J = 9.4 Hz, NH), 7.32 (2H, d, J = 8.3 Hz, CHarom), 7.86 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  8.7, 8.8 (C(CH2CH3)2), 21.5 (CaromCH3), 24.1, 26.4 
(2xCH2(CH2)2), 29.7, 30.5 (C(CH2CH3)2), 46.7, 46.8 (2xCH2N), 52.7 (CHCO), 61.3 (CHNH), 
83.0 (CCl), 125.8 (2xCHarom), 129.7 (2xCHarom), 141.6, 143.0 (2xCarom), 171.8 (C=O). MS 
(ES, pos. mode) m/z (%): 400/402 (M + H
+
, 100). HRMS (ES) calcd for C19H30ClN3O2S: 
400.1820 MH
+
; found: 400.1827. 
 
(SS,2S,3S) N-[2-Amino-4-chloro-4-ethyl-3-(p-toluenesulfinylamino)hexanoyl]piperidine 
319d. Yellow oil, yield 59% (0.07 g). [α]D +41.8 (c 2.3, CHCl3). IR (cm
-1
): max 751, 812, 
1056, 1087, 1254, 1444, 1598, 1638, 3188. 
1
H NMR (300 MHz, CDCl3): 
 0.92 (3H, t, J = 7.2 Hz, CH2CH3), 1.10 (3H, t, J = 7.2 Hz, CH2CH3), 
1.48-1.72 (6H, m, 3xCH2(CH2)2), 1.76 (2H, br s, NH2), 1.85-2.12 (4H, m, 
C(CH2CH3)2), 2.41 (3H, s, CaromCH3), 3.36-3.53 (2H, m, 2xCH(H)N), 
3.70-3.90 (2H, m, 2xCH(H)N), 3.85 (1H, dxd, J = 9.9 Hz, 1.7 Hz, CHNH), 4.43 (1H, d, J = 
1.7 Hz, CHCO), 4.80 (1H, d , J = 9.9 Hz, NH), 7.32 (2H, d, J = 8.3 Hz, CHarom), 7.82 (2H, d, J 
= 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  8.7, 8.9 (C(CH2CH3)2), 21.5 (CaromCH3), 
24.7, 25.7, 26.6 (3xCH2(CH2)2), 29.6, 30.5 (C(CH2CH3)2), 44.0, 46.4 (2xCH2N), 50.6 
(CHCO), 61.7 (CHNH), 83.0 (CCl), 125.9 (2xCHarom), 129.7 (2xCHarom), 141.6, 142.9 
(2xCarom), 171.7 (C=O). MS (ES, pos. mode) m/z (%): 414/416 (M + H
+
, 100). HRMS (ES) 
calcd for C20H32ClN3O2S: 414.1977 MH
+
; found: 414.1980.  
 
(SS,2S,3S) N-[2-Amino-3-(1-chlorocyclohexyl)-3-(p-toluenesulfinylamino)propanoyl]-
piperidine 319f. Yellow crystals, yield 78% (0.28 g). [α]D +73.2 (c 2.3, CHCl3). Mp 95.7 ± 
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2.0 °C. IR (cm
-1
): max 813, 853, 889, 1068, 1092, 1243, 1444, 1634, 
3165. 
1
H NMR (300 MHz, CDCl3):  1.05-2.20 (18H, m, 6xCH2(CH2)2 
and 2xCCH2CH2 and NH2), 2.41 (3H, s, CaromCH3), 3.44-3.59 (2H, m, 
CH2N), 3.62 (1H, dxd, J = 9.9 Hz, 1.7 Hz, CHNH), 3.67-3.80 (2H, m, 
CH2N), 4.50 (1H, d, J = 1.7 Hz, CHCO), 4.91 (1H, d , J = 9.9 Hz, NH), 7.32 (2H, d, J = 8.3 
Hz, CHarom), 7.82 (2H, d, J = 8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  21.5 (CaromCH3), 
21.6, 22.1, 24.7, 24.8, 25.6, 26.4 (6xCH2(CH2)2), 35.8, 37.4 (2xCCH2CH2), 44.0, 46.4 
(2xCH2N), 50.3 (CHCO), 66.5 (CHNH), 80.0 (CCl), 125.9 (2xCHarom), 129.7 (2xCHarom), 
141.6, 142.8 (2xCarom), 171.6 (C=O). MS (ES, pos. mode) m/z (%): 426/428 (M + H
+
, 100). 
HRMS (ES) calcd for C21H32ClN3O2S: 426.1977 MH
+
; found: 426.1972.  
 
(SS,2S,3S) N-[2-Amino-4,4-dichloro-3-(p-toluenesulfinylamino)pentanoyl]pyrrolidine 
319g. White crystals, yield 53% (0.09 g). [α]D +52.9 (c 1.2, CHCl3). Mp 
133.8 ± 1.0 °C. IR (cm
-1
): max 814, 850, 893, 1054, 1086, 1446, 1596, 
1630, 3203. 
1
H NMR (300 MHz, CDCl3):  1.83-2.07 (6H, m, 
2xCH2(CH2)2 and NH2), 2.08 (3H, s, CH3CCl2), 2.41 (3H, s, CaromCH3), 
3.45-3.69 (4H, m, 2xCH2N), 4.03 (1H, dxd, J = 9.4 Hz, 2.2 Hz, CHNH), 4.39 (1H, d, J = 2.2 
Hz, CHCO), 5.34 (1H, d, J = 9.4 Hz, NH), 7.33 (2H, d, J = 8.3 Hz, CHarom), 7.82 (2H, d, J = 
8.3 Hz, CHarom). 
13
C NMR (75 MHz, CDCl3):  21.5 (CaromCH3), 24.2, 26.3 (2xCH2(CH2)2), 
35.9 (CH3CCl2)), 46.7, 46.9 (2xCH2N), 52.7 (CHCO), 65.8 (CHNH), 92.8 (CCl2), 125.8 
(2xCHarom), 129.7 (2xCHarom), 141.9, 142.0 (2xCarom), 171.1 (C=O). MS (ES, pos. mode) m/z 
(%): 392/394 (M + H
+
, 100). HRMS (ES) calcd for C16H23Cl2N3O2S: 392.0961 MH
+
; found: 
392.068. 
 
5.31. Synthesis of (4’S,5’S) N-[5-(2-chloro-2-propyl)-2,2-diphenyl-
imidazolidin-4-yl]carbonylpiperidine 321b 
To a solution of (SS,2S,3S) N-[4-chloro-2-diphenylmethyleneamino-4-methyl-3-(p-toluene-
sulfinylamino)pentanoyl]piperidine syn-314b (0.40 g, 0.73 mmol) in EtOH (20 mL) was 
added dropwise trifluoroacetic acid (10 equiv, 7.26 mmol, 0.56 mL) at room temperature. The 
reaction mixture was stirred for 16 hours at room temperature and subsequently quenched 
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with NH4OH in H2O until pH = 10 and concentrated in vacuo. The residue was redissolved in 
water (10 mL) and NH4OH in H2O was added until pH = 10. The aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic phases were dried (MgSO4), 
filtered and evaporated in vacuo. The crude product was purified by crystallization in diethyl 
ether to yield 0.16 g (0.40 mmol, 55%) of pure (4’S,5’S) N-[5-(2-chloro-2-propyl)-2,2-
diphenylimidazolidin-4-yl]carbonylpiperidine 321b. 
 
(4’S,5’S) N-[5-(2-Chloro-2-propyl)-2,2-diphenylimidazolidin-4-yl]carbonylpiperidine 
321b. White crystals, yield 55% (0.16 g). [α]D -33.4 (c 0.8, CHCl3). Mp 
132.7 ± 2.0 °C. IR (cm
-1
): max 707, 752, 1025, 1216, 1260, 1452, 1642, 
3315 (weak). 
1
H NMR (300 MHz, CDCl3):  1.49-1.89 (6H, m, 
3xCH2(CH2)2), 1.52 (3H, s, CCH3(CH3)), 1.73 (3H, s, CCH3(CH3)), 
2.59-2.74 (2H, m, 2xNH), 3.32-3.43 (1H, m, CH(H)N), 3.52-3.69 (2H, 
m, CH(H)N and CH(H)N), 3.76-3.98 (1H, m, CH(H)N), 3.85 (1H, d, J = 7.2 Hz, CHCCl), 
3.92 (1H, d, J = 7.2 Hz, CHCO), 7.13-7.35 (6H, m, CHarom), 7.57-7.65 (4H, m, CHarom). 
13
C 
NMR (75 MHz, CDCl3):  24.7, 25.5, 26.4 (3xCH2(CH2)2), 31.3 (CCH3(CH3)), 31.7 
(CCH3(CH3)), 43.5, 47.1 (2xCH2N), 60.4 (CHCO), 71.3 (CHCCl), 73.3 (CCl), 85.6 (CPh2), 
125.7 (2xCHarom), 126.0 (2xCHarom), 127.1 (2xCHarom), 128.2 (2xCHarom), 128.4 (2xCHarom), 
146.2, 146.7 (2xCarom), 169.6 (C=O). MS (ES, pos. mode) m/z (%): 412/414 (M + H
+
, 100). 
HRMS (ES) calcd for C24H30ClN3O: 412.2150 MH
+
; found: 376.2376 (100%), 412.2144 
(70%). 
 
5.32. Synthesis of (2S,3S) N-[2,3-diamino-4-chloro-4-methylpentanoyl]-
pyrrolidine hydrochloride 322a 
(SS,2S,3S) N-[4-Chloro-2-diphenylmethyleneamino-4-methyl-3-(p-toluenesulfinylamino)-
pentanoyl]pyrrolidine syn-314a (0.19 g, 0.35 mmol) was dissolved in a mixture of 0.5 M (aq.) 
HCl/EtOAc (2:1) (12 mL) and the mixture was stirred for 30 minutes at room temperature. 
The organic phase was removed and the aqueous phase was washed with EtOAc (3 x 5 mL). 
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Subsequently, the aqueous phase was lyophilized to yield 0.09 g (0.29 mmol, 83%) of pure 
(2S,3S) N-[2,3-diamino-4-chloro-4-methylpentanoyl]pyrrolidine hydrochloride 322a. 
 
(2S,3S) N-[2,3-diamino-4-chloro-4-methylpentanoyl]pyrrolidine hydrochloride 322a. 
White crystals, yield 83% (0.09 g). [α]D -3.1 (c 2.4, MeOH). Mp 227.3 ± 
2.0 °C. IR (cm
-1
): max 1123, 1166, 1404, 1453, 1514, 1543, 1636, 2973, 
3399. 
1
H NMR (300 MHz, D2O):  1.79 (3H, s, CCH3(CH3)), 1.82-2.04 
(4H, m, 2xCH2(CH2)2), 1.86 (3H, s, CCH3(CH3)), 3.35-3.60 (3H, m, 
CH(H)N and CH2N), 3.62-3.77 (1H, m, CH(H)N), 4.07 (1H, d, J = 2.2 Hz, CHCCl), 4.90 
(1H, d, J = 2.2 Hz, CHCO). 
13
C NMR (75 MHz, D2O):  23.8, 25.5 (2xCH2(CH2)2), 29.0 
(CCH3(CH3)), 30.9 (CCH3(CH3)), 47.3, 47.6 (2xCH2N), 49.8 (CHCO), 57.6 (CHCCl), 67.8 
(CCl), 164.1 (C=O). MS (ES, pos. mode) m/z (%): 234/236 (M + H
+
 - nxHCl, 100). HRMS 
(ES) calcd for C10H20ClN3O: 198.1601 (MH
+
 - nxHCl); found: 198.1596. 
 
5.33. Synthesis of (SS)-2-diphenylmethyleneamino-3-(p-toluenesulfinyl-
amino)butyrolactone 326 
A solution of N-[2-diphenylmethyleneaminoacetyl]piperidine 313b (1.1 equiv, 8.19 mmol, 
2.50 g) in THF (100 mL) was cooled to -78 °C under nitrogen atmosphere. A 1.0M solution 
of LiHMDS (1.1 equiv, 8.19 mL, 8.19 mmol) in THF was slowly added and the resulting 
solution was stirred for one hour at -78 °C. After deprotonation, a solution of (SS)-N-p-
toluenesulfinyl-α-chloroacetaldimine 266h (1.0 equiv, 7.45 mmol, 1.60 g) in THF (20 mL) 
was added dropwise and the reaction mixture was stirred at -78 °C for 15 minutes. To the 
reaction mixture was added a saturated solution of NH4Cl (20 mL) while stirring at -78 °C for 
two minutes. The reaction mixture was brought to room temperature followed by an 
extraction with EtOAc (3 x 20 mL). The combined organic phases were dried (MgSO4), 
filtered and evaporated in vacuo. The crude product was purified by column chromatography 
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to yield 0.28 g (0.67 mmol) of pure (SS)-2-diphenylmethyleneamino-3-(p-
toluenesulfinylamino)butyrolactone 326. 
 
(SS)-2-Diphenylmethyleneamino-3-(p-toluenesulfinylamino)butyrolactone 326. Rf = 0.17 
(petroleum ether/EtOAc : 4/3). Yellow oil, yield 9% (0.28 g). [α]D +1.4 (c 
1.0, CHCl3). IR (cm
-1
): max 696, 1017, 1088, 1158, 1624, 1780, 3179 
(weak). 
1
H NMR (300 MHz, CDCl3):  2.42 (3H, s, CaromCH3), 3.84 (1H, 
dxd, J = 8.8 Hz, 7.2 Hz, CH(H)O), 3.98 (1H, d, J = 7.7 Hz, NH), 4.25 (1H, 
d, J = 7.2 Hz, CHC=O), 4.48-4.63 (2H, m, CH(H)O and CHNH), 7.27-7.54 (12H, m, CHarom), 
7.65-7.71 (2H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  21.5 (CaromCH3), 57.9 (CHNH), 
67.1 (CHC=O), 70.9 (CH2O), 125.5 (2xCHarom), 128.3 (2xCHarom), 128.4 (2xCHarom), 128.7 
(2xCHarom), 129.3 (2xCHarom), 129.4 (CHarom), 129.8 (2xCHarom), 131.1 (CHarom), 135.5, 
138.9, 141.1, 142.2 (4xCarom), 172.4 and 174.7 (C=N and C=O). MS (ES, pos. mode) m/z (%): 
419 (M + H
+
, 100). HRMS (ES) calcd for C24H22N2O3S: 419.1424 MH
+
; found: 419.1434. 
 
5.34. Synthesis of syn N-[4-(tert-butoxycarbonylamino)-2-(diphenylmethyl-
eneamino)-3-(tert-butanesulfinylamino)butanoyl]amines syn-334 
The synthesis of (RS,2R,3S) N-[4-(tert-butoxycarbonylamino)-2-diphenylmethyleneamino-3-
(tert-butanesulfinylamino)butanoyl]pyrrolidine (RS)-syn-334a is representative. A solution of 
N-[2-diphenylmethyleneaminoacetyl]piperidine 313a (1 equiv, 0.50 mmol, 0.15 g) in THF 
(10 mL) was cooled to -78 °C under nitrogen atmosphere. A 1.0M solution of LiHMDS (1 
equiv, 0.50 mL, 0.50 mmol) in THF was slowly added and the resulting solution was stirred 
for one hour at -78 °C. After deprotonation, a solution of (RS)-N-tert-butanesulfinyl-α-(tert-
butoxycarbonylamino)acetaldimine (RS)-271 (1.0 equiv, 0.50 mmol, 0.13 g) in THF (3 mL) 
was added dropwise and the reaction mixture was stirred at -78 °C for 15 minutes. To the 
reaction mixture was added a saturated solution of NH4Cl (5 mL) while stirring at -78 °C for 
two minutes. The reaction mixture was brought to room temperature followed by an 
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extraction with EtOAc (3 x 20 mL). The combined organic phases were dried (MgSO4), 
filtered and evaporated in vacuo. The crude product was purified by column chromatography 
to yield 0.06 g (0.11 mmol, 22%) of pure (RS,2R,3S) N-[4-(tert-butoxycarbonylamino)-2-
diphenylmethyleneamino-3-(tert-butanesulfinylamino)butanoyl]-pyrrolidine (RS)-syn-334a. 
 
(RS,2R,3S) N-[4-(tert-Butoxycarbonylamino)-2-diphenylmethyleneamino-3-(tert-butane-
sulfinylamino)butanoyl]pyrrolidine (RS)-syn-334a. White crystals, 
yield 22% (0.06 g). [α]D -42.4 (c 0.7, CHCl3). Mp 191.8 ± 2.0 °C. IR 
(cm
-1
): max 696, 1066, 1161, 1249, 1446, 1529, 1621, 1714, 3266. 
1
H 
NMR (300 MHz, CDCl3):1.24 (9H, s, SC(CH3)3), 1.40 (9H, s, 
OC(CH3)3), 1.61-1.82 (4H, m, 2xCH2(CH2)2), 2.67-2.74 (1H, m, 
NCH(H)CH2), 3.11-3.30 (3H, m, NCH(H)CH2 and NCH(H)CH2 and NHCH(H)), 3.35-3.47 
(2H, m, NCH(H)CH2 and NHCH(H)), 3.62-3.70 (1H, m, CHNH), 4.21 (1H, d, J = 2.8 Hz, 
CHCO), 4.74 (1H, d, J = 9.9 Hz, SNH), 5.84-5.88 (1H, m, CONH), 7.11-7.14 (2H, m, 
CHarom), 7.30-7.43 (6H, m, CHarom), 7.61-7.64 (2H, m, CHarom). 
13
C NMR (75 MHz, CDCl3): 
22.8 (SC(CH3)3), 23.9, 26.3 (2xCH2(CH2)2), 28.5 (OC(CH3)3), 45.1 (NHCH2), 46.26, 46.28 
(2xCH2N), 56.6 (SC(CH3)3), 59.7 (CHNH), 66.5 (CHCO), 79.3 (OC(CH3)3), 127.4 
(2xCHarom), 128.2 (2xCHarom), 128.75 (2xCHarom), 128.83 (CHarom), 128.9 (2xCHarom), 130.9 
(CHarom), 137.0, 138.7 (2xCarom), 156.7 (OCONH), 168.8, 171.8 (C=N and C=O). MS (ES, 
pos. mode) m/z (%): 555 (M + H
+
, 100). HRMS (ES) calcd for C30H42N4O4S: 555.3000 MH
+
; 
found: 555.3005. 
 
(SS,2S,3R) N-[4-(tert-Butoxycarbonylamino)-2-diphenylmethyleneamino-3-(tert-butane-
sulfinylamino)butanoyl]pyrrolidine (SS)-syn-334a. White crystals, 
yield 69% (1.40 g). [α]D +40.5 (c 0.9, CHCl3). Mp 190.4 ± 2.0 °C. IR 
(cm
-1
): max 696, 704, 1066, 1162, 1249, 1620, 1715, 3266. 
1
H NMR 
(300 MHz, CDCl3):1.24 (9H, s, SC(CH3)3), 1.40 (9H, s, OC(CH3)3), 
1.61-1.82 (4H, m, 2xCH2(CH2)2), 2.66-2.74 (1H, m, NCH(H)CH2), 
3.11-3.30 (3H, m, NCH(H)CH2 and NCH(H)CH2 and NHCH(H)), 3.35-3.49 (2H, m, 
NCH(H)CH2 and NHCH(H)), 3.63-3.71 (1H, m, CHNH), 4.21 (1H, d, J = 2.8 Hz, CHCO), 
4.75 (1H, d, J = 9.9 Hz, SNH), 5.87-5.91 (1H, m, CONH), 7.11-7.14 (2H, m, CHarom), 7.30-
7.46 (6H, m, CHarom), 7.61-7.65 (2H, m, CHarom). 
13
C NMR (75 MHz, CDCl3): 22.7 
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(SC(CH3)3), 23.8, 26.2 (2xCH2(CH2)2), 28.4 (OC(CH3)3), 45.0 (NHCH2), 46.1, 46.2 
(2xCH2N), 56.5 (SC(CH3)3), 59.5 (CHNH), 66.4 (CHCO), 79.2 (OC(CH3)3), 127.3 
(2xCHarom), 128.1 (2xCHarom), 128.6 (2xCHarom), 128.7 (CHarom), 128.8 (2xCHarom), 130.7 
(CHarom), 136.9, 138.6 (2xCarom), 156.6 (OCONH), 168.6, 171.6 (C=N and C=O). MS (ES, 
pos. mode) m/z (%): 555 (M + H
+
, 100). HRMS (ES) calcd for C30H42N4O4S: 555.3000 MH
+
; 
found: 555.3003. 
 
(RS,2R,3S) N-[4-(tert-Butoxycarbonylamino)-2-diphenylmethyleneamino-3-(tert-butane- 
sulfinylamino)butanoyl]piperidine (RS)-syn-334b. Yellow oil, yield 
60% (1.19 g). [α]D -53.7 (c 0.6, CHCl3). IR (cm
-1
): max 696, 1051, 
1169, 1248, 1638, 1703, 3308 (weak). 
1
H NMR (300 MHz, CDCl3): 
0.90-1.02 (1H, m, CH(H)(CH2)2), 1.23 (9H, s, SC(CH3)3), 1.41 (9H, s, 
OC(CH3)3), 1.35-1.65 (5H, m, 2xCH2(CH2)2 and CH(H)(CH2)2), 3.03-
3.24 (4H, m, NHCH(H) and NCH(H)CH2 and NCH2CH2), 3.35-3.43 (1H, m, NHCH(H)), 
3.56-3.70 (2H, m, NHCH and NCH(H)CH2), 4.33 (1H, d, J = 2.8 Hz, CHCO), 4.72 (1H, d, J 
= 9.9 Hz, SNH), 5.91-5.96 (1H, m, CONH), 7.10-7.15 (2H, m, CHarom), 7.29-7.46 (6H, m, 
CHarom), 7.60-7.66 (2H, m, CHarom). 
13
C NMR (75 MHz, CDCl3):  22.8 (SC(CH3)3), 24.6, 
25.6, 26.2 (3xCH2(CH2)2), 28.5 (OC(CH3)3), 43.3 (CH2N), 45.4 (NHCH2), 46.5 (CH2N), 56.7 
(SC(CH3)3), 60.1 (CHNH), 64.9 (CHCO), 79.4 (OC(CH3)3), 127.7 (2xCHarom), 128.1 
(2xCHarom), 128.7 (2xCHarom), 128.8 (CHarom), 128.9 (2xCHarom), 130.2 (CHarom), 136.9, 138.8 
(2xCarom), 156.7 (OCONH), 168.3, 171.8 (C=N and C=O). MS (ES, pos. mode) m/z (%): 569 
(M + H
+
, 100). HRMS (ES) calcd for C31H44N4O4S: 569.3156 MH
+
; found: 569.3162. 
 
(SS,2S,3R) N-[4-(tert-Butoxycarbonylamino)-2-diphenylmethyleneamino-3-(tert-butane- 
sulfinylamino)butanoyl]piperidine (SS)-syn-334b. Yellow oil, yield 
74% (1.34 g). [α]D +55.9 (c 1.0, CHCl3). IR (cm
-1
): max 697, 1047, 
1169, 1247, 1637, 1705, 3305 (weak). 
1
H NMR (300 MHz, 
CDCl3):0.88-1.02 (1H, m, CH(H)(CH2)2), 1.23 (9H, s, SC(CH3)3), 
1.41 (9H, s, OC(CH3)3), 1.35-1.65 (5H, m, 2xCH2(CH2)2 and 
CH(H)(CH2)2), 3.05-3.24 (4H, m, NHCH(H) and NCH(H)CH2 and NCH2CH2), 3.35-3.43 
(1H, m, NHCH(H)), 3.56-3.69 (2H, m, NHCH and NCH(H)CH2), 4.33 (1H, d, J = 2.8 Hz, 
CHCO), 4.70 (1H, d, J = 9.9 Hz, SNH), 5.88-5.96 (1H, m, CONH), 7.09-7.15 (2H, m, 
CHarom), 7.29-7.45 (6H, m, CHarom), 7.59-7.64 (2H, m, CHarom).
13
C NMR (75 MHz, CDCl3):  
(R)
BocHN (S)
NH
S
(S)
N
O
N
Ph
Ph
O
t-Bu
(S)
BocHN (R)
NH
S
(R)
N
O
N
Ph
Ph
O
t-Bu
Chapter 5   Experimental part 
 
198 
 
22.8 (SC(CH3)3), 24.5, 25.6, 26.2 (3xCH2(CH2)2), 28.4 (OC(CH3)3), 43.2 (CH2N), 45.3 
(NHCH2), 46.5 (CH2N), 56.6 (SC(CH3)3), 60.1 (CHNH), 64.8 (CHCO), 79.3 (OC(CH3)3), 
127.6 (2xCHarom), 128.1 (2xCHarom), 128.6 (2xCHarom), 128.7 (CHarom), 128.8 (2xCHarom), 
130.7 (CHarom), 136.8, 138.8 (2xCarom), 156.7 (OCONH), 168.3, 171.7 (C=N and C=O). MS 
(ES, pos. mode) m/z (%): 569 (M + H
+
, 100). HRMS (ES) calcd for C31H44N4O4S: 569.3156 
MH
+
; found: 569.3168. 
 
5.35. Synthesis of (2R,3S) N-(2,3,4-triaminobutanoyl)piperidine 
hydrochloride syn-337b 
(RS,2R,3S) N-[4-(tert-butoxycarbonylamino)-2-diphenylmethyleneamino-3-(tert-butane-
sulfinylamino)butanoyl]piperidine (RS)-syn-334b (0.20 g, 0.35 mmol) was dissolved in a 
mixture of 0.5 M (aq.) HCl/EtOAc (2:1) (12 mL) and the mixture was stirred for 30 minutes 
at room temperature. The organic phase was removed and the aqueous phase was washed with 
EtOAc (3 x 5 mL). Subsequently, the aqueous phase was lyophilized to yield 0.07 g (0.22 
mmol, 64%) of pure (2R,3S) N-(2,3,4-triaminobutanoyl)piperidine hydrochloride syn-337b. 
 
(2R,3S) N-(2,3,4-Triaminobutanoyl)piperidine hydrochloride syn-337b. White powder, 
yield 64% (0.07 g). [α]D +18.8 (c 1.0, H2O). Mp 173.1 ± 2.0 °C. IR 
(cm
-1
): max 1052, 1164, 1710, 2845, 2862, 2949, 3190, 3358. 
1
H 
NMR (300 MHz, D2O):1.56-1.67 (2H, m, CH2(CH2)2), 1.68-1.78 
(4H, m, 2xCH2(CH2)2), 3.08-3.15 (4H, m, 2xNCH2CH2), 3.51 (1H, 
dxd, J = 11.0 Hz, J = 7.2 Hz, NH2CH(H)), 3.93 (1H, dxd, J = 11.0 Hz, J = 8.3 Hz, 
NH2CH(H)), 4.34 (1H, q, J = 8.3 Hz, CH2CHN), 4.44 (1H, d, J = 8.3 Hz, CHCO). 
13
C NMR 
(75 MHz, D2O):  21.7 (CH2(CH2)2), 22.4 (2xCH2(CH2)2), 43.0 (NH2CH2), 44.8 (2xCH2N), 
49.4 (CH2CHN), 53.3 (CHCO), 168.9 (C=O). 
 
 
(S)
H2N (R)
NH2
NH2
O
N .nHCl
Chapter 5   Experimental part 
 
199 
 
5.36. Synthesis of (RS)-syn N-[2-amino-4-(tert-butoxycarbonylamino)-3-
(tert-butanesulfinylamino)butanoyl]amines syn-338 
The synthesis of (RS,2R,3S) N-[2-amino-4-(tert-butoxycarbonylamino)-3-(tert-butanesulfinyl-
amino)butanoyl]piperidine (RS)-syn-338b is representative. To a solution of (RS,2R,3S) N-[4-
(tert-butoxycarbonylamino)-2-diphenylmethyleneamino-3-(tert-butanesulfinylamino)-
butanoyl]piperidine (RS)-syn-334b (0.25 g, 0.44 mmol) in acetone/H2O (2:1) (9 mL) was 
added dropwise trifluoroacetic acid (5 equiv, 2.20 mmol, 0.17 mL) at room temperature. The 
reaction mixture was stirred for 15 minutes at room temperature and subsequently quenched 
with NH4OH in H2O until pH = 10 and concentrated in vacuo. The residue was redissolved in 
water (10 mL) and NH4OH in H2O was added until pH = 10. The aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic phases were dried (MgSO4), 
filtered and evaporated in vacuo. The crude product was purified by column chromatography 
to yield 0.14 g (0.34 mmol, 77%) of pure (RS,2R,3S) N-[2-amino-4-(tert-
butoxycarbonylamino)-3-(tert-butanesulfinylamino)butanoyl]piperidine (RS)-syn-338b. 
 
(RS,2R,3S) N-[2-Amino-4-(tert-butoxycarbonylamino)-3-(tert-butanesulfinylamino)-
butanoyl]piperidine (RS)-syn-338b. Yellow oil, yield 77% (0.14 g). 
[α]D -69.6 (c 0.9, CHCl3). IR (cm
-1
): max 730, 1045, 1169, 1249, 1638, 
1698, 3298. 
1
H NMR (300 MHz, CDCl3):1.19 (9H, s, SC(CH3)3), 
1.45 (9H, s, OC(CH3)3), 1.53-1.72 (6H, m, 3xCH2(CH2)2), 2.40 (2H, br 
s, NH2), 3.19-3.38 (2H, m, NHCH(H) and NCH(H)CH2), 3.38-3.55 (4H, m, CHNH and 
NHCH(H) and NCH(H)CH2 and CH2NCH(H)), 3.55-3.68 (1H, m, CH2NCH(H)), 3.88 (1H, br 
s, CHCO), 4.01-4.09 (1H, m, SNH), 5.67-5.75 (1H, m, CONH). 
13
C NMR (75 MHz, CDCl3): 
 22.8 (SC(CH3)3), 24.6, 25.7, 26.6 (3xCH2(CH2)2), 28.5 (OC(CH3)3), 43.7 (CH2N), 44.7 
(CH2NH), 46.6 (CH2N), 52.2 (CHNH2), 56.7 (SC(CH3)3), 60.1 (CHNH), 79.7 (OC(CH3)3), 
156.8 (OCONH), 170.4 (C=O). MS (ES, pos. mode) m/z (%): 405 (M + H
+
, 100). HRMS (ES) 
calcd for C18H36N4O4S: 405.2530 MH
+
; found: 405.2530. 
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(SS,2S,3R) N-[2-Amino-4-(tert-butoxycarbonylamino)-3-(tert-butanesulfinylamino)-
butanoyl]pyrrolidine (SS)-syn-338a. Yellow oil, yield 81% (0.17 g). 
[α]D +45.4 (c 0.8, CHCl3). IR (cm
-1
): max 730, 1042, 1166, 1253, 1365, 
1453, 1519, 1633, 1693, 3286. 
1
H NMR (300 MHz, CDCl3):1.04 
(9H, s, SC(CH3)3), 1.27 (9H, s, OC(CH3)3), 1.63-1.88 (4H, m, 
2xCH2(CH2)2), 2.22 (2H, br s, NH2), 3.11-3.56 (8H, m, 2xNCH2 and NHCH2 and CHNH and 
CHCO), 4.06-4.23 (1H, m, SNH), 5.84-5.96 (1H, m, CONH). 
13
C NMR (75 MHz, CDCl3):  
23.5 (SC(CH3)3), 24.8, 27.0 (2xCH2(CH2)2), 29.2 (OC(CH3)3), 44.5 (CH2NH), 47.0, 47.1 
(2xCH2N), 54.8 (CHNH2 or CHNH), 57.2 (SC(CH3)3), 59.9 (CHNH or CHNH2), 80.0 
(OC(CH3)3), 157.5 (OCONH), 171.9 (C=O). MS (ES, pos. mode) m/z (%): 391 (M + H
+
, 
100). HRMS (ES) calcd for C17H34N4O4S: 391.2374 MH
+
; found: 391.2390. 
 
5.37. Synthesis of (RS,RS)-Methyl 4-(tert-butoxycarbonylamino)-3-(tert-
butanesulfinylamino)-2-chloro-N-tert-butanesulfinylbutanimidate 345 
A solution of (RS)-α-chloro-N-tert-butanesulfinyl imidate (RS)-344 (1.8 equiv, 0.69 mmol, 
0.15 g) in THF (10 mL) was cooled to -78 °C under nitrogen atmosphere. A 1.0M solution of 
LiHMDS (1.8 equiv, 0.69 mL, 0.69 mmol) in THF was slowly added and the resulting 
solution was stirred for 45 minutes at -78 °C. After deprotonation, a solution of (RS)-N-tert-
butanesulfinyl-α-(tert-butoxycarbonylamino)acetaldimine (RS)-271 (1.0 equiv, 0.38 mmol, 
0.10 g) in THF (3 mL) was added dropwise and the reaction mixture was stirred at -78 °C for 
30 minutes. To the reaction mixture was added a saturated solution of NH4Cl (5 mL) while 
stirring at -78 °C for two minutes. The reaction mixture was brought to room temperature 
followed by an extraction with EtOAc (3 x 10 mL). The combined organic phases were dried 
(MgSO4), filtered and evaporated in vacuo. The crude product was purified by column 
chromatography to yield 0.15 g (0.31 mmol, 83%) of pure (RS,RS)-methyl 4-(tert-
butoxycarbonylamino)-3-(tert-butanesulfinylamino)-2-chloro-N-tert-butane-
sulfinylbutanimidate 345. 
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(RS,RS)-Methyl 4-(tert-butoxycarbonylamino)-3-(tert-butanesulfinylamino)-2-chloro-N-
tert-butanesulfinylbutanimidate 345. Yellow oil, yield 83% (0.15 
g). [α]D -48.8 (c 1.1, CHCl3). IR (cm
-1
): max 730, 915, 1045, 1167, 
1242, 1367, 1736, 3310. 
1
H NMR (300 MHz, CDCl3):1.23 (9H, s, 
SC(CH3)3), 1.28 (9H, s, SC(CH3)3), 1.44 (9H, s, OC(CH3)3), 3.11-
3.16 (1H, m, CHNH), 3.31-3.41 (1H, m, CH(H)NH), 3.75 (3H, s, OCH3), 3.96 (1H, d, J = 3.3 
Hz, CHCl), 4.00-4.07 (1H, m, CH(H)NH), 5.66-5.74 (1H, m, CONH), SNH (not visible). 
13
C 
NMR (75 MHz, CDCl3): 22.0, 22.3 (2xSC(CH3)3), 28.5 (OC(CH3)3), 38.1 (CHCl), 39.3 
(CH2NH), 46.2 (CHNH), 54.7 (OCH3) 57.1, 57.9 (2xSC(CH3)3), 79.6 (OC(CH3)3), 155.9 
(C=O), 167.2 (C=N). MS (ES
+
): m/z (%): 474/476 (M+H
+
, 100). HRMS (ES) calcd for 
C18H36ClN3O5S2: 474.1858 MH
+
; found: 474.1861. 
 
5.38. Synthesis of (RS,2R,3R)-alkyl 4-chloro-2-hydroxy-4-methyl-3-(tert-
butanesulfinylamino)pentanoates 356 
The synthesis of (RS,2R,3R)-benzyl 4-chloro-2-hydroxy-4-methyl-3-(tert-
butanesulfinylamino)-pentanoate 356a is representative. To a solution of (RS,2R,3R)-benzyl 2-
(tert-butoxycarbonyloxy)-4-chloro-4-methyl-3-(tert-butanesulfinylamino)pentanoate 351a 
(synthesized according to ref 153) 0.61 g, 1.28 mmol) in CH2Cl2 (7 mL) was added dropwise 
trifluoroacetic acid (3 mL) at room temperature. The reaction mixture was stirred for one hour 
at room temperature and subsequently poured out in water (7 mL) and quenched with K2CO3 
until pH = 7. The aqueous phase was extracted with CH2Cl2 (3 x 10 mL) and the combined 
organic phases were dried (MgSO4), filtered and evaporated in vacuo. The crude product was 
purified by crystallization in diethyl ether to yield 0.36 g (0.96 mmol, 75%) of pure 
(RS,2R,3R)-benzyl 4-chloro-2-hydroxy-4-methyl-3-(tert-butanesulfinylamino)pentanoate 
356a. 
 
(RS,2R,3R)-Benzyl 4-chloro-2-hydroxy-4-methyl-3-(tert-butanesulfinylamino)pentanoate 
356a. Rf = 0.27 (petroleum ether/EtOAc: 1/1). Yellow oil, yield 75% (0.36 g). [α]D +6.3 (c 
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2.0, CHCl3). IR (cm
-1
): 1739, 3266. 
1
H NMR (300 MHz, CDCl3): δ 1.09 
(9H, s, SC(CH3)3), 1.68 (3H, s, CCH3(CH3)), 1.82 (3H, s, CCH3(CH3)), 
3.48 (1H, br s, OH), 3.88 (1H, dxd, J = 9.9 Hz, 1.1 Hz, NHCHCH), 4.04 
(1H, d, J = 9.9 Hz, NH), 4.86 (1H, d, J = 1.1 Hz, OCH), 5.16 (1H, d, J = 
12.1 Hz, CH(H)Ph), 5.24 (1H, d, J = 12.1 Hz, CH(H)Ph), 7.35-7.40 (5H, m, CHarom). 
13
C 
NMR (75 MHz, CDCl3): δ 22.6 (SC(CH3)3), 28.8 (CCH3(CH3)), 31.5 (CCH3(CH3)), 57.1 
(SC(CH3)3), 66.7 (NHCH), 68.1 (COOCH2), 70.8 (CHOH), 71.8 (CCl(CH3)2), 128.69 
(2xCHarom), 128.74 (2xCHarom), 128.8 (CHarom), 134.5 (Carom), 173.5 (COO). MS (ES
+
): m/z 
(%): 376/378 (M+H
+
, 100). HRMS (ES) calcd for C17H26ClNO4S: 376.1344 MH
+
; found: 
376.1345. 
 
(RS,2R,3R)-Methyl 4-chloro-2-hydroxy-4-methyl-3-(tert-butanesulfinylamino)pentanoate 
356b. Rf = 0.29 (petroleum ether/EtOAc: 1/2). White crystals, yield 80% 
(0.27 g). [α]D -27.1 (c 2.0, CHCl3). Mp 114.1 ± 1.0 °C. IR (cm
-1
): 1742, 
3293. 
1
H NMR (300 MHz, CDCl3): δ 1.17 (9H, s, SC(CH3)3), 1.70 (3H, s, 
CCH3(CH3)), 1.85 (3H, s, CCH3(CH3)), 3.23 (1H, br s, OH), 3.82 (3H, s, 
OCH3), 3.86 (1H, d , J = 9.9 Hz, NHCH), 3.97 (1H, d, J = 9.9 Hz, NH), 4.86 (1H, s, CHO). 
13
C NMR (75 MHz, CDCl3): δ 22.6 (SC(CH3)3), 28.8 (CCH3(CH3)), 31.5 (CCH3(CH3)), 53.1 
(OCH3), 57.1 (SC(CH3)3), 66.6 (NHCH), 70.7 (CHOH), 71.8 (C(CH3)2), 174.1 (COO). MS 
(ES
+
): m/z (%): 300/302 (M+H
+
, 100). HRMS (ES) calcd for C11H22ClNO4S: 300.1031 MH
+
; 
found: 300.1024. 
 
(RS,2R,3R)-Ethyl 4-chloro-2-hydroxy-4-methyl-3-(tert-butanesulfinylamino)pentanoate 
356c. White crystals, yield 86% (0.24 g). [α]D -9.3 (c 2.1, CHCl3). Mp 98.3 
± 2.0 °C. IR (cm
-1
): 1738, 3288. 
1
H NMR (300 MHz, CDCl3): δ 1.18 (9H, 
s, SC(CH3)3), 1.34 (3H, t, J = 7.2 Hz, CH2CH3), 1.70 (3H, s, CCH3(CH3)), 
1.85 (3H, s, CCH3(CH3)), 3.29 (1H, J = 3.9 Hz, OH), 3.85 (1H, dxd , J = 
9.9 Hz, 1.1 Hz, NHCH), 3.99 (1H, d, J = 9.9 Hz, NH), 4.16-4.35 (2H, m, OCH2CH3), 4.82 
(1H, dxd, J = 3.9 Hz, 1.1 Hz, CHO). 
13
C NMR (75 MHz, CDCl3): δ 14.2 (CH2CH3), 22.6 
(SC(CH3)3), 28.8 (CCH3(CH3)), 31.6 (CCH3(CH3)), 57.0 (SC(CH3)3), 62.6 (CH2CH3), 66.6 
(NHCHCH), 70.7 (CHCHO), 71.8 (CCl(CH3)2), 173.7 (C=O). MS (ES
+
): m/z (%): 314/316 
(M+H
+
, 100). HRMS (ES) calcd for C12H24ClNO4S: 314.1187 MH
+
; found: 314.1176. 
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5.39. Synthesis of (2R,3R)-methyl 3-amino-2-(tert-butoxycarbonyloxy)-4-
chloro-4-methylpentanoate hydrochloride 363b 
To a solution of (RS,2R,3R)-methyl 2-(tert-butoxycarbonyloxy)-4-chloor-4-methyl-3-(tert-
butane-sulfinylamino)pentanoate 351b (0.19 g, 0.48 mmol) in dioxane (20 mL) was added a 
saturated solution of HCl in dioxane (5 mL) at room temperature. The reaction mixture was 
stirred for one hour at room temperature and subsequently the solvent was evaporated in 
vacuo. The crude product was purified by washing with diethyl ether to yield 0.14 g (0.45 
mmol, 93%) of pure (2R,3R)-methyl 3-amino-2-(tert-butoxycarbonyloxy)-4-chloro-4-
methylpentanoate hydrochloride 363b. 
 
(2R,3R)-Methyl 3-amino-2-(tert-butoxycarbonyloxy)-4-chloro-4-methylpentanoate 
hydrochloride 363b. White powder, yield 93% (0.14 g). [α]D -13.0 (c 2.2, 
CHCl3). Mp 149.2 ± 2.0 °C. IR (cm
-1
): 1727, 1752, 2509 (broad). 
1
H NMR 
(300 MHz, CDCl3): δ 1.50 (9H, s, OC(CH3)3), 1.87 (6H, br s, C(CH3)2), 
3.89 (3H, s, OCH3), 4.26 (1H, br s, NH2CH), 5.73 (1H, br s, CHO), 9.01 
(3H, br s, NH3Cl). 
13
C NMR (75 MHz, ref = CDCl3): δ 27.8 (OC(CH3)3), 
30.4 (CCH3(CH3)), 31.3 (CCH3(CH3)), 54.2 (NH2CH), 59.8 (OCH3), 67.8 (C(CH3)2), 70.8 
(CHO), 84.3 (OC(CH3)3), 151.8 (O(C=O)O), 167.7 (CHCOO). MS (ES
+
): m/z (%): 296/298 
(M+H
+
 - HCl, 100). HRMS (ES) calcd for C12H22ClNO5: 296.1259 MH
+
 - HCl; found: 
296.1259. 
 
5.40. Synthesis of (2R,3R)-alkyl 3-amino-4-chloro-2-hydroxy-4-methyl-
pentanoate trifluoroacetic acid salts 364 
The synthesis of (2R,3R)-benzyl 3-amino-4-chloro-2-hydroxy-4-methylpentanoate 364a is 
representative. To a solution of (2R,3R)-benzyl 3-amino-2-(tert-butoxycarbonyloxy)-4-
chloro-4-methylpentanoate 363a (synthesized according to ref 153) (0.78 g, 1.91 mmol) in 
CH2Cl2 (14 mL) was added trifluoroacetic acid (6 mL) at room temperature. The reaction 
(R)
Cl
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O
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mixture was stirred for one hour at room temperature and subsequently evaporated in vacuo, 
affording the pure (2R,3R)-benzyl 3-amino-4-chloro-2-hydroxy-4-methylpentanoate 364a. 
 
(2R,3R)-Benzyl 3-amino-4-chloro-2-hydroxy-4-methylpentanoate 364a. Yellow oil, yield 
97% (0.72 g). [α]D -4.5 (c 1.3, CHCl3). IR (cm
-1
): 1142, 1665, 1739, 3038. 
1
H NMR (300 MHz, CDCl3): δ 1.70 (3H, s, C(CH3)CH3), 1.76 (3H, s, 
C(CH3)CH3), 3.95 (1H, s, NH2CHCH), 4.65 (1H, s, CHCHO), 5.12 (1H, d, 
J = 12.1 Hz, COOCH(H)), 5.29 (1H, d, J = 12.1 Hz, COOCH(H)), 7.26-7.35 (5H, m, CHarom), 
8.21 (4H, br s, NH2.TFA and OH). 
13
C NMR (75 MHz, ref = CDCl3): δ 28.1 (CCH3(CH3)), 
29.9 (CCH3(CH3)), 61.9 (NH2CHCH), 67.1 (CHCHO), 68.9 (COOCH2), 69.2 (CCl(CH3)2), 
128.7 (2xCHarom), 128.9 (2xCHarom), 129.1 (CHarom), 134.1 (Carom), 171.6 (CHCOO). MS 
(ES
+
): m/z (%): 272/274 (M+H
+
 - TFA, 100). HRMS (ES) calcd for C13H18ClNO3: 272.1048 
MH
+
 - TFA; found: 272.1058. 
 
(2R,3R)-Methyl 3-amino-4-chloro-2-hydroxy-4-methylpentanoate 364b. Yellow oil, yield 
84% (0.98 g). [α]D -18.4 (c 2.0, CHCl3). IR (cm
-1
): 1135, 1183, 1669, 
1742, 2961. 
1
H NMR (300 MHz, CDCl3): δ 1.72 (3H, s, C(CH3)CH3), 1.78 
(3H, s, C(CH3)CH3), 3.79 (3H, s, OCH3), 3.91 (1H, s, NH2CHCH), 4.66 
(1H, s, CHCHO), 7.60 (4H, br s, NH2.TFA and OH). 
13
C NMR (75 MHz, ref = CDCl3): δ 28.2 
(CCH3(CH3)), 29.7 (CCH3(CH3)), 53.6 (OCH3), 61.8 (NH2CHCH), 67.0 (CHCHO), 69.0 
(CCl(CH3)2), 172.4 (CHCOO). MS (ES
+
): m/z (%): 196/198 (M+H
+
 - TFA, 100). HRMS (ES) 
calcd for C7H14ClNO3: 196.0735 MH
+
 - TFA; found: 196.0740. 
 
(2R,3R)-Ethyl 3-amino-4-chloro-2-hydroxy-4-methylpentanoate 364c. Yellow oil, yield 
96% (0.27 g). [α]D -14.7 (c 1.0, CHCl3). IR (cm
-1
): 1135, 1184, 1668, 1734, 
2987. 
1
H NMR (300 MHz, CDCl3): δ 1.30 (3H, t, J = 7.2 Hz, CH2CH3), 
1.73 (3H, s, CCH3(CH3)), 1.80 (3H, s, CCH3(CH3)), 3.90 (1H, br s, 
NH2CH), 4.16-4.36 (2H, m, OCH2CH3), 4.62 (1H, br s, CHO), 6.96 (4H, br s, NH2.TFA and 
OH). 
13
C NMR (75 MHz, ref = CDCl3): δ 13.8 (CH2CH3), 28.1 (CCH3(CH3)), 29.9 
(CCH3(CH3)), 61.9 (NH2CH), 63.5 (COOCH2), 67.0 (C(CH3)2), 69.2 (CHO), 171.9 
(CHCOO). MS (ES
+
): m/z (%): 210/212 (M+H
+
 - TFA, 100). HRMS (ES) calcd for 
C8H16ClNO3: 210.0891 MH
+
 - TFA; found: 210.0896. 
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5.41. Synthesis of (4R,5R)-alkyl 4-(2-chloro-2-propyl)oxazolidin-2-one-5-
carboxylates 358 
The synthesis of (4R,5R)-ethyl 4-(2-chloro-2-propyl)oxazolidin-2-one-5-carboxylate 358c is 
representative. To a solution of (2R,3R)-ethyl 3-amino-4-chloro-2-hydroxy-4-
methylpentanoate 364c (0.09 g, 0.28 mmol) in dry CH2Cl2 (5 mL) was added dropwise 
DIPEA (4 equiv, 0.14 g, 1.11 mmol) at 0 °C. The reaction mixture was stirred for 15 minutes 
at 0 °C, and subsequently triphosgene (1.2 equiv, 0.10 g, 0.33 mmol) dissolved in dry CH2Cl2 
was added dropwise. The reaction was allowed to warm up to room temperature and after one 
hour, the reaction mixture was poured out in brine (5 mL). The aqueous phase was extracted 
with CH2Cl2 (3 x 5 mL) and the combined organic phases were dried (MgSO4), filtered and 
evaporated in vacuo. The crude product was purified by crystallization in diethyl ether to 
yield 0.05 g (0.21 mmol, 76%) of pure (4R,5R)-ethyl 4-(2-chloro-2-propyloxazolidin-2-one-5-
carboxylate 358c. 
 
(4R,5R)-Benzyl 4-(2-chloro-2-propyl)oxazolidin-2-one-5-carboxylate 358a.
 
White powder, 
yield 82% (0.09 g). [α]D -16.1 (c 0.8, CHCl3). Mp 68.0 ± 2.0 °C. IR (cm
-1
): 
1096, 1209, 1761, 3262. 
1
H NMR (300 MHz, CDCl3): δ 1.57 (6H, s, 
C(CH3)2), 3.93 (1H, d, J = 3.3 Hz, NHCH), 4.91 (1H, d, J = 3.3 Hz, CHO), 
5.26 (1H, d, J = 12.1 Hz, OCH(H)), 5.28 (1H, d, J = 12.1 Hz, OCH(H)), 
7.02 (1H, br s, NH), 7.28-7.47 (5H, m, CHarom). 
13
C NMR (75 MHz, CDCl3): δ 27.6 
(CCH3(CH3)), 27.8 (CCH3(CH3)), 65.1 (NHCH), 68.1 (OCH2), 69.2 (C(CH3)2), 75.0 (CHO), 
128.5 (2xCHarom), 128.9 (3xCHarom), 134.6 (Carom), 158.3 (N(C=O)O), 168.4 (CHCOO). MS 
(ES
+
): m/z (%): 315/317 (M+NH4
+
, 100). HRMS (ES) calcd for C14H16ClNO4: 298.0841 
MH
+
; found: 298.0844. 
 
(4R,5R)-Methyl 4-(2-chloro-2-propyl)oxazolidin-2-one-5-carboxylate 358b.
 
White 
powder, yield 76% (0.08 g). [α]D -23.1 (c 0.9, CHCl3). Mp 127.4 ± 2.0 °C. IR (cm
-1
): 1116, 
1240, 1720, 1746, 3297. 
1
H NMR (300 MHz, CDCl3): δ 1.60 (6H, s, C(CH3)2), 3.86 (3H, s, 
OCH3), 3.97 (1H, dxd, J = 3.3 Hz, 1.1 Hz, NHCH), 4.89 (1H, d, J = 3.3 Hz, CHO), 6.89 (1H, 
(R)
Cl
(R)
O
OBn
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br s, NH). 
13
C NMR (75 MHz, CDCl3): δ 27.6 (CCH3(CH3)), 27.7 
(CCH3(CH3)), 53.4 (OCH3), 65.1 (NHCH), 69.2 (C(CH3)2), 74.9 (CHO), 
158.1 (N(C=O)O), 169.1 (CHCOO). MS (ES
+
): m/z (%): 239/241 
(M+NH4
+
, 100). HRMS (ES) calcd for C8H12ClNO4: 222.0528 MH
+
; 
found: 222.0530. 
 
(4R,5R)-Ethyl 4-(2-chloro-2-propyl)oxazolidin-2-one-5-carboxylate 358c.
 
White powder, 
yield 64% (0.06 g). [α]D -23.0 (c 0.5, CHCl3). Mp 142.1 ± 2.0 °C. IR (cm
-
1
): 1110, 1238, 1728, 1754, 3251. 
1
H NMR (300 MHz, CDCl3): δ 1.34 (3H, 
t, J = 7.2 Hz, CH2CH3), 1.60 (6H, s, C(CH3)2), 3.96 (1H, d, J = 3.3 Hz, 
NHCH), 4.31 (2H, q, J = 7.2 Hz, OCH2), 4.86 (1H, d, J = 3.3 Hz, CHO), 
6.95 (1H, br s, NH). 
13
C NMR (75 MHz, CDCl3): δ 14.1 (CH2CH3), 27.6 (CCH3(CH3)), 27.7 
(CCH3(CH3)), 62.7 (OCH2), 65.2 (NHCH), 69.3 (C(CH3)2), 75.0 (CHO), 158.2 (N(C=O)O), 
168.6 (CHCOO). MS (ES
+
): m/z (%): 253/255 (M+NH4
+
, 100). HRMS (ES) calcd for 
C9H14ClNO4: 236.0684 MH
+
; found: 236.0685. 
 
5.42. Synthesis of (SS,2S,2’R)-alkyl 2-(tert-butoxycarbonyloxy)-2-(3,3-
dimethyl-1-p-toluenesulfinylaziridin-2-yl)acetates 367  
The synthesis of (SS,2S,2’R)-benzyl 2-(tert-butoxycarbonyloxy)-2-(3,3-dimethyl-1-p-
toluenesulfinylaziridin-2-yl)acetate 367a is representative. To a solution of (SS,2S,3S)-benzyl 
2-(tert-butoxycarbonyloxy)-4-chloro-4-methyl-3-(tert-butanesulfinylamino)pentanoate 366a 
(0.18 g, 0.35 mmol) in acetone (10 mL) was added K2CO3 (3.0 equiv, 1.06 mmol, 0.15 g) at 
room temperature. The reaction mixture was allowed to stir for 24 hours at reflux 
temperature. After 24 hours, the K2CO3 was filtered off and the solvent was evaporated in 
vacuo. The resulting oil was redissolved in EtOAc (10 mL) and washed with water (2 x 5 
mL). The organic phase was dried (MgSO4), filtered and evaporated in vacuo. The crude 
product was purified by column chromatography to yield 0.16 g (0.34 mmol, 96%) of 
(SS,2S,2’R)-benzyl 2-(tert-butoxycarbonyloxy)-2-(3,3-dimethyl-1-p-toluenesulfinylaziridin-2-
yl)acetate 367a. 
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(SS,2S,2’R)-Benzyl 2-(tert-butoxycarbonyloxy)-2-(3,3-dimethyl-1-p-toluenesulfinyl-
aziridin-2-yl)acetate 367a. Rf = 0.31 (petroleum ether/EtOAc: 3/1). Yellow oil, yield 96% 
(0.16 g). [α]D -50.5 (c 2.1, CHCl3). IR (cm
-1
): 1099, 1252, 1743. 
1
H 
NMR (300 MHz, CDCl3): δ 1.24 (3H, s, CCH3(CH3)), 1.34 (3H, s, 
CCH3(CH3)), 1.44 (9H, s, OC(CH3)3), 2.42 (3H, s, CaromCH3), 2.77 (1H, 
d , J = 9.4 Hz, NCH), 4.72 (1H, d, J = 9.4 Hz, CHO), 5.08 (1H, d, J = 
12.1 Hz, OCH(H)), 5.33 (1H, d, J = 12.1 Hz, OCH(H)), 7.26-7.37 (7H, 
m, CHarom), 7.65 (2H, d, J = 8.3 Hz, 2xCHarom). 
13
C NMR (75 MHz, 
CDCl3): δ 20.5 (CCH3(CH3)), 21.5 (CaromCH3), 23.1 (CCH3(CH3)), 27.6 (OC(CH3)3), 44.4 
(NCH), 49.1 (C(CH3)2), 67.5 (OCH2Ph), 74.0 (CHO), 83.2 (OC(CH3)3), 125.4 (2xCHarom), 
128.47 (2xCHarom), 128.53 (CHarom), 128.6 (2xCHarom), 129.5 (2xCHarom), 134.9 (Carom), 141.6 
(Carom), 142.0 (Carom), 152.5 (O(C=O)O), 167.7 (CHCOO). MS (ES
+
): m/z (%): 474 (M+H
+
, 
100). HRMS (ES) calcd for C25H31NO6S: 474.1945 MH
+
; found: 474.1934. 
 
(SS,2S,2’R)-Ethyl 2-(tert-butoxycarbonyloxy)-2-(3,3-dimethyl-1-p-toluenesulfinyl-
aziridin-2-yl)acetate 367c. Rf = 0.33 (petroleum ether/EtOAc: 3/1). 
Yellow oil, yield 82% (0.50 g). [α]D +18.0 (c 2.8, CHCl3). IR (cm
-1
): 
1045, 1241, 1737. 
1
H NMR (300 MHz, CDCl3): δ 1.28 (3H, t, J = 7.2 
Hz, OCH2CH3), 1.34 (3H, s, CCH3(CH3)), 1.46 (3H, s, CCH3(CH3)), 
1.48 (9H, s, OC(CH3)3), 2.43 (3H, s, CaromCH3), 2.81 (1H, d , J = 9.4 Hz, 
NCH), 4.11-4.35 (2H, m, OCH2CH3), 4.70 (1H, d, J = 9.4 Hz, CHO), 
7.31 (2H, d, J = 8.3 Hz, 2xCHarom), 7.67 (2H, d, J = 8.3 Hz, 2xCHarom). 
13
C NMR (75 MHz, 
ref = CDCl3): δ 14.1 (OCH2CH3), 20.7 (CCH3(CH3)), 21.6 (CaromCH3), 23.2 (CCH3(CH3)), 
27.7 (OC(CH3)3), 44.4 (NCH), 49.2 (C(CH3)2), 61.9 (OCH2CH3), 74.1 (CHO), 83.2 
(OC(CH3)3), 125.5 (2xCHarom), 129.6 (2xCHarom), 141.6 (Carom), 142.2 (Carom), 152.6 
(O(C=O)O), 167.8 (CHCOO). MS (ES
+
): m/z (%): 412 (M+H
+
, 100). HRMS (ES) calcd for 
C20H29NO6S: 412.1788 MH
+
; found: 412.1781. 
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6. Summary 
Nucleophilic ring opening of N-protected aziridines is one of the few known methods for 
providing access to a protected chiral aminoethyl unit in organic chemistry. The interest in N-
sulfinylaziridines as new chiral building blocks for introducing a chiral aminoethyl-unit in a 
regio- and stereoselective manner increased significantly in recent years and this is mainly 
due to the ubiquity of the aminoethyl function in a wide range of natural products and N-
containing drugs. Therefore, new N-sulfinylaziridines were synthesized starting from 
Mannich-type additions of various enolates across chiral N-sulfinyl-α-chloroimines. The 
application of this methodology with various substrates also provided access to new α,β-
diamino carboxylic acid derivatives, α,β-diaminoacylpyrrolidines and -piperidines, α,β,γ-
triamino carboxylic amides, an α-chloro-β,γ-diamino imidate and γ-chloro-α-hydroxy-β-
amino esters. Next to synthetic applications as building blocks in organic chemistry, these 
compounds had also a potential as bioactive molecules.  
In this PhD thesis, the synthesis and reactivity of N-sulfinyl-α-functionalized aldimines in 
stereoselective Mannich-type additions has been investigated. These N-sulfinyl-α-
functionalized aldimines showed great potential in the asymmetric synthesis of a variety of 
new chiral chemically and biologically important compounds such as N-sulfinylaziridines. 
First, new chiral N-(p-toluenesulfinyl)-α-chloroaldimines (SS)-iia-d and N-(p-toluenesulfinyl)-
α,α-dichloroaldimines (SS)-iiia-d were synthesized in good to excellent yield via condensation 
of the corresponding α-chloro-aldehydes iva-d or α,α-dichloroaldehydes va-d, respectively, 
with (SS)-p-toluenesulfinamide i in the presence of a Lewis acid (Scheme 129).  
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Scheme 129 
In addition, chiral N-(tert-butanesulfinyl)-α-chloroaldimines (SS)-via and (RS)-via-b, and N-
(tert-butanesulfinyl)-α-N-Boc-aminoaldimines (SS)-vii and (RS)-vii were also synthesized 
starting from the corresponding α-chloroaldehydes iva-b and α-N-Boc-aminoaldehyde viii 
and (RS)- or (SS)-tert-butanesulfinamide (SS)-ix and (RS)-ix, again in the presence of a Lewis 
acid (Scheme 130).  
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Scheme 130 
In a second part of this work, the asymmetric synthesis of new protected syn- and anti-γ-
chloro-α,β-diamino esters x was elaborated via stereoselective Mannich-type additions of N-
(diphenylmethylene)glycine esters xia-c across N-p-toluenesulfinyl-α-chloroimine (SS)-iia 
(Scheme 131). The influence of the base used for deprotonation of the glycine esters xi was 
crucial for the diastereoselectivity of the Mannich-type reaction, with LDA leading selectively 
to anti-diastereomers anti-x, whereas LiHMDS gave exclusively syn-diastereomers syn-x. 
Both the syn- and anti-addition products syn-x and anti-x, were in a next step cyclized to the 
corresponding N-sulfinylaziridines xii upon treatment with K2CO3 (73-99% yield). 
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Scheme 131 
The chiral γ-chloro-α,β-diamino esters x have shown to be useful building blocks in 
asymmetric synthesis as demonstrated by several selective transformations.  
Reduction of the N-diphenylmethylene group of anti-N-sulfinylaziridine anti-xiib by means 
of NaCNBH3 resulted in the formation of aziridine anti-xiii with a nucleophilic α-amino 
function (68% yield) (Scheme 132). Several attempts were made to achieve ring 
transformation of N-sulfinylaziridine anti-xiii into trans-3-aminoazetidine-2-carboxylate xiv, 
but only formation of the 3-amino-1,5-dihydropyrrol-2-one xv was observed upon treatment 
with various bases (45-98% yield).  
Chapter 6     Summary 
 
213 
 
anti-xiib
(dr > 99:1)
(R)
N
S
(S)O
(S)
N
H
Ph
Ph
OEt
O
p-Tol
(R)
N
S
(S)O
(S)
HN
H
Ph
Ph
OEt
O
anti-xiii 
(68%, dr > 99:1)
p-Tol
xv (45-98%)
N (S)
(R)
Ph
Ph
COOEt
NH
S
(S)O p-Tol
xAcOH
NaCNBH3
xiv
H
N O
HN
Base
Ph
Ph
MeOH, rt, 6 h
 
Scheme 132 
In order to synthesize the trans-3-aminoazetidine-2-carboxylate derivatives, the p-
toluenesulfinyl group of aziridine anti-xiib was oxidized with mCPBA to the corresponding 
tosyl group, which has a stronger electron-withdrawing character (Scheme 133). The resulting 
N-tosylaziridine anti-xvi was reduced by treatment with NaCNBH3, and the reduced product 
xvii underwent a microwave-induced ring transformation into the desired trans-3-
aminoazetidine-2-carboxylate xviii, which was subjected to several deprotection steps. In a 
first reaction, azetidine-2-carboxylate xviii was treated with NaOH (aq.) resulting in the 
formation of the corresponding carboxylic acid xix (69% yield). Hydrogenolysis of the N-
(diphenylmethyl)amino group in the presence of Pd(OH)2/C afforded azetidine xx in 92% 
yield. This hydrogenolysis procedure was also directly applied on the ethyl ester xviii, leading 
to ethyl 3-(N-tosylamino)azetidine-2-carboxylate xxi in 87% yield. 
As direct deprotection of the N-tosyl group of azetidine xviii was not successful, N-
benzylation of azetidine xviii with benzyl bromide, prior to the N-tosyl deprotection, was 
performed. Treatment of the resulting N-benzylazetidine xxii with magnesium metal resulted 
in the formation of the detosylated azetidine xxiii, via precipitation as the corresponding 
oxalate salt. 
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Scheme 133 
In addition, the syn-N-sulfinylaziridine syn-xiib was transformed into trans-α,β-diamino-γ-
butyrolactone xxiv in almost quantitative yield, via an acid-promoted ring transformation 
involving intramolecular O-alkylation (Scheme 134).  
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Scheme 134 
The synthesis of the analogous enantiopure syn- and anti-γ-chloro-β-N-tert-
butanesulfinylamino-α-amino esters xxv was also demonstrated via stereoselective Mannich-
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type reactions of the ethyl N-(diphenylmethylene)glycine ester xib across chiral N-tert-
butanesulfinyl-α-chloroimine (RS)-via (Scheme 135). The base used for the deprotonation of 
the glycine ester xib had again a great influence on the diastereoselectivity of the Mannich-
type reaction, with LDA leading selectively to anti-diastereomers anti-xxv, whereas the use of 
LiHMDS led to syn-diastereomers syn-xxv. This addition reaction proceeded in lower yields, 
caused by the low conversions of the chiral N-tert-butanesulfinyl-α-chloroimine (RS)-via, 
which was probably due to retro-Mannich-type addition. Noteworthy, the syn-γ-chloro-α,β-
diamino ester xxv was selectively transformed into a new anti-β,γ-aziridino-α-amino ester 
xxvi upon base-induced cyclization with K2CO3. 
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Scheme 135 
Given the fact that α,γ-diamino carboxylic amides, as well as β-amino carboxylic amides, are 
known for their activity as dipeptidyl peptidase inhibitors, novel α,β-diamino carboxylic 
amides have been synthesized. Asymmetric Mannich-type addition of N-
(diphenylmethylene)glycine amides xxviia-b across chiral N-p-toluenesulfinyl-α-
Chapter 6     Summary 
 
216 
 
chloroaldimines (SS)-iia-c and N-p-toluenesulfinyl-α,α-dichloroaldimines (SS)-iiia-d resulted 
in the formation of chiral syn-γ-chloro-α,β-diamino carboxylic amides xxviiia-f and syn-γ,γ-
dichloro-α,β-diamino carboxylic amides xxixa-h in acceptable to good yields and with 
excellent diastereomeric ratios (Scheme 136). Notably, a very high syn-diastereoselectivity 
was obtained in the synthesis of these (SS,2S,3S)-γ-chlorinated-α,β-diamino carboxylic amides 
xxviiia-f and xxixa-h, with the opposite enantiotopic face selectivity as compared to the 
Mannich-type additions of N-(diphenylmethylene)glycine esters xia-b across chiral N-p-
toluenesulfinyl-α-chloroaldimine (SS)-iia. The synthesized γ-chloro-α,β-diamino carboxylic 
amides xxviiia-f underwent again a base-promoted ring-closure reaction to the corresponding 
aziridines xxxa-f. In addition, γ-chloro-α,β-diamino carboxylic amides xxviiia-d,f and γ,γ-
dichloro-α,β-diamino carboxylic amide xxixa were selectively Nα-deprotected under acidic 
conditions and the resulting α,β-diaminoacylpiperidine xxxib could be ring closed to the 
corresponding N
α
-deprotected aziridine xxxiib. 
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Scheme 136 
Furthermore, a first small library of diamino amide derivatives xxxa-b and xxxia-b was 
screened for their FAP and DPP inhibitory activity. These biotesting results showed that only 
the deprotected α-amino pyrrolidine amide 45a had some selectivity for DPP2 and that 
presence of the diphenylmethyleneamino moiety lowers the affinity for the enzymes. 
In analogy, it was demonstrated that new chiral α,β,γ-triamino carboxylic amides (SS)-xxxiiia-
b and (RS)-xxxiiia-b could be synthesized in moderate to good yields and excellent 
diastereomeric ratios via stereoselective Mannich-type reactions of N-
(diphenylmethylene)glycine amides xxviia-b across chiral N-tert-butanesulfinyl-α-N-Boc-
aminoacetaldimines (SS)-vii and (RS)-vii (Scheme 137). Notably, a very high syn-
diastereoselectivity was again obtained in the synthesis of these compounds xxxiii, which 
were formed via the same transition state model as the previously described (SS,2S,3S)-γ-
chlorinated-α,β-diamino carboxylic amides xviiia-f and xxixa-h. The synthesized α,β,γ-
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triamino carboxylic amides (SS)-xxxiiia and (RS)-xxxiiib were selectively N
α
-deprotected 
under acidic conditions (aq. TFA), and the resulting α,β,γ-triaminoacylpyrrolidines and -
piperidines (SS)-xxxiva and (RS)-xxxivb could have a potential applicability as dipeptidyl 
peptidase inhibitors or as fibroblast activation protein inhibitors. In addition, also the fully 
deprotected α,β,γ-triaminoacylpiperidine xxxvb was obtained by treatment of compound (RS)-
xxxiiib with an aqueous HCl-solution. 
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Scheme 137 
The synthesis of the chiral α-chloro-β,γ-diamino imidate xxxvi has also been performed in 
high yield and excellent diastereoselectivity via a stereoselective Mannich-type reaction of an 
α-chloro-N-tert-butanesulfinyl imidate (RS)-xxxvii across the chiral N-tert-butanesulfinyl-α-
N-Boc-aminoacetaldimine (RS)-vii (Scheme 138). Unfortunately, the absolute stereochemistry 
of this compound xxxvi could not be determined and further efforts are required to use this 
compound xxxvi as a potential building block in heterocyclic chemistry. 
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Scheme 138 
The synthesis of non-proteinogenic α-hydroxy-β-amino acids has attracted much attention, as 
these compounds provide access to new drug candidates and act as valuable biological probes. 
Therefore, the efficient and stereoselective synthesis of new (RS,2R,3R)-γ-chloro-α-hydroxy-
β-amino esters xxxviiia-c, via stereoselective Mannich-type reactions of O-Boc glycolic 
esters xxxixa-c across chiral N-(tert-butanesulfinyl)-α-chloroaldimine (RS)-via was elaborated 
(Scheme 139). Furthermore, the γ-chloro-α-hydroxy-β-amino esters xxxviiia-c proved to be 
useful building blocks in asymmetric synthesis of novel syn-β,γ-aziridino-α-hydroxy esters 
xla-c via a base-induced cyclization. Next, the synthesized γ-chloro-α-hydroxy-β-amino esters 
xxxviiia-c were selectively O
α
-deprotected by treatment with TFA, affording α-hydroxy esters 
xlia-c in high yields. The selective cleavage of the N
β
-tert-butanesulfinyl group was 
performed as well by treatment with HCl, resulting in the formation of hydrochloric acid salts 
xliia-c. In addition, also the fully deprotected γ-chloro-α-hydroxy-β-amino esters xliiia-c were 
obtained by treatment of compounds xliia-c with TFA. Treatment of the fully deprotected γ-
chloro-α-hydroxy-β-amino esters xliiia-c with triphosgene afforded finally the corresponding 
trans-oxazolidinone carboxylic esters xliva-c. 
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Scheme 139 
The synthesis of the enantiopure (SS,2S,3S)-γ-chloro-α-hydroxy-β-amino esters xlva-c has 
also been performed by Mannich-type reactions of O-Boc glycolic esters xxxixa-c across 
chiral N-p-toluenesulfinyl-α-chloroaldimine (SS)-iia (Scheme 140). Treatment of these 
compounds xlva-c with K2CO3 afforded the corresponding N-p-toluenesulfinylaziridines 
xlvia-c. 
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Scheme 140 
In conclusion, this research showed that the use of N-p-toluenesulfinyl- and N-tert-
butanesulfinyl-α-functionalized aldimines has great potential in the development of very 
straightforward and enantioselective syntheses of a large variety of biologically important 
molecules via Mannich-type additions. 
The significance of the developed methodologies was acknowledged by the (novel) 
asymmetric synthesis of syn- and anti-γ-chloro-α,β-diamino esters, syn- and anti-β,γ-
aziridino-α-amino esters, trans-3-aminoazetidine-2-carboxylates, a trans-α,β-diamino-γ-
butyrolactone, syn-γ-chloro-α,β-diamino carboxylic amides, syn-γ,γ-dichloro-α,β-diamino 
carboxylic amides, syn-β,γ-aziridino-α-amino carboxylic amides, syn-α,β,γ-triamino 
carboxylic amides, a α-chloro-β,γ-diamino imidate, syn-γ-chloro-α-hydroxy-β-amino esters, 
syn-β,γ-aziridino-α-hydroxy esters and trans-oxazolidinone carboxylic esters. 
The newly established synthetic approaches in this PhD thesis provide further great potential 
in the straightforward syntheses of various (biologically) interesting compounds. 
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7. Samenvatting 
De nucleofiele ringopening van N-beschermde aziridinen staat bekend als één van de weinige 
methoden voor het leveren van een beschermde chirale aminoëthyl-eenheid in de organische 
chemie. De interesse in N-sulfinylaziridinen als nieuwe chirale bouwstenen voor het 
produceren van een chirale aminoëthyl-eenheid op een regio- en stereoselectieve manier, is de 
voorbije jaren significant toegenomen, hetgeen hoofdzakelijk te wijten is aan de 
alomtegenwoordigheid van de aminoëthyl-eenheid in een grote waaier aan natuurproducten 
en N-bevattende geneesmiddelen. Om aan deze vraag te kunnen beantwoorden, zullen nieuwe 
N-sulfinylaziridinen worden gesynthetiseerd startende van een Mannich-type additie van 
verscheidene enolaten aan chirale N-sulfinyl-α-gechloreerde iminen. Het toepassen van deze 
methodologie met verschillende substraten biedt ook de mogelijkheid voor de synthese van 
nieuwe α,β-diaminocarbonzuurderivaten, α,β-diaminoacylpyrrolidinen en -piperidinen, α,β,γ-
triaminoamiden, een α-chloor-β,γ-diamino-imidaat en γ-chloor-α-hydroxy-β-amino-esters. 
Deze verbindingen hebben naast hun synthetische toepassingen als bouwsteen in de 
organische chemie, ook potentieel als bioactieve verbindingen.  
In deze doctoraatsthesis zal de synthese en reactiviteit van N-sulfinyl-α-gefunctionaliseerde 
aldiminen in stereoselectieve Mannich-type addities worden onderzocht. Deze N-sulfinyl-α-
gefunctionaliseerde aldiminen vertoonden een groot potentieel in de asymmetrische synthese 
van een grote waaier van nieuwe chirale, chemisch en biologisch belangrijke verbindingen 
zoals N-sulfinylaziridinen. Eerst werden nieuwe chirale N-(p-tolylsulfinyl)-α-chlooraldiminen 
(SS)-iia-d en N-(p-tolylsulfinyl)-α,α-dichlooraldiminen (SS)-iiia-d gesynthetiseerd in goede tot 
uitstekende rendementen via condensatie van respectievelijk de overeenkomstige α-
chlooraldehyden iva-d of α,α-dichlooraldehyden va-d met (SS)-p-tolylsulfinamide i in de 
aanwezigheid van een Lewiszuur (Schema 129).  
Chapter 7   Samenvatting 
 
224 
 
2 equiv Ti(OEt)4
     
1 equiv H
Cl
Cl
O
R
H
Cl
N
S
(S)
p-Tol
Cl
R
O
H2N
S
(S)
O
p-Tol
va (R = Me)
vb (R = Et)
vc (R = nPr)
vd (R = iPr)
ivd
3 equiv CuSO4
1 equiv
H
O
H
N
S
(S)
O
Cl
p-Tol
Cl
(SS)-iid (96%)
(SS)-i
(ee > 98%) (SS)-iiia-d
(40-59%)
2 equiv Ti(OEt)4
     
1 equiv H
R
Cl
O
R
H
Cl
N
S
(S)
p-Tol
R
R
O
iva (R = Me)
ivb (R = Et)
ivc (R,R = (CH2)5)
(SS)-iia-c
(30-92%)
CH2Cl2, kt, 18 h, N2 CH2Cl2, kt, 18 h, N2
CH2Cl2, kt, 14 h, N2
 
Schema 129 
Vervolgens werden de chirale N-(tert-butylsulfinyl)-α-chlooraldiminen (SS)-via en (RS)-via-b, 
en N-(tert-butylsulfinyl)-α-N-Boc-aminoaldiminen (SS)-vii en (RS)-vii gesynthetiseerd 
uitgaande van de overeenkomstige α-chlooraldehyden iva-b en α-N-Boc-aminoaldehyde viii 
en (RS)- of (SS)-tert-butylsulfinamide (SS)-ix en (RS)-ix, opnieuw in de aanwezigheid van een 
Lewiszuur (Schema 130).  
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Schema 130 
In het tweede deel van dit werk werd de asymmetrische synthese van nieuwe beschermde syn- 
en anti-γ-chloor-α,β-diamino-esters x beschreven, via stereoselectieve Mannich-type addities 
van N-(difenylmethyleen)glycine-esters xia-c aan N-p-tolylsulfinyl-α-chloorimine (SS)-iia 
(Schema 131). De invloed van de gebruikte base bij deprotonering van de glycine-esters xi 
was van cruciaal belang voor de diastereoselectiviteit van de Mannich-type reactie, waarbij 
LDA selectief aanleiding gaf tot anti-diastereomeren anti-x, en LiHMDS exclusief leidde tot 
syn-diastereomeren syn-x. Zowel de syn- als anti-additieproducten syn-x en anti-x werden in 
een volgende stap gecycliseerd tot de overeenkomstige N-sulfinylaziridinen xii door 
behandeling met K2CO3 (73-99% rendement). 
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Schema 131 
De chirale γ-chloor-α,β-diamino-esters x bleken tevens in asymmetrische synthese nuttige 
bouwstenen te zijn, zoals gedemonstreerd werd via enkele selectieve transformaties.  
Reductie van de N-difenylmethyleengroep van anti-N-sulfinylaziridine anti-xiib door middel 
van NaCNBH3, resulteerde in de vorming van aziridine anti-xiii met een nucleofiele α-
aminogroep (68% rendement) (Schema 132). Verschillende pogingen werden ondernomen 
om het N-sulfinylaziridine anti-xiii een ringtransformatie te laten ondergaan tot het 
overeenkomstige trans-3-aminoazetidine-2-carboxylaat xiv, maar deze pogingen leidden 
slechts tot de vorming van het 3-amino-1,5-dihydropyrrool-2-on xv via behandeling met 
verschillende basen (45-98% rendement).  
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Schema 132 
Om de beoogde trans-3-aminoazetidine-2-carbonzuurderivaten te synthetiseren, werd de p-
tolylsulfinylgroep van aziridine anti-xiib geoxideerd met mCPBA tot de overeenkomstige 
tosylgroep, dewelke een sterker elektronenzuigend karakter heeft (Schema 133). Vervolgens 
werd het resulterende N-tosylaziridine anti-xvi gereduceerd door behandeling met NaCNBH3, 
en dit gereduceerde product xvii onderging een microgolf-geïnduceerde ringtransformatie tot 
het gewenste trans-3-aminoazetidine-2-carbonzuurderivaat xviii, dat onderworpen werd aan 
verscheidene ontschermingsreacties. In een eerste reactie werd het azetidine-2-carboxylaat 
xviii met NaOH (aq.) omgezet tot het overeenkomstige carbonzuur xix (69% rendement). 
Hydrogenolyse van de N-(difenylmethyl)aminogroep van dit carbonzuur xix in de 
aanwezigheid van Pd(OH)2/C leverde het azetidine xx op in 92% rendement. Deze 
hydrogenolyseprocedure kon tevens direct toegepast worden op ethylester xviii, wat ethyl-3-
(N-tosylamino)azetidine-2-carboxylaat xxi opleverde in 87% rendement. 
Omdat directe ontscherming van de N-tosylgroep van azetidine xviii niet succesvol was, werd 
een N-benzylering van azetidine xviii met benzylbromide uitgevoerd, voorafgaand aan de N-
tosyl ontscherming. Behandeling van het resulterende N-benzylazetidine xxii met magnesium 
metaal gaf aanleiding tot het gedetosyleerde azetidine xxiii, via precipitatie van het 
overeenkomstige oxalaat. 
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Schema 133 
Het syn-N-sulfinylaziridine syn-xiib kon door middel van een zuurgekatalyseerde 
ringtransformatie via een intramoleculaire O-alkylering tevens omgezet worden tot het trans-
α,β-diamino-γ-butyrolacton xxiv in een bijna kwantitatief rendement (Schema 134).  
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Schema 134 
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De synthese van de analoge enantiomeer zuivere syn- en anti-γ-chloor-β-N-tert-
butylsulfinylamino-α-amino-esters xxv was eveneens mogelijk via een stereoselectieve 
Mannich-type additie van ethyl-N-(difenylmethyleen)glycine-ester xib aan chiraal N-tert-
butylsulfinyl-α-chloorimine (RS)-via (Schema 135). De gebruikte base bij deprotonering van 
het glycine-ester xib had opnieuw een grote invloed op de diastereoselectiviteit van de 
Mannich-type reactie, waarbij LDA selectief leidde tot anti-diastereomeren anti-xxv, en 
LiHMDS aanleiding gaf tot syn-diastereomeren syn-xxv. Deze additie reactie verliep in lagere 
rendementen, wat veroorzaakt werd door de lage conversie van het chiraal N-tert-
butylsulfinyl-α-chloorimine (RS)-via, omdat er waarschijnlijk een retro-Mannich-type additie 
optrad. Het syn-γ-chloor-α,β-diamino-ester xxv kon opmerkelijk genoeg, selectief in een 
nieuw anti-β,γ-aziridino-α-amino-ester xxvi getransformeerd worden via een base-
geïnduceerde cyclizatie met K2CO3. 
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Schema 135 
Chapter 7   Samenvatting 
 
230 
 
Gezien het feit dat zowel α,γ-diaminoamiden als β-aminoamiden gekend zijn om hun 
activiteit als dipeptidyl peptidase inhibitoren, werden tevens nieuwe α,β-diaminoamiden 
gesynthetiseerd. Asymmetrische Mannich-type additie van N-
(difenylmethyleen)glycinamiden xxviia-b aan chirale N-p-tolylsulfinyl-α-chlooraldiminen 
(SS)-iia-c en N-p-tolylsulfinyl-α,α-dichlooraldiminen (SS)-iiia-d resulteerde in de vorming van 
chirale syn-γ-chloor-α,β-diaminoamiden xxviiia-f en syn-γ,γ-dichloor-α,β-diaminoamiden 
xxixa-h in matige tot goede rendementen en in uitstekende diastereomere verhoudingen 
(Schema 136). Er werd tevens een hoge syn-diastereoselectiviteit verkregen bij de synthese 
van deze (SS,2S,3S)-γ-gechloreerde-α,β-diaminoamiden xxviiia-f en xxixa-h, dewelke een 
tegenovergestelde enantioselectiviteit bekomen werden in vergelijking met de Mannich-type 
addities van N-(difenylmethyleen)glycine-esters xia-b aan het chiraal N-p-tolylsulfinyl-α-
chlooraldimine (SS)-iia. De gesynthetiseerde γ-chloor-α,β-diaminoamiden xxviiia-f 
ondergingen vervolgens een base-geïnduceerde ringsluitingsreactie tot de overeenkomstige 
aziridinen xxxa-f. Bovendien konden de γ-chloor-α,β-diaminoamiden xxviiia-d,f en het γ,γ-
dichloor-α,β-diaminoamide xxixa selectief Nα-ontschermd worden door een zure behandeling 
en het resulterende α,β-diaminoacylpiperidine xxxib kon vervolgens gecycliseerd worden tot 
het overeenkomstige N
α
-ontschermde aziridine xxxiib.  
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Schema 136 
Er werd tevens een kleine bibliotheek aan diaminoamidederivaten xxxa-b en xxxia-b getest 
op hun potentiële FAP en DPP inhibitoractiviteit. Dese biotesting resultaten toonden aan dat 
enkel het ontschermde α-aminopyrrolidine 45a enige selectiviteit had voor de DPP2-receptor 
en dat de aanwezigheid van de difenylmethyleenaminogroep de affiniteit voor de enzymen 
sterk verlaagde. 
In analogie werd er aangetoond dat nieuwe chirale α,β,γ-triaminoamiden (SS)-xxxiiia-b en 
(RS)-xxxiiia-b gesynthetiseerd konden worden in matige tot goede rendementen en 
uitstekende diastereomere verhoudingen via stereoselectieve Mannich-type reacties van N-
(difenylmethyleen)-glycinamiden xxviia-b aan chirale N-tert-butylsulfinyl-α-N-Boc-
aminoacetaldiminen (SS)-vii en (RS)-vii (Schema 137). Er werd opnieuw een zeer hoge syn-
diastereoselectiviteit bekomen bij de synthese van deze verbindingen xxxiii, dewelke werden 
gevormd via eenzelfde transitietoestandsmodel als de eerder beschreven (SS,2S,3S)-γ-
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gechloreerde-α,β-diaminoamiden xviiia-f en xxixa-h. De gesynthetiseerde α,β,γ-
triaminoamiden (SS)-xxxiiia en (RS)-xxxiiib werden selectief N
α
-ontschermd onder zure 
reactie condities (aq. TFA), en de resulterende α,β,γ-triaminoacylpyrrolidinen en -piperidinen 
(SS)-xxxiva en (RS)-xxxivb konden een potentiële toepassing vinden als dipeptidyl-peptidase-
inhibitoren of als fibroblast activerende proteïne inhibitoren. Bovendien kon ook het volledig 
ontschermde α,β,γ-triaminoacylpiperidine xxxvb bekomen worden door behandeling van 
verbinding (RS)-xxxiiib met een waterige HCl-oplossing. 
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Schema 137 
De synthese van het chirale α-chloor-β,γ-diamino-imidaat xxxvi werd tevens uitgevoerd in 
hoog rendement en met een uitstekende diastereoselectiviteit via een stereoselectieve 
Mannich-type reactie van het α-chloor-N-tert-butylsulfinyl imidaat (RS)-xxxvii aan het chirale 
N-tert-butylsulfinyl-α-N-Boc-aminoacetaldimine (RS)-vii (Schema 138). Helaas kon de 
absolute stereochemie van deze verbinding xxxvi niet bepaald worden en is er verder 
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onderzoek nodig om deze verbinding xxxvi als een potentiële bouwsteen in de 
heterocyclische chemie te gebruiken. 
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Schema 138 
De voorbije jaren heeft de synthese van niet-proteïnogene α-hydroxy-β-aminozuren veel 
aandacht gekregen omdat deze verbindingen gebruikt kunnen worden bij de ontwikkeling van 
nieuwe geneesmiddelen en omdat het waardevolle biologische verbindingen zijn. Daarom 
werd de efficiënte en stereoselectieve synthese van nieuwe (RS,2R,3R)-γ-chloor-α-hydroxy-β-
amino-esters xxxviiia-c, via een stereoselectieve Mannich-type reactie van O-Boc glycol-
esters xxxixa-c aan het chirale N-(tert-butylsulfinyl)-α-chlooraldimine (RS)-via uitgewerkt 
(Schema 139). Bovendien kunnen deze γ-chloor-α-hydroxy-β-amino-esters xxxviiia-c 
gebruikt worden als bouwstenen in de asymmetrische synthese van nieuwe syn-β,γ-aziridino-
α-hydroxy-esters xla-c via een base-geïnduceerde cyclizatie. De gesynthetiseerde γ-chloor-α-
hydroxy-β-amino-esters xxxviiia-c werden tevens selectief Oα-ontschermd door behandeling 
met TFA, hetgeen α-hydroxy-esters xlia-c in hoge rendementen opleverde. De selectieve 
ontscherming van de N
β
-tert-butylsulfinylgroep werd uitgevoerd door behandeling met HCl, 
en resulteerde in de vorming van HCl-zouten xliia-c. Tevens werden de volledig ontschermde 
γ-chloor-α-hydroxy-β-amino-esters xliiia-c bekomen door behandeling van verbindingen 
xliia-c met TFA. Behandeling van deze volledig ontschermde γ-chloor-α-hydroxy-β-amino-
esters xliiia-c met trifosgeen leverde uiteindelijk de overeenkomstige trans-oxazolidinon-
esters xliva-c op. 
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Schema 139 
De synthese van de enantiomeer zuivere (SS,2S,3S)-γ-chloor-α-hydroxy-β-amino-esters xlva-c 
werd tevens uitgevoerd via Mannich-type reacties van O-Boc glycolesters xxxixa-c aan 
chiraal N-p-tolylsulfinyl-α-chlooraldimine (SS)-iia (Schema 140). Behandeling van deze 
verbindingen xlva-c met K2CO3 resulteerde in de vorming van de overeenkomstige N-p-
tolylsulfinylaziridinen xlvia-c. 
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Schema 140 
 
Samenvattend kan gesteld worden dat in de loop van dit onderzoek is aangetoond dat het 
gebruik van N-p-tolylsulfinyl- en N-tert-butylsulfinyl-α-gefunctionaliseerde aldiminen, een 
groot potentieel heeft in de ontwikkeling van efficiënte en enantioselectieve synthesen van 
een hele waaier aan verbindingen van biologisch belang via Mannich-type addities. 
De mogelijkheden van de ontwikkelde methoden werd aangetoond door de (nieuwe) 
asymmetrische synthese van syn- en anti-γ-chloor-α,β-diamino esters, syn- en anti-β,γ-
aziridino-α-amino esters, trans-3-aminoazetidine-2-carboxylaten, een trans-α,β-diamino-γ-
butyrolacton, syn-γ-chloor-α,β-diamino amiden, syn-γ,γ-dichloor-α,β-diamino amiden, syn-
β,γ-aziridino-α-amino amiden, syn-α,β,γ-triamino amiden, een α-chloor-β,γ-diamino imidaat, 
syn-γ-chloor-α-hydroxy-β-amino esters, syn-β,γ-aziridino-α-hydroxy esters en trans-
oxazolidinon carbonzuur derivaten. 
Naast de ontwikkelde methoden hebben andere reacties in dit domein eveneens een groot 
potentieel en is er nog een groot scala aan verdere toepassingen mogelijk. 
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